{"idB": "1095981_12_item1a_p13_s2", "idA": "1095981_11_item1a_p23_s1", "sentA": "With respect to our Joint Venture, although Olympus is a highly capable and experienced manufacturer of medical devices, there can be no guarantee that the Olympus-Cytori Joint Venture will be able to successfully develop and manufacture the next generation Celution System in a manner that is cost-effective or commercially viable, or that development and manufacturing capabilities might not take much longer than currently anticipated to be ready for the market.", "sentB": "If the Joint Venture is materially impacted by such changes in a manner that significantly disrupts our operations and commercialization efforts (clinical, regulatory and/or commercial sales), then our business could be harmed.", "type": 1, "words": ["<tag1>", "With", "respect", "to", "our", "Joint", "Venture,", "although", "Olympus", "is", "a", "highly", "capable", "and", "experienced", "manufacturer", "of", "medical", "devices,", "there", "can", "be", "no", "guarantee", "that", "the", "Olympus-Cytori", "Joint", "Venture", "will", "be", "able", "to", "successfully", "develop", "and", "manufacture", "the", "next", "generation", "Celution", "System", "in", "a", "manner", "that", "is", "cost-effective", "or", "commercially", "viable,", "or", "that", "development", "and", "manufacturing", "capabilities", "might", "not", "take", "much", "longer", "than", "currently", "anticipated", "to", "be", "ready", "for", "the", "market.", "<tag2>", "If", "the", "Joint", "Venture", "is", "materially", "impacted", "by", "such", "changes", "in", "a", "manner", "that", "significantly", "disrupts", "our", "operations", "and", "commercialization", "efforts", "(clinical,", "regulatory", "and/or", "commercial", "sales),", "then", "our", "business", "could", "be", "harmed.", "<tag3>"], "wordsA": ["With", "respect", "to", "our", "Joint", "Venture,", "although", "Olympus", "is", "a", "highly", "capable", "and", "experienced", "manufacturer", "of", "medical", "devices,", "there", "can", "be", "no", "guarantee", "that", "the", "Olympus-Cytori", "Joint", "Venture", "will", "be", "able", "to", "successfully", "develop", "and", "manufacture", "the", "next", "generation", "Celution", "System", "in", "a", "manner", "that", "is", "cost-effective", "or", "commercially", "viable,", "or", "that", "development", "and", "manufacturing", "capabilities", "might", "not", "take", "much", "longer", "than", "currently", "anticipated", "to", "be", "ready", "for", "the", "market."], "wordsB": ["If", "the", "Joint", "Venture", "is", "materially", "impacted", "by", "such", "changes", "in", "a", "manner", "that", "significantly", "disrupts", "our", "operations", "and", "commercialization", "efforts", "(clinical,", "regulatory", "and/or", "commercial", "sales),", "then", "our", "business", "could", "be", "harmed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item1a_p61_s2", "idA": "1095981_11_item1a_p24_s0", "sentA": "Although we have begun introduction of the Celution 800 and the StemSource 900-based Cell Bank in 2008, we cannot assure that we will be able to manufacture sufficient numbers of such products to meet the demand, or that we will be able to overcome unforeseen manufacturing difficulties for these sophisticated medical devices, as we await the availability of the Joint Venture next generation Celution System.", "sentB": "Although we have significant operations in Asia, a substantial portion of transactions are denominated in U.S. dollars.", "type": 1, "words": ["<tag1>", "Although", "we", "have", "begun", "introduction", "of", "the", "Celution", "800", "and", "the", "StemSource", "900-based", "Cell", "Bank", "in", "2008,", "we", "cannot", "assure", "that", "we", "will", "be", "able", "to", "manufacture", "sufficient", "numbers", "of", "such", "products", "to", "meet", "the", "demand,", "or", "that", "we", "will", "be", "able", "to", "overcome", "unforeseen", "manufacturing", "difficulties", "for", "these", "sophisticated", "medical", "devices,", "as", "we", "await", "the", "availability", "of", "the", "Joint", "Venture", "next", "generation", "Celution", "System.", "<tag2>", "Although", "we", "have", "significant", "operations", "in", "Asia,", "a", "substantial", "portion", "of", "transactions", "are", "denominated", "in", "U.S.", "dollars.", "<tag3>"], "wordsA": ["Although", "we", "have", "begun", "introduction", "of", "the", "Celution", "800", "and", "the", "StemSource", "900-based", "Cell", "Bank", "in", "2008,", "we", "cannot", "assure", "that", "we", "will", "be", "able", "to", "manufacture", "sufficient", "numbers", "of", "such", "products", "to", "meet", "the", "demand,", "or", "that", "we", "will", "be", "able", "to", "overcome", "unforeseen", "manufacturing", "difficulties", "for", "these", "sophisticated", "medical", "devices,", "as", "we", "await", "the", "availability", "of", "the", "Joint", "Venture", "next", "generation", "Celution", "System."], "wordsB": ["Although", "we", "have", "significant", "operations", "in", "Asia,", "a", "substantial", "portion", "of", "transactions", "are", "denominated", "in", "U.S.", "dollars."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item1a_p68_s1", "idA": "1095981_11_item1a_p2_s3", "sentA": "We do not currently believe that our cash balance and the revenues from our operations will be sufficient to fund the development and marketing efforts required to reach profitability without raising additional capital from accessible sources of financing in the future.", "sentB": "This could make an investment in our company inappropriate for some investors, and may serve to narrow our potential sources of additional capital.", "type": 1, "words": ["<tag1>", "We", "do", "not", "currently", "believe", "that", "our", "cash", "balance", "and", "the", "revenues", "from", "our", "operations", "will", "be", "sufficient", "to", "fund", "the", "development", "and", "marketing", "efforts", "required", "to", "reach", "profitability", "without", "raising", "additional", "capital", "from", "accessible", "sources", "of", "financing", "in", "the", "future.", "<tag2>", "This", "could", "make", "an", "investment", "in", "our", "company", "inappropriate", "for", "some", "investors,", "and", "may", "serve", "to", "narrow", "our", "potential", "sources", "of", "additional", "capital.", "<tag3>"], "wordsA": ["We", "do", "not", "currently", "believe", "that", "our", "cash", "balance", "and", "the", "revenues", "from", "our", "operations", "will", "be", "sufficient", "to", "fund", "the", "development", "and", "marketing", "efforts", "required", "to", "reach", "profitability", "without", "raising", "additional", "capital", "from", "accessible", "sources", "of", "financing", "in", "the", "future."], "wordsB": ["This", "could", "make", "an", "investment", "in", "our", "company", "inappropriate", "for", "some", "investors,", "and", "may", "serve", "to", "narrow", "our", "potential", "sources", "of", "additional", "capital."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item1a_p58_s2", "idA": "1095981_11_item1a_p32_s2", "sentA": "Furthermore, if such challenges to our patent rights are not resolved in our favor, we could be delayed or prevented from entering into new collaborations or from commercializing certain products, which could adversely affect our business and results of operations.", "sentB": "While we expect that the situation has stabilized and will improve, if it does not, these circumstances could be harmful to our business since the Celution One device is manufactured in Japan, and a substantial portion of our sales have come from Japan.", "type": 1, "words": ["<tag1>", "Furthermore,", "if", "such", "challenges", "to", "our", "patent", "rights", "are", "not", "resolved", "in", "our", "favor,", "we", "could", "be", "delayed", "or", "prevented", "from", "entering", "into", "new", "collaborations", "or", "from", "commercializing", "certain", "products,", "which", "could", "adversely", "affect", "our", "business", "and", "results", "of", "operations.", "<tag2>", "While", "we", "expect", "that", "the", "situation", "has", "stabilized", "and", "will", "improve,", "if", "it", "does", "not,", "these", "circumstances", "could", "be", "harmful", "to", "our", "business", "since", "the", "Celution", "One", "device", "is", "manufactured", "in", "Japan,", "and", "a", "substantial", "portion", "of", "our", "sales", "have", "come", "from", "Japan.", "<tag3>"], "wordsA": ["Furthermore,", "if", "such", "challenges", "to", "our", "patent", "rights", "are", "not", "resolved", "in", "our", "favor,", "we", "could", "be", "delayed", "or", "prevented", "from", "entering", "into", "new", "collaborations", "or", "from", "commercializing", "certain", "products,", "which", "could", "adversely", "affect", "our", "business", "and", "results", "of", "operations."], "wordsB": ["While", "we", "expect", "that", "the", "situation", "has", "stabilized", "and", "will", "improve,", "if", "it", "does", "not,", "these", "circumstances", "could", "be", "harmful", "to", "our", "business", "since", "the", "Celution", "One", "device", "is", "manufactured", "in", "Japan,", "and", "a", "substantial", "portion", "of", "our", "sales", "have", "come", "from", "Japan."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item1a_p59_s0", "idA": "1095981_11_item1a_p39_s2", "sentA": "It may be necessary or useful for us to participate in proceedings to determine the validity of our patents or our competitors patents that have been issued in countries other than the U.S.", "sentB": "Our global operations expose us to additional risk and uncertainties.", "type": 1, "words": ["<tag1>", "It", "may", "be", "necessary", "or", "useful", "for", "us", "to", "participate", "in", "proceedings", "to", "determine", "the", "validity", "of", "our", "patents", "or", "our", "competitors", "patents", "that", "have", "been", "issued", "in", "countries", "other", "than", "the", "U.S.", "<tag2>", "Our", "global", "operations", "expose", "us", "to", "additional", "risk", "and", "uncertainties.", "<tag3>"], "wordsA": ["It", "may", "be", "necessary", "or", "useful", "for", "us", "to", "participate", "in", "proceedings", "to", "determine", "the", "validity", "of", "our", "patents", "or", "our", "competitors", "patents", "that", "have", "been", "issued", "in", "countries", "other", "than", "the", "U.S."], "wordsB": ["Our", "global", "operations", "expose", "us", "to", "additional", "risk", "and", "uncertainties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item1a_p58_s0", "idA": "1095981_11_item1a_p49_s2", "sentA": "For example, we still have not obtained regulatory approval for our Thin Film products in Japan.", "sentB": "Recently, the earthquake, tsunami and subsequent problems affecting nuclear power plants in Japan have dramatically impacted Japan s manufacturing capacity and business activities.", "type": 1, "words": ["<tag1>", "For", "example,", "we", "still", "have", "not", "obtained", "regulatory", "approval", "for", "our", "Thin", "Film", "products", "in", "Japan.", "<tag2>", "Recently,", "the", "earthquake,", "tsunami", "and", "subsequent", "problems", "affecting", "nuclear", "power", "plants", "in", "Japan", "have", "dramatically", "impacted", "Japan", "s", "manufacturing", "capacity", "and", "business", "activities.", "<tag3>"], "wordsA": ["For", "example,", "we", "still", "have", "not", "obtained", "regulatory", "approval", "for", "our", "Thin", "Film", "products", "in", "Japan."], "wordsB": ["Recently,", "the", "earthquake,", "tsunami", "and", "subsequent", "problems", "affecting", "nuclear", "power", "plants", "in", "Japan", "have", "dramatically", "impacted", "Japan", "s", "manufacturing", "capacity", "and", "business", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_12_item1a_p13_s0", "idA": "1095981_11_item1a_p56_s1", "sentA": "As a result of this regional concentration of sales, changes in the regulatory environment in these countries, or any other countries in which we have a significant concentration of sales, could adversely impact our sales.", "sentB": "In 2011 Olympus experienced issues which have led to a significant change in the management structure at Olympus.", "type": 1, "words": ["<tag1>", "As", "a", "result", "of", "this", "regional", "concentration", "of", "sales,", "changes", "in", "the", "regulatory", "environment", "in", "these", "countries,", "or", "any", "other", "countries", "in", "which", "we", "have", "a", "significant", "concentration", "of", "sales,", "could", "adversely", "impact", "our", "sales.", "<tag2>", "In", "2011", "Olympus", "experienced", "issues", "which", "have", "led", "to", "a", "significant", "change", "in", "the", "management", "structure", "at", "Olympus.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "this", "regional", "concentration", "of", "sales,", "changes", "in", "the", "regulatory", "environment", "in", "these", "countries,", "or", "any", "other", "countries", "in", "which", "we", "have", "a", "significant", "concentration", "of", "sales,", "could", "adversely", "impact", "our", "sales."], "wordsB": ["In", "2011", "Olympus", "experienced", "issues", "which", "have", "led", "to", "a", "significant", "change", "in", "the", "management", "structure", "at", "Olympus."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p0_s2", "idA": "1095981_12_item1a_p14_s1", "sentA": "From time to time, we have tried to update our investors expectations as to our operating results by periodically announcing financial guidance.", "sentB": "We undertake no obligation to update any forward-looking statements.", "type": 1, "words": ["<tag1>", "From", "time", "to", "time,", "we", "have", "tried", "to", "update", "our", "investors", "expectations", "as", "to", "our", "operating", "results", "by", "periodically", "announcing", "financial", "guidance.", "<tag2>", "We", "undertake", "no", "obligation", "to", "update", "any", "forward-looking", "statements.", "<tag3>"], "wordsA": ["From", "time", "to", "time,", "we", "have", "tried", "to", "update", "our", "investors", "expectations", "as", "to", "our", "operating", "results", "by", "periodically", "announcing", "financial", "guidance."], "wordsB": ["We", "undertake", "no", "obligation", "to", "update", "any", "forward-looking", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p13_s2", "idA": "1095981_12_item1a_p16_s2", "sentA": "Finally, Olympus and our other partners might pursue parallel development of other technologies or products, which may result in a partner developing additional products competitive with ours.", "sentB": "In light of these events, we have been engaged in ongoing discussions with Olympus relating to the future of the joint venture relationship for some time and it now appears that these discussions may result in a mutual agreement to terminate the Olympus-Cytori, Inc. Joint Venture.", "type": 1, "words": ["<tag1>", "Finally,", "Olympus", "and", "our", "other", "partners", "might", "pursue", "parallel", "development", "of", "other", "technologies", "or", "products,", "which", "may", "result", "in", "a", "partner", "developing", "additional", "products", "competitive", "with", "ours.", "<tag2>", "In", "light", "of", "these", "events,", "we", "have", "been", "engaged", "in", "ongoing", "discussions", "with", "Olympus", "relating", "to", "the", "future", "of", "the", "joint", "venture", "relationship", "for", "some", "time", "and", "it", "now", "appears", "that", "these", "discussions", "may", "result", "in", "a", "mutual", "agreement", "to", "terminate", "the", "Olympus-Cytori,", "Inc.", "Joint", "Venture.", "<tag3>"], "wordsA": ["Finally,", "Olympus", "and", "our", "other", "partners", "might", "pursue", "parallel", "development", "of", "other", "technologies", "or", "products,", "which", "may", "result", "in", "a", "partner", "developing", "additional", "products", "competitive", "with", "ours."], "wordsB": ["In", "light", "of", "these", "events,", "we", "have", "been", "engaged", "in", "ongoing", "discussions", "with", "Olympus", "relating", "to", "the", "future", "of", "the", "joint", "venture", "relationship", "for", "some", "time", "and", "it", "now", "appears", "that", "these", "discussions", "may", "result", "in", "a", "mutual", "agreement", "to", "terminate", "the", "Olympus-Cytori,", "Inc.", "Joint", "Venture."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p4_s0", "idA": "1095981_12_item1a_p21_s2", "sentA": "Failure to successfully develop and market our products would have a substantial negative effect on our results of operations and financial condition.", "sentB": "During 2012, we expanded our commercialization activities while simultaneously pursuing available financing sources to support operations and growth.", "type": 1, "words": ["<tag1>", "Failure", "to", "successfully", "develop", "and", "market", "our", "products", "would", "have", "a", "substantial", "negative", "effect", "on", "our", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "During", "2012,", "we", "expanded", "our", "commercialization", "activities", "while", "simultaneously", "pursuing", "available", "financing", "sources", "to", "support", "operations", "and", "growth.", "<tag3>"], "wordsA": ["Failure", "to", "successfully", "develop", "and", "market", "our", "products", "would", "have", "a", "substantial", "negative", "effect", "on", "our", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["During", "2012,", "we", "expanded", "our", "commercialization", "activities", "while", "simultaneously", "pursuing", "available", "financing", "sources", "to", "support", "operations", "and", "growth."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p33_s0", "idA": "1095981_12_item1a_p23_s0", "sentA": "While we have proceeded incrementally with our clinical trials in an effort to gauge the risks of proceeding with larger and more expensive trials, we cannot guarantee that we will not experience negative results larger and much more expensive clinical trials than we have conducted to date, such as the new ADVANCE acute heart attack trial in Europe.", "sentB": "On September 16, 2011, President Obama signed into law major patent law reform known as the Leahy-Smith America Invents Act (AIA).", "type": 1, "words": ["<tag1>", "While", "we", "have", "proceeded", "incrementally", "with", "our", "clinical", "trials", "in", "an", "effort", "to", "gauge", "the", "risks", "of", "proceeding", "with", "larger", "and", "more", "expensive", "trials,", "we", "cannot", "guarantee", "that", "we", "will", "not", "experience", "negative", "results", "larger", "and", "much", "more", "expensive", "clinical", "trials", "than", "we", "have", "conducted", "to", "date,", "such", "as", "the", "new", "ADVANCE", "acute", "heart", "attack", "trial", "in", "Europe.", "<tag2>", "On", "September", "16,", "2011,", "President", "Obama", "signed", "into", "law", "major", "patent", "law", "reform", "known", "as", "the", "Leahy-Smith", "America", "Invents", "Act", "(AIA).", "<tag3>"], "wordsA": ["While", "we", "have", "proceeded", "incrementally", "with", "our", "clinical", "trials", "in", "an", "effort", "to", "gauge", "the", "risks", "of", "proceeding", "with", "larger", "and", "more", "expensive", "trials,", "we", "cannot", "guarantee", "that", "we", "will", "not", "experience", "negative", "results", "larger", "and", "much", "more", "expensive", "clinical", "trials", "than", "we", "have", "conducted", "to", "date,", "such", "as", "the", "new", "ADVANCE", "acute", "heart", "attack", "trial", "in", "Europe."], "wordsB": ["On", "September", "16,", "2011,", "President", "Obama", "signed", "into", "law", "major", "patent", "law", "reform", "known", "as", "the", "Leahy-Smith", "America", "Invents", "Act", "(AIA)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p83_s0", "idA": "1095981_12_item1a_p23_s2", "sentA": "These risks are increased by our reliance on third parties in the performance of many of the clinical trial functions, including the clinical investigators, hospitals, and other third party service providers.", "sentB": "limit who may call stockholder meetings.", "type": 1, "words": ["<tag1>", "These", "risks", "are", "increased", "by", "our", "reliance", "on", "third", "parties", "in", "the", "performance", "of", "many", "of", "the", "clinical", "trial", "functions,", "including", "the", "clinical", "investigators,", "hospitals,", "and", "other", "third", "party", "service", "providers.", "<tag2>", "limit", "who", "may", "call", "stockholder", "meetings.", "<tag3>"], "wordsA": ["These", "risks", "are", "increased", "by", "our", "reliance", "on", "third", "parties", "in", "the", "performance", "of", "many", "of", "the", "clinical", "trial", "functions,", "including", "the", "clinical", "investigators,", "hospitals,", "and", "other", "third", "party", "service", "providers."], "wordsB": ["limit", "who", "may", "call", "stockholder", "meetings."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p63_s2", "idA": "1095981_12_item1a_p26_s0", "sentA": "In the event that the Olympus-Cytori Joint Venture is not successful in the development and manufacture of the next generation Celution One System, Cytori may not have the resources or ability to self-manufacture sufficient numbers of devices and consumables to meet market demand, and this failure may substantially extend the time it would take for us to bring a more advanced commercial device to market.", "sentB": "Upon satisfactory proof of concept, BARDA may elect to exercise up to three contract options which will extend the contract term to up to five years if all options are exercised.", "type": 1, "words": ["<tag1>", "In", "the", "event", "that", "the", "Olympus-Cytori", "Joint", "Venture", "is", "not", "successful", "in", "the", "development", "and", "manufacture", "of", "the", "next", "generation", "Celution", "One", "System,", "Cytori", "may", "not", "have", "the", "resources", "or", "ability", "to", "self-manufacture", "sufficient", "numbers", "of", "devices", "and", "consumables", "to", "meet", "market", "demand,", "and", "this", "failure", "may", "substantially", "extend", "the", "time", "it", "would", "take", "for", "us", "to", "bring", "a", "more", "advanced", "commercial", "device", "to", "market.", "<tag2>", "Upon", "satisfactory", "proof", "of", "concept,", "BARDA", "may", "elect", "to", "exercise", "up", "to", "three", "contract", "options", "which", "will", "extend", "the", "contract", "term", "to", "up", "to", "five", "years", "if", "all", "options", "are", "exercised.", "<tag3>"], "wordsA": ["In", "the", "event", "that", "the", "Olympus-Cytori", "Joint", "Venture", "is", "not", "successful", "in", "the", "development", "and", "manufacture", "of", "the", "next", "generation", "Celution", "One", "System,", "Cytori", "may", "not", "have", "the", "resources", "or", "ability", "to", "self-manufacture", "sufficient", "numbers", "of", "devices", "and", "consumables", "to", "meet", "market", "demand,", "and", "this", "failure", "may", "substantially", "extend", "the", "time", "it", "would", "take", "for", "us", "to", "bring", "a", "more", "advanced", "commercial", "device", "to", "market."], "wordsB": ["Upon", "satisfactory", "proof", "of", "concept,", "BARDA", "may", "elect", "to", "exercise", "up", "to", "three", "contract", "options", "which", "will", "extend", "the", "contract", "term", "to", "up", "to", "five", "years", "if", "all", "options", "are", "exercised."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p0_s1", "idA": "1095981_12_item1a_p29_s2", "sentA": "If we are required in the future to obtain any licenses from third parties for some of our products, there can be no guarantee that we would be able to do so on commercially favorable terms, if at all.", "sentB": "All statements, other than statements of historical fact, that address activities, events or developments that we intend, expect, project, believe or anticipate and similar expressions or future conditional verbs such as will, should, would, could or may occur in the future are forward-looking statements.", "type": 1, "words": ["<tag1>", "If", "we", "are", "required", "in", "the", "future", "to", "obtain", "any", "licenses", "from", "third", "parties", "for", "some", "of", "our", "products,", "there", "can", "be", "no", "guarantee", "that", "we", "would", "be", "able", "to", "do", "so", "on", "commercially", "favorable", "terms,", "if", "at", "all.", "<tag2>", "All", "statements,", "other", "than", "statements", "of", "historical", "fact,", "that", "address", "activities,", "events", "or", "developments", "that", "we", "intend,", "expect,", "project,", "believe", "or", "anticipate", "and", "similar", "expressions", "or", "future", "conditional", "verbs", "such", "as", "will,", "should,", "would,", "could", "or", "may", "occur", "in", "the", "future", "are", "forward-looking", "statements.", "<tag3>"], "wordsA": ["If", "we", "are", "required", "in", "the", "future", "to", "obtain", "any", "licenses", "from", "third", "parties", "for", "some", "of", "our", "products,", "there", "can", "be", "no", "guarantee", "that", "we", "would", "be", "able", "to", "do", "so", "on", "commercially", "favorable", "terms,", "if", "at", "all."], "wordsB": ["All", "statements,", "other", "than", "statements", "of", "historical", "fact,", "that", "address", "activities,", "events", "or", "developments", "that", "we", "intend,", "expect,", "project,", "believe", "or", "anticipate", "and", "similar", "expressions", "or", "future", "conditional", "verbs", "such", "as", "will,", "should,", "would,", "could", "or", "may", "occur", "in", "the", "future", "are", "forward-looking", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p34_s0", "idA": "1095981_12_item1a_p33_s0", "sentA": "Successful challenges to our patents through oppositions, reexamination proceedings or interference proceedings could result in a loss of patent rights in the relevant jurisdiction.", "sentB": "As a result of the added uncertainty of interpretation of the AIA and the uncertainty of patent law in general, we cannot predict with certainty how much protection, if any, will be given to our patents if we attempt to enforce them and they are challenged in court.", "type": 1, "words": ["<tag1>", "Successful", "challenges", "to", "our", "patents", "through", "oppositions,", "reexamination", "proceedings", "or", "interference", "proceedings", "could", "result", "in", "a", "loss", "of", "patent", "rights", "in", "the", "relevant", "jurisdiction.", "<tag2>", "As", "a", "result", "of", "the", "added", "uncertainty", "of", "interpretation", "of", "the", "AIA", "and", "the", "uncertainty", "of", "patent", "law", "in", "general,", "we", "cannot", "predict", "with", "certainty", "how", "much", "protection,", "if", "any,", "will", "be", "given", "to", "our", "patents", "if", "we", "attempt", "to", "enforce", "them", "and", "they", "are", "challenged", "in", "court.", "<tag3>"], "wordsA": ["Successful", "challenges", "to", "our", "patents", "through", "oppositions,", "reexamination", "proceedings", "or", "interference", "proceedings", "could", "result", "in", "a", "loss", "of", "patent", "rights", "in", "the", "relevant", "jurisdiction."], "wordsB": ["As", "a", "result", "of", "the", "added", "uncertainty", "of", "interpretation", "of", "the", "AIA", "and", "the", "uncertainty", "of", "patent", "law", "in", "general,", "we", "cannot", "predict", "with", "certainty", "how", "much", "protection,", "if", "any,", "will", "be", "given", "to", "our", "patents", "if", "we", "attempt", "to", "enforce", "them", "and", "they", "are", "challenged", "in", "court."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p77_s0", "idA": "1095981_12_item1a_p33_s0", "sentA": "Successful challenges to our patents through oppositions, reexamination proceedings or interference proceedings could result in a loss of patent rights in the relevant jurisdiction.", "sentB": "In addition, the stock market in general, the NASDAQ Global Market and the market for cell therapy development companies in particular may experience a loss of investor confidence.", "type": 1, "words": ["<tag1>", "Successful", "challenges", "to", "our", "patents", "through", "oppositions,", "reexamination", "proceedings", "or", "interference", "proceedings", "could", "result", "in", "a", "loss", "of", "patent", "rights", "in", "the", "relevant", "jurisdiction.", "<tag2>", "In", "addition,", "the", "stock", "market", "in", "general,", "the", "NASDAQ", "Global", "Market", "and", "the", "market", "for", "cell", "therapy", "development", "companies", "in", "particular", "may", "experience", "a", "loss", "of", "investor", "confidence.", "<tag3>"], "wordsA": ["Successful", "challenges", "to", "our", "patents", "through", "oppositions,", "reexamination", "proceedings", "or", "interference", "proceedings", "could", "result", "in", "a", "loss", "of", "patent", "rights", "in", "the", "relevant", "jurisdiction."], "wordsB": ["In", "addition,", "the", "stock", "market", "in", "general,", "the", "NASDAQ", "Global", "Market", "and", "the", "market", "for", "cell", "therapy", "development", "companies", "in", "particular", "may", "experience", "a", "loss", "of", "investor", "confidence."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p80_s2", "idA": "1095981_12_item1a_p33_s1", "sentA": "If we are unsuccessful in actions we bring against the patents of other parties and it is determined that we infringe the patents of third-parties, we may be subject to litigation, or otherwise prevented from commercializing potential products in the relevant jurisdiction, or may be required to obtain licenses to those patents or develop or obtain alternative technologies, any of which could harm our business.", "sentB": "If we receive a written request from any of these stockholders to file a registration statement under the Securities Act covering its shares of unregistered common stock, we are required to use reasonable efforts to prepare and file with the SEC within 30 business days of such request a registration statement covering the resale of the shares for an offering to be made on a continuous basis pursuant to Rule 415 under the Securities Act.", "type": 1, "words": ["<tag1>", "If", "we", "are", "unsuccessful", "in", "actions", "we", "bring", "against", "the", "patents", "of", "other", "parties", "and", "it", "is", "determined", "that", "we", "infringe", "the", "patents", "of", "third-parties,", "we", "may", "be", "subject", "to", "litigation,", "or", "otherwise", "prevented", "from", "commercializing", "potential", "products", "in", "the", "relevant", "jurisdiction,", "or", "may", "be", "required", "to", "obtain", "licenses", "to", "those", "patents", "or", "develop", "or", "obtain", "alternative", "technologies,", "any", "of", "which", "could", "harm", "our", "business.", "<tag2>", "If", "we", "receive", "a", "written", "request", "from", "any", "of", "these", "stockholders", "to", "file", "a", "registration", "statement", "under", "the", "Securities", "Act", "covering", "its", "shares", "of", "unregistered", "common", "stock,", "we", "are", "required", "to", "use", "reasonable", "efforts", "to", "prepare", "and", "file", "with", "the", "SEC", "within", "30", "business", "days", "of", "such", "request", "a", "registration", "statement", "covering", "the", "resale", "of", "the", "shares", "for", "an", "offering", "to", "be", "made", "on", "a", "continuous", "basis", "pursuant", "to", "Rule", "415", "under", "the", "Securities", "Act.", "<tag3>"], "wordsA": ["If", "we", "are", "unsuccessful", "in", "actions", "we", "bring", "against", "the", "patents", "of", "other", "parties", "and", "it", "is", "determined", "that", "we", "infringe", "the", "patents", "of", "third-parties,", "we", "may", "be", "subject", "to", "litigation,", "or", "otherwise", "prevented", "from", "commercializing", "potential", "products", "in", "the", "relevant", "jurisdiction,", "or", "may", "be", "required", "to", "obtain", "licenses", "to", "those", "patents", "or", "develop", "or", "obtain", "alternative", "technologies,", "any", "of", "which", "could", "harm", "our", "business."], "wordsB": ["If", "we", "receive", "a", "written", "request", "from", "any", "of", "these", "stockholders", "to", "file", "a", "registration", "statement", "under", "the", "Securities", "Act", "covering", "its", "shares", "of", "unregistered", "common", "stock,", "we", "are", "required", "to", "use", "reasonable", "efforts", "to", "prepare", "and", "file", "with", "the", "SEC", "within", "30", "business", "days", "of", "such", "request", "a", "registration", "statement", "covering", "the", "resale", "of", "the", "shares", "for", "an", "offering", "to", "be", "made", "on", "a", "continuous", "basis", "pursuant", "to", "Rule", "415", "under", "the", "Securities", "Act."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p80_s0", "idA": "1095981_12_item1a_p34_s8", "sentA": "If securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock.", "sentB": "We have granted demand registration rights for the registration of the resale of certain shares of our common stock to each of Olympus Corporation, Astellas Pharma Inc. and Green Hospital Supply, Inc. pursuant to common stock purchase agreements previously entered into with each of these stockholders.", "type": 1, "words": ["<tag1>", "If", "securities", "analysts", "or", "investors", "perceive", "these", "results", "to", "be", "negative,", "it", "could", "have", "a", "substantial", "adverse", "effect", "on", "the", "price", "of", "our", "common", "stock.", "<tag2>", "We", "have", "granted", "demand", "registration", "rights", "for", "the", "registration", "of", "the", "resale", "of", "certain", "shares", "of", "our", "common", "stock", "to", "each", "of", "Olympus", "Corporation,", "Astellas", "Pharma", "Inc.", "and", "Green", "Hospital", "Supply,", "Inc.", "pursuant", "to", "common", "stock", "purchase", "agreements", "previously", "entered", "into", "with", "each", "of", "these", "stockholders.", "<tag3>"], "wordsA": ["If", "securities", "analysts", "or", "investors", "perceive", "these", "results", "to", "be", "negative,", "it", "could", "have", "a", "substantial", "adverse", "effect", "on", "the", "price", "of", "our", "common", "stock."], "wordsB": ["We", "have", "granted", "demand", "registration", "rights", "for", "the", "registration", "of", "the", "resale", "of", "certain", "shares", "of", "our", "common", "stock", "to", "each", "of", "Olympus", "Corporation,", "Astellas", "Pharma", "Inc.", "and", "Green", "Hospital", "Supply,", "Inc.", "pursuant", "to", "common", "stock", "purchase", "agreements", "previously", "entered", "into", "with", "each", "of", "these", "stockholders."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p59_s0", "idA": "1095981_12_item1a_p35_s1", "sentA": "Some of our intended future cell-related therapeutic products may fit into this category.", "sentB": "Our largest customer in Japan accounted for 12% of our revenue during the year ended December 31, 2012.", "type": 1, "words": ["<tag1>", "Some", "of", "our", "intended", "future", "cell-related", "therapeutic", "products", "may", "fit", "into", "this", "category.", "<tag2>", "Our", "largest", "customer", "in", "Japan", "accounted", "for", "12%", "of", "our", "revenue", "during", "the", "year", "ended", "December", "31,", "2012.", "<tag3>"], "wordsA": ["Some", "of", "our", "intended", "future", "cell-related", "therapeutic", "products", "may", "fit", "into", "this", "category."], "wordsB": ["Our", "largest", "customer", "in", "Japan", "accounted", "for", "12%", "of", "our", "revenue", "during", "the", "year", "ended", "December", "31,", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p70_s0", "idA": "1095981_12_item1a_p36_s1", "sentA": "There can be no guarantee that these agreements will not be breached, or that we will have adequate remedies for any breach, or that our unpatented trade secrets and proprietary technological expertise will not otherwise become known or be independently discovered by competitors.", "sentB": "Any costs found to be improperly allocated to a contract will not be reimbursed, while such costs already reimbursed must generally be repaid.", "type": 1, "words": ["<tag1>", "There", "can", "be", "no", "guarantee", "that", "these", "agreements", "will", "not", "be", "breached,", "or", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "our", "unpatented", "trade", "secrets", "and", "proprietary", "technological", "expertise", "will", "not", "otherwise", "become", "known", "or", "be", "independently", "discovered", "by", "competitors.", "<tag2>", "Any", "costs", "found", "to", "be", "improperly", "allocated", "to", "a", "contract", "will", "not", "be", "reimbursed,", "while", "such", "costs", "already", "reimbursed", "must", "generally", "be", "repaid.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "guarantee", "that", "these", "agreements", "will", "not", "be", "breached,", "or", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "our", "unpatented", "trade", "secrets", "and", "proprietary", "technological", "expertise", "will", "not", "otherwise", "become", "known", "or", "be", "independently", "discovered", "by", "competitors."], "wordsB": ["Any", "costs", "found", "to", "be", "improperly", "allocated", "to", "a", "contract", "will", "not", "be", "reimbursed,", "while", "such", "costs", "already", "reimbursed", "must", "generally", "be", "repaid."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p63_s0", "idA": "1095981_12_item1a_p37_s1", "sentA": "The loss of such rights could impact our ability to develop certain regenerative cell technology products.", "sentB": "Cytori was awarded the contract with BARDA in September 2012 with the aim to develop a new countermeasure for a combined injury involving thermal burn and radiation exposure which would be useful following a mass-casualty event.", "type": 1, "words": ["<tag1>", "The", "loss", "of", "such", "rights", "could", "impact", "our", "ability", "to", "develop", "certain", "regenerative", "cell", "technology", "products.", "<tag2>", "Cytori", "was", "awarded", "the", "contract", "with", "BARDA", "in", "September", "2012", "with", "the", "aim", "to", "develop", "a", "new", "countermeasure", "for", "a", "combined", "injury", "involving", "thermal", "burn", "and", "radiation", "exposure", "which", "would", "be", "useful", "following", "a", "mass-casualty", "event.", "<tag3>"], "wordsA": ["The", "loss", "of", "such", "rights", "could", "impact", "our", "ability", "to", "develop", "certain", "regenerative", "cell", "technology", "products."], "wordsB": ["Cytori", "was", "awarded", "the", "contract", "with", "BARDA", "in", "September", "2012", "with", "the", "aim", "to", "develop", "a", "new", "countermeasure", "for", "a", "combined", "injury", "involving", "thermal", "burn", "and", "radiation", "exposure", "which", "would", "be", "useful", "following", "a", "mass-casualty", "event."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p34_s1", "idA": "1095981_12_item1a_p39_s1", "sentA": "The laws of some countries do not protect our patent and other intellectual property rights to the same extent as United States laws.", "sentB": "Changes to the patent law under the AIA also may provoke third parties to assert claims against us or result in our intellectual property being narrowed in scope or declared to be invalid or unenforceable.", "type": 1, "words": ["<tag1>", "The", "laws", "of", "some", "countries", "do", "not", "protect", "our", "patent", "and", "other", "intellectual", "property", "rights", "to", "the", "same", "extent", "as", "United", "States", "laws.", "<tag2>", "Changes", "to", "the", "patent", "law", "under", "the", "AIA", "also", "may", "provoke", "third", "parties", "to", "assert", "claims", "against", "us", "or", "result", "in", "our", "intellectual", "property", "being", "narrowed", "in", "scope", "or", "declared", "to", "be", "invalid", "or", "unenforceable.", "<tag3>"], "wordsA": ["The", "laws", "of", "some", "countries", "do", "not", "protect", "our", "patent", "and", "other", "intellectual", "property", "rights", "to", "the", "same", "extent", "as", "United", "States", "laws."], "wordsB": ["Changes", "to", "the", "patent", "law", "under", "the", "AIA", "also", "may", "provoke", "third", "parties", "to", "assert", "claims", "against", "us", "or", "result", "in", "our", "intellectual", "property", "being", "narrowed", "in", "scope", "or", "declared", "to", "be", "invalid", "or", "unenforceable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p0_s3", "idA": "1095981_12_item1a_p3_s0", "sentA": "Negative trends in the general economy, including trends resulting from an actual or perceived recession, tightening credit markets, increased cost of commodities, including oil, actual or threatened military action by the United States and threats of terrorist attacks in the United States and abroad, could cause a reduction of investment in and available funding for companies in certain industries, including ours and our customers.", "sentB": "Readers are cautioned that forward-looking statements are not guarantees of future performance and our actual results may differ materially from those anticipated, projected or assumed in the forward-looking statements.", "type": 1, "words": ["<tag1>", "Negative", "trends", "in", "the", "general", "economy,", "including", "trends", "resulting", "from", "an", "actual", "or", "perceived", "recession,", "tightening", "credit", "markets,", "increased", "cost", "of", "commodities,", "including", "oil,", "actual", "or", "threatened", "military", "action", "by", "the", "United", "States", "and", "threats", "of", "terrorist", "attacks", "in", "the", "United", "States", "and", "abroad,", "could", "cause", "a", "reduction", "of", "investment", "in", "and", "available", "funding", "for", "companies", "in", "certain", "industries,", "including", "ours", "and", "our", "customers.", "<tag2>", "Readers", "are", "cautioned", "that", "forward-looking", "statements", "are", "not", "guarantees", "of", "future", "performance", "and", "our", "actual", "results", "may", "differ", "materially", "from", "those", "anticipated,", "projected", "or", "assumed", "in", "the", "forward-looking", "statements.", "<tag3>"], "wordsA": ["Negative", "trends", "in", "the", "general", "economy,", "including", "trends", "resulting", "from", "an", "actual", "or", "perceived", "recession,", "tightening", "credit", "markets,", "increased", "cost", "of", "commodities,", "including", "oil,", "actual", "or", "threatened", "military", "action", "by", "the", "United", "States", "and", "threats", "of", "terrorist", "attacks", "in", "the", "United", "States", "and", "abroad,", "could", "cause", "a", "reduction", "of", "investment", "in", "and", "available", "funding", "for", "companies", "in", "certain", "industries,", "including", "ours", "and", "our", "customers."], "wordsB": ["Readers", "are", "cautioned", "that", "forward-looking", "statements", "are", "not", "guarantees", "of", "future", "performance", "and", "our", "actual", "results", "may", "differ", "materially", "from", "those", "anticipated,", "projected", "or", "assumed", "in", "the", "forward-looking", "statements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p82_s2", "idA": "1095981_12_item1a_p40_s2", "sentA": "It may be necessary or useful for us to participate in proceedings to determine the validity of our patents or our competitors patents that have been issued in countries other than the U.S.", "sentB": "Stockholders who wish to participate in these transactions may not have the opportunity to do so.", "type": 1, "words": ["<tag1>", "It", "may", "be", "necessary", "or", "useful", "for", "us", "to", "participate", "in", "proceedings", "to", "determine", "the", "validity", "of", "our", "patents", "or", "our", "competitors", "patents", "that", "have", "been", "issued", "in", "countries", "other", "than", "the", "U.S.", "<tag2>", "Stockholders", "who", "wish", "to", "participate", "in", "these", "transactions", "may", "not", "have", "the", "opportunity", "to", "do", "so.", "<tag3>"], "wordsA": ["It", "may", "be", "necessary", "or", "useful", "for", "us", "to", "participate", "in", "proceedings", "to", "determine", "the", "validity", "of", "our", "patents", "or", "our", "competitors", "patents", "that", "have", "been", "issued", "in", "countries", "other", "than", "the", "U.S."], "wordsB": ["Stockholders", "who", "wish", "to", "participate", "in", "these", "transactions", "may", "not", "have", "the", "opportunity", "to", "do", "so."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p68_s0", "idA": "1095981_12_item1a_p44_s0", "sentA": "Before any new medical device may be introduced to the U.S. market, the manufacturer generally must obtain FDA clearance or approval through either the 510(k) pre-market notification process or the lengthier pre-market approval application, or PMA, process.", "sentB": "U.S. government agencies, such as the Department of Health and Human Services, or DHHS, and the Defense Contract Audit Agency, or the DCAA, routinely audit and investigate government contractors and recipients of federal grants.", "type": 1, "words": ["<tag1>", "Before", "any", "new", "medical", "device", "may", "be", "introduced", "to", "the", "U.S.", "market,", "the", "manufacturer", "generally", "must", "obtain", "FDA", "clearance", "or", "approval", "through", "either", "the", "510(k)", "pre-market", "notification", "process", "or", "the", "lengthier", "pre-market", "approval", "application,", "or", "PMA,", "process.", "<tag2>", "U.S.", "government", "agencies,", "such", "as", "the", "Department", "of", "Health", "and", "Human", "Services,", "or", "DHHS,", "and", "the", "Defense", "Contract", "Audit", "Agency,", "or", "the", "DCAA,", "routinely", "audit", "and", "investigate", "government", "contractors", "and", "recipients", "of", "federal", "grants.", "<tag3>"], "wordsA": ["Before", "any", "new", "medical", "device", "may", "be", "introduced", "to", "the", "U.S.", "market,", "the", "manufacturer", "generally", "must", "obtain", "FDA", "clearance", "or", "approval", "through", "either", "the", "510(k)", "pre-market", "notification", "process", "or", "the", "lengthier", "pre-market", "approval", "application,", "or", "PMA,", "process."], "wordsB": ["U.S.", "government", "agencies,", "such", "as", "the", "Department", "of", "Health", "and", "Human", "Services,", "or", "DHHS,", "and", "the", "Defense", "Contract", "Audit", "Agency,", "or", "the", "DCAA,", "routinely", "audit", "and", "investigate", "government", "contractors", "and", "recipients", "of", "federal", "grants."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p63_s3", "idA": "1095981_12_item1a_p48_s1", "sentA": "Delays in receipt of or failure to receive such clearances or approvals, the loss of previously received clearances or approvals, or failure to comply with existing or future regulatory requirements could have a substantial negative effect on our results of operations and financial condition.", "sentB": "BARDA may suspend or terminate this contract should we fail to achieve key objectives or milestones, or fail to comply with the operating procedures and processes approved by BARDA and its audit agency, the Defense Contract Audit Agency.", "type": 1, "words": ["<tag1>", "Delays", "in", "receipt", "of", "or", "failure", "to", "receive", "such", "clearances", "or", "approvals,", "the", "loss", "of", "previously", "received", "clearances", "or", "approvals,", "or", "failure", "to", "comply", "with", "existing", "or", "future", "regulatory", "requirements", "could", "have", "a", "substantial", "negative", "effect", "on", "our", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "BARDA", "may", "suspend", "or", "terminate", "this", "contract", "should", "we", "fail", "to", "achieve", "key", "objectives", "or", "milestones,", "or", "fail", "to", "comply", "with", "the", "operating", "procedures", "and", "processes", "approved", "by", "BARDA", "and", "its", "audit", "agency,", "the", "Defense", "Contract", "Audit", "Agency.", "<tag3>"], "wordsA": ["Delays", "in", "receipt", "of", "or", "failure", "to", "receive", "such", "clearances", "or", "approvals,", "the", "loss", "of", "previously", "received", "clearances", "or", "approvals,", "or", "failure", "to", "comply", "with", "existing", "or", "future", "regulatory", "requirements", "could", "have", "a", "substantial", "negative", "effect", "on", "our", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["BARDA", "may", "suspend", "or", "terminate", "this", "contract", "should", "we", "fail", "to", "achieve", "key", "objectives", "or", "milestones,", "or", "fail", "to", "comply", "with", "the", "operating", "procedures", "and", "processes", "approved", "by", "BARDA", "and", "its", "audit", "agency,", "the", "Defense", "Contract", "Audit", "Agency."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p5_s2", "idA": "1095981_12_item1a_p4_s2", "sentA": "While we work continuously to implement cost reduction measures where possible, we nonetheless expect to continue operating in a loss position on a consolidated basis and that recurring operating expenses will be at high levels for the next several years, in order to perform clinical trials, additional pre-clinical research, product development, and marketing.", "sentB": "In order to continue operations through the next twelve months, we are pursuing additional cash through strategic corporate partnership and future sales of equity, and the restructure of our short-term debt obligations, in addition to our gross profits.", "type": 1, "words": ["<tag1>", "While", "we", "work", "continuously", "to", "implement", "cost", "reduction", "measures", "where", "possible,", "we", "nonetheless", "expect", "to", "continue", "operating", "in", "a", "loss", "position", "on", "a", "consolidated", "basis", "and", "that", "recurring", "operating", "expenses", "will", "be", "at", "high", "levels", "for", "the", "next", "several", "years,", "in", "order", "to", "perform", "clinical", "trials,", "additional", "pre-clinical", "research,", "product", "development,", "and", "marketing.", "<tag2>", "In", "order", "to", "continue", "operations", "through", "the", "next", "twelve", "months,", "we", "are", "pursuing", "additional", "cash", "through", "strategic", "corporate", "partnership", "and", "future", "sales", "of", "equity,", "and", "the", "restructure", "of", "our", "short-term", "debt", "obligations,", "in", "addition", "to", "our", "gross", "profits.", "<tag3>"], "wordsA": ["While", "we", "work", "continuously", "to", "implement", "cost", "reduction", "measures", "where", "possible,", "we", "nonetheless", "expect", "to", "continue", "operating", "in", "a", "loss", "position", "on", "a", "consolidated", "basis", "and", "that", "recurring", "operating", "expenses", "will", "be", "at", "high", "levels", "for", "the", "next", "several", "years,", "in", "order", "to", "perform", "clinical", "trials,", "additional", "pre-clinical", "research,", "product", "development,", "and", "marketing."], "wordsB": ["In", "order", "to", "continue", "operations", "through", "the", "next", "twelve", "months,", "we", "are", "pursuing", "additional", "cash", "through", "strategic", "corporate", "partnership", "and", "future", "sales", "of", "equity,", "and", "the", "restructure", "of", "our", "short-term", "debt", "obligations,", "in", "addition", "to", "our", "gross", "profits."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p69_s0", "idA": "1095981_12_item1a_p50_s3", "sentA": "These regulations, including the requirements for approvals or clearances to market, may differ from the FDA regulatory scheme.", "sentB": "The DHHS and the DCAA also review the adequacy of, and a contractor s compliance with, its internal control systems and policies, including the contractor s purchasing, property, estimating, compensation and management information systems.", "type": 1, "words": ["<tag1>", "These", "regulations,", "including", "the", "requirements", "for", "approvals", "or", "clearances", "to", "market,", "may", "differ", "from", "the", "FDA", "regulatory", "scheme.", "<tag2>", "The", "DHHS", "and", "the", "DCAA", "also", "review", "the", "adequacy", "of,", "and", "a", "contractor", "s", "compliance", "with,", "its", "internal", "control", "systems", "and", "policies,", "including", "the", "contractor", "s", "purchasing,", "property,", "estimating,", "compensation", "and", "management", "information", "systems.", "<tag3>"], "wordsA": ["These", "regulations,", "including", "the", "requirements", "for", "approvals", "or", "clearances", "to", "market,", "may", "differ", "from", "the", "FDA", "regulatory", "scheme."], "wordsB": ["The", "DHHS", "and", "the", "DCAA", "also", "review", "the", "adequacy", "of,", "and", "a", "contractor", "s", "compliance", "with,", "its", "internal", "control", "systems", "and", "policies,", "including", "the", "contractor", "s", "purchasing,", "property,", "estimating,", "compensation", "and", "management", "information", "systems."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p67_s1", "idA": "1095981_12_item1a_p59_s0", "sentA": "Our global operations expose us to additional risk and uncertainties.", "sentB": "Termination-for-convenience provisions generally enable us to recover only our costs incurred or committed and settlement expenses on the work completed prior to termination.", "type": 1, "words": ["<tag1>", "Our", "global", "operations", "expose", "us", "to", "additional", "risk", "and", "uncertainties.", "<tag2>", "Termination-for-convenience", "provisions", "generally", "enable", "us", "to", "recover", "only", "our", "costs", "incurred", "or", "committed", "and", "settlement", "expenses", "on", "the", "work", "completed", "prior", "to", "termination.", "<tag3>"], "wordsA": ["Our", "global", "operations", "expose", "us", "to", "additional", "risk", "and", "uncertainties."], "wordsB": ["Termination-for-convenience", "provisions", "generally", "enable", "us", "to", "recover", "only", "our", "costs", "incurred", "or", "committed", "and", "settlement", "expenses", "on", "the", "work", "completed", "prior", "to", "termination."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p67_s0", "idA": "1095981_12_item1a_p5_s1", "sentA": "This is a high-risk strategy because there is no assurance that our future products will ever become commercially viable (commercial risk), that we will prevent other companies from depriving us of market share and profit margins by selling products based on our inventions and developments (legal risk), that we will successfully manage a company in a new area of business (regenerative medicine) and on a different scale than we have operated in the past (operational risk), that we will be able to achieve the desired therapeutic results using stem and regenerative cells (scientific risk), or that our cash resources will be adequate to develop our products until we become profitable, if ever (financial risk).", "sentB": "BARDA is able to terminate its contracts with us, either for its best interests or if we default by failing to perform in accordance with or to achieve the milestones set forth in the contract schedules and terms.", "type": 1, "words": ["<tag1>", "This", "is", "a", "high-risk", "strategy", "because", "there", "is", "no", "assurance", "that", "our", "future", "products", "will", "ever", "become", "commercially", "viable", "(commercial", "risk),", "that", "we", "will", "prevent", "other", "companies", "from", "depriving", "us", "of", "market", "share", "and", "profit", "margins", "by", "selling", "products", "based", "on", "our", "inventions", "and", "developments", "(legal", "risk),", "that", "we", "will", "successfully", "manage", "a", "company", "in", "a", "new", "area", "of", "business", "(regenerative", "medicine)", "and", "on", "a", "different", "scale", "than", "we", "have", "operated", "in", "the", "past", "(operational", "risk),", "that", "we", "will", "be", "able", "to", "achieve", "the", "desired", "therapeutic", "results", "using", "stem", "and", "regenerative", "cells", "(scientific", "risk),", "or", "that", "our", "cash", "resources", "will", "be", "adequate", "to", "develop", "our", "products", "until", "we", "become", "profitable,", "if", "ever", "(financial", "risk).", "<tag2>", "BARDA", "is", "able", "to", "terminate", "its", "contracts", "with", "us,", "either", "for", "its", "best", "interests", "or", "if", "we", "default", "by", "failing", "to", "perform", "in", "accordance", "with", "or", "to", "achieve", "the", "milestones", "set", "forth", "in", "the", "contract", "schedules", "and", "terms.", "<tag3>"], "wordsA": ["This", "is", "a", "high-risk", "strategy", "because", "there", "is", "no", "assurance", "that", "our", "future", "products", "will", "ever", "become", "commercially", "viable", "(commercial", "risk),", "that", "we", "will", "prevent", "other", "companies", "from", "depriving", "us", "of", "market", "share", "and", "profit", "margins", "by", "selling", "products", "based", "on", "our", "inventions", "and", "developments", "(legal", "risk),", "that", "we", "will", "successfully", "manage", "a", "company", "in", "a", "new", "area", "of", "business", "(regenerative", "medicine)", "and", "on", "a", "different", "scale", "than", "we", "have", "operated", "in", "the", "past", "(operational", "risk),", "that", "we", "will", "be", "able", "to", "achieve", "the", "desired", "therapeutic", "results", "using", "stem", "and", "regenerative", "cells", "(scientific", "risk),", "or", "that", "our", "cash", "resources", "will", "be", "adequate", "to", "develop", "our", "products", "until", "we", "become", "profitable,", "if", "ever", "(financial", "risk)."], "wordsB": ["BARDA", "is", "able", "to", "terminate", "its", "contracts", "with", "us,", "either", "for", "its", "best", "interests", "or", "if", "we", "default", "by", "failing", "to", "perform", "in", "accordance", "with", "or", "to", "achieve", "the", "milestones", "set", "forth", "in", "the", "contract", "schedules", "and", "terms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p68_s1", "idA": "1095981_12_item1a_p63_s1", "sentA": "There can be no guarantee that the FDA or other authorities will not, during the course of an inspection of existing or new facilities, identify what they consider to be deficiencies in our compliance with QSRs or other requirements and request, or seek remedial action.", "sentB": "These agencies evaluate a contractor s performance under its contracts, cost structure and compliance with applicable laws, regulations and standards.", "type": 1, "words": ["<tag1>", "There", "can", "be", "no", "guarantee", "that", "the", "FDA", "or", "other", "authorities", "will", "not,", "during", "the", "course", "of", "an", "inspection", "of", "existing", "or", "new", "facilities,", "identify", "what", "they", "consider", "to", "be", "deficiencies", "in", "our", "compliance", "with", "QSRs", "or", "other", "requirements", "and", "request,", "or", "seek", "remedial", "action.", "<tag2>", "These", "agencies", "evaluate", "a", "contractor", "s", "performance", "under", "its", "contracts,", "cost", "structure", "and", "compliance", "with", "applicable", "laws,", "regulations", "and", "standards.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "guarantee", "that", "the", "FDA", "or", "other", "authorities", "will", "not,", "during", "the", "course", "of", "an", "inspection", "of", "existing", "or", "new", "facilities,", "identify", "what", "they", "consider", "to", "be", "deficiencies", "in", "our", "compliance", "with", "QSRs", "or", "other", "requirements", "and", "request,", "or", "seek", "remedial", "action."], "wordsB": ["These", "agencies", "evaluate", "a", "contractor", "s", "performance", "under", "its", "contracts,", "cost", "structure", "and", "compliance", "with", "applicable", "laws,", "regulations", "and", "standards."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p85_s0", "idA": "1095981_12_item1a_p65_s4", "sentA": "The loss of the services of one or more of our executive officers or key scientific staff, or the inability to attract and retain additional personnel and develop expertise as needed could have a substantial negative effect on our results of operations and financial condition.", "sentB": "We are governed by the provisions of Section 203 of the Delaware General Corporation Law, which may, unless certain criteria are met, prohibit large stockholders, in particular those owning 15% or more of the voting rights on our common stock, from merging or combining with us for a prescribed period of time.", "type": 1, "words": ["<tag1>", "The", "loss", "of", "the", "services", "of", "one", "or", "more", "of", "our", "executive", "officers", "or", "key", "scientific", "staff,", "or", "the", "inability", "to", "attract", "and", "retain", "additional", "personnel", "and", "develop", "expertise", "as", "needed", "could", "have", "a", "substantial", "negative", "effect", "on", "our", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "We", "are", "governed", "by", "the", "provisions", "of", "Section", "203", "of", "the", "Delaware", "General", "Corporation", "Law,", "which", "may,", "unless", "certain", "criteria", "are", "met,", "prohibit", "large", "stockholders,", "in", "particular", "those", "owning", "15%", "or", "more", "of", "the", "voting", "rights", "on", "our", "common", "stock,", "from", "merging", "or", "combining", "with", "us", "for", "a", "prescribed", "period", "of", "time.", "<tag3>"], "wordsA": ["The", "loss", "of", "the", "services", "of", "one", "or", "more", "of", "our", "executive", "officers", "or", "key", "scientific", "staff,", "or", "the", "inability", "to", "attract", "and", "retain", "additional", "personnel", "and", "develop", "expertise", "as", "needed", "could", "have", "a", "substantial", "negative", "effect", "on", "our", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["We", "are", "governed", "by", "the", "provisions", "of", "Section", "203", "of", "the", "Delaware", "General", "Corporation", "Law,", "which", "may,", "unless", "certain", "criteria", "are", "met,", "prohibit", "large", "stockholders,", "in", "particular", "those", "owning", "15%", "or", "more", "of", "the", "voting", "rights", "on", "our", "common", "stock,", "from", "merging", "or", "combining", "with", "us", "for", "a", "prescribed", "period", "of", "time."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p66_s0", "idA": "1095981_12_item1a_p68_s1", "sentA": "This could make an investment in our company inappropriate for some investors, and may serve to narrow our potential sources of additional capital.", "sentB": "change certain terms and conditions in our contracts.", "type": 1, "words": ["<tag1>", "This", "could", "make", "an", "investment", "in", "our", "company", "inappropriate", "for", "some", "investors,", "and", "may", "serve", "to", "narrow", "our", "potential", "sources", "of", "additional", "capital.", "<tag2>", "change", "certain", "terms", "and", "conditions", "in", "our", "contracts.", "<tag3>"], "wordsA": ["This", "could", "make", "an", "investment", "in", "our", "company", "inappropriate", "for", "some", "investors,", "and", "may", "serve", "to", "narrow", "our", "potential", "sources", "of", "additional", "capital."], "wordsB": ["change", "certain", "terms", "and", "conditions", "in", "our", "contracts."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_13_item1a_p33_s1", "idA": "1095981_12_item1a_p8_s1", "sentA": "Cultural differences, including language barrier to some degree, may affect the efficiency of the relationship.", "sentB": "Among other things the AIA implements a first inventor to file standard for patent approval, changes the legal standards for patentability under section 102 of the statute, and creates a post grant review system.", "type": 1, "words": ["<tag1>", "Cultural", "differences,", "including", "language", "barrier", "to", "some", "degree,", "may", "affect", "the", "efficiency", "of", "the", "relationship.", "<tag2>", "Among", "other", "things", "the", "AIA", "implements", "a", "first", "inventor", "to", "file", "standard", "for", "patent", "approval,", "changes", "the", "legal", "standards", "for", "patentability", "under", "section", "102", "of", "the", "statute,", "and", "creates", "a", "post", "grant", "review", "system.", "<tag3>"], "wordsA": ["Cultural", "differences,", "including", "language", "barrier", "to", "some", "degree,", "may", "affect", "the", "efficiency", "of", "the", "relationship."], "wordsB": ["Among", "other", "things", "the", "AIA", "implements", "a", "first", "inventor", "to", "file", "standard", "for", "patent", "approval,", "changes", "the", "legal", "standards", "for", "patentability", "under", "section", "102", "of", "the", "statute,", "and", "creates", "a", "post", "grant", "review", "system."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p29_s1", "idA": "1095981_13_item1a_p15_s3", "sentA": "In general, we may not be able to prevent others from developing and marketing competitive products similar to ours or which perform similar functions.", "sentB": "Even if initial results of preclinical and nonclinical studies or clinical trial results are promising, we may obtain different results in subsequent trials or studies that fail to show the desired levels of safety and efficacy, or we may not obtain applicable regulatory approval for a variety of other reasons.", "type": 1, "words": ["<tag1>", "In", "general,", "we", "may", "not", "be", "able", "to", "prevent", "others", "from", "developing", "and", "marketing", "competitive", "products", "similar", "to", "ours", "or", "which", "perform", "similar", "functions.", "<tag2>", "Even", "if", "initial", "results", "of", "preclinical", "and", "nonclinical", "studies", "or", "clinical", "trial", "results", "are", "promising,", "we", "may", "obtain", "different", "results", "in", "subsequent", "trials", "or", "studies", "that", "fail", "to", "show", "the", "desired", "levels", "of", "safety", "and", "efficacy,", "or", "we", "may", "not", "obtain", "applicable", "regulatory", "approval", "for", "a", "variety", "of", "other", "reasons.", "<tag3>"], "wordsA": ["In", "general,", "we", "may", "not", "be", "able", "to", "prevent", "others", "from", "developing", "and", "marketing", "competitive", "products", "similar", "to", "ours", "or", "which", "perform", "similar", "functions."], "wordsB": ["Even", "if", "initial", "results", "of", "preclinical", "and", "nonclinical", "studies", "or", "clinical", "trial", "results", "are", "promising,", "we", "may", "obtain", "different", "results", "in", "subsequent", "trials", "or", "studies", "that", "fail", "to", "show", "the", "desired", "levels", "of", "safety", "and", "efficacy,", "or", "we", "may", "not", "obtain", "applicable", "regulatory", "approval", "for", "a", "variety", "of", "other", "reasons."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p22_s0", "idA": "1095981_13_item1a_p17_s1", "sentA": "Doctors historically are slow to adopt new technologies like ours, regardless of the perceived merits, when older technologies continue to be supported by established providers.", "sentB": "Regulatory agencies may change existing requirements or adopt new requirements or policies.", "type": 1, "words": ["<tag1>", "Doctors", "historically", "are", "slow", "to", "adopt", "new", "technologies", "like", "ours,", "regardless", "of", "the", "perceived", "merits,", "when", "older", "technologies", "continue", "to", "be", "supported", "by", "established", "providers.", "<tag2>", "Regulatory", "agencies", "may", "change", "existing", "requirements", "or", "adopt", "new", "requirements", "or", "policies.", "<tag3>"], "wordsA": ["Doctors", "historically", "are", "slow", "to", "adopt", "new", "technologies", "like", "ours,", "regardless", "of", "the", "perceived", "merits,", "when", "older", "technologies", "continue", "to", "be", "supported", "by", "established", "providers."], "wordsB": ["Regulatory", "agencies", "may", "change", "existing", "requirements", "or", "adopt", "new", "requirements", "or", "policies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p26_s2", "idA": "1095981_13_item1a_p29_s1", "sentA": "If we were judicially determined to be infringing on any third-party patent, we could be required to pay damages, alter our products or processes, obtain licenses, or cease certain activities.", "sentB": "We cannot guarantee that Lorem Vascular will make the investments required to be successful in these countries.", "type": 1, "words": ["<tag1>", "If", "we", "were", "judicially", "determined", "to", "be", "infringing", "on", "any", "third-party", "patent,", "we", "could", "be", "required", "to", "pay", "damages,", "alter", "our", "products", "or", "processes,", "obtain", "licenses,", "or", "cease", "certain", "activities.", "<tag2>", "We", "cannot", "guarantee", "that", "Lorem", "Vascular", "will", "make", "the", "investments", "required", "to", "be", "successful", "in", "these", "countries.", "<tag3>"], "wordsA": ["If", "we", "were", "judicially", "determined", "to", "be", "infringing", "on", "any", "third-party", "patent,", "we", "could", "be", "required", "to", "pay", "damages,", "alter", "our", "products", "or", "processes,", "obtain", "licenses,", "or", "cease", "certain", "activities."], "wordsB": ["We", "cannot", "guarantee", "that", "Lorem", "Vascular", "will", "make", "the", "investments", "required", "to", "be", "successful", "in", "these", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p34_s0", "idA": "1095981_13_item1a_p31_s0", "sentA": "Litigation, which would result in substantial costs to us and diversion of effort on our part, may be necessary to enforce or confirm the ownership of any patents issued or licensed to us, or to determine the scope and validity of third-party proprietary rights.", "sentB": "The approval process varies among countries and jurisdictions and can involve additional testing.", "type": 1, "words": ["<tag1>", "Litigation,", "which", "would", "result", "in", "substantial", "costs", "to", "us", "and", "diversion", "of", "effort", "on", "our", "part,", "may", "be", "necessary", "to", "enforce", "or", "confirm", "the", "ownership", "of", "any", "patents", "issued", "or", "licensed", "to", "us,", "or", "to", "determine", "the", "scope", "and", "validity", "of", "third-party", "proprietary", "rights.", "<tag2>", "The", "approval", "process", "varies", "among", "countries", "and", "jurisdictions", "and", "can", "involve", "additional", "testing.", "<tag3>"], "wordsA": ["Litigation,", "which", "would", "result", "in", "substantial", "costs", "to", "us", "and", "diversion", "of", "effort", "on", "our", "part,", "may", "be", "necessary", "to", "enforce", "or", "confirm", "the", "ownership", "of", "any", "patents", "issued", "or", "licensed", "to", "us,", "or", "to", "determine", "the", "scope", "and", "validity", "of", "third-party", "proprietary", "rights."], "wordsB": ["The", "approval", "process", "varies", "among", "countries", "and", "jurisdictions", "and", "can", "involve", "additional", "testing."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p3_s0", "idA": "1095981_13_item1a_p31_s0", "sentA": "Litigation, which would result in substantial costs to us and diversion of effort on our part, may be necessary to enforce or confirm the ownership of any patents issued or licensed to us, or to determine the scope and validity of third-party proprietary rights.", "sentB": "we lv e m o n t h s .", "type": 1, "words": ["<tag1>", "Litigation,", "which", "would", "result", "in", "substantial", "costs", "to", "us", "and", "diversion", "of", "effort", "on", "our", "part,", "may", "be", "necessary", "to", "enforce", "or", "confirm", "the", "ownership", "of", "any", "patents", "issued", "or", "licensed", "to", "us,", "or", "to", "determine", "the", "scope", "and", "validity", "of", "third-party", "proprietary", "rights.", "<tag2>", "we", "lv", "e", "m", "o", "n", "t", "h", "s", ".", "<tag3>"], "wordsA": ["Litigation,", "which", "would", "result", "in", "substantial", "costs", "to", "us", "and", "diversion", "of", "effort", "on", "our", "part,", "may", "be", "necessary", "to", "enforce", "or", "confirm", "the", "ownership", "of", "any", "patents", "issued", "or", "licensed", "to", "us,", "or", "to", "determine", "the", "scope", "and", "validity", "of", "third-party", "proprietary", "rights."], "wordsB": ["we", "lv", "e", "m", "o", "n", "t", "h", "s", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p3_s1", "idA": "1095981_13_item1a_p31_s0", "sentA": "Litigation, which would result in substantial costs to us and diversion of effort on our part, may be necessary to enforce or confirm the ownership of any patents issued or licensed to us, or to determine the scope and validity of third-party proprietary rights.", "sentB": "c i e nt addition a l funds ar e n o t s u ccess ful .", "type": 1, "words": ["<tag1>", "Litigation,", "which", "would", "result", "in", "substantial", "costs", "to", "us", "and", "diversion", "of", "effort", "on", "our", "part,", "may", "be", "necessary", "to", "enforce", "or", "confirm", "the", "ownership", "of", "any", "patents", "issued", "or", "licensed", "to", "us,", "or", "to", "determine", "the", "scope", "and", "validity", "of", "third-party", "proprietary", "rights.", "<tag2>", "c", "i", "e", "nt", "addition", "a", "l", "funds", "ar", "e", "n", "o", "t", "s", "u", "ccess", "ful", ".", "<tag3>"], "wordsA": ["Litigation,", "which", "would", "result", "in", "substantial", "costs", "to", "us", "and", "diversion", "of", "effort", "on", "our", "part,", "may", "be", "necessary", "to", "enforce", "or", "confirm", "the", "ownership", "of", "any", "patents", "issued", "or", "licensed", "to", "us,", "or", "to", "determine", "the", "scope", "and", "validity", "of", "third-party", "proprietary", "rights."], "wordsB": ["c", "i", "e", "nt", "addition", "a", "l", "funds", "ar", "e", "n", "o", "t", "s", "u", "ccess", "ful", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p3_s2", "idA": "1095981_13_item1a_p31_s0", "sentA": "Litigation, which would result in substantial costs to us and diversion of effort on our part, may be necessary to enforce or confirm the ownership of any patents issued or licensed to us, or to determine the scope and validity of third-party proprietary rights.", "sentB": "rp o r a t e goa l s .", "type": 1, "words": ["<tag1>", "Litigation,", "which", "would", "result", "in", "substantial", "costs", "to", "us", "and", "diversion", "of", "effort", "on", "our", "part,", "may", "be", "necessary", "to", "enforce", "or", "confirm", "the", "ownership", "of", "any", "patents", "issued", "or", "licensed", "to", "us,", "or", "to", "determine", "the", "scope", "and", "validity", "of", "third-party", "proprietary", "rights.", "<tag2>", "rp", "o", "r", "a", "t", "e", "goa", "l", "s", ".", "<tag3>"], "wordsA": ["Litigation,", "which", "would", "result", "in", "substantial", "costs", "to", "us", "and", "diversion", "of", "effort", "on", "our", "part,", "may", "be", "necessary", "to", "enforce", "or", "confirm", "the", "ownership", "of", "any", "patents", "issued", "or", "licensed", "to", "us,", "or", "to", "determine", "the", "scope", "and", "validity", "of", "third-party", "proprietary", "rights."], "wordsB": ["rp", "o", "r", "a", "t", "e", "goa", "l", "s", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p19_s3", "idA": "1095981_13_item1a_p35_s2", "sentA": "In addition, in an infringement proceeding, a court may decide that a patent of ours is not valid or is unenforceable, or that the third party s technology does not in fact infringe upon our patents.", "sentB": "In addition, in the event that a party fails to perform under a key collaboration agreement, or if a key collaboration agreement is terminated, the reduction in anticipated revenues could delay or suspend our product commercialization in certain countries.", "type": 1, "words": ["<tag1>", "In", "addition,", "in", "an", "infringement", "proceeding,", "a", "court", "may", "decide", "that", "a", "patent", "of", "ours", "is", "not", "valid", "or", "is", "unenforceable,", "or", "that", "the", "third", "party", "s", "technology", "does", "not", "in", "fact", "infringe", "upon", "our", "patents.", "<tag2>", "In", "addition,", "in", "the", "event", "that", "a", "party", "fails", "to", "perform", "under", "a", "key", "collaboration", "agreement,", "or", "if", "a", "key", "collaboration", "agreement", "is", "terminated,", "the", "reduction", "in", "anticipated", "revenues", "could", "delay", "or", "suspend", "our", "product", "commercialization", "in", "certain", "countries.", "<tag3>"], "wordsA": ["In", "addition,", "in", "an", "infringement", "proceeding,", "a", "court", "may", "decide", "that", "a", "patent", "of", "ours", "is", "not", "valid", "or", "is", "unenforceable,", "or", "that", "the", "third", "party", "s", "technology", "does", "not", "in", "fact", "infringe", "upon", "our", "patents."], "wordsB": ["In", "addition,", "in", "the", "event", "that", "a", "party", "fails", "to", "perform", "under", "a", "key", "collaboration", "agreement,", "or", "if", "a", "key", "collaboration", "agreement", "is", "terminated,", "the", "reduction", "in", "anticipated", "revenues", "could", "delay", "or", "suspend", "our", "product", "commercialization", "in", "certain", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p21_s0", "idA": "1095981_13_item1a_p39_s0", "sentA": "Intellectual property law outside the United States is uncertain and in many countries is currently undergoing review and revisions.", "sentB": "Regulatory authorities subject a marketed product, its manufacturer and the manufacturing facilities to continual review and periodic inspections.", "type": 1, "words": ["<tag1>", "Intellectual", "property", "law", "outside", "the", "United", "States", "is", "uncertain", "and", "in", "many", "countries", "is", "currently", "undergoing", "review", "and", "revisions.", "<tag2>", "Regulatory", "authorities", "subject", "a", "marketed", "product,", "its", "manufacturer", "and", "the", "manufacturing", "facilities", "to", "continual", "review", "and", "periodic", "inspections.", "<tag3>"], "wordsA": ["Intellectual", "property", "law", "outside", "the", "United", "States", "is", "uncertain", "and", "in", "many", "countries", "is", "currently", "undergoing", "review", "and", "revisions."], "wordsB": ["Regulatory", "authorities", "subject", "a", "marketed", "product,", "its", "manufacturer", "and", "the", "manufacturing", "facilities", "to", "continual", "review", "and", "periodic", "inspections."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p21_s1", "idA": "1095981_13_item1a_p44_s4", "sentA": "We expect that some of our products under development today or in the future will be subject to the lengthier PMA process.", "sentB": "We, our collaborators and our respective contractors, suppliers and vendors, will be subject to ongoing regulatory requirements, including complying with regulations and laws regarding advertising, promotion and sales of products, required submissions of safety and other post-market information and reports, registration requirements, cGMP regulations (including requirements relating to quality control and quality assurance, as well as the corresponding maintenance of records and documentation), and the requirements regarding the distribution of samples to physicians and recordkeeping requirements.", "type": 1, "words": ["<tag1>", "We", "expect", "that", "some", "of", "our", "products", "under", "development", "today", "or", "in", "the", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process.", "<tag2>", "We,", "our", "collaborators", "and", "our", "respective", "contractors,", "suppliers", "and", "vendors,", "will", "be", "subject", "to", "ongoing", "regulatory", "requirements,", "including", "complying", "with", "regulations", "and", "laws", "regarding", "advertising,", "promotion", "and", "sales", "of", "products,", "required", "submissions", "of", "safety", "and", "other", "post-market", "information", "and", "reports,", "registration", "requirements,", "cGMP", "regulations", "(including", "requirements", "relating", "to", "quality", "control", "and", "quality", "assurance,", "as", "well", "as", "the", "corresponding", "maintenance", "of", "records", "and", "documentation),", "and", "the", "requirements", "regarding", "the", "distribution", "of", "samples", "to", "physicians", "and", "recordkeeping", "requirements.", "<tag3>"], "wordsA": ["We", "expect", "that", "some", "of", "our", "products", "under", "development", "today", "or", "in", "the", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process."], "wordsB": ["We,", "our", "collaborators", "and", "our", "respective", "contractors,", "suppliers", "and", "vendors,", "will", "be", "subject", "to", "ongoing", "regulatory", "requirements,", "including", "complying", "with", "regulations", "and", "laws", "regarding", "advertising,", "promotion", "and", "sales", "of", "products,", "required", "submissions", "of", "safety", "and", "other", "post-market", "information", "and", "reports,", "registration", "requirements,", "cGMP", "regulations", "(including", "requirements", "relating", "to", "quality", "control", "and", "quality", "assurance,", "as", "well", "as", "the", "corresponding", "maintenance", "of", "records", "and", "documentation),", "and", "the", "requirements", "regarding", "the", "distribution", "of", "samples", "to", "physicians", "and", "recordkeeping", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p26_s0", "idA": "1095981_13_item1a_p50_s4", "sentA": "Additionally, fluctuations in currency exchange rates may adversely affect demand for our products by increasing the price of our products in the currency of the countries in which the products are sold.", "sentB": "Lorem Vascular is the exclusive licensee for our products in China, Hong Kong, Singapore, Malaysia and Australia, and while we will be strongly supportive to their efforts, they are responsible for obtaining regulatory approvals, market development and sales in these countries.", "type": 1, "words": ["<tag1>", "Additionally,", "fluctuations", "in", "currency", "exchange", "rates", "may", "adversely", "affect", "demand", "for", "our", "products", "by", "increasing", "the", "price", "of", "our", "products", "in", "the", "currency", "of", "the", "countries", "in", "which", "the", "products", "are", "sold.", "<tag2>", "Lorem", "Vascular", "is", "the", "exclusive", "licensee", "for", "our", "products", "in", "China,", "Hong", "Kong,", "Singapore,", "Malaysia", "and", "Australia,", "and", "while", "we", "will", "be", "strongly", "supportive", "to", "their", "efforts,", "they", "are", "responsible", "for", "obtaining", "regulatory", "approvals,", "market", "development", "and", "sales", "in", "these", "countries.", "<tag3>"], "wordsA": ["Additionally,", "fluctuations", "in", "currency", "exchange", "rates", "may", "adversely", "affect", "demand", "for", "our", "products", "by", "increasing", "the", "price", "of", "our", "products", "in", "the", "currency", "of", "the", "countries", "in", "which", "the", "products", "are", "sold."], "wordsB": ["Lorem", "Vascular", "is", "the", "exclusive", "licensee", "for", "our", "products", "in", "China,", "Hong", "Kong,", "Singapore,", "Malaysia", "and", "Australia,", "and", "while", "we", "will", "be", "strongly", "supportive", "to", "their", "efforts,", "they", "are", "responsible", "for", "obtaining", "regulatory", "approvals,", "market", "development", "and", "sales", "in", "these", "countries."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p31_s0", "idA": "1095981_13_item1a_p56_s1", "sentA": "Our global operations may be subject to risks that may limit our ability to operate our business.", "sentB": "a product candidate may be approved only for indications that are narrow or under conditions that place the product at a competitive disadvantage, which may limit the sales and marketing activities for such products or otherwise adversely impact the commercial potential of a product.", "type": 1, "words": ["<tag1>", "Our", "global", "operations", "may", "be", "subject", "to", "risks", "that", "may", "limit", "our", "ability", "to", "operate", "our", "business.", "<tag2>", "a", "product", "candidate", "may", "be", "approved", "only", "for", "indications", "that", "are", "narrow", "or", "under", "conditions", "that", "place", "the", "product", "at", "a", "competitive", "disadvantage,", "which", "may", "limit", "the", "sales", "and", "marketing", "activities", "for", "such", "products", "or", "otherwise", "adversely", "impact", "the", "commercial", "potential", "of", "a", "product.", "<tag3>"], "wordsA": ["Our", "global", "operations", "may", "be", "subject", "to", "risks", "that", "may", "limit", "our", "ability", "to", "operate", "our", "business."], "wordsB": ["a", "product", "candidate", "may", "be", "approved", "only", "for", "indications", "that", "are", "narrow", "or", "under", "conditions", "that", "place", "the", "product", "at", "a", "competitive", "disadvantage,", "which", "may", "limit", "the", "sales", "and", "marketing", "activities", "for", "such", "products", "or", "otherwise", "adversely", "impact", "the", "commercial", "potential", "of", "a", "product."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p24_s0", "idA": "1095981_13_item1a_p70_s1", "sentA": "If an audit identifies improper or illegal activities, we may be subject to civil and criminal penalties and administrative sanctions, including, but not limited to:", "sentB": "imposition of civil or criminal penalties.", "type": 1, "words": ["<tag1>", "If", "an", "audit", "identifies", "improper", "or", "illegal", "activities,", "we", "may", "be", "subject", "to", "civil", "and", "criminal", "penalties", "and", "administrative", "sanctions,", "including,", "but", "not", "limited", "to:", "<tag2>", "imposition", "of", "civil", "or", "criminal", "penalties.", "<tag3>"], "wordsA": ["If", "an", "audit", "identifies", "improper", "or", "illegal", "activities,", "we", "may", "be", "subject", "to", "civil", "and", "criminal", "penalties", "and", "administrative", "sanctions,", "including,", "but", "not", "limited", "to:"], "wordsB": ["imposition", "of", "civil", "or", "criminal", "penalties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_14_item1a_p11_s0", "idA": "1095981_13_item1a_p7_s1", "sentA": "As our focus on the Celution System platform and development of therapeutic applications for its cellular output has increased, losses have resulted primarily from expenses associated with research and development activities and general and administrative expenses.", "sentB": "Our budgeted expense levels are based in part on our expectations concerning future revenues from sales as well our assessment of the future investments needed to expand our commercial organization and support research and development activities.", "type": 1, "words": ["<tag1>", "As", "our", "focus", "on", "the", "Celution", "System", "platform", "and", "development", "of", "therapeutic", "applications", "for", "its", "cellular", "output", "has", "increased,", "losses", "have", "resulted", "primarily", "from", "expenses", "associated", "with", "research", "and", "development", "activities", "and", "general", "and", "administrative", "expenses.", "<tag2>", "Our", "budgeted", "expense", "levels", "are", "based", "in", "part", "on", "our", "expectations", "concerning", "future", "revenues", "from", "sales", "as", "well", "our", "assessment", "of", "the", "future", "investments", "needed", "to", "expand", "our", "commercial", "organization", "and", "support", "research", "and", "development", "activities.", "<tag3>"], "wordsA": ["As", "our", "focus", "on", "the", "Celution", "System", "platform", "and", "development", "of", "therapeutic", "applications", "for", "its", "cellular", "output", "has", "increased,", "losses", "have", "resulted", "primarily", "from", "expenses", "associated", "with", "research", "and", "development", "activities", "and", "general", "and", "administrative", "expenses."], "wordsB": ["Our", "budgeted", "expense", "levels", "are", "based", "in", "part", "on", "our", "expectations", "concerning", "future", "revenues", "from", "sales", "as", "well", "our", "assessment", "of", "the", "future", "investments", "needed", "to", "expand", "our", "commercial", "organization", "and", "support", "research", "and", "development", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p5_s3", "idA": "1095981_14_item1a_p19_s0", "sentA": "We have entered into collaboration agreements under which we may receive future payments in the form of milestone payments, maintenance fees and royalties.", "sentB": "On September 19, 2014, we entered into a letter agreement with the Lenders (the Letter Agreement ) pursuant to which we received a waiver of compliance with the Loan Agreement through October 31, 2014.", "type": 1, "words": ["<tag1>", "We", "have", "entered", "into", "collaboration", "agreements", "under", "which", "we", "may", "receive", "future", "payments", "in", "the", "form", "of", "milestone", "payments,", "maintenance", "fees", "and", "royalties.", "<tag2>", "On", "September", "19,", "2014,", "we", "entered", "into", "a", "letter", "agreement", "with", "the", "Lenders", "(the", "Letter", "Agreement", ")", "pursuant", "to", "which", "we", "received", "a", "waiver", "of", "compliance", "with", "the", "Loan", "Agreement", "through", "October", "31,", "2014.", "<tag3>"], "wordsA": ["We", "have", "entered", "into", "collaboration", "agreements", "under", "which", "we", "may", "receive", "future", "payments", "in", "the", "form", "of", "milestone", "payments,", "maintenance", "fees", "and", "royalties."], "wordsB": ["On", "September", "19,", "2014,", "we", "entered", "into", "a", "letter", "agreement", "with", "the", "Lenders", "(the", "Letter", "Agreement", ")", "pursuant", "to", "which", "we", "received", "a", "waiver", "of", "compliance", "with", "the", "Loan", "Agreement", "through", "October", "31,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p10_s1", "idA": "1095981_14_item1a_p21_s0", "sentA": "Regulatory authorities subject a marketed product, its manufacturer and the manufacturing facilities to continual review and periodic inspections.", "sentB": "Subsequently we regained compliance with this listing rule and the matter was closed by Nasdaq.", "type": 1, "words": ["<tag1>", "Regulatory", "authorities", "subject", "a", "marketed", "product,", "its", "manufacturer", "and", "the", "manufacturing", "facilities", "to", "continual", "review", "and", "periodic", "inspections.", "<tag2>", "Subsequently", "we", "regained", "compliance", "with", "this", "listing", "rule", "and", "the", "matter", "was", "closed", "by", "Nasdaq.", "<tag3>"], "wordsA": ["Regulatory", "authorities", "subject", "a", "marketed", "product,", "its", "manufacturer", "and", "the", "manufacturing", "facilities", "to", "continual", "review", "and", "periodic", "inspections."], "wordsB": ["Subsequently", "we", "regained", "compliance", "with", "this", "listing", "rule", "and", "the", "matter", "was", "closed", "by", "Nasdaq."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p11_s1", "idA": "1095981_14_item1a_p21_s0", "sentA": "Regulatory authorities subject a marketed product, its manufacturer and the manufacturing facilities to continual review and periodic inspections.", "sentB": "Subsequently we regained compliance with this listing rule and the matter was closed by Nasdaq.", "type": 1, "words": ["<tag1>", "Regulatory", "authorities", "subject", "a", "marketed", "product,", "its", "manufacturer", "and", "the", "manufacturing", "facilities", "to", "continual", "review", "and", "periodic", "inspections.", "<tag2>", "Subsequently", "we", "regained", "compliance", "with", "this", "listing", "rule", "and", "the", "matter", "was", "closed", "by", "Nasdaq.", "<tag3>"], "wordsA": ["Regulatory", "authorities", "subject", "a", "marketed", "product,", "its", "manufacturer", "and", "the", "manufacturing", "facilities", "to", "continual", "review", "and", "periodic", "inspections."], "wordsB": ["Subsequently", "we", "regained", "compliance", "with", "this", "listing", "rule", "and", "the", "matter", "was", "closed", "by", "Nasdaq."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p80_s0", "idA": "1095981_14_item1a_p28_s2", "sentA": "These risks are increased by our reliance on third parties in the performance of many of the clinical trial functions, including the clinical investigators, hospitals, and other third party service providers.", "sentB": "On August 13, 2014, we and BARDA amended the contract exercising Option 1 to perform research, regulatory, clinical and other tasks required for initiation of a pilot clinical trial of the Celution System in thermal burn injury, amended the Statement of Work and reorganized the contract options.", "type": 1, "words": ["<tag1>", "These", "risks", "are", "increased", "by", "our", "reliance", "on", "third", "parties", "in", "the", "performance", "of", "many", "of", "the", "clinical", "trial", "functions,", "including", "the", "clinical", "investigators,", "hospitals,", "and", "other", "third", "party", "service", "providers.", "<tag2>", "On", "August", "13,", "2014,", "we", "and", "BARDA", "amended", "the", "contract", "exercising", "Option", "1", "to", "perform", "research,", "regulatory,", "clinical", "and", "other", "tasks", "required", "for", "initiation", "of", "a", "pilot", "clinical", "trial", "of", "the", "Celution", "System", "in", "thermal", "burn", "injury,", "amended", "the", "Statement", "of", "Work", "and", "reorganized", "the", "contract", "options.", "<tag3>"], "wordsA": ["These", "risks", "are", "increased", "by", "our", "reliance", "on", "third", "parties", "in", "the", "performance", "of", "many", "of", "the", "clinical", "trial", "functions,", "including", "the", "clinical", "investigators,", "hospitals,", "and", "other", "third", "party", "service", "providers."], "wordsB": ["On", "August", "13,", "2014,", "we", "and", "BARDA", "amended", "the", "contract", "exercising", "Option", "1", "to", "perform", "research,", "regulatory,", "clinical", "and", "other", "tasks", "required", "for", "initiation", "of", "a", "pilot", "clinical", "trial", "of", "the", "Celution", "System", "in", "thermal", "burn", "injury,", "amended", "the", "Statement", "of", "Work", "and", "reorganized", "the", "contract", "options."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p80_s3", "idA": "1095981_14_item1a_p28_s2", "sentA": "These risks are increased by our reliance on third parties in the performance of many of the clinical trial functions, including the clinical investigators, hospitals, and other third party service providers.", "sentB": "The revised Option 2 consists of execution of the pilot clinical study, regulatory, and other tasks for a cost plus fixed fee of up to $8.3 million.", "type": 1, "words": ["<tag1>", "These", "risks", "are", "increased", "by", "our", "reliance", "on", "third", "parties", "in", "the", "performance", "of", "many", "of", "the", "clinical", "trial", "functions,", "including", "the", "clinical", "investigators,", "hospitals,", "and", "other", "third", "party", "service", "providers.", "<tag2>", "The", "revised", "Option", "2", "consists", "of", "execution", "of", "the", "pilot", "clinical", "study,", "regulatory,", "and", "other", "tasks", "for", "a", "cost", "plus", "fixed", "fee", "of", "up", "to", "$8.3", "million.", "<tag3>"], "wordsA": ["These", "risks", "are", "increased", "by", "our", "reliance", "on", "third", "parties", "in", "the", "performance", "of", "many", "of", "the", "clinical", "trial", "functions,", "including", "the", "clinical", "investigators,", "hospitals,", "and", "other", "third", "party", "service", "providers."], "wordsB": ["The", "revised", "Option", "2", "consists", "of", "execution", "of", "the", "pilot", "clinical", "study,", "regulatory,", "and", "other", "tasks", "for", "a", "cost", "plus", "fixed", "fee", "of", "up", "to", "$8.3", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p80_s4", "idA": "1095981_14_item1a_p28_s2", "sentA": "These risks are increased by our reliance on third parties in the performance of many of the clinical trial functions, including the clinical investigators, hospitals, and other third party service providers.", "sentB": "The revised Option 3 consists of clinical, regulatory, and other tasks for completion of a pivotal clinical trial leading to FDA approval for use of the Celution System in thermal burn injury, for a cost plus fixed fee of up to $45.5 million.", "type": 1, "words": ["<tag1>", "These", "risks", "are", "increased", "by", "our", "reliance", "on", "third", "parties", "in", "the", "performance", "of", "many", "of", "the", "clinical", "trial", "functions,", "including", "the", "clinical", "investigators,", "hospitals,", "and", "other", "third", "party", "service", "providers.", "<tag2>", "The", "revised", "Option", "3", "consists", "of", "clinical,", "regulatory,", "and", "other", "tasks", "for", "completion", "of", "a", "pivotal", "clinical", "trial", "leading", "to", "FDA", "approval", "for", "use", "of", "the", "Celution", "System", "in", "thermal", "burn", "injury,", "for", "a", "cost", "plus", "fixed", "fee", "of", "up", "to", "$45.5", "million.", "<tag3>"], "wordsA": ["These", "risks", "are", "increased", "by", "our", "reliance", "on", "third", "parties", "in", "the", "performance", "of", "many", "of", "the", "clinical", "trial", "functions,", "including", "the", "clinical", "investigators,", "hospitals,", "and", "other", "third", "party", "service", "providers."], "wordsB": ["The", "revised", "Option", "3", "consists", "of", "clinical,", "regulatory,", "and", "other", "tasks", "for", "completion", "of", "a", "pivotal", "clinical", "trial", "leading", "to", "FDA", "approval", "for", "use", "of", "the", "Celution", "System", "in", "thermal", "burn", "injury,", "for", "a", "cost", "plus", "fixed", "fee", "of", "up", "to", "$45.5", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p34_s4", "idA": "1095981_14_item1a_p29_s2", "sentA": "Clinical trials for any of our products could be unsuccessful, which would delay or prohibit regulatory approval and commercialization of the product.", "sentB": "Further, to the extent Lorem fails to comply with any regulations applicable to its marketing and commercialization of our products, we cannot assure you that regulators might not try to hold us responsible for such activities if they believe we somehow facilitated or were otherwise responsible for Lorem s actions.", "type": 1, "words": ["<tag1>", "Clinical", "trials", "for", "any", "of", "our", "products", "could", "be", "unsuccessful,", "which", "would", "delay", "or", "prohibit", "regulatory", "approval", "and", "commercialization", "of", "the", "product.", "<tag2>", "Further,", "to", "the", "extent", "Lorem", "fails", "to", "comply", "with", "any", "regulations", "applicable", "to", "its", "marketing", "and", "commercialization", "of", "our", "products,", "we", "cannot", "assure", "you", "that", "regulators", "might", "not", "try", "to", "hold", "us", "responsible", "for", "such", "activities", "if", "they", "believe", "we", "somehow", "facilitated", "or", "were", "otherwise", "responsible", "for", "Lorem", "s", "actions.", "<tag3>"], "wordsA": ["Clinical", "trials", "for", "any", "of", "our", "products", "could", "be", "unsuccessful,", "which", "would", "delay", "or", "prohibit", "regulatory", "approval", "and", "commercialization", "of", "the", "product."], "wordsB": ["Further,", "to", "the", "extent", "Lorem", "fails", "to", "comply", "with", "any", "regulations", "applicable", "to", "its", "marketing", "and", "commercialization", "of", "our", "products,", "we", "cannot", "assure", "you", "that", "regulators", "might", "not", "try", "to", "hold", "us", "responsible", "for", "such", "activities", "if", "they", "believe", "we", "somehow", "facilitated", "or", "were", "otherwise", "responsible", "for", "Lorem", "s", "actions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p5_s1", "idA": "1095981_14_item1a_p31_s0", "sentA": "a product candidate may be approved only for indications that are narrow or under conditions that place the product at a competitive disadvantage, which may limit the sales and marketing activities for such products or otherwise adversely impact the commercial potential of a product.", "sentB": "The Term Loan accrues interest at a fixed rate of 9.75% per annum.", "type": 1, "words": ["<tag1>", "a", "product", "candidate", "may", "be", "approved", "only", "for", "indications", "that", "are", "narrow", "or", "under", "conditions", "that", "place", "the", "product", "at", "a", "competitive", "disadvantage,", "which", "may", "limit", "the", "sales", "and", "marketing", "activities", "for", "such", "products", "or", "otherwise", "adversely", "impact", "the", "commercial", "potential", "of", "a", "product.", "<tag2>", "The", "Term", "Loan", "accrues", "interest", "at", "a", "fixed", "rate", "of", "9.75%", "per", "annum.", "<tag3>"], "wordsA": ["a", "product", "candidate", "may", "be", "approved", "only", "for", "indications", "that", "are", "narrow", "or", "under", "conditions", "that", "place", "the", "product", "at", "a", "competitive", "disadvantage,", "which", "may", "limit", "the", "sales", "and", "marketing", "activities", "for", "such", "products", "or", "otherwise", "adversely", "impact", "the", "commercial", "potential", "of", "a", "product."], "wordsB": ["The", "Term", "Loan", "accrues", "interest", "at", "a", "fixed", "rate", "of", "9.75%", "per", "annum."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p5_s2", "idA": "1095981_14_item1a_p37_s1", "sentA": "If we were judicially determined to be infringing on any third-party patent, we could be required to pay damages, alter our products or processes, obtain licenses, or cease certain activities.", "sentB": "Pursuant to the Loan Agreement, we were required to make interest only payments through July 1, 2014.", "type": 1, "words": ["<tag1>", "If", "we", "were", "judicially", "determined", "to", "be", "infringing", "on", "any", "third-party", "patent,", "we", "could", "be", "required", "to", "pay", "damages,", "alter", "our", "products", "or", "processes,", "obtain", "licenses,", "or", "cease", "certain", "activities.", "<tag2>", "Pursuant", "to", "the", "Loan", "Agreement,", "we", "were", "required", "to", "make", "interest", "only", "payments", "through", "July", "1,", "2014.", "<tag3>"], "wordsA": ["If", "we", "were", "judicially", "determined", "to", "be", "infringing", "on", "any", "third-party", "patent,", "we", "could", "be", "required", "to", "pay", "damages,", "alter", "our", "products", "or", "processes,", "obtain", "licenses,", "or", "cease", "certain", "activities."], "wordsB": ["Pursuant", "to", "the", "Loan", "Agreement,", "we", "were", "required", "to", "make", "interest", "only", "payments", "through", "July", "1,", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p4_s0", "idA": "1095981_14_item1a_p44_s0", "sentA": "In addition to patents, which alone may not be able to protect the fundamentals of our business, we also rely on unpatented trade secrets and proprietary technological expertise.", "sentB": "In addition to the funding sources previously mentioned, we continue to seek additional capital through product revenues, strategic transactions, IP licensing, and State and Federal development programs, including additional funding opportunities though our current BARDA contract.", "type": 1, "words": ["<tag1>", "In", "addition", "to", "patents,", "which", "alone", "may", "not", "be", "able", "to", "protect", "the", "fundamentals", "of", "our", "business,", "we", "also", "rely", "on", "unpatented", "trade", "secrets", "and", "proprietary", "technological", "expertise.", "<tag2>", "In", "addition", "to", "the", "funding", "sources", "previously", "mentioned,", "we", "continue", "to", "seek", "additional", "capital", "through", "product", "revenues,", "strategic", "transactions,", "IP", "licensing,", "and", "State", "and", "Federal", "development", "programs,", "including", "additional", "funding", "opportunities", "though", "our", "current", "BARDA", "contract.", "<tag3>"], "wordsA": ["In", "addition", "to", "patents,", "which", "alone", "may", "not", "be", "able", "to", "protect", "the", "fundamentals", "of", "our", "business,", "we", "also", "rely", "on", "unpatented", "trade", "secrets", "and", "proprietary", "technological", "expertise."], "wordsB": ["In", "addition", "to", "the", "funding", "sources", "previously", "mentioned,", "we", "continue", "to", "seek", "additional", "capital", "through", "product", "revenues,", "strategic", "transactions,", "IP", "licensing,", "and", "State", "and", "Federal", "development", "programs,", "including", "additional", "funding", "opportunities", "though", "our", "current", "BARDA", "contract."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p5_s4", "idA": "1095981_14_item1a_p52_s4", "sentA": "Our Celution products under development today and in the foreseeable future will be subject to the lengthier PMA process.", "sentB": "On June 5, 2014 we entered into a First Amendment to the Loan Agreement which modified the definition of Permitted Investments to allow the Company to establish and invest up to $500,000 per year in its wholly owned Subsidiary in the United Kingdom (Cytori Ltd.).", "type": 1, "words": ["<tag1>", "Our", "Celution", "products", "under", "development", "today", "and", "in", "the", "foreseeable", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process.", "<tag2>", "On", "June", "5,", "2014", "we", "entered", "into", "a", "First", "Amendment", "to", "the", "Loan", "Agreement", "which", "modified", "the", "definition", "of", "Permitted", "Investments", "to", "allow", "the", "Company", "to", "establish", "and", "invest", "up", "to", "$500,000", "per", "year", "in", "its", "wholly", "owned", "Subsidiary", "in", "the", "United", "Kingdom", "(Cytori", "Ltd.).", "<tag3>"], "wordsA": ["Our", "Celution", "products", "under", "development", "today", "and", "in", "the", "foreseeable", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process."], "wordsB": ["On", "June", "5,", "2014", "we", "entered", "into", "a", "First", "Amendment", "to", "the", "Loan", "Agreement", "which", "modified", "the", "definition", "of", "Permitted", "Investments", "to", "allow", "the", "Company", "to", "establish", "and", "invest", "up", "to", "$500,000", "per", "year", "in", "its", "wholly", "owned", "Subsidiary", "in", "the", "United", "Kingdom", "(Cytori", "Ltd.)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p5_s5", "idA": "1095981_14_item1a_p52_s4", "sentA": "Our Celution products under development today and in the foreseeable future will be subject to the lengthier PMA process.", "sentB": "On September 29, 2014 we entered into a Second Amendment to the Loan Agreement with the Lenders wherein we were provided a conditional waiver of principal payments subject to meeting certain capital raise requirements, which we achieved in October 2014.", "type": 1, "words": ["<tag1>", "Our", "Celution", "products", "under", "development", "today", "and", "in", "the", "foreseeable", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process.", "<tag2>", "On", "September", "29,", "2014", "we", "entered", "into", "a", "Second", "Amendment", "to", "the", "Loan", "Agreement", "with", "the", "Lenders", "wherein", "we", "were", "provided", "a", "conditional", "waiver", "of", "principal", "payments", "subject", "to", "meeting", "certain", "capital", "raise", "requirements,", "which", "we", "achieved", "in", "October", "2014.", "<tag3>"], "wordsA": ["Our", "Celution", "products", "under", "development", "today", "and", "in", "the", "foreseeable", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process."], "wordsB": ["On", "September", "29,", "2014", "we", "entered", "into", "a", "Second", "Amendment", "to", "the", "Loan", "Agreement", "with", "the", "Lenders", "wherein", "we", "were", "provided", "a", "conditional", "waiver", "of", "principal", "payments", "subject", "to", "meeting", "certain", "capital", "raise", "requirements,", "which", "we", "achieved", "in", "October", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p80_s2", "idA": "1095981_14_item1a_p5_s1", "sentA": "As our focus on the Celution System platform and development of therapeutic applications for its cellular output has increased, losses have resulted primarily from expenses associated with research and development activities and general and administrative expenses.", "sentB": "In December 2014, we executed an amendment to the August 2014 contract option to fund continued investigation and development of Cytori Cell Therapy for use in thermal burn injuries , which increased the option extension to $14.1 million.", "type": 1, "words": ["<tag1>", "As", "our", "focus", "on", "the", "Celution", "System", "platform", "and", "development", "of", "therapeutic", "applications", "for", "its", "cellular", "output", "has", "increased,", "losses", "have", "resulted", "primarily", "from", "expenses", "associated", "with", "research", "and", "development", "activities", "and", "general", "and", "administrative", "expenses.", "<tag2>", "In", "December", "2014,", "we", "executed", "an", "amendment", "to", "the", "August", "2014", "contract", "option", "to", "fund", "continued", "investigation", "and", "development", "of", "Cytori", "Cell", "Therapy", "for", "use", "in", "thermal", "burn", "injuries", ",", "which", "increased", "the", "option", "extension", "to", "$14.1", "million.", "<tag3>"], "wordsA": ["As", "our", "focus", "on", "the", "Celution", "System", "platform", "and", "development", "of", "therapeutic", "applications", "for", "its", "cellular", "output", "has", "increased,", "losses", "have", "resulted", "primarily", "from", "expenses", "associated", "with", "research", "and", "development", "activities", "and", "general", "and", "administrative", "expenses."], "wordsB": ["In", "December", "2014,", "we", "executed", "an", "amendment", "to", "the", "August", "2014", "contract", "option", "to", "fund", "continued", "investigation", "and", "development", "of", "Cytori", "Cell", "Therapy", "for", "use", "in", "thermal", "burn", "injuries", ",", "which", "increased", "the", "option", "extension", "to", "$14.1", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p10_s0", "idA": "1095981_14_item1a_p87_s2", "sentA": "In addition, our 2004 Equity Incentive Plan provides for annual increases in the number of shares available for issuance under the plan, which may, among other things, result in dilution of the price of our common stock.", "sentB": "On October 30, 2014 we received a letter from the Listing Qualifications staff of The NASDAQ Stock Market LLC ( Nasdaq ) indicating that, based upon the closing bid price of the our common stock for the last 30 consecutive business days, we no longer meet the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5450(a)(1).", "type": 1, "words": ["<tag1>", "In", "addition,", "our", "2004", "Equity", "Incentive", "Plan", "provides", "for", "annual", "increases", "in", "the", "number", "of", "shares", "available", "for", "issuance", "under", "the", "plan,", "which", "may,", "among", "other", "things,", "result", "in", "dilution", "of", "the", "price", "of", "our", "common", "stock.", "<tag2>", "On", "October", "30,", "2014", "we", "received", "a", "letter", "from", "the", "Listing", "Qualifications", "staff", "of", "The", "NASDAQ", "Stock", "Market", "LLC", "(", "Nasdaq", ")", "indicating", "that,", "based", "upon", "the", "closing", "bid", "price", "of", "the", "our", "common", "stock", "for", "the", "last", "30", "consecutive", "business", "days,", "we", "no", "longer", "meet", "the", "requirement", "to", "maintain", "a", "minimum", "bid", "price", "of", "$1", "per", "share,", "as", "set", "forth", "in", "Nasdaq", "Listing", "Rule", "5450(a)(1).", "<tag3>"], "wordsA": ["In", "addition,", "our", "2004", "Equity", "Incentive", "Plan", "provides", "for", "annual", "increases", "in", "the", "number", "of", "shares", "available", "for", "issuance", "under", "the", "plan,", "which", "may,", "among", "other", "things,", "result", "in", "dilution", "of", "the", "price", "of", "our", "common", "stock."], "wordsB": ["On", "October", "30,", "2014", "we", "received", "a", "letter", "from", "the", "Listing", "Qualifications", "staff", "of", "The", "NASDAQ", "Stock", "Market", "LLC", "(", "Nasdaq", ")", "indicating", "that,", "based", "upon", "the", "closing", "bid", "price", "of", "the", "our", "common", "stock", "for", "the", "last", "30", "consecutive", "business", "days,", "we", "no", "longer", "meet", "the", "requirement", "to", "maintain", "a", "minimum", "bid", "price", "of", "$1", "per", "share,", "as", "set", "forth", "in", "Nasdaq", "Listing", "Rule", "5450(a)(1)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p5_s6", "idA": "1095981_14_item1a_p88_s2", "sentA": "If we receive a written request from any of these stockholders to file a registration statement under the Securities Act covering its shares of unregistered common stock, we are required to use reasonable efforts to prepare and file with the SEC within 30 business days of such request a registration statement covering the resale of the shares for an offering to be made on a continuous basis pursuant to Rule 415 under the Securities Act.", "sentB": "Pursuant to the Second Amendment to the Loan Agreement we obtained a deferral of principal payments from November 1, 2014 through April 1, 2015 and thereafter we are required to make payments of principal and accrued interest in equal monthly installments (of approximately$1,003,000) sufficient to amortize the Term Loans through the maturity date.", "type": 1, "words": ["<tag1>", "If", "we", "receive", "a", "written", "request", "from", "any", "of", "these", "stockholders", "to", "file", "a", "registration", "statement", "under", "the", "Securities", "Act", "covering", "its", "shares", "of", "unregistered", "common", "stock,", "we", "are", "required", "to", "use", "reasonable", "efforts", "to", "prepare", "and", "file", "with", "the", "SEC", "within", "30", "business", "days", "of", "such", "request", "a", "registration", "statement", "covering", "the", "resale", "of", "the", "shares", "for", "an", "offering", "to", "be", "made", "on", "a", "continuous", "basis", "pursuant", "to", "Rule", "415", "under", "the", "Securities", "Act.", "<tag2>", "Pursuant", "to", "the", "Second", "Amendment", "to", "the", "Loan", "Agreement", "we", "obtained", "a", "deferral", "of", "principal", "payments", "from", "November", "1,", "2014", "through", "April", "1,", "2015", "and", "thereafter", "we", "are", "required", "to", "make", "payments", "of", "principal", "and", "accrued", "interest", "in", "equal", "monthly", "installments", "(of", "approximately$1,003,000)", "sufficient", "to", "amortize", "the", "Term", "Loans", "through", "the", "maturity", "date.", "<tag3>"], "wordsA": ["If", "we", "receive", "a", "written", "request", "from", "any", "of", "these", "stockholders", "to", "file", "a", "registration", "statement", "under", "the", "Securities", "Act", "covering", "its", "shares", "of", "unregistered", "common", "stock,", "we", "are", "required", "to", "use", "reasonable", "efforts", "to", "prepare", "and", "file", "with", "the", "SEC", "within", "30", "business", "days", "of", "such", "request", "a", "registration", "statement", "covering", "the", "resale", "of", "the", "shares", "for", "an", "offering", "to", "be", "made", "on", "a", "continuous", "basis", "pursuant", "to", "Rule", "415", "under", "the", "Securities", "Act."], "wordsB": ["Pursuant", "to", "the", "Second", "Amendment", "to", "the", "Loan", "Agreement", "we", "obtained", "a", "deferral", "of", "principal", "payments", "from", "November", "1,", "2014", "through", "April", "1,", "2015", "and", "thereafter", "we", "are", "required", "to", "make", "payments", "of", "principal", "and", "accrued", "interest", "in", "equal", "monthly", "installments", "(of", "approximately$1,003,000)", "sufficient", "to", "amortize", "the", "Term", "Loans", "through", "the", "maturity", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p3_s4", "idA": "1095981_14_item1a_p8_s0", "sentA": "Although we have significant experience in manufacturing the current Celution System platform and its consumables at a commercial level, there can be no guarantee that we will be able to successfully develop and manufacture future generation Celution Systems in a manner that is cost-effective or commercially viable, or that development and manufacturing capabilities might not take much longer than currently anticipated to be ready for the market.", "sentB": "While we have an established history of raising capital through these platforms, and we are currently involved in negotiations with multiple parties, there is no guarantee that adequate funds will be available when needed from additional debt or equity financing, development and commercialization partnerships or from other sources, or on terms acceptable to us.", "type": 1, "words": ["<tag1>", "Although", "we", "have", "significant", "experience", "in", "manufacturing", "the", "current", "Celution", "System", "platform", "and", "its", "consumables", "at", "a", "commercial", "level,", "there", "can", "be", "no", "guarantee", "that", "we", "will", "be", "able", "to", "successfully", "develop", "and", "manufacture", "future", "generation", "Celution", "Systems", "in", "a", "manner", "that", "is", "cost-effective", "or", "commercially", "viable,", "or", "that", "development", "and", "manufacturing", "capabilities", "might", "not", "take", "much", "longer", "than", "currently", "anticipated", "to", "be", "ready", "for", "the", "market.", "<tag2>", "While", "we", "have", "an", "established", "history", "of", "raising", "capital", "through", "these", "platforms,", "and", "we", "are", "currently", "involved", "in", "negotiations", "with", "multiple", "parties,", "there", "is", "no", "guarantee", "that", "adequate", "funds", "will", "be", "available", "when", "needed", "from", "additional", "debt", "or", "equity", "financing,", "development", "and", "commercialization", "partnerships", "or", "from", "other", "sources,", "or", "on", "terms", "acceptable", "to", "us.", "<tag3>"], "wordsA": ["Although", "we", "have", "significant", "experience", "in", "manufacturing", "the", "current", "Celution", "System", "platform", "and", "its", "consumables", "at", "a", "commercial", "level,", "there", "can", "be", "no", "guarantee", "that", "we", "will", "be", "able", "to", "successfully", "develop", "and", "manufacture", "future", "generation", "Celution", "Systems", "in", "a", "manner", "that", "is", "cost-effective", "or", "commercially", "viable,", "or", "that", "development", "and", "manufacturing", "capabilities", "might", "not", "take", "much", "longer", "than", "currently", "anticipated", "to", "be", "ready", "for", "the", "market."], "wordsB": ["While", "we", "have", "an", "established", "history", "of", "raising", "capital", "through", "these", "platforms,", "and", "we", "are", "currently", "involved", "in", "negotiations", "with", "multiple", "parties,", "there", "is", "no", "guarantee", "that", "adequate", "funds", "will", "be", "available", "when", "needed", "from", "additional", "debt", "or", "equity", "financing,", "development", "and", "commercialization", "partnerships", "or", "from", "other", "sources,", "or", "on", "terms", "acceptable", "to", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_15_item1a_p11_s0", "idA": "1095981_14_item1a_p94_s0", "sentA": "The trading market for our common stock will be influenced by the research and reports that industry or securities analysts publish about us or our business.", "sentB": "On November 20, 2014 we received a second letter from Nasdaq indicating that, based upon the Market Value of Listed Securities (MVLS) for our common stock for the last 30 consecutive business days, we no longer meet the requirement to maintain a minimum MVLS of $50,000,000, as set forth in Nasdaq Listing Rule 5450(b)(2)(a).", "type": 1, "words": ["<tag1>", "The", "trading", "market", "for", "our", "common", "stock", "will", "be", "influenced", "by", "the", "research", "and", "reports", "that", "industry", "or", "securities", "analysts", "publish", "about", "us", "or", "our", "business.", "<tag2>", "On", "November", "20,", "2014", "we", "received", "a", "second", "letter", "from", "Nasdaq", "indicating", "that,", "based", "upon", "the", "Market", "Value", "of", "Listed", "Securities", "(MVLS)", "for", "our", "common", "stock", "for", "the", "last", "30", "consecutive", "business", "days,", "we", "no", "longer", "meet", "the", "requirement", "to", "maintain", "a", "minimum", "MVLS", "of", "$50,000,000,", "as", "set", "forth", "in", "Nasdaq", "Listing", "Rule", "5450(b)(2)(a).", "<tag3>"], "wordsA": ["The", "trading", "market", "for", "our", "common", "stock", "will", "be", "influenced", "by", "the", "research", "and", "reports", "that", "industry", "or", "securities", "analysts", "publish", "about", "us", "or", "our", "business."], "wordsB": ["On", "November", "20,", "2014", "we", "received", "a", "second", "letter", "from", "Nasdaq", "indicating", "that,", "based", "upon", "the", "Market", "Value", "of", "Listed", "Securities", "(MVLS)", "for", "our", "common", "stock", "for", "the", "last", "30", "consecutive", "business", "days,", "we", "no", "longer", "meet", "the", "requirement", "to", "maintain", "a", "minimum", "MVLS", "of", "$50,000,000,", "as", "set", "forth", "in", "Nasdaq", "Listing", "Rule", "5450(b)(2)(a)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item1a_p16_s1", "idA": "1095981_15_item1a_p105_s0", "sentA": "The trading market for our common stock will be influenced by the research and reports that industry or securities analysts publish about us or our business.", "sentB": "To regain compliance with Nasdaq s minimum bid requirement, we have committed to consummate a reverse stock split at our annual stockholder meeting (unless our stock price organically rises above $1 and cures our bid price deficiency), which split would likely be unfavorably received by the market and could further depress the market for our shares.", "type": 1, "words": ["<tag1>", "The", "trading", "market", "for", "our", "common", "stock", "will", "be", "influenced", "by", "the", "research", "and", "reports", "that", "industry", "or", "securities", "analysts", "publish", "about", "us", "or", "our", "business.", "<tag2>", "To", "regain", "compliance", "with", "Nasdaq", "s", "minimum", "bid", "requirement,", "we", "have", "committed", "to", "consummate", "a", "reverse", "stock", "split", "at", "our", "annual", "stockholder", "meeting", "(unless", "our", "stock", "price", "organically", "rises", "above", "$1", "and", "cures", "our", "bid", "price", "deficiency),", "which", "split", "would", "likely", "be", "unfavorably", "received", "by", "the", "market", "and", "could", "further", "depress", "the", "market", "for", "our", "shares.", "<tag3>"], "wordsA": ["The", "trading", "market", "for", "our", "common", "stock", "will", "be", "influenced", "by", "the", "research", "and", "reports", "that", "industry", "or", "securities", "analysts", "publish", "about", "us", "or", "our", "business."], "wordsB": ["To", "regain", "compliance", "with", "Nasdaq", "s", "minimum", "bid", "requirement,", "we", "have", "committed", "to", "consummate", "a", "reverse", "stock", "split", "at", "our", "annual", "stockholder", "meeting", "(unless", "our", "stock", "price", "organically", "rises", "above", "$1", "and", "cures", "our", "bid", "price", "deficiency),", "which", "split", "would", "likely", "be", "unfavorably", "received", "by", "the", "market", "and", "could", "further", "depress", "the", "market", "for", "our", "shares."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item1a_p13_s4", "idA": "1095981_15_item1a_p12_s0", "sentA": "There can be no assurance that we will be able to maintain compliance with the minimum bid price requirement or the MVLS requirement, or maintain compliance with the other listing requirements, or that we will be eligible for listing on any comparable trading market.", "sentB": "The hearing was held on January 21, 2016, and on January 27, 2016, the Nasdaq Hearing Panel issued its determination letter which it granted us an additional 180-day period (expiring May 31, 2016) to come into compliance with its minimum bid price requirement, and which required that:", "type": 1, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "we", "will", "be", "able", "to", "maintain", "compliance", "with", "the", "minimum", "bid", "price", "requirement", "or", "the", "MVLS", "requirement,", "or", "maintain", "compliance", "with", "the", "other", "listing", "requirements,", "or", "that", "we", "will", "be", "eligible", "for", "listing", "on", "any", "comparable", "trading", "market.", "<tag2>", "The", "hearing", "was", "held", "on", "January", "21,", "2016,", "and", "on", "January", "27,", "2016,", "the", "Nasdaq", "Hearing", "Panel", "issued", "its", "determination", "letter", "which", "it", "granted", "us", "an", "additional", "180-day", "period", "(expiring", "May", "31,", "2016)", "to", "come", "into", "compliance", "with", "its", "minimum", "bid", "price", "requirement,", "and", "which", "required", "that:", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "we", "will", "be", "able", "to", "maintain", "compliance", "with", "the", "minimum", "bid", "price", "requirement", "or", "the", "MVLS", "requirement,", "or", "maintain", "compliance", "with", "the", "other", "listing", "requirements,", "or", "that", "we", "will", "be", "eligible", "for", "listing", "on", "any", "comparable", "trading", "market."], "wordsB": ["The", "hearing", "was", "held", "on", "January", "21,", "2016,", "and", "on", "January", "27,", "2016,", "the", "Nasdaq", "Hearing", "Panel", "issued", "its", "determination", "letter", "which", "it", "granted", "us", "an", "additional", "180-day", "period", "(expiring", "May", "31,", "2016)", "to", "come", "into", "compliance", "with", "its", "minimum", "bid", "price", "requirement,", "and", "which", "required", "that:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item1a_p42_s0", "idA": "1095981_15_item1a_p22_s0", "sentA": "We compete with many domestic and foreign companies in developing our technology and products, including biotechnology, medical device, and pharmaceutical companies.", "sentB": "The EU regulatory environment is complicated, and our technology approach is novel.", "type": 1, "words": ["<tag1>", "We", "compete", "with", "many", "domestic", "and", "foreign", "companies", "in", "developing", "our", "technology", "and", "products,", "including", "biotechnology,", "medical", "device,", "and", "pharmaceutical", "companies.", "<tag2>", "The", "EU", "regulatory", "environment", "is", "complicated,", "and", "our", "technology", "approach", "is", "novel.", "<tag3>"], "wordsA": ["We", "compete", "with", "many", "domestic", "and", "foreign", "companies", "in", "developing", "our", "technology", "and", "products,", "including", "biotechnology,", "medical", "device,", "and", "pharmaceutical", "companies."], "wordsB": ["The", "EU", "regulatory", "environment", "is", "complicated,", "and", "our", "technology", "approach", "is", "novel."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item1a_p40_s0", "idA": "1095981_15_item1a_p26_s0", "sentA": "We are in a relatively early stage of the path to commercialization with many of our products.", "sentB": "Further, we are in discussions with Lorem Vascular to appropriately restructure our agreement with them.", "type": 1, "words": ["<tag1>", "We", "are", "in", "a", "relatively", "early", "stage", "of", "the", "path", "to", "commercialization", "with", "many", "of", "our", "products.", "<tag2>", "Further,", "we", "are", "in", "discussions", "with", "Lorem", "Vascular", "to", "appropriately", "restructure", "our", "agreement", "with", "them.", "<tag3>"], "wordsA": ["We", "are", "in", "a", "relatively", "early", "stage", "of", "the", "path", "to", "commercialization", "with", "many", "of", "our", "products."], "wordsB": ["Further,", "we", "are", "in", "discussions", "with", "Lorem", "Vascular", "to", "appropriately", "restructure", "our", "agreement", "with", "them."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item1a_p40_s2", "idA": "1095981_15_item1a_p29_s1", "sentA": "We are dependent on our collaborators to commercialize Cytori Cell Therapy in certain countries in order for us to realize any financial benefits from these collaborations.", "sentB": "A dispute may arise between us and Lorem Vascular that could lead to diversion of management time and attention and cause us to realize little if any sales or royalty revenues from sales activities in the territories under our exclusive license with Lorem Vascular .", "type": 1, "words": ["<tag1>", "We", "are", "dependent", "on", "our", "collaborators", "to", "commercialize", "Cytori", "Cell", "Therapy", "in", "certain", "countries", "in", "order", "for", "us", "to", "realize", "any", "financial", "benefits", "from", "these", "collaborations.", "<tag2>", "A", "dispute", "may", "arise", "between", "us", "and", "Lorem", "Vascular", "that", "could", "lead", "to", "diversion", "of", "management", "time", "and", "attention", "and", "cause", "us", "to", "realize", "little", "if", "any", "sales", "or", "royalty", "revenues", "from", "sales", "activities", "in", "the", "territories", "under", "our", "exclusive", "license", "with", "Lorem", "Vascular", ".", "<tag3>"], "wordsA": ["We", "are", "dependent", "on", "our", "collaborators", "to", "commercialize", "Cytori", "Cell", "Therapy", "in", "certain", "countries", "in", "order", "for", "us", "to", "realize", "any", "financial", "benefits", "from", "these", "collaborations."], "wordsB": ["A", "dispute", "may", "arise", "between", "us", "and", "Lorem", "Vascular", "that", "could", "lead", "to", "diversion", "of", "management", "time", "and", "attention", "and", "cause", "us", "to", "realize", "little", "if", "any", "sales", "or", "royalty", "revenues", "from", "sales", "activities", "in", "the", "territories", "under", "our", "exclusive", "license", "with", "Lorem", "Vascular", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item1a_p41_s1", "idA": "1095981_15_item1a_p56_s1", "sentA": "The laws of some countries do not protect our patent and other intellectual property rights to the same extent as United States laws.", "sentB": "We expect that our partners would provide regulatory and reimbursement/pricing expertise, sales and marketing resources, and other expertise and resources vital to the success of our product offerings in their territories.", "type": 1, "words": ["<tag1>", "The", "laws", "of", "some", "countries", "do", "not", "protect", "our", "patent", "and", "other", "intellectual", "property", "rights", "to", "the", "same", "extent", "as", "United", "States", "laws.", "<tag2>", "We", "expect", "that", "our", "partners", "would", "provide", "regulatory", "and", "reimbursement/pricing", "expertise,", "sales", "and", "marketing", "resources,", "and", "other", "expertise", "and", "resources", "vital", "to", "the", "success", "of", "our", "product", "offerings", "in", "their", "territories.", "<tag3>"], "wordsA": ["The", "laws", "of", "some", "countries", "do", "not", "protect", "our", "patent", "and", "other", "intellectual", "property", "rights", "to", "the", "same", "extent", "as", "United", "States", "laws."], "wordsB": ["We", "expect", "that", "our", "partners", "would", "provide", "regulatory", "and", "reimbursement/pricing", "expertise,", "sales", "and", "marketing", "resources,", "and", "other", "expertise", "and", "resources", "vital", "to", "the", "success", "of", "our", "product", "offerings", "in", "their", "territories."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_16_item1a_p13_s3", "idA": "1095981_15_item1a_p5_s2", "sentA": "Pursuant to the Loan Agreement, we were required to make interest only payments through July 1, 2014.", "sentB": "Though we were eligible to transfer to the NCM, we elected to appeal the delisting determination to the Nasdaq Hearing Panel, which election stayed the Nasdaq Staff s determination pending the Hearing Panel s decision on our appeal.", "type": 1, "words": ["<tag1>", "Pursuant", "to", "the", "Loan", "Agreement,", "we", "were", "required", "to", "make", "interest", "only", "payments", "through", "July", "1,", "2014.", "<tag2>", "Though", "we", "were", "eligible", "to", "transfer", "to", "the", "NCM,", "we", "elected", "to", "appeal", "the", "delisting", "determination", "to", "the", "Nasdaq", "Hearing", "Panel,", "which", "election", "stayed", "the", "Nasdaq", "Staff", "s", "determination", "pending", "the", "Hearing", "Panel", "s", "decision", "on", "our", "appeal.", "<tag3>"], "wordsA": ["Pursuant", "to", "the", "Loan", "Agreement,", "we", "were", "required", "to", "make", "interest", "only", "payments", "through", "July", "1,", "2014."], "wordsB": ["Though", "we", "were", "eligible", "to", "transfer", "to", "the", "NCM,", "we", "elected", "to", "appeal", "the", "delisting", "determination", "to", "the", "Nasdaq", "Hearing", "Panel,", "which", "election", "stayed", "the", "Nasdaq", "Staff", "s", "determination", "pending", "the", "Hearing", "Panel", "s", "decision", "on", "our", "appeal."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p140_s0", "idA": "1095981_16_item1a_p101_s2", "sentA": "We believe that our future success in developing marketable products and achieving a competitive position will depend in large part upon whether we can attract and retain additional qualified management and scientific personnel.", "sentB": "Our future success also depends on the personal efforts and abilities of the principal members of our senior management and scientific staff to provide strategic direction, manage our operations, and maintain a cohesive and stable environment.", "type": 1, "words": ["<tag1>", "We", "believe", "that", "our", "future", "success", "in", "developing", "marketable", "products", "and", "achieving", "a", "competitive", "position", "will", "depend", "in", "large", "part", "upon", "whether", "we", "can", "attract", "and", "retain", "additional", "qualified", "management", "and", "scientific", "personnel.", "<tag2>", "Our", "future", "success", "also", "depends", "on", "the", "personal", "efforts", "and", "abilities", "of", "the", "principal", "members", "of", "our", "senior", "management", "and", "scientific", "staff", "to", "provide", "strategic", "direction,", "manage", "our", "operations,", "and", "maintain", "a", "cohesive", "and", "stable", "environment.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "future", "success", "in", "developing", "marketable", "products", "and", "achieving", "a", "competitive", "position", "will", "depend", "in", "large", "part", "upon", "whether", "we", "can", "attract", "and", "retain", "additional", "qualified", "management", "and", "scientific", "personnel."], "wordsB": ["Our", "future", "success", "also", "depends", "on", "the", "personal", "efforts", "and", "abilities", "of", "the", "principal", "members", "of", "our", "senior", "management", "and", "scientific", "staff", "to", "provide", "strategic", "direction,", "manage", "our", "operations,", "and", "maintain", "a", "cohesive", "and", "stable", "environment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p141_s0", "idA": "1095981_16_item1a_p102_s0", "sentA": "The testing, manufacturing, marketing, and sale of our regenerative cell products involve an inherent risk that product liability claims will be asserted against us, our distribution partners, or licensees.", "sentB": "We face potential product liability exposure, and if successful claims are brought against us, we may incur substantial liability if our insurance coverage for those claims is inadequate.", "type": 1, "words": ["<tag1>", "The", "testing,", "manufacturing,", "marketing,", "and", "sale", "of", "our", "regenerative", "cell", "products", "involve", "an", "inherent", "risk", "that", "product", "liability", "claims", "will", "be", "asserted", "against", "us,", "our", "distribution", "partners,", "or", "licensees.", "<tag2>", "We", "face", "potential", "product", "liability", "exposure,", "and", "if", "successful", "claims", "are", "brought", "against", "us,", "we", "may", "incur", "substantial", "liability", "if", "our", "insurance", "coverage", "for", "those", "claims", "is", "inadequate.", "<tag3>"], "wordsA": ["The", "testing,", "manufacturing,", "marketing,", "and", "sale", "of", "our", "regenerative", "cell", "products", "involve", "an", "inherent", "risk", "that", "product", "liability", "claims", "will", "be", "asserted", "against", "us,", "our", "distribution", "partners,", "or", "licensees."], "wordsB": ["We", "face", "potential", "product", "liability", "exposure,", "and", "if", "successful", "claims", "are", "brought", "against", "us,", "we", "may", "incur", "substantial", "liability", "if", "our", "insurance", "coverage", "for", "those", "claims", "is", "inadequate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p226_s2", "idA": "1095981_16_item1a_p103_s0", "sentA": "The market price of our common stock may be subject to significant fluctuations.", "sentB": "Because our decision to incur debt and issue securities in future offerings may be influenced by market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of our future offerings or debt financings.", "type": 1, "words": ["<tag1>", "The", "market", "price", "of", "our", "common", "stock", "may", "be", "subject", "to", "significant", "fluctuations.", "<tag2>", "Because", "our", "decision", "to", "incur", "debt", "and", "issue", "securities", "in", "future", "offerings", "may", "be", "influenced", "by", "market", "conditions", "and", "other", "factors", "beyond", "our", "control,", "we", "cannot", "predict", "or", "estimate", "the", "amount,", "timing", "or", "nature", "of", "our", "future", "offerings", "or", "debt", "financings.", "<tag3>"], "wordsA": ["The", "market", "price", "of", "our", "common", "stock", "may", "be", "subject", "to", "significant", "fluctuations."], "wordsB": ["Because", "our", "decision", "to", "incur", "debt", "and", "issue", "securities", "in", "future", "offerings", "may", "be", "influenced", "by", "market", "conditions", "and", "other", "factors", "beyond", "our", "control,", "we", "cannot", "predict", "or", "estimate", "the", "amount,", "timing", "or", "nature", "of", "our", "future", "offerings", "or", "debt", "financings."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p163_s3", "idA": "1095981_16_item1a_p103_s1", "sentA": "Among the factors that may cause the market price of our common stock to fluctuate are the risks described in this Risk Factors section and other factors, including:", "sentB": "Our future capital requirements will depend on many factors, including:", "type": 1, "words": ["<tag1>", "Among", "the", "factors", "that", "may", "cause", "the", "market", "price", "of", "our", "common", "stock", "to", "fluctuate", "are", "the", "risks", "described", "in", "this", "Risk", "Factors", "section", "and", "other", "factors,", "including:", "<tag2>", "Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including:", "<tag3>"], "wordsA": ["Among", "the", "factors", "that", "may", "cause", "the", "market", "price", "of", "our", "common", "stock", "to", "fluctuate", "are", "the", "risks", "described", "in", "this", "Risk", "Factors", "section", "and", "other", "factors,", "including:"], "wordsB": ["Our", "future", "capital", "requirements", "will", "depend", "on", "many", "factors,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p107_s5", "idA": "1095981_16_item1a_p104_s0", "sentA": "the trading volume of our common stock.", "sentB": "In 2016, we generated approximately $3.3 million in sales revenues in Japan, representing 71% of our overall global sales revenues.", "type": 1, "words": ["<tag1>", "the", "trading", "volume", "of", "our", "common", "stock.", "<tag2>", "In", "2016,", "we", "generated", "approximately", "$3.3", "million", "in", "sales", "revenues", "in", "Japan,", "representing", "71%", "of", "our", "overall", "global", "sales", "revenues.", "<tag3>"], "wordsA": ["the", "trading", "volume", "of", "our", "common", "stock."], "wordsB": ["In", "2016,", "we", "generated", "approximately", "$3.3", "million", "in", "sales", "revenues", "in", "Japan,", "representing", "71%", "of", "our", "overall", "global", "sales", "revenues."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p88_s0", "idA": "1095981_16_item1a_p104_s0", "sentA": "the trading volume of our common stock.", "sentB": "The platform consists of our Celution device that processes the patient s own adipose (fat) tissue to create a heterogeneous mixture of regenerative cells.", "type": 1, "words": ["<tag1>", "the", "trading", "volume", "of", "our", "common", "stock.", "<tag2>", "The", "platform", "consists", "of", "our", "Celution", "device", "that", "processes", "the", "patient", "s", "own", "adipose", "(fat)", "tissue", "to", "create", "a", "heterogeneous", "mixture", "of", "regenerative", "cells.", "<tag3>"], "wordsA": ["the", "trading", "volume", "of", "our", "common", "stock."], "wordsB": ["The", "platform", "consists", "of", "our", "Celution", "device", "that", "processes", "the", "patient", "s", "own", "adipose", "(fat)", "tissue", "to", "create", "a", "heterogeneous", "mixture", "of", "regenerative", "cells."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p30_s6", "idA": "1095981_16_item1a_p105_s0", "sentA": "In addition, the stock market in general, the NASDAQ markets and the market for cell therapy development companies in particular may experience a loss of investor confidence.", "sentB": "In addition, competitors may seek to develop alternative formulations of or technological approaches to our product candidates and/or alternative cell therapy or drug delivery technologies that address our targeted indications.", "type": 1, "words": ["<tag1>", "In", "addition,", "the", "stock", "market", "in", "general,", "the", "NASDAQ", "markets", "and", "the", "market", "for", "cell", "therapy", "development", "companies", "in", "particular", "may", "experience", "a", "loss", "of", "investor", "confidence.", "<tag2>", "In", "addition,", "competitors", "may", "seek", "to", "develop", "alternative", "formulations", "of", "or", "technological", "approaches", "to", "our", "product", "candidates", "and/or", "alternative", "cell", "therapy", "or", "drug", "delivery", "technologies", "that", "address", "our", "targeted", "indications.", "<tag3>"], "wordsA": ["In", "addition,", "the", "stock", "market", "in", "general,", "the", "NASDAQ", "markets", "and", "the", "market", "for", "cell", "therapy", "development", "companies", "in", "particular", "may", "experience", "a", "loss", "of", "investor", "confidence."], "wordsB": ["In", "addition,", "competitors", "may", "seek", "to", "develop", "alternative", "formulations", "of", "or", "technological", "approaches", "to", "our", "product", "candidates", "and/or", "alternative", "cell", "therapy", "or", "drug", "delivery", "technologies", "that", "address", "our", "targeted", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p27_s0", "idA": "1095981_16_item1a_p105_s2", "sentA": "These broad market and industry factors may materially harm the market price of our common stock and expose us to securities class-action litigation.", "sentB": "Our business is sensitive to general economic, business and industry conditions.", "type": 1, "words": ["<tag1>", "These", "broad", "market", "and", "industry", "factors", "may", "materially", "harm", "the", "market", "price", "of", "our", "common", "stock", "and", "expose", "us", "to", "securities", "class-action", "litigation.", "<tag2>", "Our", "business", "is", "sensitive", "to", "general", "economic,", "business", "and", "industry", "conditions.", "<tag3>"], "wordsA": ["These", "broad", "market", "and", "industry", "factors", "may", "materially", "harm", "the", "market", "price", "of", "our", "common", "stock", "and", "expose", "us", "to", "securities", "class-action", "litigation."], "wordsB": ["Our", "business", "is", "sensitive", "to", "general", "economic,", "business", "and", "industry", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p59_s2", "idA": "1095981_16_item1a_p105_s2", "sentA": "These broad market and industry factors may materially harm the market price of our common stock and expose us to securities class-action litigation.", "sentB": "In addition, some of them have approved products with therapeutic claims, established revenues and broad market recognition.", "type": 1, "words": ["<tag1>", "These", "broad", "market", "and", "industry", "factors", "may", "materially", "harm", "the", "market", "price", "of", "our", "common", "stock", "and", "expose", "us", "to", "securities", "class-action", "litigation.", "<tag2>", "In", "addition,", "some", "of", "them", "have", "approved", "products", "with", "therapeutic", "claims,", "established", "revenues", "and", "broad", "market", "recognition.", "<tag3>"], "wordsA": ["These", "broad", "market", "and", "industry", "factors", "may", "materially", "harm", "the", "market", "price", "of", "our", "common", "stock", "and", "expose", "us", "to", "securities", "class-action", "litigation."], "wordsB": ["In", "addition,", "some", "of", "them", "have", "approved", "products", "with", "therapeutic", "claims,", "established", "revenues", "and", "broad", "market", "recognition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p218_s0", "idA": "1095981_16_item1a_p106_s0", "sentA": "As of December 31, 2015, we had 195,058,395 shares of our common stock outstanding.", "sentB": "Following notice from Nasdaq staff in June 2015 and December 2015, we had a hearing in January 2016 relating to our noncompliance with the $1.00 minimum bid price per share requirement.", "type": 1, "words": ["<tag1>", "As", "of", "December", "31,", "2015,", "we", "had", "195,058,395", "shares", "of", "our", "common", "stock", "outstanding.", "<tag2>", "Following", "notice", "from", "Nasdaq", "staff", "in", "June", "2015", "and", "December", "2015,", "we", "had", "a", "hearing", "in", "January", "2016", "relating", "to", "our", "noncompliance", "with", "the", "$1.00", "minimum", "bid", "price", "per", "share", "requirement.", "<tag3>"], "wordsA": ["As", "of", "December", "31,", "2015,", "we", "had", "195,058,395", "shares", "of", "our", "common", "stock", "outstanding."], "wordsB": ["Following", "notice", "from", "Nasdaq", "staff", "in", "June", "2015", "and", "December", "2015,", "we", "had", "a", "hearing", "in", "January", "2016", "relating", "to", "our", "noncompliance", "with", "the", "$1.00", "minimum", "bid", "price", "per", "share", "requirement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p156_s1", "idA": "1095981_16_item1a_p106_s1", "sentA": "Sales of a number of shares of common stock in the public market, or the expectation of such sales, could cause the market price of our common stock to decline.", "sentB": "While we attempt to mitigate these risks by employing a number of measures, including employee refreshers, monitoring of our networks and systems, and maintenance of backup and protective systems, our systems, networks and products remain potentially vulnerable to advanced persistent threats.", "type": 1, "words": ["<tag1>", "Sales", "of", "a", "number", "of", "shares", "of", "common", "stock", "in", "the", "public", "market,", "or", "the", "expectation", "of", "such", "sales,", "could", "cause", "the", "market", "price", "of", "our", "common", "stock", "to", "decline.", "<tag2>", "While", "we", "attempt", "to", "mitigate", "these", "risks", "by", "employing", "a", "number", "of", "measures,", "including", "employee", "refreshers,", "monitoring", "of", "our", "networks", "and", "systems,", "and", "maintenance", "of", "backup", "and", "protective", "systems,", "our", "systems,", "networks", "and", "products", "remain", "potentially", "vulnerable", "to", "advanced", "persistent", "threats.", "<tag3>"], "wordsA": ["Sales", "of", "a", "number", "of", "shares", "of", "common", "stock", "in", "the", "public", "market,", "or", "the", "expectation", "of", "such", "sales,", "could", "cause", "the", "market", "price", "of", "our", "common", "stock", "to", "decline."], "wordsB": ["While", "we", "attempt", "to", "mitigate", "these", "risks", "by", "employing", "a", "number", "of", "measures,", "including", "employee", "refreshers,", "monitoring", "of", "our", "networks", "and", "systems,", "and", "maintenance", "of", "backup", "and", "protective", "systems,", "our", "systems,", "networks", "and", "products", "remain", "potentially", "vulnerable", "to", "advanced", "persistent", "threats."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p140_s2", "idA": "1095981_16_item1a_p108_s1", "sentA": "These provisions could also prevent or frustrate attempts by our stockholders to replace or remove members of our Board of Directors.", "sentB": "Given their leadership, extensive technical, scientific and financial expertise and management and operational experience, these individuals would be difficult to replace.", "type": 1, "words": ["<tag1>", "These", "provisions", "could", "also", "prevent", "or", "frustrate", "attempts", "by", "our", "stockholders", "to", "replace", "or", "remove", "members", "of", "our", "Board", "of", "Directors.", "<tag2>", "Given", "their", "leadership,", "extensive", "technical,", "scientific", "and", "financial", "expertise", "and", "management", "and", "operational", "experience,", "these", "individuals", "would", "be", "difficult", "to", "replace.", "<tag3>"], "wordsA": ["These", "provisions", "could", "also", "prevent", "or", "frustrate", "attempts", "by", "our", "stockholders", "to", "replace", "or", "remove", "members", "of", "our", "Board", "of", "Directors."], "wordsB": ["Given", "their", "leadership,", "extensive", "technical,", "scientific", "and", "financial", "expertise", "and", "management", "and", "operational", "experience,", "these", "individuals", "would", "be", "difficult", "to", "replace."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p229_s4", "idA": "1095981_16_item1a_p112_s2", "sentA": "In addition, it is likely that in some future period our operating results will be below the expectations of securities analysts or investors.", "sentB": "The notice of redemption could come at a time when it is not advisable or possible for Warrant holders to exercise the Warrants.", "type": 1, "words": ["<tag1>", "In", "addition,", "it", "is", "likely", "that", "in", "some", "future", "period", "our", "operating", "results", "will", "be", "below", "the", "expectations", "of", "securities", "analysts", "or", "investors.", "<tag2>", "The", "notice", "of", "redemption", "could", "come", "at", "a", "time", "when", "it", "is", "not", "advisable", "or", "possible", "for", "Warrant", "holders", "to", "exercise", "the", "Warrants.", "<tag3>"], "wordsA": ["In", "addition,", "it", "is", "likely", "that", "in", "some", "future", "period", "our", "operating", "results", "will", "be", "below", "the", "expectations", "of", "securities", "analysts", "or", "investors."], "wordsB": ["The", "notice", "of", "redemption", "could", "come", "at", "a", "time", "when", "it", "is", "not", "advisable", "or", "possible", "for", "Warrant", "holders", "to", "exercise", "the", "Warrants."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p107_s3", "idA": "1095981_16_item1a_p11_s1", "sentA": "If we fail to comply with any of these covenants or restrictions, such failure may result in an event of default, which if not cured or waived, could result in the lender accelerating the maturity of our indebtedness.", "sentB": "We generate 71% of our sales revenues from Japan, with 76% of those revenues generated by sales to four customers and 49% of these revenues generated by sales to one customer.", "type": 1, "words": ["<tag1>", "If", "we", "fail", "to", "comply", "with", "any", "of", "these", "covenants", "or", "restrictions,", "such", "failure", "may", "result", "in", "an", "event", "of", "default,", "which", "if", "not", "cured", "or", "waived,", "could", "result", "in", "the", "lender", "accelerating", "the", "maturity", "of", "our", "indebtedness.", "<tag2>", "We", "generate", "71%", "of", "our", "sales", "revenues", "from", "Japan,", "with", "76%", "of", "those", "revenues", "generated", "by", "sales", "to", "four", "customers", "and", "49%", "of", "these", "revenues", "generated", "by", "sales", "to", "one", "customer.", "<tag3>"], "wordsA": ["If", "we", "fail", "to", "comply", "with", "any", "of", "these", "covenants", "or", "restrictions,", "such", "failure", "may", "result", "in", "an", "event", "of", "default,", "which", "if", "not", "cured", "or", "waived,", "could", "result", "in", "the", "lender", "accelerating", "the", "maturity", "of", "our", "indebtedness."], "wordsB": ["We", "generate", "71%", "of", "our", "sales", "revenues", "from", "Japan,", "with", "76%", "of", "those", "revenues", "generated", "by", "sales", "to", "four", "customers", "and", "49%", "of", "these", "revenues", "generated", "by", "sales", "to", "one", "customer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p84_s2", "idA": "1095981_16_item1a_p11_s1", "sentA": "If we fail to comply with any of these covenants or restrictions, such failure may result in an event of default, which if not cured or waived, could result in the lender accelerating the maturity of our indebtedness.", "sentB": "Changes in the RLD may result in the nullification of BE clinical studies and can result in significant delays in the regulatory process as BE clinical studies may need to be repeated for jurisdictions that no longer recognize the reference drug utilized in BE clinical studies.", "type": 1, "words": ["<tag1>", "If", "we", "fail", "to", "comply", "with", "any", "of", "these", "covenants", "or", "restrictions,", "such", "failure", "may", "result", "in", "an", "event", "of", "default,", "which", "if", "not", "cured", "or", "waived,", "could", "result", "in", "the", "lender", "accelerating", "the", "maturity", "of", "our", "indebtedness.", "<tag2>", "Changes", "in", "the", "RLD", "may", "result", "in", "the", "nullification", "of", "BE", "clinical", "studies", "and", "can", "result", "in", "significant", "delays", "in", "the", "regulatory", "process", "as", "BE", "clinical", "studies", "may", "need", "to", "be", "repeated", "for", "jurisdictions", "that", "no", "longer", "recognize", "the", "reference", "drug", "utilized", "in", "BE", "clinical", "studies.", "<tag3>"], "wordsA": ["If", "we", "fail", "to", "comply", "with", "any", "of", "these", "covenants", "or", "restrictions,", "such", "failure", "may", "result", "in", "an", "event", "of", "default,", "which", "if", "not", "cured", "or", "waived,", "could", "result", "in", "the", "lender", "accelerating", "the", "maturity", "of", "our", "indebtedness."], "wordsB": ["Changes", "in", "the", "RLD", "may", "result", "in", "the", "nullification", "of", "BE", "clinical", "studies", "and", "can", "result", "in", "significant", "delays", "in", "the", "regulatory", "process", "as", "BE", "clinical", "studies", "may", "need", "to", "be", "repeated", "for", "jurisdictions", "that", "no", "longer", "recognize", "the", "reference", "drug", "utilized", "in", "BE", "clinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p226_s5", "idA": "1095981_16_item1a_p14_s0", "sentA": "On or before May 31, 2016, we shall have demonstrated a closing bid price of $1 or more for a minimum of ten consecutive trading days.", "sentB": "In June 2016, we closed our rights offering to subscribe for units at a subscription price of $2.55 per unit, or the Rights Offering.", "type": 1, "words": ["<tag1>", "On", "or", "before", "May", "31,", "2016,", "we", "shall", "have", "demonstrated", "a", "closing", "bid", "price", "of", "$1", "or", "more", "for", "a", "minimum", "of", "ten", "consecutive", "trading", "days.", "<tag2>", "In", "June", "2016,", "we", "closed", "our", "rights", "offering", "to", "subscribe", "for", "units", "at", "a", "subscription", "price", "of", "$2.55", "per", "unit,", "or", "the", "Rights", "Offering.", "<tag3>"], "wordsA": ["On", "or", "before", "May", "31,", "2016,", "we", "shall", "have", "demonstrated", "a", "closing", "bid", "price", "of", "$1", "or", "more", "for", "a", "minimum", "of", "ten", "consecutive", "trading", "days."], "wordsB": ["In", "June", "2016,", "we", "closed", "our", "rights", "offering", "to", "subscribe", "for", "units", "at", "a", "subscription", "price", "of", "$2.55", "per", "unit,", "or", "the", "Rights", "Offering."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p228_s1", "idA": "1095981_16_item1a_p15_s0", "sentA": "The Company transferred the listing of its common stock from The NASDAQ Global Market tier to The NASDAQ Capital Market tier on February 1, 2016 and on February 10, 2016, the Listing Qualification Staff sent a letter to the Company approving and confirming the Company s move from the NGM tier to the NGM tier.", "sentB": "The Warrants issued pursuant to the Rights Offering became exercisable upon issuance and will expire thirty (30) months from the date of issuance.", "type": 1, "words": ["<tag1>", "The", "Company", "transferred", "the", "listing", "of", "its", "common", "stock", "from", "The", "NASDAQ", "Global", "Market", "tier", "to", "The", "NASDAQ", "Capital", "Market", "tier", "on", "February", "1,", "2016", "and", "on", "February", "10,", "2016,", "the", "Listing", "Qualification", "Staff", "sent", "a", "letter", "to", "the", "Company", "approving", "and", "confirming", "the", "Company", "s", "move", "from", "the", "NGM", "tier", "to", "the", "NGM", "tier.", "<tag2>", "The", "Warrants", "issued", "pursuant", "to", "the", "Rights", "Offering", "became", "exercisable", "upon", "issuance", "and", "will", "expire", "thirty", "(30)", "months", "from", "the", "date", "of", "issuance.", "<tag3>"], "wordsA": ["The", "Company", "transferred", "the", "listing", "of", "its", "common", "stock", "from", "The", "NASDAQ", "Global", "Market", "tier", "to", "The", "NASDAQ", "Capital", "Market", "tier", "on", "February", "1,", "2016", "and", "on", "February", "10,", "2016,", "the", "Listing", "Qualification", "Staff", "sent", "a", "letter", "to", "the", "Company", "approving", "and", "confirming", "the", "Company", "s", "move", "from", "the", "NGM", "tier", "to", "the", "NGM", "tier."], "wordsB": ["The", "Warrants", "issued", "pursuant", "to", "the", "Rights", "Offering", "became", "exercisable", "upon", "issuance", "and", "will", "expire", "thirty", "(30)", "months", "from", "the", "date", "of", "issuance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p142_s5", "idA": "1095981_16_item1a_p16_s3", "sentA": "If we cease to be eligible to trade on either the NGM or NCM:", "sentB": "If we cannot successfully defend ourselves against product liability claims, we will incur substantial liabilities.", "type": 1, "words": ["<tag1>", "If", "we", "cease", "to", "be", "eligible", "to", "trade", "on", "either", "the", "NGM", "or", "NCM:", "<tag2>", "If", "we", "cannot", "successfully", "defend", "ourselves", "against", "product", "liability", "claims,", "we", "will", "incur", "substantial", "liabilities.", "<tag3>"], "wordsA": ["If", "we", "cease", "to", "be", "eligible", "to", "trade", "on", "either", "the", "NGM", "or", "NCM:"], "wordsB": ["If", "we", "cannot", "successfully", "defend", "ourselves", "against", "product", "liability", "claims,", "we", "will", "incur", "substantial", "liabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p93_s4", "idA": "1095981_16_item1a_p16_s3", "sentA": "If we cease to be eligible to trade on either the NGM or NCM:", "sentB": "Furthermore, bioequivalence studies may need to be repeated in certain foreign entities as some governments may require additional confirmatory studies in their patient populations.", "type": 1, "words": ["<tag1>", "If", "we", "cease", "to", "be", "eligible", "to", "trade", "on", "either", "the", "NGM", "or", "NCM:", "<tag2>", "Furthermore,", "bioequivalence", "studies", "may", "need", "to", "be", "repeated", "in", "certain", "foreign", "entities", "as", "some", "governments", "may", "require", "additional", "confirmatory", "studies", "in", "their", "patient", "populations.", "<tag3>"], "wordsA": ["If", "we", "cease", "to", "be", "eligible", "to", "trade", "on", "either", "the", "NGM", "or", "NCM:"], "wordsB": ["Furthermore,", "bioequivalence", "studies", "may", "need", "to", "be", "repeated", "in", "certain", "foreign", "entities", "as", "some", "governments", "may", "require", "additional", "confirmatory", "studies", "in", "their", "patient", "populations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p193_s3", "idA": "1095981_16_item1a_p18_s1", "sentA": "Our ability to raise capital has been, and may in the future, be adversely affected by downturns in current credit conditions, financial markets and the global economy.", "sentB": "Our ability to stop unauthorized third parties from making using selling, offering to sell or importing our platform technology and/or our product candidates is dependent upon the extent to which we have rights under valid and enforceable patents or trade secrets that cover these activities.", "type": 1, "words": ["<tag1>", "Our", "ability", "to", "raise", "capital", "has", "been,", "and", "may", "in", "the", "future,", "be", "adversely", "affected", "by", "downturns", "in", "current", "credit", "conditions,", "financial", "markets", "and", "the", "global", "economy.", "<tag2>", "Our", "ability", "to", "stop", "unauthorized", "third", "parties", "from", "making", "using", "selling,", "offering", "to", "sell", "or", "importing", "our", "platform", "technology", "and/or", "our", "product", "candidates", "is", "dependent", "upon", "the", "extent", "to", "which", "we", "have", "rights", "under", "valid", "and", "enforceable", "patents", "or", "trade", "secrets", "that", "cover", "these", "activities.", "<tag3>"], "wordsA": ["Our", "ability", "to", "raise", "capital", "has", "been,", "and", "may", "in", "the", "future,", "be", "adversely", "affected", "by", "downturns", "in", "current", "credit", "conditions,", "financial", "markets", "and", "the", "global", "economy."], "wordsB": ["Our", "ability", "to", "stop", "unauthorized", "third", "parties", "from", "making", "using", "selling,", "offering", "to", "sell", "or", "importing", "our", "platform", "technology", "and/or", "our", "product", "candidates", "is", "dependent", "upon", "the", "extent", "to", "which", "we", "have", "rights", "under", "valid", "and", "enforceable", "patents", "or", "trade", "secrets", "that", "cover", "these", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p59_s7", "idA": "1095981_16_item1a_p19_s3", "sentA": "As a result of our historic losses, we have been, and are likely to continue to be, reliant on raising outside capital to fund our operations.", "sentB": "These existing competitive liposomal doxorubicin products have been on the market for many years, have gained widespread physician acceptance and are marketed by competitors with substantially greater resources than we have.", "type": 1, "words": ["<tag1>", "As", "a", "result", "of", "our", "historic", "losses,", "we", "have", "been,", "and", "are", "likely", "to", "continue", "to", "be,", "reliant", "on", "raising", "outside", "capital", "to", "fund", "our", "operations.", "<tag2>", "These", "existing", "competitive", "liposomal", "doxorubicin", "products", "have", "been", "on", "the", "market", "for", "many", "years,", "have", "gained", "widespread", "physician", "acceptance", "and", "are", "marketed", "by", "competitors", "with", "substantially", "greater", "resources", "than", "we", "have.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "our", "historic", "losses,", "we", "have", "been,", "and", "are", "likely", "to", "continue", "to", "be,", "reliant", "on", "raising", "outside", "capital", "to", "fund", "our", "operations."], "wordsB": ["These", "existing", "competitive", "liposomal", "doxorubicin", "products", "have", "been", "on", "the", "market", "for", "many", "years,", "have", "gained", "widespread", "physician", "acceptance", "and", "are", "marketed", "by", "competitors", "with", "substantially", "greater", "resources", "than", "we", "have."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p165_s0", "idA": "1095981_16_item1a_p1_s0", "sentA": "We have almost always had negative cash flows from operations.", "sentB": "We have secured capital historically from grant revenues, collaboration proceeds, and debt and equity offerings.", "type": 1, "words": ["<tag1>", "We", "have", "almost", "always", "had", "negative", "cash", "flows", "from", "operations.", "<tag2>", "We", "have", "secured", "capital", "historically", "from", "grant", "revenues,", "collaboration", "proceeds,", "and", "debt", "and", "equity", "offerings.", "<tag3>"], "wordsA": ["We", "have", "almost", "always", "had", "negative", "cash", "flows", "from", "operations."], "wordsB": ["We", "have", "secured", "capital", "historically", "from", "grant", "revenues,", "collaboration", "proceeds,", "and", "debt", "and", "equity", "offerings."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p140_s5", "idA": "1095981_16_item1a_p1_s1", "sentA": "Our business will continue to result in a substantial requirement for research and development expenses for several years, during which we may not be able to bring in sufficient cash and/or revenues to offset these expenses.", "sentB": "Although we have a stock option plan pursuant to which we provide our executive officers with various economic incentives to remain employed with us, these incentives may not be sufficient to retain them.", "type": 1, "words": ["<tag1>", "Our", "business", "will", "continue", "to", "result", "in", "a", "substantial", "requirement", "for", "research", "and", "development", "expenses", "for", "several", "years,", "during", "which", "we", "may", "not", "be", "able", "to", "bring", "in", "sufficient", "cash", "and/or", "revenues", "to", "offset", "these", "expenses.", "<tag2>", "Although", "we", "have", "a", "stock", "option", "plan", "pursuant", "to", "which", "we", "provide", "our", "executive", "officers", "with", "various", "economic", "incentives", "to", "remain", "employed", "with", "us,", "these", "incentives", "may", "not", "be", "sufficient", "to", "retain", "them.", "<tag3>"], "wordsA": ["Our", "business", "will", "continue", "to", "result", "in", "a", "substantial", "requirement", "for", "research", "and", "development", "expenses", "for", "several", "years,", "during", "which", "we", "may", "not", "be", "able", "to", "bring", "in", "sufficient", "cash", "and/or", "revenues", "to", "offset", "these", "expenses."], "wordsB": ["Although", "we", "have", "a", "stock", "option", "plan", "pursuant", "to", "which", "we", "provide", "our", "executive", "officers", "with", "various", "economic", "incentives", "to", "remain", "employed", "with", "us,", "these", "incentives", "may", "not", "be", "sufficient", "to", "retain", "them."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p153_s3", "idA": "1095981_16_item1a_p20_s2", "sentA": "We are using our cash in one of the riskiest industries in the economy (strategic risk).", "sentB": "ARRA also made significant increases in the penalties for improper use or disclosure of an individual s health information under HIPAA and extended enforcement authority to state attorneys general.", "type": 1, "words": ["<tag1>", "We", "are", "using", "our", "cash", "in", "one", "of", "the", "riskiest", "industries", "in", "the", "economy", "(strategic", "risk).", "<tag2>", "ARRA", "also", "made", "significant", "increases", "in", "the", "penalties", "for", "improper", "use", "or", "disclosure", "of", "an", "individual", "s", "health", "information", "under", "HIPAA", "and", "extended", "enforcement", "authority", "to", "state", "attorneys", "general.", "<tag3>"], "wordsA": ["We", "are", "using", "our", "cash", "in", "one", "of", "the", "riskiest", "industries", "in", "the", "economy", "(strategic", "risk)."], "wordsB": ["ARRA", "also", "made", "significant", "increases", "in", "the", "penalties", "for", "improper", "use", "or", "disclosure", "of", "an", "individual", "s", "health", "information", "under", "HIPAA", "and", "extended", "enforcement", "authority", "to", "state", "attorneys", "general."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p8_s0", "idA": "1095981_16_item1a_p20_s2", "sentA": "We are using our cash in one of the riskiest industries in the economy (strategic risk).", "sentB": "We are not experienced in acquiring and integrating new businesses.", "type": 1, "words": ["<tag1>", "We", "are", "using", "our", "cash", "in", "one", "of", "the", "riskiest", "industries", "in", "the", "economy", "(strategic", "risk).", "<tag2>", "We", "are", "not", "experienced", "in", "acquiring", "and", "integrating", "new", "businesses.", "<tag3>"], "wordsA": ["We", "are", "using", "our", "cash", "in", "one", "of", "the", "riskiest", "industries", "in", "the", "economy", "(strategic", "risk)."], "wordsB": ["We", "are", "not", "experienced", "in", "acquiring", "and", "integrating", "new", "businesses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p116_s0", "idA": "1095981_16_item1a_p21_s0", "sentA": "We must continue to develop and manufacture both the current and future generation Celution System devices.", "sentB": "We must maintain quality assurance certification and manufacturing approvals.", "type": 1, "words": ["<tag1>", "We", "must", "continue", "to", "develop", "and", "manufacture", "both", "the", "current", "and", "future", "generation", "Celution", "System", "devices.", "<tag2>", "We", "must", "maintain", "quality", "assurance", "certification", "and", "manufacturing", "approvals.", "<tag3>"], "wordsA": ["We", "must", "continue", "to", "develop", "and", "manufacture", "both", "the", "current", "and", "future", "generation", "Celution", "System", "devices."], "wordsB": ["We", "must", "maintain", "quality", "assurance", "certification", "and", "manufacturing", "approvals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p81_s2", "idA": "1095981_16_item1a_p21_s0", "sentA": "We must continue to develop and manufacture both the current and future generation Celution System devices.", "sentB": "Clinical trial applications are approved at the member state level, whereas marketing authorization applications are approved at both the member state and centralized levels.", "type": 1, "words": ["<tag1>", "We", "must", "continue", "to", "develop", "and", "manufacture", "both", "the", "current", "and", "future", "generation", "Celution", "System", "devices.", "<tag2>", "Clinical", "trial", "applications", "are", "approved", "at", "the", "member", "state", "level,", "whereas", "marketing", "authorization", "applications", "are", "approved", "at", "both", "the", "member", "state", "and", "centralized", "levels.", "<tag3>"], "wordsA": ["We", "must", "continue", "to", "develop", "and", "manufacture", "both", "the", "current", "and", "future", "generation", "Celution", "System", "devices."], "wordsB": ["Clinical", "trial", "applications", "are", "approved", "at", "the", "member", "state", "level,", "whereas", "marketing", "authorization", "applications", "are", "approved", "at", "both", "the", "member", "state", "and", "centralized", "levels."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p229_s10", "idA": "1095981_16_item1a_p21_s1", "sentA": "If we are not successful in further development of the current and future generation Celution System devices, we may not be able to compete successfully in the marketplace (technology risk), and if we experience disruptions and/or delays in our production of these devices as required by the marketplace, our operations and commercialization efforts (clinical, regulatory and/or commercial sales) would be harmed (manufacturing risk).", "sentB": "As a result, holders of the Warrants may, even if we have sufficient funds, not be entitled to receive any consideration for their Warrants or may receive an amount less than they would be entitled to if they had exercised their Warrants prior to the commencement of any such bankruptcy or reorganization proceeding.", "type": 1, "words": ["<tag1>", "If", "we", "are", "not", "successful", "in", "further", "development", "of", "the", "current", "and", "future", "generation", "Celution", "System", "devices,", "we", "may", "not", "be", "able", "to", "compete", "successfully", "in", "the", "marketplace", "(technology", "risk),", "and", "if", "we", "experience", "disruptions", "and/or", "delays", "in", "our", "production", "of", "these", "devices", "as", "required", "by", "the", "marketplace,", "our", "operations", "and", "commercialization", "efforts", "(clinical,", "regulatory", "and/or", "commercial", "sales)", "would", "be", "harmed", "(manufacturing", "risk).", "<tag2>", "As", "a", "result,", "holders", "of", "the", "Warrants", "may,", "even", "if", "we", "have", "sufficient", "funds,", "not", "be", "entitled", "to", "receive", "any", "consideration", "for", "their", "Warrants", "or", "may", "receive", "an", "amount", "less", "than", "they", "would", "be", "entitled", "to", "if", "they", "had", "exercised", "their", "Warrants", "prior", "to", "the", "commencement", "of", "any", "such", "bankruptcy", "or", "reorganization", "proceeding.", "<tag3>"], "wordsA": ["If", "we", "are", "not", "successful", "in", "further", "development", "of", "the", "current", "and", "future", "generation", "Celution", "System", "devices,", "we", "may", "not", "be", "able", "to", "compete", "successfully", "in", "the", "marketplace", "(technology", "risk),", "and", "if", "we", "experience", "disruptions", "and/or", "delays", "in", "our", "production", "of", "these", "devices", "as", "required", "by", "the", "marketplace,", "our", "operations", "and", "commercialization", "efforts", "(clinical,", "regulatory", "and/or", "commercial", "sales)", "would", "be", "harmed", "(manufacturing", "risk)."], "wordsB": ["As", "a", "result,", "holders", "of", "the", "Warrants", "may,", "even", "if", "we", "have", "sufficient", "funds,", "not", "be", "entitled", "to", "receive", "any", "consideration", "for", "their", "Warrants", "or", "may", "receive", "an", "amount", "less", "than", "they", "would", "be", "entitled", "to", "if", "they", "had", "exercised", "their", "Warrants", "prior", "to", "the", "commencement", "of", "any", "such", "bankruptcy", "or", "reorganization", "proceeding."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p196_s0", "idA": "1095981_16_item1a_p24_s0", "sentA": "Our prospects must be evaluated in light of the risks and difficulties frequently encountered by emerging companies and particularly by such companies in rapidly evolving and technologically advanced biotech and medical device fields.", "sentB": "The patent positions of pharmaceutical, biopharmaceutical and medical device companies can be highly uncertain and involve complex legal and factual questions for which important legal principles remain unresolved.", "type": 1, "words": ["<tag1>", "Our", "prospects", "must", "be", "evaluated", "in", "light", "of", "the", "risks", "and", "difficulties", "frequently", "encountered", "by", "emerging", "companies", "and", "particularly", "by", "such", "companies", "in", "rapidly", "evolving", "and", "technologically", "advanced", "biotech", "and", "medical", "device", "fields.", "<tag2>", "The", "patent", "positions", "of", "pharmaceutical,", "biopharmaceutical", "and", "medical", "device", "companies", "can", "be", "highly", "uncertain", "and", "involve", "complex", "legal", "and", "factual", "questions", "for", "which", "important", "legal", "principles", "remain", "unresolved.", "<tag3>"], "wordsA": ["Our", "prospects", "must", "be", "evaluated", "in", "light", "of", "the", "risks", "and", "difficulties", "frequently", "encountered", "by", "emerging", "companies", "and", "particularly", "by", "such", "companies", "in", "rapidly", "evolving", "and", "technologically", "advanced", "biotech", "and", "medical", "device", "fields."], "wordsB": ["The", "patent", "positions", "of", "pharmaceutical,", "biopharmaceutical", "and", "medical", "device", "companies", "can", "be", "highly", "uncertain", "and", "involve", "complex", "legal", "and", "factual", "questions", "for", "which", "important", "legal", "principles", "remain", "unresolved."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p4_s0", "idA": "1095981_16_item1a_p26_s0", "sentA": "Our budgeted expense levels are based in part on our expectations concerning future revenues from sales as well our assessment of the future investments needed to expand our commercial organization and support research and development activities.", "sentB": "Azaya suspended its business, including its research and development efforts, at the end of 2015, so we must recommence the business, including (i) recalibration, revalidation and requalification of the acquired drug manufacturing equipment and manufacturing facility located in San Antonio, Texas; and (ii) hiring of substantial numbers of new employees to operate the Cytori Nanomedicines business.", "type": 1, "words": ["<tag1>", "Our", "budgeted", "expense", "levels", "are", "based", "in", "part", "on", "our", "expectations", "concerning", "future", "revenues", "from", "sales", "as", "well", "our", "assessment", "of", "the", "future", "investments", "needed", "to", "expand", "our", "commercial", "organization", "and", "support", "research", "and", "development", "activities.", "<tag2>", "Azaya", "suspended", "its", "business,", "including", "its", "research", "and", "development", "efforts,", "at", "the", "end", "of", "2015,", "so", "we", "must", "recommence", "the", "business,", "including", "(i)", "recalibration,", "revalidation", "and", "requalification", "of", "the", "acquired", "drug", "manufacturing", "equipment", "and", "manufacturing", "facility", "located", "in", "San", "Antonio,", "Texas;", "and", "(ii)", "hiring", "of", "substantial", "numbers", "of", "new", "employees", "to", "operate", "the", "Cytori", "Nanomedicines", "business.", "<tag3>"], "wordsA": ["Our", "budgeted", "expense", "levels", "are", "based", "in", "part", "on", "our", "expectations", "concerning", "future", "revenues", "from", "sales", "as", "well", "our", "assessment", "of", "the", "future", "investments", "needed", "to", "expand", "our", "commercial", "organization", "and", "support", "research", "and", "development", "activities."], "wordsB": ["Azaya", "suspended", "its", "business,", "including", "its", "research", "and", "development", "efforts,", "at", "the", "end", "of", "2015,", "so", "we", "must", "recommence", "the", "business,", "including", "(i)", "recalibration,", "revalidation", "and", "requalification", "of", "the", "acquired", "drug", "manufacturing", "equipment", "and", "manufacturing", "facility", "located", "in", "San", "Antonio,", "Texas;", "and", "(ii)", "hiring", "of", "substantial", "numbers", "of", "new", "employees", "to", "operate", "the", "Cytori", "Nanomedicines", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p88_s4", "idA": "1095981_16_item1a_p26_s1", "sentA": "We may be unable to reduce our expenditures in a timely manner to compensate for any unexpected events or a shortfall in revenue.", "sentB": "The EMA has not made a determination whether it would classify Habeo Cell Therapy as an ATMP or a medical device.", "type": 1, "words": ["<tag1>", "We", "may", "be", "unable", "to", "reduce", "our", "expenditures", "in", "a", "timely", "manner", "to", "compensate", "for", "any", "unexpected", "events", "or", "a", "shortfall", "in", "revenue.", "<tag2>", "The", "EMA", "has", "not", "made", "a", "determination", "whether", "it", "would", "classify", "Habeo", "Cell", "Therapy", "as", "an", "ATMP", "or", "a", "medical", "device.", "<tag3>"], "wordsA": ["We", "may", "be", "unable", "to", "reduce", "our", "expenditures", "in", "a", "timely", "manner", "to", "compensate", "for", "any", "unexpected", "events", "or", "a", "shortfall", "in", "revenue."], "wordsB": ["The", "EMA", "has", "not", "made", "a", "determination", "whether", "it", "would", "classify", "Habeo", "Cell", "Therapy", "as", "an", "ATMP", "or", "a", "medical", "device."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p13_s1", "idA": "1095981_16_item1a_p26_s2", "sentA": "Accordingly, a shortfall in demand for our products or other unexpected events could have an immediate and material impact on our business and financial condition.", "sentB": "If we do conclude a partnering arrangement for our Habeo Cell Therapy prior to announcement of STAR clinical trial data, any such agreement may contain certain payment conditions, termination rights or other rights and obligations that would be triggered by positive or negative STAR data.", "type": 1, "words": ["<tag1>", "Accordingly,", "a", "shortfall", "in", "demand", "for", "our", "products", "or", "other", "unexpected", "events", "could", "have", "an", "immediate", "and", "material", "impact", "on", "our", "business", "and", "financial", "condition.", "<tag2>", "If", "we", "do", "conclude", "a", "partnering", "arrangement", "for", "our", "Habeo", "Cell", "Therapy", "prior", "to", "announcement", "of", "STAR", "clinical", "trial", "data,", "any", "such", "agreement", "may", "contain", "certain", "payment", "conditions,", "termination", "rights", "or", "other", "rights", "and", "obligations", "that", "would", "be", "triggered", "by", "positive", "or", "negative", "STAR", "data.", "<tag3>"], "wordsA": ["Accordingly,", "a", "shortfall", "in", "demand", "for", "our", "products", "or", "other", "unexpected", "events", "could", "have", "an", "immediate", "and", "material", "impact", "on", "our", "business", "and", "financial", "condition."], "wordsB": ["If", "we", "do", "conclude", "a", "partnering", "arrangement", "for", "our", "Habeo", "Cell", "Therapy", "prior", "to", "announcement", "of", "STAR", "clinical", "trial", "data,", "any", "such", "agreement", "may", "contain", "certain", "payment", "conditions,", "termination", "rights", "or", "other", "rights", "and", "obligations", "that", "would", "be", "triggered", "by", "positive", "or", "negative", "STAR", "data."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p204_s0", "idA": "1095981_16_item1a_p27_s2", "sentA": "There is no assurance that our competitors will not succeed in developing alternative products that are more effective, easier to use, or more economical than those which we have developed or are in the process of developing, or that would render our products obsolete and non-competitive.", "sentB": "As is common in the device, biotechnology and pharmaceutical industries, we employ individuals who were previously employed at other device, biotechnology or pharmaceutical companies, including our competitors or potential competitors.", "type": 1, "words": ["<tag1>", "There", "is", "no", "assurance", "that", "our", "competitors", "will", "not", "succeed", "in", "developing", "alternative", "products", "that", "are", "more", "effective,", "easier", "to", "use,", "or", "more", "economical", "than", "those", "which", "we", "have", "developed", "or", "are", "in", "the", "process", "of", "developing,", "or", "that", "would", "render", "our", "products", "obsolete", "and", "non-competitive.", "<tag2>", "As", "is", "common", "in", "the", "device,", "biotechnology", "and", "pharmaceutical", "industries,", "we", "employ", "individuals", "who", "were", "previously", "employed", "at", "other", "device,", "biotechnology", "or", "pharmaceutical", "companies,", "including", "our", "competitors", "or", "potential", "competitors.", "<tag3>"], "wordsA": ["There", "is", "no", "assurance", "that", "our", "competitors", "will", "not", "succeed", "in", "developing", "alternative", "products", "that", "are", "more", "effective,", "easier", "to", "use,", "or", "more", "economical", "than", "those", "which", "we", "have", "developed", "or", "are", "in", "the", "process", "of", "developing,", "or", "that", "would", "render", "our", "products", "obsolete", "and", "non-competitive."], "wordsB": ["As", "is", "common", "in", "the", "device,", "biotechnology", "and", "pharmaceutical", "industries,", "we", "employ", "individuals", "who", "were", "previously", "employed", "at", "other", "device,", "biotechnology", "or", "pharmaceutical", "companies,", "including", "our", "competitors", "or", "potential", "competitors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p59_s12", "idA": "1095981_16_item1a_p27_s3", "sentA": "In general, we may not be able to prevent others from developing and marketing competitive products similar to ours or which perform similar functions.", "sentB": "If our products and technologies do not achieve an adequate level of acceptance by physicians, pharmacists and patients, we may not generate sufficient revenue from these products to become or remain profitable.", "type": 1, "words": ["<tag1>", "In", "general,", "we", "may", "not", "be", "able", "to", "prevent", "others", "from", "developing", "and", "marketing", "competitive", "products", "similar", "to", "ours", "or", "which", "perform", "similar", "functions.", "<tag2>", "If", "our", "products", "and", "technologies", "do", "not", "achieve", "an", "adequate", "level", "of", "acceptance", "by", "physicians,", "pharmacists", "and", "patients,", "we", "may", "not", "generate", "sufficient", "revenue", "from", "these", "products", "to", "become", "or", "remain", "profitable.", "<tag3>"], "wordsA": ["In", "general,", "we", "may", "not", "be", "able", "to", "prevent", "others", "from", "developing", "and", "marketing", "competitive", "products", "similar", "to", "ours", "or", "which", "perform", "similar", "functions."], "wordsB": ["If", "our", "products", "and", "technologies", "do", "not", "achieve", "an", "adequate", "level", "of", "acceptance", "by", "physicians,", "pharmacists", "and", "patients,", "we", "may", "not", "generate", "sufficient", "revenue", "from", "these", "products", "to", "become", "or", "remain", "profitable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p81_s1", "idA": "1095981_16_item1a_p27_s3", "sentA": "In general, we may not be able to prevent others from developing and marketing competitive products similar to ours or which perform similar functions.", "sentB": "These two steps are clinical trial application and marketing authorization application.", "type": 1, "words": ["<tag1>", "In", "general,", "we", "may", "not", "be", "able", "to", "prevent", "others", "from", "developing", "and", "marketing", "competitive", "products", "similar", "to", "ours", "or", "which", "perform", "similar", "functions.", "<tag2>", "These", "two", "steps", "are", "clinical", "trial", "application", "and", "marketing", "authorization", "application.", "<tag3>"], "wordsA": ["In", "general,", "we", "may", "not", "be", "able", "to", "prevent", "others", "from", "developing", "and", "marketing", "competitive", "products", "similar", "to", "ours", "or", "which", "perform", "similar", "functions."], "wordsB": ["These", "two", "steps", "are", "clinical", "trial", "application", "and", "marketing", "authorization", "application."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p31_s0", "idA": "1095981_16_item1a_p29_s0", "sentA": "We compete against cell-based therapies derived from alternate sources, such as bone marrow, umbilical cord blood and potentially embryos.", "sentB": "Cytori Cell Therapy may face competition from cell therapies derived from autologous or allogeneic tissue sources such as adipose tissue, bone marrow and cord blood, and processed using alternative approaches, methods and technologies such as cryopreserved, cultured, expanded, manual, non-enzymatic, selectively isolated cell therapies, and other therapeutic approaches including those administered using oral, subcutaneous, topical and intravenous routes.", "type": 1, "words": ["<tag1>", "We", "compete", "against", "cell-based", "therapies", "derived", "from", "alternate", "sources,", "such", "as", "bone", "marrow,", "umbilical", "cord", "blood", "and", "potentially", "embryos.", "<tag2>", "Cytori", "Cell", "Therapy", "may", "face", "competition", "from", "cell", "therapies", "derived", "from", "autologous", "or", "allogeneic", "tissue", "sources", "such", "as", "adipose", "tissue,", "bone", "marrow", "and", "cord", "blood,", "and", "processed", "using", "alternative", "approaches,", "methods", "and", "technologies", "such", "as", "cryopreserved,", "cultured,", "expanded,", "manual,", "non-enzymatic,", "selectively", "isolated", "cell", "therapies,", "and", "other", "therapeutic", "approaches", "including", "those", "administered", "using", "oral,", "subcutaneous,", "topical", "and", "intravenous", "routes.", "<tag3>"], "wordsA": ["We", "compete", "against", "cell-based", "therapies", "derived", "from", "alternate", "sources,", "such", "as", "bone", "marrow,", "umbilical", "cord", "blood", "and", "potentially", "embryos."], "wordsB": ["Cytori", "Cell", "Therapy", "may", "face", "competition", "from", "cell", "therapies", "derived", "from", "autologous", "or", "allogeneic", "tissue", "sources", "such", "as", "adipose", "tissue,", "bone", "marrow", "and", "cord", "blood,", "and", "processed", "using", "alternative", "approaches,", "methods", "and", "technologies", "such", "as", "cryopreserved,", "cultured,", "expanded,", "manual,", "non-enzymatic,", "selectively", "isolated", "cell", "therapies,", "and", "other", "therapeutic", "approaches", "including", "those", "administered", "using", "oral,", "subcutaneous,", "topical", "and", "intravenous", "routes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p145_s0", "idA": "1095981_16_item1a_p2_s0", "sentA": "To date, these operating losses have been funded primarily from outside sources of invested capital and gross profits.", "sentB": "Large judgments have been awarded in class action or individual lawsuits based on drugs that had unanticipated side effects.", "type": 1, "words": ["<tag1>", "To", "date,", "these", "operating", "losses", "have", "been", "funded", "primarily", "from", "outside", "sources", "of", "invested", "capital", "and", "gross", "profits.", "<tag2>", "Large", "judgments", "have", "been", "awarded", "in", "class", "action", "or", "individual", "lawsuits", "based", "on", "drugs", "that", "had", "unanticipated", "side", "effects.", "<tag3>"], "wordsA": ["To", "date,", "these", "operating", "losses", "have", "been", "funded", "primarily", "from", "outside", "sources", "of", "invested", "capital", "and", "gross", "profits."], "wordsB": ["Large", "judgments", "have", "been", "awarded", "in", "class", "action", "or", "individual", "lawsuits", "based", "on", "drugs", "that", "had", "unanticipated", "side", "effects."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p27_s2", "idA": "1095981_16_item1a_p2_s3", "sentA": "More recently, a continued downward trend in our stock price resulting from general economic and industry conditions as well as the market s unfavorable view of our recent equity financings (which financings were priced at a discount to market and included 100% warrant coverage and our Nasdaq listing deficiency, have made it more difficult to procure additional capital on terms reasonably acceptable to us.", "sentB": "Adverse global economic and financial conditions are difficult to predict and mitigate against, and therefore the potential impact is difficult to estimate.", "type": 1, "words": ["<tag1>", "More", "recently,", "a", "continued", "downward", "trend", "in", "our", "stock", "price", "resulting", "from", "general", "economic", "and", "industry", "conditions", "as", "well", "as", "the", "market", "s", "unfavorable", "view", "of", "our", "recent", "equity", "financings", "(which", "financings", "were", "priced", "at", "a", "discount", "to", "market", "and", "included", "100%", "warrant", "coverage", "and", "our", "Nasdaq", "listing", "deficiency,", "have", "made", "it", "more", "difficult", "to", "procure", "additional", "capital", "on", "terms", "reasonably", "acceptable", "to", "us.", "<tag2>", "Adverse", "global", "economic", "and", "financial", "conditions", "are", "difficult", "to", "predict", "and", "mitigate", "against,", "and", "therefore", "the", "potential", "impact", "is", "difficult", "to", "estimate.", "<tag3>"], "wordsA": ["More", "recently,", "a", "continued", "downward", "trend", "in", "our", "stock", "price", "resulting", "from", "general", "economic", "and", "industry", "conditions", "as", "well", "as", "the", "market", "s", "unfavorable", "view", "of", "our", "recent", "equity", "financings", "(which", "financings", "were", "priced", "at", "a", "discount", "to", "market", "and", "included", "100%", "warrant", "coverage", "and", "our", "Nasdaq", "listing", "deficiency,", "have", "made", "it", "more", "difficult", "to", "procure", "additional", "capital", "on", "terms", "reasonably", "acceptable", "to", "us."], "wordsB": ["Adverse", "global", "economic", "and", "financial", "conditions", "are", "difficult", "to", "predict", "and", "mitigate", "against,", "and", "therefore", "the", "potential", "impact", "is", "difficult", "to", "estimate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p138_s1", "idA": "1095981_16_item1a_p2_s4", "sentA": "If we are unsuccessful in our efforts to raise outside capital in the near term, we will be required to significantly reduce our research, development, and administrative operations, including reduction of our employee base, in order to offset the lack of available funding.", "sentB": "In the near term, we intend to hire a significant number of scientists, quality and regulatory personnel, and other technical s taff with the requisite expertise to support and expand our Cytori Nanomedicines business.", "type": 1, "words": ["<tag1>", "If", "we", "are", "unsuccessful", "in", "our", "efforts", "to", "raise", "outside", "capital", "in", "the", "near", "term,", "we", "will", "be", "required", "to", "significantly", "reduce", "our", "research,", "development,", "and", "administrative", "operations,", "including", "reduction", "of", "our", "employee", "base,", "in", "order", "to", "offset", "the", "lack", "of", "available", "funding.", "<tag2>", "In", "the", "near", "term,", "we", "intend", "to", "hire", "a", "significant", "number", "of", "scientists,", "quality", "and", "regulatory", "personnel,", "and", "other", "technical", "s", "taff", "with", "the", "requisite", "expertise", "to", "support", "and", "expand", "our", "Cytori", "Nanomedicines", "business.", "<tag3>"], "wordsA": ["If", "we", "are", "unsuccessful", "in", "our", "efforts", "to", "raise", "outside", "capital", "in", "the", "near", "term,", "we", "will", "be", "required", "to", "significantly", "reduce", "our", "research,", "development,", "and", "administrative", "operations,", "including", "reduction", "of", "our", "employee", "base,", "in", "order", "to", "offset", "the", "lack", "of", "available", "funding."], "wordsB": ["In", "the", "near", "term,", "we", "intend", "to", "hire", "a", "significant", "number", "of", "scientists,", "quality", "and", "regulatory", "personnel,", "and", "other", "technical", "s", "taff", "with", "the", "requisite", "expertise", "to", "support", "and", "expand", "our", "Cytori", "Nanomedicines", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p229_s3", "idA": "1095981_16_item1a_p2_s4", "sentA": "If we are unsuccessful in our efforts to raise outside capital in the near term, we will be required to significantly reduce our research, development, and administrative operations, including reduction of our employee base, in order to offset the lack of available funding.", "sentB": "If we give notice of redemption, Warrant holders will be forced to sell or exercise their Warrants or accept the redemption price.", "type": 1, "words": ["<tag1>", "If", "we", "are", "unsuccessful", "in", "our", "efforts", "to", "raise", "outside", "capital", "in", "the", "near", "term,", "we", "will", "be", "required", "to", "significantly", "reduce", "our", "research,", "development,", "and", "administrative", "operations,", "including", "reduction", "of", "our", "employee", "base,", "in", "order", "to", "offset", "the", "lack", "of", "available", "funding.", "<tag2>", "If", "we", "give", "notice", "of", "redemption,", "Warrant", "holders", "will", "be", "forced", "to", "sell", "or", "exercise", "their", "Warrants", "or", "accept", "the", "redemption", "price.", "<tag3>"], "wordsA": ["If", "we", "are", "unsuccessful", "in", "our", "efforts", "to", "raise", "outside", "capital", "in", "the", "near", "term,", "we", "will", "be", "required", "to", "significantly", "reduce", "our", "research,", "development,", "and", "administrative", "operations,", "including", "reduction", "of", "our", "employee", "base,", "in", "order", "to", "offset", "the", "lack", "of", "available", "funding."], "wordsB": ["If", "we", "give", "notice", "of", "redemption,", "Warrant", "holders", "will", "be", "forced", "to", "sell", "or", "exercise", "their", "Warrants", "or", "accept", "the", "redemption", "price."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p98_s3", "idA": "1095981_16_item1a_p2_s4", "sentA": "If we are unsuccessful in our efforts to raise outside capital in the near term, we will be required to significantly reduce our research, development, and administrative operations, including reduction of our employee base, in order to offset the lack of available funding.", "sentB": "Further, in Europe, we expect that Habeo Cell Therapy will be classified as an ATMP with orphan drug status, and if we are the first ATMP approved for this indication in Europe, we will receive certain benefits, including market exclusivity (subject to certain caveats).", "type": 1, "words": ["<tag1>", "If", "we", "are", "unsuccessful", "in", "our", "efforts", "to", "raise", "outside", "capital", "in", "the", "near", "term,", "we", "will", "be", "required", "to", "significantly", "reduce", "our", "research,", "development,", "and", "administrative", "operations,", "including", "reduction", "of", "our", "employee", "base,", "in", "order", "to", "offset", "the", "lack", "of", "available", "funding.", "<tag2>", "Further,", "in", "Europe,", "we", "expect", "that", "Habeo", "Cell", "Therapy", "will", "be", "classified", "as", "an", "ATMP", "with", "orphan", "drug", "status,", "and", "if", "we", "are", "the", "first", "ATMP", "approved", "for", "this", "indication", "in", "Europe,", "we", "will", "receive", "certain", "benefits,", "including", "market", "exclusivity", "(subject", "to", "certain", "caveats).", "<tag3>"], "wordsA": ["If", "we", "are", "unsuccessful", "in", "our", "efforts", "to", "raise", "outside", "capital", "in", "the", "near", "term,", "we", "will", "be", "required", "to", "significantly", "reduce", "our", "research,", "development,", "and", "administrative", "operations,", "including", "reduction", "of", "our", "employee", "base,", "in", "order", "to", "offset", "the", "lack", "of", "available", "funding."], "wordsB": ["Further,", "in", "Europe,", "we", "expect", "that", "Habeo", "Cell", "Therapy", "will", "be", "classified", "as", "an", "ATMP", "with", "orphan", "drug", "status,", "and", "if", "we", "are", "the", "first", "ATMP", "approved", "for", "this", "indication", "in", "Europe,", "we", "will", "receive", "certain", "benefits,", "including", "market", "exclusivity", "(subject", "to", "certain", "caveats)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p100_s1", "idA": "1095981_16_item1a_p30_s0", "sentA": "We expect physicians inertia and skepticism to also be a significant barrier as we attempt to gain market penetration with our future products.", "sentB": "This imposes a significant administrative burden on participating physicians, and requires them to navigate a process with which they are oftentimes unfamiliar.", "type": 1, "words": ["<tag1>", "We", "expect", "physicians", "inertia", "and", "skepticism", "to", "also", "be", "a", "significant", "barrier", "as", "we", "attempt", "to", "gain", "market", "penetration", "with", "our", "future", "products.", "<tag2>", "This", "imposes", "a", "significant", "administrative", "burden", "on", "participating", "physicians,", "and", "requires", "them", "to", "navigate", "a", "process", "with", "which", "they", "are", "oftentimes", "unfamiliar.", "<tag3>"], "wordsA": ["We", "expect", "physicians", "inertia", "and", "skepticism", "to", "also", "be", "a", "significant", "barrier", "as", "we", "attempt", "to", "gain", "market", "penetration", "with", "our", "future", "products."], "wordsB": ["This", "imposes", "a", "significant", "administrative", "burden", "on", "participating", "physicians,", "and", "requires", "them", "to", "navigate", "a", "process", "with", "which", "they", "are", "oftentimes", "unfamiliar."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p229_s8", "idA": "1095981_16_item1a_p31_s0", "sentA": "We are in a relatively early stage of the path to commercialization with many of our products.", "sentB": "Since the Warrants are executory contracts, they may have no value in a bankruptcy or reorganization proceeding.", "type": 1, "words": ["<tag1>", "We", "are", "in", "a", "relatively", "early", "stage", "of", "the", "path", "to", "commercialization", "with", "many", "of", "our", "products.", "<tag2>", "Since", "the", "Warrants", "are", "executory", "contracts,", "they", "may", "have", "no", "value", "in", "a", "bankruptcy", "or", "reorganization", "proceeding.", "<tag3>"], "wordsA": ["We", "are", "in", "a", "relatively", "early", "stage", "of", "the", "path", "to", "commercialization", "with", "many", "of", "our", "products."], "wordsB": ["Since", "the", "Warrants", "are", "executory", "contracts,", "they", "may", "have", "no", "value", "in", "a", "bankruptcy", "or", "reorganization", "proceeding."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p32_s8", "idA": "1095981_16_item1a_p31_s0", "sentA": "We are in a relatively early stage of the path to commercialization with many of our products.", "sentB": "Bristol-Myers Squibb and NIAID are collaborators in a Phase 2 clinical trial evaluating Abatacept in patients with diffuse cutaneous systemic sclerosis.", "type": 1, "words": ["<tag1>", "We", "are", "in", "a", "relatively", "early", "stage", "of", "the", "path", "to", "commercialization", "with", "many", "of", "our", "products.", "<tag2>", "Bristol-Myers", "Squibb", "and", "NIAID", "are", "collaborators", "in", "a", "Phase", "2", "clinical", "trial", "evaluating", "Abatacept", "in", "patients", "with", "diffuse", "cutaneous", "systemic", "sclerosis.", "<tag3>"], "wordsA": ["We", "are", "in", "a", "relatively", "early", "stage", "of", "the", "path", "to", "commercialization", "with", "many", "of", "our", "products."], "wordsB": ["Bristol-Myers", "Squibb", "and", "NIAID", "are", "collaborators", "in", "a", "Phase", "2", "clinical", "trial", "evaluating", "Abatacept", "in", "patients", "with", "diffuse", "cutaneous", "systemic", "sclerosis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p37_s0", "idA": "1095981_16_item1a_p31_s0", "sentA": "We are in a relatively early stage of the path to commercialization with many of our products.", "sentB": "Oasmia s Docecal, a formulation of docetaxel combined with a patented nanoparticle-based technology, XR17, which is currently being evaluated in a Phase 1 clinical trial.", "type": 1, "words": ["<tag1>", "We", "are", "in", "a", "relatively", "early", "stage", "of", "the", "path", "to", "commercialization", "with", "many", "of", "our", "products.", "<tag2>", "Oasmia", "s", "Docecal,", "a", "formulation", "of", "docetaxel", "combined", "with", "a", "patented", "nanoparticle-based", "technology,", "XR17,", "which", "is", "currently", "being", "evaluated", "in", "a", "Phase", "1", "clinical", "trial.", "<tag3>"], "wordsA": ["We", "are", "in", "a", "relatively", "early", "stage", "of", "the", "path", "to", "commercialization", "with", "many", "of", "our", "products."], "wordsB": ["Oasmia", "s", "Docecal,", "a", "formulation", "of", "docetaxel", "combined", "with", "a", "patented", "nanoparticle-based", "technology,", "XR17,", "which", "is", "currently", "being", "evaluated", "in", "a", "Phase", "1", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p42_s3", "idA": "1095981_16_item1a_p31_s1", "sentA": "We believe that our long-term viability and growth will depend in large part on our ability to develop commercial quality cell processing devices and useful procedure-specific consumables, and to establish the safety and efficacy of our therapies through clinical trials and studies.", "sentB": "For instance, the investigator-initiated 12-patient, open-label SCLERADEC I trial investigating use of Habeo Cell Therapy for hand complications of scleroderma, sponsored by the Assistance Publique H pitaux de Marseille, or AP-HM, located in Marseille, France, has reported strong clinical data suggesting safety and efficacy of a single treatment of Habeo Cell Therapyout to three years after treatment.", "type": 1, "words": ["<tag1>", "We", "believe", "that", "our", "long-term", "viability", "and", "growth", "will", "depend", "in", "large", "part", "on", "our", "ability", "to", "develop", "commercial", "quality", "cell", "processing", "devices", "and", "useful", "procedure-specific", "consumables,", "and", "to", "establish", "the", "safety", "and", "efficacy", "of", "our", "therapies", "through", "clinical", "trials", "and", "studies.", "<tag2>", "For", "instance,", "the", "investigator-initiated", "12-patient,", "open-label", "SCLERADEC", "I", "trial", "investigating", "use", "of", "Habeo", "Cell", "Therapy", "for", "hand", "complications", "of", "scleroderma,", "sponsored", "by", "the", "Assistance", "Publique", "H", "pitaux", "de", "Marseille,", "or", "AP-HM,", "located", "in", "Marseille,", "France,", "has", "reported", "strong", "clinical", "data", "suggesting", "safety", "and", "efficacy", "of", "a", "single", "treatment", "of", "Habeo", "Cell", "Therapyout", "to", "three", "years", "after", "treatment.", "<tag3>"], "wordsA": ["We", "believe", "that", "our", "long-term", "viability", "and", "growth", "will", "depend", "in", "large", "part", "on", "our", "ability", "to", "develop", "commercial", "quality", "cell", "processing", "devices", "and", "useful", "procedure-specific", "consumables,", "and", "to", "establish", "the", "safety", "and", "efficacy", "of", "our", "therapies", "through", "clinical", "trials", "and", "studies."], "wordsB": ["For", "instance,", "the", "investigator-initiated", "12-patient,", "open-label", "SCLERADEC", "I", "trial", "investigating", "use", "of", "Habeo", "Cell", "Therapy", "for", "hand", "complications", "of", "scleroderma,", "sponsored", "by", "the", "Assistance", "Publique", "H", "pitaux", "de", "Marseille,", "or", "AP-HM,", "located", "in", "Marseille,", "France,", "has", "reported", "strong", "clinical", "data", "suggesting", "safety", "and", "efficacy", "of", "a", "single", "treatment", "of", "Habeo", "Cell", "Therapyout", "to", "three", "years", "after", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p100_s0", "idA": "1095981_16_item1a_p31_s3", "sentA": "There is no assurance that our development programs will be successfully completed or that required regulatory clearances or approvals will be obtained on a timely basis, if at all.", "sentB": "In most countries, patient access to Habeo Cell therapy will be provided on an individual patient basis where physicians will make an application to their Competent Authority in each country on a patient-by-patient basis.", "type": 1, "words": ["<tag1>", "There", "is", "no", "assurance", "that", "our", "development", "programs", "will", "be", "successfully", "completed", "or", "that", "required", "regulatory", "clearances", "or", "approvals", "will", "be", "obtained", "on", "a", "timely", "basis,", "if", "at", "all.", "<tag2>", "In", "most", "countries,", "patient", "access", "to", "Habeo", "Cell", "therapy", "will", "be", "provided", "on", "an", "individual", "patient", "basis", "where", "physicians", "will", "make", "an", "application", "to", "their", "Competent", "Authority", "in", "each", "country", "on", "a", "patient-by-patient", "basis.", "<tag3>"], "wordsA": ["There", "is", "no", "assurance", "that", "our", "development", "programs", "will", "be", "successfully", "completed", "or", "that", "required", "regulatory", "clearances", "or", "approvals", "will", "be", "obtained", "on", "a", "timely", "basis,", "if", "at", "all."], "wordsB": ["In", "most", "countries,", "patient", "access", "to", "Habeo", "Cell", "therapy", "will", "be", "provided", "on", "an", "individual", "patient", "basis", "where", "physicians", "will", "make", "an", "application", "to", "their", "Competent", "Authority", "in", "each", "country", "on", "a", "patient-by-patient", "basis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p32_s1", "idA": "1095981_16_item1a_p32_s0", "sentA": "There is no proven path for commercializing Cytori Cell Therapy in a way to earn a durable profit commensurate with the medical benefit.", "sentB": "Further, Corbus Pharmaceuticals is conducting a Phase II clinical trial evaluating Resunab (JBT-101) in patients with diffuse cutaneous systemic sclerosis and has reported positive topline results showing a clear signal of clinical benefit.", "type": 1, "words": ["<tag1>", "There", "is", "no", "proven", "path", "for", "commercializing", "Cytori", "Cell", "Therapy", "in", "a", "way", "to", "earn", "a", "durable", "profit", "commensurate", "with", "the", "medical", "benefit.", "<tag2>", "Further,", "Corbus", "Pharmaceuticals", "is", "conducting", "a", "Phase", "II", "clinical", "trial", "evaluating", "Resunab", "(JBT-101)", "in", "patients", "with", "diffuse", "cutaneous", "systemic", "sclerosis", "and", "has", "reported", "positive", "topline", "results", "showing", "a", "clear", "signal", "of", "clinical", "benefit.", "<tag3>"], "wordsA": ["There", "is", "no", "proven", "path", "for", "commercializing", "Cytori", "Cell", "Therapy", "in", "a", "way", "to", "earn", "a", "durable", "profit", "commensurate", "with", "the", "medical", "benefit."], "wordsB": ["Further,", "Corbus", "Pharmaceuticals", "is", "conducting", "a", "Phase", "II", "clinical", "trial", "evaluating", "Resunab", "(JBT-101)", "in", "patients", "with", "diffuse", "cutaneous", "systemic", "sclerosis", "and", "has", "reported", "positive", "topline", "results", "showing", "a", "clear", "signal", "of", "clinical", "benefit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p33_s0", "idA": "1095981_16_item1a_p32_s0", "sentA": "There is no proven path for commercializing Cytori Cell Therapy in a way to earn a durable profit commensurate with the medical benefit.", "sentB": "Our Cytori Cell Therapy may also face competition from lower price alternative cell therapies, including manually processed, or home brewed ADRCs that are harvested and used to treat patients for a wide range of indications.", "type": 1, "words": ["<tag1>", "There", "is", "no", "proven", "path", "for", "commercializing", "Cytori", "Cell", "Therapy", "in", "a", "way", "to", "earn", "a", "durable", "profit", "commensurate", "with", "the", "medical", "benefit.", "<tag2>", "Our", "Cytori", "Cell", "Therapy", "may", "also", "face", "competition", "from", "lower", "price", "alternative", "cell", "therapies,", "including", "manually", "processed,", "or", "home", "brewed", "ADRCs", "that", "are", "harvested", "and", "used", "to", "treat", "patients", "for", "a", "wide", "range", "of", "indications.", "<tag3>"], "wordsA": ["There", "is", "no", "proven", "path", "for", "commercializing", "Cytori", "Cell", "Therapy", "in", "a", "way", "to", "earn", "a", "durable", "profit", "commensurate", "with", "the", "medical", "benefit."], "wordsB": ["Our", "Cytori", "Cell", "Therapy", "may", "also", "face", "competition", "from", "lower", "price", "alternative", "cell", "therapies,", "including", "manually", "processed,", "or", "home", "brewed", "ADRCs", "that", "are", "harvested", "and", "used", "to", "treat", "patients", "for", "a", "wide", "range", "of", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p42_s5", "idA": "1095981_16_item1a_p32_s0", "sentA": "There is no proven path for commercializing Cytori Cell Therapy in a way to earn a durable profit commensurate with the medical benefit.", "sentB": "These trials are testing broader human use of Habeo Cell Therapy in blinded, randomized, placebo-controlled trial settings, as opposed to SCLERADEC I s open-label, single arm, uncontrolled, unblinded format.", "type": 1, "words": ["<tag1>", "There", "is", "no", "proven", "path", "for", "commercializing", "Cytori", "Cell", "Therapy", "in", "a", "way", "to", "earn", "a", "durable", "profit", "commensurate", "with", "the", "medical", "benefit.", "<tag2>", "These", "trials", "are", "testing", "broader", "human", "use", "of", "Habeo", "Cell", "Therapy", "in", "blinded,", "randomized,", "placebo-controlled", "trial", "settings,", "as", "opposed", "to", "SCLERADEC", "I", "s", "open-label,", "single", "arm,", "uncontrolled,", "unblinded", "format.", "<tag3>"], "wordsA": ["There", "is", "no", "proven", "path", "for", "commercializing", "Cytori", "Cell", "Therapy", "in", "a", "way", "to", "earn", "a", "durable", "profit", "commensurate", "with", "the", "medical", "benefit."], "wordsB": ["These", "trials", "are", "testing", "broader", "human", "use", "of", "Habeo", "Cell", "Therapy", "in", "blinded,", "randomized,", "placebo-controlled", "trial", "settings,", "as", "opposed", "to", "SCLERADEC", "I", "s", "open-label,", "single", "arm,", "uncontrolled,", "unblinded", "format."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p89_s1", "idA": "1095981_16_item1a_p32_s0", "sentA": "There is no proven path for commercializing Cytori Cell Therapy in a way to earn a durable profit commensurate with the medical benefit.", "sentB": "The Regenerative Medicine Law initially caused some confusion for regenerative companies operating in Japan, but we believe that this law, as currently implemented, benefits Cytori and its customers by allowing an expedited path for our customers in Japan to obtain licenses under the Regenerative Medicine Law to treat patients with Cytori Cell Therapy.", "type": 1, "words": ["<tag1>", "There", "is", "no", "proven", "path", "for", "commercializing", "Cytori", "Cell", "Therapy", "in", "a", "way", "to", "earn", "a", "durable", "profit", "commensurate", "with", "the", "medical", "benefit.", "<tag2>", "The", "Regenerative", "Medicine", "Law", "initially", "caused", "some", "confusion", "for", "regenerative", "companies", "operating", "in", "Japan,", "but", "we", "believe", "that", "this", "law,", "as", "currently", "implemented,", "benefits", "Cytori", "and", "its", "customers", "by", "allowing", "an", "expedited", "path", "for", "our", "customers", "in", "Japan", "to", "obtain", "licenses", "under", "the", "Regenerative", "Medicine", "Law", "to", "treat", "patients", "with", "Cytori", "Cell", "Therapy.", "<tag3>"], "wordsA": ["There", "is", "no", "proven", "path", "for", "commercializing", "Cytori", "Cell", "Therapy", "in", "a", "way", "to", "earn", "a", "durable", "profit", "commensurate", "with", "the", "medical", "benefit."], "wordsB": ["The", "Regenerative", "Medicine", "Law", "initially", "caused", "some", "confusion", "for", "regenerative", "companies", "operating", "in", "Japan,", "but", "we", "believe", "that", "this", "law,", "as", "currently", "implemented,", "benefits", "Cytori", "and", "its", "customers", "by", "allowing", "an", "expedited", "path", "for", "our", "customers", "in", "Japan", "to", "obtain", "licenses", "under", "the", "Regenerative", "Medicine", "Law", "to", "treat", "patients", "with", "Cytori", "Cell", "Therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p111_s5", "idA": "1095981_16_item1a_p32_s1", "sentA": "Although we began to commercialize our reconstructive surgery products in Europe and certain Asian markets, and our cell banking products in Japan, Europe, and certain Asian markets in 2008, additional market opportunities for many of our products and/or services may not materialize for a number of years.", "sentB": "Regardless whether a sole source supplier enters into a written supply arrangement with us, such supplier could still delay, suspend or terminate supply of raw materials to us for a number of reasons, including manufacturing or quality issues, payment disputes with us, bankruptcy or insolvency, or other occurrences.", "type": 1, "words": ["<tag1>", "Although", "we", "began", "to", "commercialize", "our", "reconstructive", "surgery", "products", "in", "Europe", "and", "certain", "Asian", "markets,", "and", "our", "cell", "banking", "products", "in", "Japan,", "Europe,", "and", "certain", "Asian", "markets", "in", "2008,", "additional", "market", "opportunities", "for", "many", "of", "our", "products", "and/or", "services", "may", "not", "materialize", "for", "a", "number", "of", "years.", "<tag2>", "Regardless", "whether", "a", "sole", "source", "supplier", "enters", "into", "a", "written", "supply", "arrangement", "with", "us,", "such", "supplier", "could", "still", "delay,", "suspend", "or", "terminate", "supply", "of", "raw", "materials", "to", "us", "for", "a", "number", "of", "reasons,", "including", "manufacturing", "or", "quality", "issues,", "payment", "disputes", "with", "us,", "bankruptcy", "or", "insolvency,", "or", "other", "occurrences.", "<tag3>"], "wordsA": ["Although", "we", "began", "to", "commercialize", "our", "reconstructive", "surgery", "products", "in", "Europe", "and", "certain", "Asian", "markets,", "and", "our", "cell", "banking", "products", "in", "Japan,", "Europe,", "and", "certain", "Asian", "markets", "in", "2008,", "additional", "market", "opportunities", "for", "many", "of", "our", "products", "and/or", "services", "may", "not", "materialize", "for", "a", "number", "of", "years."], "wordsB": ["Regardless", "whether", "a", "sole", "source", "supplier", "enters", "into", "a", "written", "supply", "arrangement", "with", "us,", "such", "supplier", "could", "still", "delay,", "suspend", "or", "terminate", "supply", "of", "raw", "materials", "to", "us", "for", "a", "number", "of", "reasons,", "including", "manufacturing", "or", "quality", "issues,", "payment", "disputes", "with", "us,", "bankruptcy", "or", "insolvency,", "or", "other", "occurrences."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p30_s1", "idA": "1095981_16_item1a_p32_s1", "sentA": "Although we began to commercialize our reconstructive surgery products in Europe and certain Asian markets, and our cell banking products in Japan, Europe, and certain Asian markets in 2008, additional market opportunities for many of our products and/or services may not materialize for a number of years.", "sentB": "We face competition from a number of sources, some of which may target the same indications as our products or product candidates, including small and large, domestic and multinational, medical device, biotechnology and pharmaceutical companies, academic institutions, government agencies and private and public research institutions, many of which have greater financial resources, sales and marketing capabilities, including larger, well-established sales forces, manufacturing capabilities, experience in obtaining regulatory approvals for product candidates and other resources than we do.", "type": 1, "words": ["<tag1>", "Although", "we", "began", "to", "commercialize", "our", "reconstructive", "surgery", "products", "in", "Europe", "and", "certain", "Asian", "markets,", "and", "our", "cell", "banking", "products", "in", "Japan,", "Europe,", "and", "certain", "Asian", "markets", "in", "2008,", "additional", "market", "opportunities", "for", "many", "of", "our", "products", "and/or", "services", "may", "not", "materialize", "for", "a", "number", "of", "years.", "<tag2>", "We", "face", "competition", "from", "a", "number", "of", "sources,", "some", "of", "which", "may", "target", "the", "same", "indications", "as", "our", "products", "or", "product", "candidates,", "including", "small", "and", "large,", "domestic", "and", "multinational,", "medical", "device,", "biotechnology", "and", "pharmaceutical", "companies,", "academic", "institutions,", "government", "agencies", "and", "private", "and", "public", "research", "institutions,", "many", "of", "which", "have", "greater", "financial", "resources,", "sales", "and", "marketing", "capabilities,", "including", "larger,", "well-established", "sales", "forces,", "manufacturing", "capabilities,", "experience", "in", "obtaining", "regulatory", "approvals", "for", "product", "candidates", "and", "other", "resources", "than", "we", "do.", "<tag3>"], "wordsA": ["Although", "we", "began", "to", "commercialize", "our", "reconstructive", "surgery", "products", "in", "Europe", "and", "certain", "Asian", "markets,", "and", "our", "cell", "banking", "products", "in", "Japan,", "Europe,", "and", "certain", "Asian", "markets", "in", "2008,", "additional", "market", "opportunities", "for", "many", "of", "our", "products", "and/or", "services", "may", "not", "materialize", "for", "a", "number", "of", "years."], "wordsB": ["We", "face", "competition", "from", "a", "number", "of", "sources,", "some", "of", "which", "may", "target", "the", "same", "indications", "as", "our", "products", "or", "product", "candidates,", "including", "small", "and", "large,", "domestic", "and", "multinational,", "medical", "device,", "biotechnology", "and", "pharmaceutical", "companies,", "academic", "institutions,", "government", "agencies", "and", "private", "and", "public", "research", "institutions,", "many", "of", "which", "have", "greater", "financial", "resources,", "sales", "and", "marketing", "capabilities,", "including", "larger,", "well-established", "sales", "forces,", "manufacturing", "capabilities,", "experience", "in", "obtaining", "regulatory", "approvals", "for", "product", "candidates", "and", "other", "resources", "than", "we", "do."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p50_s0", "idA": "1095981_16_item1a_p32_s1", "sentA": "Although we began to commercialize our reconstructive surgery products in Europe and certain Asian markets, and our cell banking products in Japan, Europe, and certain Asian markets in 2008, additional market opportunities for many of our products and/or services may not materialize for a number of years.", "sentB": "The EMA has approved eight ATMPs in Europe to date, with application review periods ranging from approximately thirteen to thirty-five months.", "type": 1, "words": ["<tag1>", "Although", "we", "began", "to", "commercialize", "our", "reconstructive", "surgery", "products", "in", "Europe", "and", "certain", "Asian", "markets,", "and", "our", "cell", "banking", "products", "in", "Japan,", "Europe,", "and", "certain", "Asian", "markets", "in", "2008,", "additional", "market", "opportunities", "for", "many", "of", "our", "products", "and/or", "services", "may", "not", "materialize", "for", "a", "number", "of", "years.", "<tag2>", "The", "EMA", "has", "approved", "eight", "ATMPs", "in", "Europe", "to", "date,", "with", "application", "review", "periods", "ranging", "from", "approximately", "thirteen", "to", "thirty-five", "months.", "<tag3>"], "wordsA": ["Although", "we", "began", "to", "commercialize", "our", "reconstructive", "surgery", "products", "in", "Europe", "and", "certain", "Asian", "markets,", "and", "our", "cell", "banking", "products", "in", "Japan,", "Europe,", "and", "certain", "Asian", "markets", "in", "2008,", "additional", "market", "opportunities", "for", "many", "of", "our", "products", "and/or", "services", "may", "not", "materialize", "for", "a", "number", "of", "years."], "wordsB": ["The", "EMA", "has", "approved", "eight", "ATMPs", "in", "Europe", "to", "date,", "with", "application", "review", "periods", "ranging", "from", "approximately", "thirteen", "to", "thirty-five", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p229_s1", "idA": "1095981_16_item1a_p34_s1", "sentA": "We are dependent on our collaborators to commercialize Cytori Cell Therapy in certain countries in order for us to realize any financial benefits from these collaborations.", "sentB": "The Warrants contain features that allow us to redeem the Warrants and that prohibit Warrant holders from engaging in certain investment strategies.", "type": 1, "words": ["<tag1>", "We", "are", "dependent", "on", "our", "collaborators", "to", "commercialize", "Cytori", "Cell", "Therapy", "in", "certain", "countries", "in", "order", "for", "us", "to", "realize", "any", "financial", "benefits", "from", "these", "collaborations.", "<tag2>", "The", "Warrants", "contain", "features", "that", "allow", "us", "to", "redeem", "the", "Warrants", "and", "that", "prohibit", "Warrant", "holders", "from", "engaging", "in", "certain", "investment", "strategies.", "<tag3>"], "wordsA": ["We", "are", "dependent", "on", "our", "collaborators", "to", "commercialize", "Cytori", "Cell", "Therapy", "in", "certain", "countries", "in", "order", "for", "us", "to", "realize", "any", "financial", "benefits", "from", "these", "collaborations."], "wordsB": ["The", "Warrants", "contain", "features", "that", "allow", "us", "to", "redeem", "the", "Warrants", "and", "that", "prohibit", "Warrant", "holders", "from", "engaging", "in", "certain", "investment", "strategies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p229_s7", "idA": "1095981_16_item1a_p34_s1", "sentA": "We are dependent on our collaborators to commercialize Cytori Cell Therapy in certain countries in order for us to realize any financial benefits from these collaborations.", "sentB": "This could prevent Warrant holders from pursuing investment strategies that could provide them greater financial benefits from owning the Warrants.", "type": 1, "words": ["<tag1>", "We", "are", "dependent", "on", "our", "collaborators", "to", "commercialize", "Cytori", "Cell", "Therapy", "in", "certain", "countries", "in", "order", "for", "us", "to", "realize", "any", "financial", "benefits", "from", "these", "collaborations.", "<tag2>", "This", "could", "prevent", "Warrant", "holders", "from", "pursuing", "investment", "strategies", "that", "could", "provide", "them", "greater", "financial", "benefits", "from", "owning", "the", "Warrants.", "<tag3>"], "wordsA": ["We", "are", "dependent", "on", "our", "collaborators", "to", "commercialize", "Cytori", "Cell", "Therapy", "in", "certain", "countries", "in", "order", "for", "us", "to", "realize", "any", "financial", "benefits", "from", "these", "collaborations."], "wordsB": ["This", "could", "prevent", "Warrant", "holders", "from", "pursuing", "investment", "strategies", "that", "could", "provide", "them", "greater", "financial", "benefits", "from", "owning", "the", "Warrants."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p98_s6", "idA": "1095981_16_item1a_p34_s1", "sentA": "We are dependent on our collaborators to commercialize Cytori Cell Therapy in certain countries in order for us to realize any financial benefits from these collaborations.", "sentB": "It is possible that our clinical trial data are sufficient to support regulatory approval of Habeo Cell Therapy, but not sufficient to support pricing at a level that makes Habeo Cell Therapy attractive to potential partners or to make it economically viable for us to directly commercialize Habeo Cell Therapy.", "type": 1, "words": ["<tag1>", "We", "are", "dependent", "on", "our", "collaborators", "to", "commercialize", "Cytori", "Cell", "Therapy", "in", "certain", "countries", "in", "order", "for", "us", "to", "realize", "any", "financial", "benefits", "from", "these", "collaborations.", "<tag2>", "It", "is", "possible", "that", "our", "clinical", "trial", "data", "are", "sufficient", "to", "support", "regulatory", "approval", "of", "Habeo", "Cell", "Therapy,", "but", "not", "sufficient", "to", "support", "pricing", "at", "a", "level", "that", "makes", "Habeo", "Cell", "Therapy", "attractive", "to", "potential", "partners", "or", "to", "make", "it", "economically", "viable", "for", "us", "to", "directly", "commercialize", "Habeo", "Cell", "Therapy.", "<tag3>"], "wordsA": ["We", "are", "dependent", "on", "our", "collaborators", "to", "commercialize", "Cytori", "Cell", "Therapy", "in", "certain", "countries", "in", "order", "for", "us", "to", "realize", "any", "financial", "benefits", "from", "these", "collaborations."], "wordsB": ["It", "is", "possible", "that", "our", "clinical", "trial", "data", "are", "sufficient", "to", "support", "regulatory", "approval", "of", "Habeo", "Cell", "Therapy,", "but", "not", "sufficient", "to", "support", "pricing", "at", "a", "level", "that", "makes", "Habeo", "Cell", "Therapy", "attractive", "to", "potential", "partners", "or", "to", "make", "it", "economically", "viable", "for", "us", "to", "directly", "commercialize", "Habeo", "Cell", "Therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p155_s0", "idA": "1095981_16_item1a_p35_s0", "sentA": "Our products and product candidates, along with the clinical development process, the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for these products, are subject to continual requirements and review by the FDA, state and foreign regulatory bodies.", "sentB": "We and our collaborators are subject to various federal, state and local environmental laws, rules and regulations, including those relating to discharge of materials into the air, water and ground, those relating to manufacturing, storage, use, transportation and disposal of hazardous and biological materials, and those relating to the health and safety of employees with respect to laboratory activities required for the development of our products and activities.", "type": 1, "words": ["<tag1>", "Our", "products", "and", "product", "candidates,", "along", "with", "the", "clinical", "development", "process,", "the", "manufacturing", "processes,", "post-approval", "clinical", "data,", "labeling,", "advertising", "and", "promotional", "activities", "for", "these", "products,", "are", "subject", "to", "continual", "requirements", "and", "review", "by", "the", "FDA,", "state", "and", "foreign", "regulatory", "bodies.", "<tag2>", "We", "and", "our", "collaborators", "are", "subject", "to", "various", "federal,", "state", "and", "local", "environmental", "laws,", "rules", "and", "regulations,", "including", "those", "relating", "to", "discharge", "of", "materials", "into", "the", "air,", "water", "and", "ground,", "those", "relating", "to", "manufacturing,", "storage,", "use,", "transportation", "and", "disposal", "of", "hazardous", "and", "biological", "materials,", "and", "those", "relating", "to", "the", "health", "and", "safety", "of", "employees", "with", "respect", "to", "laboratory", "activities", "required", "for", "the", "development", "of", "our", "products", "and", "activities.", "<tag3>"], "wordsA": ["Our", "products", "and", "product", "candidates,", "along", "with", "the", "clinical", "development", "process,", "the", "manufacturing", "processes,", "post-approval", "clinical", "data,", "labeling,", "advertising", "and", "promotional", "activities", "for", "these", "products,", "are", "subject", "to", "continual", "requirements", "and", "review", "by", "the", "FDA,", "state", "and", "foreign", "regulatory", "bodies."], "wordsB": ["We", "and", "our", "collaborators", "are", "subject", "to", "various", "federal,", "state", "and", "local", "environmental", "laws,", "rules", "and", "regulations,", "including", "those", "relating", "to", "discharge", "of", "materials", "into", "the", "air,", "water", "and", "ground,", "those", "relating", "to", "manufacturing,", "storage,", "use,", "transportation", "and", "disposal", "of", "hazardous", "and", "biological", "materials,", "and", "those", "relating", "to", "the", "health", "and", "safety", "of", "employees", "with", "respect", "to", "laboratory", "activities", "required", "for", "the", "development", "of", "our", "products", "and", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p31_s1", "idA": "1095981_16_item1a_p35_s0", "sentA": "Our products and product candidates, along with the clinical development process, the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for these products, are subject to continual requirements and review by the FDA, state and foreign regulatory bodies.", "sentB": "If approved for the treatment of hand dysfunction and/or Raynaud s Phenomenon in scleroderma patients, Habeo Cell Therapy will likely compete against other products and product candidates.", "type": 1, "words": ["<tag1>", "Our", "products", "and", "product", "candidates,", "along", "with", "the", "clinical", "development", "process,", "the", "manufacturing", "processes,", "post-approval", "clinical", "data,", "labeling,", "advertising", "and", "promotional", "activities", "for", "these", "products,", "are", "subject", "to", "continual", "requirements", "and", "review", "by", "the", "FDA,", "state", "and", "foreign", "regulatory", "bodies.", "<tag2>", "If", "approved", "for", "the", "treatment", "of", "hand", "dysfunction", "and/or", "Raynaud", "s", "Phenomenon", "in", "scleroderma", "patients,", "Habeo", "Cell", "Therapy", "will", "likely", "compete", "against", "other", "products", "and", "product", "candidates.", "<tag3>"], "wordsA": ["Our", "products", "and", "product", "candidates,", "along", "with", "the", "clinical", "development", "process,", "the", "manufacturing", "processes,", "post-approval", "clinical", "data,", "labeling,", "advertising", "and", "promotional", "activities", "for", "these", "products,", "are", "subject", "to", "continual", "requirements", "and", "review", "by", "the", "FDA,", "state", "and", "foreign", "regulatory", "bodies."], "wordsB": ["If", "approved", "for", "the", "treatment", "of", "hand", "dysfunction", "and/or", "Raynaud", "s", "Phenomenon", "in", "scleroderma", "patients,", "Habeo", "Cell", "Therapy", "will", "likely", "compete", "against", "other", "products", "and", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p59_s14", "idA": "1095981_16_item1a_p35_s0", "sentA": "Our products and product candidates, along with the clinical development process, the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for these products, are subject to continual requirements and review by the FDA, state and foreign regulatory bodies.", "sentB": "Our products candidates are at various stages of development.", "type": 1, "words": ["<tag1>", "Our", "products", "and", "product", "candidates,", "along", "with", "the", "clinical", "development", "process,", "the", "manufacturing", "processes,", "post-approval", "clinical", "data,", "labeling,", "advertising", "and", "promotional", "activities", "for", "these", "products,", "are", "subject", "to", "continual", "requirements", "and", "review", "by", "the", "FDA,", "state", "and", "foreign", "regulatory", "bodies.", "<tag2>", "Our", "products", "candidates", "are", "at", "various", "stages", "of", "development.", "<tag3>"], "wordsA": ["Our", "products", "and", "product", "candidates,", "along", "with", "the", "clinical", "development", "process,", "the", "manufacturing", "processes,", "post-approval", "clinical", "data,", "labeling,", "advertising", "and", "promotional", "activities", "for", "these", "products,", "are", "subject", "to", "continual", "requirements", "and", "review", "by", "the", "FDA,", "state", "and", "foreign", "regulatory", "bodies."], "wordsB": ["Our", "products", "candidates", "are", "at", "various", "stages", "of", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p80_s1", "idA": "1095981_16_item1a_p35_s0", "sentA": "Our products and product candidates, along with the clinical development process, the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for these products, are subject to continual requirements and review by the FDA, state and foreign regulatory bodies.", "sentB": "NDA drugs could take significantly longer due to the additional preclinical requirements along with the typical requirement for two successful Phase III clinical studies.", "type": 1, "words": ["<tag1>", "Our", "products", "and", "product", "candidates,", "along", "with", "the", "clinical", "development", "process,", "the", "manufacturing", "processes,", "post-approval", "clinical", "data,", "labeling,", "advertising", "and", "promotional", "activities", "for", "these", "products,", "are", "subject", "to", "continual", "requirements", "and", "review", "by", "the", "FDA,", "state", "and", "foreign", "regulatory", "bodies.", "<tag2>", "NDA", "drugs", "could", "take", "significantly", "longer", "due", "to", "the", "additional", "preclinical", "requirements", "along", "with", "the", "typical", "requirement", "for", "two", "successful", "Phase", "III", "clinical", "studies.", "<tag3>"], "wordsA": ["Our", "products", "and", "product", "candidates,", "along", "with", "the", "clinical", "development", "process,", "the", "manufacturing", "processes,", "post-approval", "clinical", "data,", "labeling,", "advertising", "and", "promotional", "activities", "for", "these", "products,", "are", "subject", "to", "continual", "requirements", "and", "review", "by", "the", "FDA,", "state", "and", "foreign", "regulatory", "bodies."], "wordsB": ["NDA", "drugs", "could", "take", "significantly", "longer", "due", "to", "the", "additional", "preclinical", "requirements", "along", "with", "the", "typical", "requirement", "for", "two", "successful", "Phase", "III", "clinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p18_s1", "idA": "1095981_16_item1a_p35_s1", "sentA": "Regulatory authorities subject a marketed product, its manufacturer and the manufacturing facilities to continual review and periodic inspections.", "sentB": "The male SUI market is small (approximately $45.0 million), and the long-term viability of both indications, especially SRP, is in substantial part dependent upon receipt of positive STAR and/or SCLERADEC II clinical data.", "type": 1, "words": ["<tag1>", "Regulatory", "authorities", "subject", "a", "marketed", "product,", "its", "manufacturer", "and", "the", "manufacturing", "facilities", "to", "continual", "review", "and", "periodic", "inspections.", "<tag2>", "The", "male", "SUI", "market", "is", "small", "(approximately", "$45.0", "million),", "and", "the", "long-term", "viability", "of", "both", "indications,", "especially", "SRP,", "is", "in", "substantial", "part", "dependent", "upon", "receipt", "of", "positive", "STAR", "and/or", "SCLERADEC", "II", "clinical", "data.", "<tag3>"], "wordsA": ["Regulatory", "authorities", "subject", "a", "marketed", "product,", "its", "manufacturer", "and", "the", "manufacturing", "facilities", "to", "continual", "review", "and", "periodic", "inspections."], "wordsB": ["The", "male", "SUI", "market", "is", "small", "(approximately", "$45.0", "million),", "and", "the", "long-term", "viability", "of", "both", "indications,", "especially", "SRP,", "is", "in", "substantial", "part", "dependent", "upon", "receipt", "of", "positive", "STAR", "and/or", "SCLERADEC", "II", "clinical", "data."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p93_s12", "idA": "1095981_16_item1a_p36_s0", "sentA": "Regulatory agencies may change existing requirements or adopt new requirements or policies.", "sentB": "Clinical and/or pre-clinical criteria in addition to cGMP manufacturing requirements may change and impose additional regulatory burdens.", "type": 1, "words": ["<tag1>", "Regulatory", "agencies", "may", "change", "existing", "requirements", "or", "adopt", "new", "requirements", "or", "policies.", "<tag2>", "Clinical", "and/or", "pre-clinical", "criteria", "in", "addition", "to", "cGMP", "manufacturing", "requirements", "may", "change", "and", "impose", "additional", "regulatory", "burdens.", "<tag3>"], "wordsA": ["Regulatory", "agencies", "may", "change", "existing", "requirements", "or", "adopt", "new", "requirements", "or", "policies."], "wordsB": ["Clinical", "and/or", "pre-clinical", "criteria", "in", "addition", "to", "cGMP", "manufacturing", "requirements", "may", "change", "and", "impose", "additional", "regulatory", "burdens."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p154_s4", "idA": "1095981_16_item1a_p37_s0", "sentA": "Failure to comply with regulatory requirements may result in any of the following:", "sentB": "We and our collaborators must comply with environmental laws and regulations, including those pertaining to use of hazardous and biological materials in our business, and failure to comply with these laws and regulations could expose us to significant liabilities.", "type": 1, "words": ["<tag1>", "Failure", "to", "comply", "with", "regulatory", "requirements", "may", "result", "in", "any", "of", "the", "following:", "<tag2>", "We", "and", "our", "collaborators", "must", "comply", "with", "environmental", "laws", "and", "regulations,", "including", "those", "pertaining", "to", "use", "of", "hazardous", "and", "biological", "materials", "in", "our", "business,", "and", "failure", "to", "comply", "with", "these", "laws", "and", "regulations", "could", "expose", "us", "to", "significant", "liabilities.", "<tag3>"], "wordsA": ["Failure", "to", "comply", "with", "regulatory", "requirements", "may", "result", "in", "any", "of", "the", "following:"], "wordsB": ["We", "and", "our", "collaborators", "must", "comply", "with", "environmental", "laws", "and", "regulations,", "including", "those", "pertaining", "to", "use", "of", "hazardous", "and", "biological", "materials", "in", "our", "business,", "and", "failure", "to", "comply", "with", "these", "laws", "and", "regulations", "could", "expose", "us", "to", "significant", "liabilities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p54_s0", "idA": "1095981_16_item1a_p39_s3", "sentA": "We cannot guarantee that the necessary regulatory approvals can be obtained, and we cannot guarantee that our products will be successful in these markets even if advantageous market regulatory approvals are obtained.", "sentB": "Though it is our intent to expeditiously pursue regulatory review of ATI-0918 in Europe through submission of a marketing authorization application, or MAA, to the EMA, prior to submission of this application we must first conduct and complete certain activities, including chemistry, manufacturing and controls, or CMC, activities, for inclusion in the application, and we cannot guarantee that we will successfully complete these activities.", "type": 1, "words": ["<tag1>", "We", "cannot", "guarantee", "that", "the", "necessary", "regulatory", "approvals", "can", "be", "obtained,", "and", "we", "cannot", "guarantee", "that", "our", "products", "will", "be", "successful", "in", "these", "markets", "even", "if", "advantageous", "market", "regulatory", "approvals", "are", "obtained.", "<tag2>", "Though", "it", "is", "our", "intent", "to", "expeditiously", "pursue", "regulatory", "review", "of", "ATI-0918", "in", "Europe", "through", "submission", "of", "a", "marketing", "authorization", "application,", "or", "MAA,", "to", "the", "EMA,", "prior", "to", "submission", "of", "this", "application", "we", "must", "first", "conduct", "and", "complete", "certain", "activities,", "including", "chemistry,", "manufacturing", "and", "controls,", "or", "CMC,", "activities,", "for", "inclusion", "in", "the", "application,", "and", "we", "cannot", "guarantee", "that", "we", "will", "successfully", "complete", "these", "activities.", "<tag3>"], "wordsA": ["We", "cannot", "guarantee", "that", "the", "necessary", "regulatory", "approvals", "can", "be", "obtained,", "and", "we", "cannot", "guarantee", "that", "our", "products", "will", "be", "successful", "in", "these", "markets", "even", "if", "advantageous", "market", "regulatory", "approvals", "are", "obtained."], "wordsB": ["Though", "it", "is", "our", "intent", "to", "expeditiously", "pursue", "regulatory", "review", "of", "ATI-0918", "in", "Europe", "through", "submission", "of", "a", "marketing", "authorization", "application,", "or", "MAA,", "to", "the", "EMA,", "prior", "to", "submission", "of", "this", "application", "we", "must", "first", "conduct", "and", "complete", "certain", "activities,", "including", "chemistry,", "manufacturing", "and", "controls,", "or", "CMC,", "activities,", "for", "inclusion", "in", "the", "application,", "and", "we", "cannot", "guarantee", "that", "we", "will", "successfully", "complete", "these", "activities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p102_s0", "idA": "1095981_16_item1a_p3_s0", "sentA": "We have been placing, and will continue to place, significant effort into raising additional capital that will provide adequate capital resources to allow us to continue to fund our future operations.", "sentB": "Because Cytori is targeting an orphan indication in scleroderma where there is an established need for effective therapies, regulators in Europe have been willing to allow an approval trial based on limited data from the 12-patient, investigator initiated SCLERADEC I pilot trial.", "type": 1, "words": ["<tag1>", "We", "have", "been", "placing,", "and", "will", "continue", "to", "place,", "significant", "effort", "into", "raising", "additional", "capital", "that", "will", "provide", "adequate", "capital", "resources", "to", "allow", "us", "to", "continue", "to", "fund", "our", "future", "operations.", "<tag2>", "Because", "Cytori", "is", "targeting", "an", "orphan", "indication", "in", "scleroderma", "where", "there", "is", "an", "established", "need", "for", "effective", "therapies,", "regulators", "in", "Europe", "have", "been", "willing", "to", "allow", "an", "approval", "trial", "based", "on", "limited", "data", "from", "the", "12-patient,", "investigator", "initiated", "SCLERADEC", "I", "pilot", "trial.", "<tag3>"], "wordsA": ["We", "have", "been", "placing,", "and", "will", "continue", "to", "place,", "significant", "effort", "into", "raising", "additional", "capital", "that", "will", "provide", "adequate", "capital", "resources", "to", "allow", "us", "to", "continue", "to", "fund", "our", "future", "operations."], "wordsB": ["Because", "Cytori", "is", "targeting", "an", "orphan", "indication", "in", "scleroderma", "where", "there", "is", "an", "established", "need", "for", "effective", "therapies,", "regulators", "in", "Europe", "have", "been", "willing", "to", "allow", "an", "approval", "trial", "based", "on", "limited", "data", "from", "the", "12-patient,", "investigator", "initiated", "SCLERADEC", "I", "pilot", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p45_s8", "idA": "1095981_16_item1a_p3_s3", "sentA": "Our financing plans include pursuing additional cash through use of our at-the-market offering program ( ATM ), strategic corporate partnerships, licensing and sales of equity.", "sentB": "Our product candidates will require development, regulatory review and approval in multiple jurisdictions, substantial investment, access to sufficient commercial manufacturing capacity and significant marketing efforts before we can generate any revenues from sales of our product candidates.", "type": 1, "words": ["<tag1>", "Our", "financing", "plans", "include", "pursuing", "additional", "cash", "through", "use", "of", "our", "at-the-market", "offering", "program", "(", "ATM", "),", "strategic", "corporate", "partnerships,", "licensing", "and", "sales", "of", "equity.", "<tag2>", "Our", "product", "candidates", "will", "require", "development,", "regulatory", "review", "and", "approval", "in", "multiple", "jurisdictions,", "substantial", "investment,", "access", "to", "sufficient", "commercial", "manufacturing", "capacity", "and", "significant", "marketing", "efforts", "before", "we", "can", "generate", "any", "revenues", "from", "sales", "of", "our", "product", "candidates.", "<tag3>"], "wordsA": ["Our", "financing", "plans", "include", "pursuing", "additional", "cash", "through", "use", "of", "our", "at-the-market", "offering", "program", "(", "ATM", "),", "strategic", "corporate", "partnerships,", "licensing", "and", "sales", "of", "equity."], "wordsB": ["Our", "product", "candidates", "will", "require", "development,", "regulatory", "review", "and", "approval", "in", "multiple", "jurisdictions,", "substantial", "investment,", "access", "to", "sufficient", "commercial", "manufacturing", "capacity", "and", "significant", "marketing", "efforts", "before", "we", "can", "generate", "any", "revenues", "from", "sales", "of", "our", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p229_s0", "idA": "1095981_16_item1a_p40_s0", "sentA": "Further, we are in discussions with Lorem Vascular to appropriately restructure our agreement with them.", "sentB": "The Warrants contain features that may reduce Warrant holders economic benefit from owning them.", "type": 1, "words": ["<tag1>", "Further,", "we", "are", "in", "discussions", "with", "Lorem", "Vascular", "to", "appropriately", "restructure", "our", "agreement", "with", "them.", "<tag2>", "The", "Warrants", "contain", "features", "that", "may", "reduce", "Warrant", "holders", "economic", "benefit", "from", "owning", "them.", "<tag3>"], "wordsA": ["Further,", "we", "are", "in", "discussions", "with", "Lorem", "Vascular", "to", "appropriately", "restructure", "our", "agreement", "with", "them."], "wordsB": ["The", "Warrants", "contain", "features", "that", "may", "reduce", "Warrant", "holders", "economic", "benefit", "from", "owning", "them."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p154_s0", "idA": "1095981_16_item1a_p40_s1", "sentA": "If we are unable to agree with Lorem Vascular on revised terms to our agreement, our relationship with them could suffer.", "sentB": "terms to ensure ongoing protection of personal information.", "type": 1, "words": ["<tag1>", "If", "we", "are", "unable", "to", "agree", "with", "Lorem", "Vascular", "on", "revised", "terms", "to", "our", "agreement,", "our", "relationship", "with", "them", "could", "suffer.", "<tag2>", "terms", "to", "ensure", "ongoing", "protection", "of", "personal", "information.", "<tag3>"], "wordsA": ["If", "we", "are", "unable", "to", "agree", "with", "Lorem", "Vascular", "on", "revised", "terms", "to", "our", "agreement,", "our", "relationship", "with", "them", "could", "suffer."], "wordsB": ["terms", "to", "ensure", "ongoing", "protection", "of", "personal", "information."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p155_s2", "idA": "1095981_16_item1a_p40_s3", "sentA": "Even if we successfully restructure our agreement with Lorem Vascular, there can be no assurance that Lorem Vascular will be able to successfully grow its Celution business in China.", "sentB": "Even if we and these suppliers and collaborators comply with the standards prescribed by law and regulation, the risk of accidental contamination or injury from hazardous materials, or other violations of applicable environmental laws, rules or regulations cannot be completely eliminated.", "type": 1, "words": ["<tag1>", "Even", "if", "we", "successfully", "restructure", "our", "agreement", "with", "Lorem", "Vascular,", "there", "can", "be", "no", "assurance", "that", "Lorem", "Vascular", "will", "be", "able", "to", "successfully", "grow", "its", "Celution", "business", "in", "China.", "<tag2>", "Even", "if", "we", "and", "these", "suppliers", "and", "collaborators", "comply", "with", "the", "standards", "prescribed", "by", "law", "and", "regulation,", "the", "risk", "of", "accidental", "contamination", "or", "injury", "from", "hazardous", "materials,", "or", "other", "violations", "of", "applicable", "environmental", "laws,", "rules", "or", "regulations", "cannot", "be", "completely", "eliminated.", "<tag3>"], "wordsA": ["Even", "if", "we", "successfully", "restructure", "our", "agreement", "with", "Lorem", "Vascular,", "there", "can", "be", "no", "assurance", "that", "Lorem", "Vascular", "will", "be", "able", "to", "successfully", "grow", "its", "Celution", "business", "in", "China."], "wordsB": ["Even", "if", "we", "and", "these", "suppliers", "and", "collaborators", "comply", "with", "the", "standards", "prescribed", "by", "law", "and", "regulation,", "the", "risk", "of", "accidental", "contamination", "or", "injury", "from", "hazardous", "materials,", "or", "other", "violations", "of", "applicable", "environmental", "laws,", "rules", "or", "regulations", "cannot", "be", "completely", "eliminated."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p22_s0", "idA": "1095981_16_item1a_p40_s4", "sentA": "Further, to the extent Lorem fails to comply with any regulations applicable to its marketing and commercialization of our products, we cannot assure you that regulators might not try to hold us responsible for such activities if they believe we somehow facilitated or were otherwise responsible for Lorem s actions.", "sentB": "Our current business strategy is high-risk.", "type": 1, "words": ["<tag1>", "Further,", "to", "the", "extent", "Lorem", "fails", "to", "comply", "with", "any", "regulations", "applicable", "to", "its", "marketing", "and", "commercialization", "of", "our", "products,", "we", "cannot", "assure", "you", "that", "regulators", "might", "not", "try", "to", "hold", "us", "responsible", "for", "such", "activities", "if", "they", "believe", "we", "somehow", "facilitated", "or", "were", "otherwise", "responsible", "for", "Lorem", "s", "actions.", "<tag2>", "Our", "current", "business", "strategy", "is", "high-risk.", "<tag3>"], "wordsA": ["Further,", "to", "the", "extent", "Lorem", "fails", "to", "comply", "with", "any", "regulations", "applicable", "to", "its", "marketing", "and", "commercialization", "of", "our", "products,", "we", "cannot", "assure", "you", "that", "regulators", "might", "not", "try", "to", "hold", "us", "responsible", "for", "such", "activities", "if", "they", "believe", "we", "somehow", "facilitated", "or", "were", "otherwise", "responsible", "for", "Lorem", "s", "actions."], "wordsB": ["Our", "current", "business", "strategy", "is", "high-risk."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p230_s0", "idA": "1095981_16_item1a_p40_s4", "sentA": "Further, to the extent Lorem fails to comply with any regulations applicable to its marketing and commercialization of our products, we cannot assure you that regulators might not try to hold us responsible for such activities if they believe we somehow facilitated or were otherwise responsible for Lorem s actions.", "sentB": "Our charter documents contain anti-takeover provisions.", "type": 1, "words": ["<tag1>", "Further,", "to", "the", "extent", "Lorem", "fails", "to", "comply", "with", "any", "regulations", "applicable", "to", "its", "marketing", "and", "commercialization", "of", "our", "products,", "we", "cannot", "assure", "you", "that", "regulators", "might", "not", "try", "to", "hold", "us", "responsible", "for", "such", "activities", "if", "they", "believe", "we", "somehow", "facilitated", "or", "were", "otherwise", "responsible", "for", "Lorem", "s", "actions.", "<tag2>", "Our", "charter", "documents", "contain", "anti-takeover", "provisions.", "<tag3>"], "wordsA": ["Further,", "to", "the", "extent", "Lorem", "fails", "to", "comply", "with", "any", "regulations", "applicable", "to", "its", "marketing", "and", "commercialization", "of", "our", "products,", "we", "cannot", "assure", "you", "that", "regulators", "might", "not", "try", "to", "hold", "us", "responsible", "for", "such", "activities", "if", "they", "believe", "we", "somehow", "facilitated", "or", "were", "otherwise", "responsible", "for", "Lorem", "s", "actions."], "wordsB": ["Our", "charter", "documents", "contain", "anti-takeover", "provisions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p111_s1", "idA": "1095981_16_item1a_p41_s0", "sentA": "We intend to enter into strategic partnerships/collaborations to commercialize our indications, as we do not have the financial, human or other resources necessary to introduce and sell our therapeutic offerings in all of the geographies that we are targeting.", "sentB": "We do not have a second qualified supplier to manufacture these reagents, a nd we estimate that it would take approximately two years to qualify another manufacturing source for our reagents.", "type": 1, "words": ["<tag1>", "We", "intend", "to", "enter", "into", "strategic", "partnerships/collaborations", "to", "commercialize", "our", "indications,", "as", "we", "do", "not", "have", "the", "financial,", "human", "or", "other", "resources", "necessary", "to", "introduce", "and", "sell", "our", "therapeutic", "offerings", "in", "all", "of", "the", "geographies", "that", "we", "are", "targeting.", "<tag2>", "We", "do", "not", "have", "a", "second", "qualified", "supplier", "to", "manufacture", "these", "reagents,", "a", "nd", "we", "estimate", "that", "it", "would", "take", "approximately", "two", "years", "to", "qualify", "another", "manufacturing", "source", "for", "our", "reagents.", "<tag3>"], "wordsA": ["We", "intend", "to", "enter", "into", "strategic", "partnerships/collaborations", "to", "commercialize", "our", "indications,", "as", "we", "do", "not", "have", "the", "financial,", "human", "or", "other", "resources", "necessary", "to", "introduce", "and", "sell", "our", "therapeutic", "offerings", "in", "all", "of", "the", "geographies", "that", "we", "are", "targeting."], "wordsB": ["We", "do", "not", "have", "a", "second", "qualified", "supplier", "to", "manufacture", "these", "reagents,", "a", "nd", "we", "estimate", "that", "it", "would", "take", "approximately", "two", "years", "to", "qualify", "another", "manufacturing", "source", "for", "our", "reagents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p3_s5", "idA": "1095981_16_item1a_p41_s0", "sentA": "We intend to enter into strategic partnerships/collaborations to commercialize our indications, as we do not have the financial, human or other resources necessary to introduce and sell our therapeutic offerings in all of the geographies that we are targeting.", "sentB": "In February 2017, we acquired substantially all of the assets of Azaya Therapeutics Inc, or Azaya, including Azaya s two drug candidates, ATI-0918 and ATI-1123, and related manufacturing equipment and inventory.", "type": 1, "words": ["<tag1>", "We", "intend", "to", "enter", "into", "strategic", "partnerships/collaborations", "to", "commercialize", "our", "indications,", "as", "we", "do", "not", "have", "the", "financial,", "human", "or", "other", "resources", "necessary", "to", "introduce", "and", "sell", "our", "therapeutic", "offerings", "in", "all", "of", "the", "geographies", "that", "we", "are", "targeting.", "<tag2>", "In", "February", "2017,", "we", "acquired", "substantially", "all", "of", "the", "assets", "of", "Azaya", "Therapeutics", "Inc,", "or", "Azaya,", "including", "Azaya", "s", "two", "drug", "candidates,", "ATI-0918", "and", "ATI-1123,", "and", "related", "manufacturing", "equipment", "and", "inventory.", "<tag3>"], "wordsA": ["We", "intend", "to", "enter", "into", "strategic", "partnerships/collaborations", "to", "commercialize", "our", "indications,", "as", "we", "do", "not", "have", "the", "financial,", "human", "or", "other", "resources", "necessary", "to", "introduce", "and", "sell", "our", "therapeutic", "offerings", "in", "all", "of", "the", "geographies", "that", "we", "are", "targeting."], "wordsB": ["In", "February", "2017,", "we", "acquired", "substantially", "all", "of", "the", "assets", "of", "Azaya", "Therapeutics", "Inc,", "or", "Azaya,", "including", "Azaya", "s", "two", "drug", "candidates,", "ATI-0918", "and", "ATI-1123,", "and", "related", "manufacturing", "equipment", "and", "inventory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p55_s0", "idA": "1095981_16_item1a_p41_s0", "sentA": "We intend to enter into strategic partnerships/collaborations to commercialize our indications, as we do not have the financial, human or other resources necessary to introduce and sell our therapeutic offerings in all of the geographies that we are targeting.", "sentB": "We intend to seek scientific advice from the EMA regarding required elements of the MAA before we submit the MAA, and if the EMA s scientific advice requires us to conduct substantive additional work (including possible provision of substantial additional data or information), our submission of the MAA could be materially delayed, which in turn would materially push back our anticipated launch date for ATI-0918 in Europe.", "type": 1, "words": ["<tag1>", "We", "intend", "to", "enter", "into", "strategic", "partnerships/collaborations", "to", "commercialize", "our", "indications,", "as", "we", "do", "not", "have", "the", "financial,", "human", "or", "other", "resources", "necessary", "to", "introduce", "and", "sell", "our", "therapeutic", "offerings", "in", "all", "of", "the", "geographies", "that", "we", "are", "targeting.", "<tag2>", "We", "intend", "to", "seek", "scientific", "advice", "from", "the", "EMA", "regarding", "required", "elements", "of", "the", "MAA", "before", "we", "submit", "the", "MAA,", "and", "if", "the", "EMA", "s", "scientific", "advice", "requires", "us", "to", "conduct", "substantive", "additional", "work", "(including", "possible", "provision", "of", "substantial", "additional", "data", "or", "information),", "our", "submission", "of", "the", "MAA", "could", "be", "materially", "delayed,", "which", "in", "turn", "would", "materially", "push", "back", "our", "anticipated", "launch", "date", "for", "ATI-0918", "in", "Europe.", "<tag3>"], "wordsA": ["We", "intend", "to", "enter", "into", "strategic", "partnerships/collaborations", "to", "commercialize", "our", "indications,", "as", "we", "do", "not", "have", "the", "financial,", "human", "or", "other", "resources", "necessary", "to", "introduce", "and", "sell", "our", "therapeutic", "offerings", "in", "all", "of", "the", "geographies", "that", "we", "are", "targeting."], "wordsB": ["We", "intend", "to", "seek", "scientific", "advice", "from", "the", "EMA", "regarding", "required", "elements", "of", "the", "MAA", "before", "we", "submit", "the", "MAA,", "and", "if", "the", "EMA", "s", "scientific", "advice", "requires", "us", "to", "conduct", "substantive", "additional", "work", "(including", "possible", "provision", "of", "substantial", "additional", "data", "or", "information),", "our", "submission", "of", "the", "MAA", "could", "be", "materially", "delayed,", "which", "in", "turn", "would", "materially", "push", "back", "our", "anticipated", "launch", "date", "for", "ATI-0918", "in", "Europe."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p83_s0", "idA": "1095981_16_item1a_p41_s0", "sentA": "We intend to enter into strategic partnerships/collaborations to commercialize our indications, as we do not have the financial, human or other resources necessary to introduce and sell our therapeutic offerings in all of the geographies that we are targeting.", "sentB": "We intend to seek regulatory of our ATI-0918 drug candidate via abbreviated approval processes referred to as bioequivalence or BE, approved under an abbreviated new drug application, or ANDA.", "type": 1, "words": ["<tag1>", "We", "intend", "to", "enter", "into", "strategic", "partnerships/collaborations", "to", "commercialize", "our", "indications,", "as", "we", "do", "not", "have", "the", "financial,", "human", "or", "other", "resources", "necessary", "to", "introduce", "and", "sell", "our", "therapeutic", "offerings", "in", "all", "of", "the", "geographies", "that", "we", "are", "targeting.", "<tag2>", "We", "intend", "to", "seek", "regulatory", "of", "our", "ATI-0918", "drug", "candidate", "via", "abbreviated", "approval", "processes", "referred", "to", "as", "bioequivalence", "or", "BE,", "approved", "under", "an", "abbreviated", "new", "drug", "application,", "or", "ANDA.", "<tag3>"], "wordsA": ["We", "intend", "to", "enter", "into", "strategic", "partnerships/collaborations", "to", "commercialize", "our", "indications,", "as", "we", "do", "not", "have", "the", "financial,", "human", "or", "other", "resources", "necessary", "to", "introduce", "and", "sell", "our", "therapeutic", "offerings", "in", "all", "of", "the", "geographies", "that", "we", "are", "targeting."], "wordsB": ["We", "intend", "to", "seek", "regulatory", "of", "our", "ATI-0918", "drug", "candidate", "via", "abbreviated", "approval", "processes", "referred", "to", "as", "bioequivalence", "or", "BE,", "approved", "under", "an", "abbreviated", "new", "drug", "application,", "or", "ANDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p105_s1", "idA": "1095981_16_item1a_p41_s4", "sentA": "We are currently prioritizing our efforts to find a strategic partner for our hand scleroderma therapy (ECCS-50) in the EU.", "sentB": "In the European Union, or EU, the EMA s Committee for Orphan Medicinal Products, or COMP, grants orphan drug designation to promote the development of products that are intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition affecting not more than 10,000 persons in the EU.", "type": 1, "words": ["<tag1>", "We", "are", "currently", "prioritizing", "our", "efforts", "to", "find", "a", "strategic", "partner", "for", "our", "hand", "scleroderma", "therapy", "(ECCS-50)", "in", "the", "EU.", "<tag2>", "In", "the", "European", "Union,", "or", "EU,", "the", "EMA", "s", "Committee", "for", "Orphan", "Medicinal", "Products,", "or", "COMP,", "grants", "orphan", "drug", "designation", "to", "promote", "the", "development", "of", "products", "that", "are", "intended", "for", "the", "diagnosis,", "prevention", "or", "treatment", "of", "a", "life-threatening", "or", "chronically", "debilitating", "condition", "affecting", "not", "more", "than", "10,000", "persons", "in", "the", "EU.", "<tag3>"], "wordsA": ["We", "are", "currently", "prioritizing", "our", "efforts", "to", "find", "a", "strategic", "partner", "for", "our", "hand", "scleroderma", "therapy", "(ECCS-50)", "in", "the", "EU."], "wordsB": ["In", "the", "European", "Union,", "or", "EU,", "the", "EMA", "s", "Committee", "for", "Orphan", "Medicinal", "Products,", "or", "COMP,", "grants", "orphan", "drug", "designation", "to", "promote", "the", "development", "of", "products", "that", "are", "intended", "for", "the", "diagnosis,", "prevention", "or", "treatment", "of", "a", "life-threatening", "or", "chronically", "debilitating", "condition", "affecting", "not", "more", "than", "10,000", "persons", "in", "the", "EU."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p154_s2", "idA": "1095981_16_item1a_p42_s0", "sentA": "The EU regulatory environment is complicated, and our technology approach is novel.", "sentB": "The EU s Data Protection Directive, Canada s Personal Information Protection and Electronic Documents Act and other data protection, privacy and similar na tional, state/provincial and local laws may also restrict the access, use and disclosure of patient health information abroad.", "type": 1, "words": ["<tag1>", "The", "EU", "regulatory", "environment", "is", "complicated,", "and", "our", "technology", "approach", "is", "novel.", "<tag2>", "The", "EU", "s", "Data", "Protection", "Directive,", "Canada", "s", "Personal", "Information", "Protection", "and", "Electronic", "Documents", "Act", "and", "other", "data", "protection,", "privacy", "and", "similar", "na", "tional,", "state/provincial", "and", "local", "laws", "may", "also", "restrict", "the", "access,", "use", "and", "disclosure", "of", "patient", "health", "information", "abroad.", "<tag3>"], "wordsA": ["The", "EU", "regulatory", "environment", "is", "complicated,", "and", "our", "technology", "approach", "is", "novel."], "wordsB": ["The", "EU", "s", "Data", "Protection", "Directive,", "Canada", "s", "Personal", "Information", "Protection", "and", "Electronic", "Documents", "Act", "and", "other", "data", "protection,", "privacy", "and", "similar", "na", "tional,", "state/provincial", "and", "local", "laws", "may", "also", "restrict", "the", "access,", "use", "and", "disclosure", "of", "patient", "health", "information", "abroad."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p126_s6", "idA": "1095981_16_item1a_p42_s2", "sentA": "These commercialization risks could affect prospective partners or collaborators willingness to enter into partnering arrangements on terms acceptable to us.", "sentB": "If we do enter into a new contract with BARDA, it might provide for lower funding caps and other material terms less favorable to us than the current BARDA Agreement.", "type": 1, "words": ["<tag1>", "These", "commercialization", "risks", "could", "affect", "prospective", "partners", "or", "collaborators", "willingness", "to", "enter", "into", "partnering", "arrangements", "on", "terms", "acceptable", "to", "us.", "<tag2>", "If", "we", "do", "enter", "into", "a", "new", "contract", "with", "BARDA,", "it", "might", "provide", "for", "lower", "funding", "caps", "and", "other", "material", "terms", "less", "favorable", "to", "us", "than", "the", "current", "BARDA", "Agreement.", "<tag3>"], "wordsA": ["These", "commercialization", "risks", "could", "affect", "prospective", "partners", "or", "collaborators", "willingness", "to", "enter", "into", "partnering", "arrangements", "on", "terms", "acceptable", "to", "us."], "wordsB": ["If", "we", "do", "enter", "into", "a", "new", "contract", "with", "BARDA,", "it", "might", "provide", "for", "lower", "funding", "caps", "and", "other", "material", "terms", "less", "favorable", "to", "us", "than", "the", "current", "BARDA", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p12_s4", "idA": "1095981_16_item1a_p42_s2", "sentA": "These commercialization risks could affect prospective partners or collaborators willingness to enter into partnering arrangements on terms acceptable to us.", "sentB": "Prospective partners may be unwilling to enter into an agreement with us unless and until we announce positive top-line data from our STAR clinical trial, which announcement is expected to occur in or around mid-2017.", "type": 1, "words": ["<tag1>", "These", "commercialization", "risks", "could", "affect", "prospective", "partners", "or", "collaborators", "willingness", "to", "enter", "into", "partnering", "arrangements", "on", "terms", "acceptable", "to", "us.", "<tag2>", "Prospective", "partners", "may", "be", "unwilling", "to", "enter", "into", "an", "agreement", "with", "us", "unless", "and", "until", "we", "announce", "positive", "top-line", "data", "from", "our", "STAR", "clinical", "trial,", "which", "announcement", "is", "expected", "to", "occur", "in", "or", "around", "mid-2017.", "<tag3>"], "wordsA": ["These", "commercialization", "risks", "could", "affect", "prospective", "partners", "or", "collaborators", "willingness", "to", "enter", "into", "partnering", "arrangements", "on", "terms", "acceptable", "to", "us."], "wordsB": ["Prospective", "partners", "may", "be", "unwilling", "to", "enter", "into", "an", "agreement", "with", "us", "unless", "and", "until", "we", "announce", "positive", "top-line", "data", "from", "our", "STAR", "clinical", "trial,", "which", "announcement", "is", "expected", "to", "occur", "in", "or", "around", "mid-2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p36_s2", "idA": "1095981_16_item1a_p42_s3", "sentA": "See risk factors below for further discussion regarding regulatory and market risks associated with our products.", "sentB": "Shanghai F-Z (Libaoduo) and Dr. Reddy s Labs are conducting ongoing bioequivalence studies versus Lipodox which they may decide to use to support FDA submissions for approval of their pegylated liposomal doxorubicin products.", "type": 1, "words": ["<tag1>", "See", "risk", "factors", "below", "for", "further", "discussion", "regarding", "regulatory", "and", "market", "risks", "associated", "with", "our", "products.", "<tag2>", "Shanghai", "F-Z", "(Libaoduo)", "and", "Dr.", "Reddy", "s", "Labs", "are", "conducting", "ongoing", "bioequivalence", "studies", "versus", "Lipodox", "which", "they", "may", "decide", "to", "use", "to", "support", "FDA", "submissions", "for", "approval", "of", "their", "pegylated", "liposomal", "doxorubicin", "products.", "<tag3>"], "wordsA": ["See", "risk", "factors", "below", "for", "further", "discussion", "regarding", "regulatory", "and", "market", "risks", "associated", "with", "our", "products."], "wordsB": ["Shanghai", "F-Z", "(Libaoduo)", "and", "Dr.", "Reddy", "s", "Labs", "are", "conducting", "ongoing", "bioequivalence", "studies", "versus", "Lipodox", "which", "they", "may", "decide", "to", "use", "to", "support", "FDA", "submissions", "for", "approval", "of", "their", "pegylated", "liposomal", "doxorubicin", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p59_s5", "idA": "1095981_16_item1a_p42_s3", "sentA": "See risk factors below for further discussion regarding regulatory and market risks associated with our products.", "sentB": "We face similar competitive pressures with our Cytori Nanomedicine product candidates.", "type": 1, "words": ["<tag1>", "See", "risk", "factors", "below", "for", "further", "discussion", "regarding", "regulatory", "and", "market", "risks", "associated", "with", "our", "products.", "<tag2>", "We", "face", "similar", "competitive", "pressures", "with", "our", "Cytori", "Nanomedicine", "product", "candidates.", "<tag3>"], "wordsA": ["See", "risk", "factors", "below", "for", "further", "discussion", "regarding", "regulatory", "and", "market", "risks", "associated", "with", "our", "products."], "wordsB": ["We", "face", "similar", "competitive", "pressures", "with", "our", "Cytori", "Nanomedicine", "product", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p139_s0", "idA": "1095981_16_item1a_p43_s1", "sentA": "Many of these markets have different, and in some cases less burdensome, regulatory schemes applicable to our products.", "sentB": "The manufacturing of these oncology drug assets is a highly complex process that requires significant experience and know-how.", "type": 1, "words": ["<tag1>", "Many", "of", "these", "markets", "have", "different,", "and", "in", "some", "cases", "less", "burdensome,", "regulatory", "schemes", "applicable", "to", "our", "products.", "<tag2>", "The", "manufacturing", "of", "these", "oncology", "drug", "assets", "is", "a", "highly", "complex", "process", "that", "requires", "significant", "experience", "and", "know-how.", "<tag3>"], "wordsA": ["Many", "of", "these", "markets", "have", "different,", "and", "in", "some", "cases", "less", "burdensome,", "regulatory", "schemes", "applicable", "to", "our", "products."], "wordsB": ["The", "manufacturing", "of", "these", "oncology", "drug", "assets", "is", "a", "highly", "complex", "process", "that", "requires", "significant", "experience", "and", "know-how."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p111_s10", "idA": "1095981_16_item1a_p43_s3", "sentA": "For example, we sell products to customers outside the U.S.", "sentB": "For example, in February 2017, we acquired intellectual property and a portfolio of investigational oncology therapies from Azaya Therapeutics.", "type": 1, "words": ["<tag1>", "For", "example,", "we", "sell", "products", "to", "customers", "outside", "the", "U.S.", "<tag2>", "For", "example,", "in", "February", "2017,", "we", "acquired", "intellectual", "property", "and", "a", "portfolio", "of", "investigational", "oncology", "therapies", "from", "Azaya", "Therapeutics.", "<tag3>"], "wordsA": ["For", "example,", "we", "sell", "products", "to", "customers", "outside", "the", "U.S."], "wordsB": ["For", "example,", "in", "February", "2017,", "we", "acquired", "intellectual", "property", "and", "a", "portfolio", "of", "investigational", "oncology", "therapies", "from", "Azaya", "Therapeutics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p155_s1", "idA": "1095981_16_item1a_p44_s1", "sentA": "Therefore, the market adoption of our Cytori Cell Therapy and cell banking technologies may be slow and lengthy with no assurances that significant market adoption will be successful.", "sentB": "In particular, our Cytori Nanomedicine products and processes involve the controlled storage, use and disposal of certain cytotoxic, or toxic to living cells, materials.", "type": 1, "words": ["<tag1>", "Therefore,", "the", "market", "adoption", "of", "our", "Cytori", "Cell", "Therapy", "and", "cell", "banking", "technologies", "may", "be", "slow", "and", "lengthy", "with", "no", "assurances", "that", "significant", "market", "adoption", "will", "be", "successful.", "<tag2>", "In", "particular,", "our", "Cytori", "Nanomedicine", "products", "and", "processes", "involve", "the", "controlled", "storage,", "use", "and", "disposal", "of", "certain", "cytotoxic,", "or", "toxic", "to", "living", "cells,", "materials.", "<tag3>"], "wordsA": ["Therefore,", "the", "market", "adoption", "of", "our", "Cytori", "Cell", "Therapy", "and", "cell", "banking", "technologies", "may", "be", "slow", "and", "lengthy", "with", "no", "assurances", "that", "significant", "market", "adoption", "will", "be", "successful."], "wordsB": ["In", "particular,", "our", "Cytori", "Nanomedicine", "products", "and", "processes", "involve", "the", "controlled", "storage,", "use", "and", "disposal", "of", "certain", "cytotoxic,", "or", "toxic", "to", "living", "cells,", "materials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p60_s0", "idA": "1095981_16_item1a_p44_s1", "sentA": "Therefore, the market adoption of our Cytori Cell Therapy and cell banking technologies may be slow and lengthy with no assurances that significant market adoption will be successful.", "sentB": "Regarding our Cytori Nanomedicine program, our ATI- 0918 generic drug candidate is pre-commercial.", "type": 1, "words": ["<tag1>", "Therefore,", "the", "market", "adoption", "of", "our", "Cytori", "Cell", "Therapy", "and", "cell", "banking", "technologies", "may", "be", "slow", "and", "lengthy", "with", "no", "assurances", "that", "significant", "market", "adoption", "will", "be", "successful.", "<tag2>", "Regarding", "our", "Cytori", "Nanomedicine", "program,", "our", "ATI-", "0918", "generic", "drug", "candidate", "is", "pre-commercial.", "<tag3>"], "wordsA": ["Therefore,", "the", "market", "adoption", "of", "our", "Cytori", "Cell", "Therapy", "and", "cell", "banking", "technologies", "may", "be", "slow", "and", "lengthy", "with", "no", "assurances", "that", "significant", "market", "adoption", "will", "be", "successful."], "wordsB": ["Regarding", "our", "Cytori", "Nanomedicine", "program,", "our", "ATI-", "0918", "generic", "drug", "candidate", "is", "pre-commercial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p98_s1", "idA": "1095981_16_item1a_p44_s1", "sentA": "Therefore, the market adoption of our Cytori Cell Therapy and cell banking technologies may be slow and lengthy with no assurances that significant market adoption will be successful.", "sentB": "As such, we anticipate that Habeo Cell Therapy will be priced to reflect its orphan status in our prior target markets for this indication.", "type": 1, "words": ["<tag1>", "Therefore,", "the", "market", "adoption", "of", "our", "Cytori", "Cell", "Therapy", "and", "cell", "banking", "technologies", "may", "be", "slow", "and", "lengthy", "with", "no", "assurances", "that", "significant", "market", "adoption", "will", "be", "successful.", "<tag2>", "As", "such,", "we", "anticipate", "that", "Habeo", "Cell", "Therapy", "will", "be", "priced", "to", "reflect", "its", "orphan", "status", "in", "our", "prior", "target", "markets", "for", "this", "indication.", "<tag3>"], "wordsA": ["Therefore,", "the", "market", "adoption", "of", "our", "Cytori", "Cell", "Therapy", "and", "cell", "banking", "technologies", "may", "be", "slow", "and", "lengthy", "with", "no", "assurances", "that", "significant", "market", "adoption", "will", "be", "successful."], "wordsB": ["As", "such,", "we", "anticipate", "that", "Habeo", "Cell", "Therapy", "will", "be", "priced", "to", "reflect", "its", "orphan", "status", "in", "our", "prior", "target", "markets", "for", "this", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p102_s1", "idA": "1095981_16_item1a_p44_s2", "sentA": "The lack of market adoption or reduced or minimal market adoption of our cell therapy and cell banking technologies may have a significant impact on our ability to successfully sell our product(s) into a country or region.", "sentB": "The lack of robust Phase II clinical data has also proven to be a hurdle to MAP acceptance.", "type": 1, "words": ["<tag1>", "The", "lack", "of", "market", "adoption", "or", "reduced", "or", "minimal", "market", "adoption", "of", "our", "cell", "therapy", "and", "cell", "banking", "technologies", "may", "have", "a", "significant", "impact", "on", "our", "ability", "to", "successfully", "sell", "our", "product(s)", "into", "a", "country", "or", "region.", "<tag2>", "The", "lack", "of", "robust", "Phase", "II", "clinical", "data", "has", "also", "proven", "to", "be", "a", "hurdle", "to", "MAP", "acceptance.", "<tag3>"], "wordsA": ["The", "lack", "of", "market", "adoption", "or", "reduced", "or", "minimal", "market", "adoption", "of", "our", "cell", "therapy", "and", "cell", "banking", "technologies", "may", "have", "a", "significant", "impact", "on", "our", "ability", "to", "successfully", "sell", "our", "product(s)", "into", "a", "country", "or", "region."], "wordsB": ["The", "lack", "of", "robust", "Phase", "II", "clinical", "data", "has", "also", "proven", "to", "be", "a", "hurdle", "to", "MAP", "acceptance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p90_s0", "idA": "1095981_16_item1a_p44_s2", "sentA": "The lack of market adoption or reduced or minimal market adoption of our cell therapy and cell banking technologies may have a significant impact on our ability to successfully sell our product(s) into a country or region.", "sentB": "approvals process without any anticipated interruption to our commercial activities, it is possible that other jurisdictions in which we currently sell may require similar heightened regulatory approvals but with potential restrictions on our ability to market and sell our Cytori Cell Therapy products in such t erritories during the application process and review period for the required regulatory approval(s).", "type": 1, "words": ["<tag1>", "The", "lack", "of", "market", "adoption", "or", "reduced", "or", "minimal", "market", "adoption", "of", "our", "cell", "therapy", "and", "cell", "banking", "technologies", "may", "have", "a", "significant", "impact", "on", "our", "ability", "to", "successfully", "sell", "our", "product(s)", "into", "a", "country", "or", "region.", "<tag2>", "approvals", "process", "without", "any", "anticipated", "interruption", "to", "our", "commercial", "activities,", "it", "is", "possible", "that", "other", "jurisdictions", "in", "which", "we", "currently", "sell", "may", "require", "similar", "heightened", "regulatory", "approvals", "but", "with", "potential", "restrictions", "on", "our", "ability", "to", "market", "and", "sell", "our", "Cytori", "Cell", "Therapy", "products", "in", "such", "t", "erritories", "during", "the", "application", "process", "and", "review", "period", "for", "the", "required", "regulatory", "approval(s).", "<tag3>"], "wordsA": ["The", "lack", "of", "market", "adoption", "or", "reduced", "or", "minimal", "market", "adoption", "of", "our", "cell", "therapy", "and", "cell", "banking", "technologies", "may", "have", "a", "significant", "impact", "on", "our", "ability", "to", "successfully", "sell", "our", "product(s)", "into", "a", "country", "or", "region."], "wordsB": ["approvals", "process", "without", "any", "anticipated", "interruption", "to", "our", "commercial", "activities,", "it", "is", "possible", "that", "other", "jurisdictions", "in", "which", "we", "currently", "sell", "may", "require", "similar", "heightened", "regulatory", "approvals", "but", "with", "potential", "restrictions", "on", "our", "ability", "to", "market", "and", "sell", "our", "Cytori", "Cell", "Therapy", "products", "in", "such", "t", "erritories", "during", "the", "application", "process", "and", "review", "period", "for", "the", "required", "regulatory", "approval(s)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p16_s0", "idA": "1095981_16_item1a_p45_s1", "sentA": "Poor results, unanticipated events or other complications in our clinical trials could result in substantial delays in commercialization, substantial negative effects on the perception of our products, and substantial additional costs.", "sentB": "In addition, we may seek development and/or commercial partners for the other therapeutic indications set forth in our clinical pipeline, including:", "type": 1, "words": ["<tag1>", "Poor", "results,", "unanticipated", "events", "or", "other", "complications", "in", "our", "clinical", "trials", "could", "result", "in", "substantial", "delays", "in", "commercialization,", "substantial", "negative", "effects", "on", "the", "perception", "of", "our", "products,", "and", "substantial", "additional", "costs.", "<tag2>", "In", "addition,", "we", "may", "seek", "development", "and/or", "commercial", "partners", "for", "the", "other", "therapeutic", "indications", "set", "forth", "in", "our", "clinical", "pipeline,", "including:", "<tag3>"], "wordsA": ["Poor", "results,", "unanticipated", "events", "or", "other", "complications", "in", "our", "clinical", "trials", "could", "result", "in", "substantial", "delays", "in", "commercialization,", "substantial", "negative", "effects", "on", "the", "perception", "of", "our", "products,", "and", "substantial", "additional", "costs."], "wordsB": ["In", "addition,", "we", "may", "seek", "development", "and/or", "commercial", "partners", "for", "the", "other", "therapeutic", "indications", "set", "forth", "in", "our", "clinical", "pipeline,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p201_s1", "idA": "1095981_16_item1a_p46_s0", "sentA": "Clinical testing of our products is a long, expensive and uncertain process, and the failure or delay of a clinical trial can occur at any stage.", "sentB": "As ATI-0918 is a generic drug, we did not acquire any patents related to ATI-0918.", "type": 1, "words": ["<tag1>", "Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage.", "<tag2>", "As", "ATI-0918", "is", "a", "generic", "drug,", "we", "did", "not", "acquire", "any", "patents", "related", "to", "ATI-0918.", "<tag3>"], "wordsA": ["Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage."], "wordsB": ["As", "ATI-0918", "is", "a", "generic", "drug,", "we", "did", "not", "acquire", "any", "patents", "related", "to", "ATI-0918."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p32_s0", "idA": "1095981_16_item1a_p46_s0", "sentA": "Clinical testing of our products is a long, expensive and uncertain process, and the failure or delay of a clinical trial can occur at any stage.", "sentB": "Johns Hopkins University, in collaboration with Allergan, recently completed and reported results from a Phase III clinical trial evaluating injection of Botox into the hands of patients with scleroderma-associated Raynaud s Syndrome.", "type": 1, "words": ["<tag1>", "Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage.", "<tag2>", "Johns", "Hopkins", "University,", "in", "collaboration", "with", "Allergan,", "recently", "completed", "and", "reported", "results", "from", "a", "Phase", "III", "clinical", "trial", "evaluating", "injection", "of", "Botox", "into", "the", "hands", "of", "patients", "with", "scleroderma-associated", "Raynaud", "s", "Syndrome.", "<tag3>"], "wordsA": ["Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage."], "wordsB": ["Johns", "Hopkins", "University,", "in", "collaboration", "with", "Allergan,", "recently", "completed", "and", "reported", "results", "from", "a", "Phase", "III", "clinical", "trial", "evaluating", "injection", "of", "Botox", "into", "the", "hands", "of", "patients", "with", "scleroderma-associated", "Raynaud", "s", "Syndrome."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p32_s10", "idA": "1095981_16_item1a_p46_s0", "sentA": "Clinical testing of our products is a long, expensive and uncertain process, and the failure or delay of a clinical trial can occur at any stage.", "sentB": "The Catholic University of Korea is sponsoring a clinical trial evaluating autologous stromal vascular fraction injected into the fingers of patients with systemic sclerosis.", "type": 1, "words": ["<tag1>", "Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage.", "<tag2>", "The", "Catholic", "University", "of", "Korea", "is", "sponsoring", "a", "clinical", "trial", "evaluating", "autologous", "stromal", "vascular", "fraction", "injected", "into", "the", "fingers", "of", "patients", "with", "systemic", "sclerosis.", "<tag3>"], "wordsA": ["Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage."], "wordsB": ["The", "Catholic", "University", "of", "Korea", "is", "sponsoring", "a", "clinical", "trial", "evaluating", "autologous", "stromal", "vascular", "fraction", "injected", "into", "the", "fingers", "of", "patients", "with", "systemic", "sclerosis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p32_s11", "idA": "1095981_16_item1a_p46_s0", "sentA": "Clinical testing of our products is a long, expensive and uncertain process, and the failure or delay of a clinical trial can occur at any stage.", "sentB": "Sanofi is sponsoring a Phase 2 clinical trial evaluating SAR156597 in patients with diffuse systemic sclerosis.", "type": 1, "words": ["<tag1>", "Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage.", "<tag2>", "Sanofi", "is", "sponsoring", "a", "Phase", "2", "clinical", "trial", "evaluating", "SAR156597", "in", "patients", "with", "diffuse", "systemic", "sclerosis.", "<tag3>"], "wordsA": ["Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage."], "wordsB": ["Sanofi", "is", "sponsoring", "a", "Phase", "2", "clinical", "trial", "evaluating", "SAR156597", "in", "patients", "with", "diffuse", "systemic", "sclerosis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p32_s4", "idA": "1095981_16_item1a_p46_s0", "sentA": "Clinical testing of our products is a long, expensive and uncertain process, and the failure or delay of a clinical trial can occur at any stage.", "sentB": "Covis Pharmaceuticals has completed a Phase 2 clinical trial to evaluate Vascana in patients with Raynaud s Phenomenon secondary to Connective Tissue Disease.", "type": 1, "words": ["<tag1>", "Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage.", "<tag2>", "Covis", "Pharmaceuticals", "has", "completed", "a", "Phase", "2", "clinical", "trial", "to", "evaluate", "Vascana", "in", "patients", "with", "Raynaud", "s", "Phenomenon", "secondary", "to", "Connective", "Tissue", "Disease.", "<tag3>"], "wordsA": ["Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage."], "wordsB": ["Covis", "Pharmaceuticals", "has", "completed", "a", "Phase", "2", "clinical", "trial", "to", "evaluate", "Vascana", "in", "patients", "with", "Raynaud", "s", "Phenomenon", "secondary", "to", "Connective", "Tissue", "Disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p32_s5", "idA": "1095981_16_item1a_p46_s0", "sentA": "Clinical testing of our products is a long, expensive and uncertain process, and the failure or delay of a clinical trial can occur at any stage.", "sentB": "Apricus Biosciences has completed a Phase 2 clinical trial for Vascana in patients with Raynaud s Phenomenon secondary to systemic sclerosis.", "type": 1, "words": ["<tag1>", "Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage.", "<tag2>", "Apricus", "Biosciences", "has", "completed", "a", "Phase", "2", "clinical", "trial", "for", "Vascana", "in", "patients", "with", "Raynaud", "s", "Phenomenon", "secondary", "to", "systemic", "sclerosis.", "<tag3>"], "wordsA": ["Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage."], "wordsB": ["Apricus", "Biosciences", "has", "completed", "a", "Phase", "2", "clinical", "trial", "for", "Vascana", "in", "patients", "with", "Raynaud", "s", "Phenomenon", "secondary", "to", "systemic", "sclerosis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p32_s9", "idA": "1095981_16_item1a_p46_s0", "sentA": "Clinical testing of our products is a long, expensive and uncertain process, and the failure or delay of a clinical trial can occur at any stage.", "sentB": "Invtiva Pharma is sponsoring a Phase 2 clinical trial evaluating IVA337 in patients with diffuse cutaneous systemic sclerosis.", "type": 1, "words": ["<tag1>", "Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage.", "<tag2>", "Invtiva", "Pharma", "is", "sponsoring", "a", "Phase", "2", "clinical", "trial", "evaluating", "IVA337", "in", "patients", "with", "diffuse", "cutaneous", "systemic", "sclerosis.", "<tag3>"], "wordsA": ["Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage."], "wordsB": ["Invtiva", "Pharma", "is", "sponsoring", "a", "Phase", "2", "clinical", "trial", "evaluating", "IVA337", "in", "patients", "with", "diffuse", "cutaneous", "systemic", "sclerosis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p98_s0", "idA": "1095981_16_item1a_p46_s0", "sentA": "Clinical testing of our products is a long, expensive and uncertain process, and the failure or delay of a clinical trial can occur at any stage.", "sentB": "Habeo Cell Therapy, our lead indication, is intended to treat hand manifestations of systemic scleroderma, which is a rare, or orphan, disease.", "type": 1, "words": ["<tag1>", "Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage.", "<tag2>", "Habeo", "Cell", "Therapy,", "our", "lead", "indication,", "is", "intended", "to", "treat", "hand", "manifestations", "of", "systemic", "scleroderma,", "which", "is", "a", "rare,", "or", "orphan,", "disease.", "<tag3>"], "wordsA": ["Clinical", "testing", "of", "our", "products", "is", "a", "long,", "expensive", "and", "uncertain", "process,", "and", "the", "failure", "or", "delay", "of", "a", "clinical", "trial", "can", "occur", "at", "any", "stage."], "wordsB": ["Habeo", "Cell", "Therapy,", "our", "lead", "indication,", "is", "intended", "to", "treat", "hand", "manifestations", "of", "systemic", "scleroderma,", "which", "is", "a", "rare,", "or", "orphan,", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p111_s13", "idA": "1095981_16_item1a_p46_s1", "sentA": "Even if initial results of preclinical and nonclinical studies or clinical trial results are promising, we may obtain different results in subsequent trials or studies that fail to show the desired levels of safety and efficacy, or we may not obtain applicable regulatory approval for a variety of other reasons.", "sentB": "Additional potential transactions that we may consider include a variety of different business arrangements, including spin-offs, strategic partnerships, joint ventures, restructurings, divestitures, business combinations and investments.", "type": 1, "words": ["<tag1>", "Even", "if", "initial", "results", "of", "preclinical", "and", "nonclinical", "studies", "or", "clinical", "trial", "results", "are", "promising,", "we", "may", "obtain", "different", "results", "in", "subsequent", "trials", "or", "studies", "that", "fail", "to", "show", "the", "desired", "levels", "of", "safety", "and", "efficacy,", "or", "we", "may", "not", "obtain", "applicable", "regulatory", "approval", "for", "a", "variety", "of", "other", "reasons.", "<tag2>", "Additional", "potential", "transactions", "that", "we", "may", "consider", "include", "a", "variety", "of", "different", "business", "arrangements,", "including", "spin-offs,", "strategic", "partnerships,", "joint", "ventures,", "restructurings,", "divestitures,", "business", "combinations", "and", "investments.", "<tag3>"], "wordsA": ["Even", "if", "initial", "results", "of", "preclinical", "and", "nonclinical", "studies", "or", "clinical", "trial", "results", "are", "promising,", "we", "may", "obtain", "different", "results", "in", "subsequent", "trials", "or", "studies", "that", "fail", "to", "show", "the", "desired", "levels", "of", "safety", "and", "efficacy,", "or", "we", "may", "not", "obtain", "applicable", "regulatory", "approval", "for", "a", "variety", "of", "other", "reasons."], "wordsB": ["Additional", "potential", "transactions", "that", "we", "may", "consider", "include", "a", "variety", "of", "different", "business", "arrangements,", "including", "spin-offs,", "strategic", "partnerships,", "joint", "ventures,", "restructurings,", "divestitures,", "business", "combinations", "and", "investments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p20_s0", "idA": "1095981_16_item1a_p46_s1", "sentA": "Even if initial results of preclinical and nonclinical studies or clinical trial results are promising, we may obtain different results in subsequent trials or studies that fail to show the desired levels of safety and efficacy, or we may not obtain applicable regulatory approval for a variety of other reasons.", "sentB": "partners may decide to terminate or not to renew their agreement with us for these reasons or other reasons.", "type": 1, "words": ["<tag1>", "Even", "if", "initial", "results", "of", "preclinical", "and", "nonclinical", "studies", "or", "clinical", "trial", "results", "are", "promising,", "we", "may", "obtain", "different", "results", "in", "subsequent", "trials", "or", "studies", "that", "fail", "to", "show", "the", "desired", "levels", "of", "safety", "and", "efficacy,", "or", "we", "may", "not", "obtain", "applicable", "regulatory", "approval", "for", "a", "variety", "of", "other", "reasons.", "<tag2>", "partners", "may", "decide", "to", "terminate", "or", "not", "to", "renew", "their", "agreement", "with", "us", "for", "these", "reasons", "or", "other", "reasons.", "<tag3>"], "wordsA": ["Even", "if", "initial", "results", "of", "preclinical", "and", "nonclinical", "studies", "or", "clinical", "trial", "results", "are", "promising,", "we", "may", "obtain", "different", "results", "in", "subsequent", "trials", "or", "studies", "that", "fail", "to", "show", "the", "desired", "levels", "of", "safety", "and", "efficacy,", "or", "we", "may", "not", "obtain", "applicable", "regulatory", "approval", "for", "a", "variety", "of", "other", "reasons."], "wordsB": ["partners", "may", "decide", "to", "terminate", "or", "not", "to", "renew", "their", "agreement", "with", "us", "for", "these", "reasons", "or", "other", "reasons."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p153_s2", "idA": "1095981_16_item1a_p47_s0", "sentA": "In the United States and other jurisdictions, regulatory approval can be delayed, limited or not granted for many reasons, including, among others:", "sentB": "The HIPAA amendments also impose compliance obligations and corresponding penalties for non-compliance on certain individuals and entities that provide services to or perform certain functions on behalf of healthcare providers and other covered entities involving the use or disclosure of individually identifiable health information, collectively referred to as business associates.", "type": 1, "words": ["<tag1>", "In", "the", "United", "States", "and", "other", "jurisdictions,", "regulatory", "approval", "can", "be", "delayed,", "limited", "or", "not", "granted", "for", "many", "reasons,", "including,", "among", "others:", "<tag2>", "The", "HIPAA", "amendments", "also", "impose", "compliance", "obligations", "and", "corresponding", "penalties", "for", "non-compliance", "on", "certain", "individuals", "and", "entities", "that", "provide", "services", "to", "or", "perform", "certain", "functions", "on", "behalf", "of", "healthcare", "providers", "and", "other", "covered", "entities", "involving", "the", "use", "or", "disclosure", "of", "individually", "identifiable", "health", "information,", "collectively", "referred", "to", "as", "business", "associates.", "<tag3>"], "wordsA": ["In", "the", "United", "States", "and", "other", "jurisdictions,", "regulatory", "approval", "can", "be", "delayed,", "limited", "or", "not", "granted", "for", "many", "reasons,", "including,", "among", "others:"], "wordsB": ["The", "HIPAA", "amendments", "also", "impose", "compliance", "obligations", "and", "corresponding", "penalties", "for", "non-compliance", "on", "certain", "individuals", "and", "entities", "that", "provide", "services", "to", "or", "perform", "certain", "functions", "on", "behalf", "of", "healthcare", "providers", "and", "other", "covered", "entities", "involving", "the", "use", "or", "disclosure", "of", "individually", "identifiable", "health", "information,", "collectively", "referred", "to", "as", "business", "associates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p138_s0", "idA": "1095981_16_item1a_p50_s1", "sentA": "The process of obtaining regulatory approvals in foreign countries is subject to delay and failure for the reasons set forth above, as well as for reasons that vary from jurisdiction to jurisdiction.", "sentB": "We compete for talent with numerous companies, as well as universities and non-profit research organizations.", "type": 1, "words": ["<tag1>", "The", "process", "of", "obtaining", "regulatory", "approvals", "in", "foreign", "countries", "is", "subject", "to", "delay", "and", "failure", "for", "the", "reasons", "set", "forth", "above,", "as", "well", "as", "for", "reasons", "that", "vary", "from", "jurisdiction", "to", "jurisdiction.", "<tag2>", "We", "compete", "for", "talent", "with", "numerous", "companies,", "as", "well", "as", "universities", "and", "non-profit", "research", "organizations.", "<tag3>"], "wordsA": ["The", "process", "of", "obtaining", "regulatory", "approvals", "in", "foreign", "countries", "is", "subject", "to", "delay", "and", "failure", "for", "the", "reasons", "set", "forth", "above,", "as", "well", "as", "for", "reasons", "that", "vary", "from", "jurisdiction", "to", "jurisdiction."], "wordsB": ["We", "compete", "for", "talent", "with", "numerous", "companies,", "as", "well", "as", "universities", "and", "non-profit", "research", "organizations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p35_s3", "idA": "1095981_16_item1a_p50_s1", "sentA": "The process of obtaining regulatory approvals in foreign countries is subject to delay and failure for the reasons set forth above, as well as for reasons that vary from jurisdiction to jurisdiction.", "sentB": "We may face competition for our ATI-0918 asset (which is intended for the treatment of breast and ovarian cancers, multiple myeloma, and Kaposi s sarcoma) from multiple drug classes including antiretrovirals, chemotherapies, corticosteroids, histone deacetaylase inhibitors, hormone therapies, immunotherapies, and targeted therapies, as well as companies seeking approvals in Europe or the United States for their pegylated liposomal doxorubicin products.", "type": 1, "words": ["<tag1>", "The", "process", "of", "obtaining", "regulatory", "approvals", "in", "foreign", "countries", "is", "subject", "to", "delay", "and", "failure", "for", "the", "reasons", "set", "forth", "above,", "as", "well", "as", "for", "reasons", "that", "vary", "from", "jurisdiction", "to", "jurisdiction.", "<tag2>", "We", "may", "face", "competition", "for", "our", "ATI-0918", "asset", "(which", "is", "intended", "for", "the", "treatment", "of", "breast", "and", "ovarian", "cancers,", "multiple", "myeloma,", "and", "Kaposi", "s", "sarcoma)", "from", "multiple", "drug", "classes", "including", "antiretrovirals,", "chemotherapies,", "corticosteroids,", "histone", "deacetaylase", "inhibitors,", "hormone", "therapies,", "immunotherapies,", "and", "targeted", "therapies,", "as", "well", "as", "companies", "seeking", "approvals", "in", "Europe", "or", "the", "United", "States", "for", "their", "pegylated", "liposomal", "doxorubicin", "products.", "<tag3>"], "wordsA": ["The", "process", "of", "obtaining", "regulatory", "approvals", "in", "foreign", "countries", "is", "subject", "to", "delay", "and", "failure", "for", "the", "reasons", "set", "forth", "above,", "as", "well", "as", "for", "reasons", "that", "vary", "from", "jurisdiction", "to", "jurisdiction."], "wordsB": ["We", "may", "face", "competition", "for", "our", "ATI-0918", "asset", "(which", "is", "intended", "for", "the", "treatment", "of", "breast", "and", "ovarian", "cancers,", "multiple", "myeloma,", "and", "Kaposi", "s", "sarcoma)", "from", "multiple", "drug", "classes", "including", "antiretrovirals,", "chemotherapies,", "corticosteroids,", "histone", "deacetaylase", "inhibitors,", "hormone", "therapies,", "immunotherapies,", "and", "targeted", "therapies,", "as", "well", "as", "companies", "seeking", "approvals", "in", "Europe", "or", "the", "United", "States", "for", "their", "pegylated", "liposomal", "doxorubicin", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p65_s1", "idA": "1095981_16_item1a_p50_s1", "sentA": "The process of obtaining regulatory approvals in foreign countries is subject to delay and failure for the reasons set forth above, as well as for reasons that vary from jurisdiction to jurisdiction.", "sentB": "Cytori and Bimini granted certain licenses to each other, and have certain license, royalty and other payment obligations under the Bimini agreement, as well as certain supply, development and non-competition obligations.", "type": 1, "words": ["<tag1>", "The", "process", "of", "obtaining", "regulatory", "approvals", "in", "foreign", "countries", "is", "subject", "to", "delay", "and", "failure", "for", "the", "reasons", "set", "forth", "above,", "as", "well", "as", "for", "reasons", "that", "vary", "from", "jurisdiction", "to", "jurisdiction.", "<tag2>", "Cytori", "and", "Bimini", "granted", "certain", "licenses", "to", "each", "other,", "and", "have", "certain", "license,", "royalty", "and", "other", "payment", "obligations", "under", "the", "Bimini", "agreement,", "as", "well", "as", "certain", "supply,", "development", "and", "non-competition", "obligations.", "<tag3>"], "wordsA": ["The", "process", "of", "obtaining", "regulatory", "approvals", "in", "foreign", "countries", "is", "subject", "to", "delay", "and", "failure", "for", "the", "reasons", "set", "forth", "above,", "as", "well", "as", "for", "reasons", "that", "vary", "from", "jurisdiction", "to", "jurisdiction."], "wordsB": ["Cytori", "and", "Bimini", "granted", "certain", "licenses", "to", "each", "other,", "and", "have", "certain", "license,", "royalty", "and", "other", "payment", "obligations", "under", "the", "Bimini", "agreement,", "as", "well", "as", "certain", "supply,", "development", "and", "non-competition", "obligations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p104_s0", "idA": "1095981_16_item1a_p51_s1", "sentA": "The time required to obtain approval may differ from that required to obtain FDA approval.", "sentB": "A product candidate that receives orphan drug designation can benefit from potential commercial benefits following approval.", "type": 1, "words": ["<tag1>", "The", "time", "required", "to", "obtain", "approval", "may", "differ", "from", "that", "required", "to", "obtain", "FDA", "approval.", "<tag2>", "A", "product", "candidate", "that", "receives", "orphan", "drug", "designation", "can", "benefit", "from", "potential", "commercial", "benefits", "following", "approval.", "<tag3>"], "wordsA": ["The", "time", "required", "to", "obtain", "approval", "may", "differ", "from", "that", "required", "to", "obtain", "FDA", "approval."], "wordsB": ["A", "product", "candidate", "that", "receives", "orphan", "drug", "designation", "can", "benefit", "from", "potential", "commercial", "benefits", "following", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p81_s3", "idA": "1095981_16_item1a_p51_s1", "sentA": "The time required to obtain approval may differ from that required to obtain FDA approval.", "sentB": "Both ATI-0918 and ATI-1123 will follow the centralized procedure for EMA regulatory approval.", "type": 1, "words": ["<tag1>", "The", "time", "required", "to", "obtain", "approval", "may", "differ", "from", "that", "required", "to", "obtain", "FDA", "approval.", "<tag2>", "Both", "ATI-0918", "and", "ATI-1123", "will", "follow", "the", "centralized", "procedure", "for", "EMA", "regulatory", "approval.", "<tag3>"], "wordsA": ["The", "time", "required", "to", "obtain", "approval", "may", "differ", "from", "that", "required", "to", "obtain", "FDA", "approval."], "wordsB": ["Both", "ATI-0918", "and", "ATI-1123", "will", "follow", "the", "centralized", "procedure", "for", "EMA", "regulatory", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p209_s5", "idA": "1095981_16_item1a_p53_s0", "sentA": "There can be no assurance that any of our pending patent applications will be approved or that we will develop additional proprietary products that are patentable.", "sentB": "Because some patent applications in the United States may be maintained in secrecy until the patents are issued, patent applications in the United States and many foreign jurisdictions are typically not published until eighteen months after filing, and publications in the scientific literature often lag behind actual discoveries, we cannot be certain that others have not filed patent applications for technology covered by our owned and in-licensed issued patents or our pending applications, or that we or, if applicable, a licensor were the first to invent the technology.", "type": 1, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "that", "any", "of", "our", "pending", "patent", "applications", "will", "be", "approved", "or", "that", "we", "will", "develop", "additional", "proprietary", "products", "that", "are", "patentable.", "<tag2>", "Because", "some", "patent", "applications", "in", "the", "United", "States", "may", "be", "maintained", "in", "secrecy", "until", "the", "patents", "are", "issued,", "patent", "applications", "in", "the", "United", "States", "and", "many", "foreign", "jurisdictions", "are", "typically", "not", "published", "until", "eighteen", "months", "after", "filing,", "and", "publications", "in", "the", "scientific", "literature", "often", "lag", "behind", "actual", "discoveries,", "we", "cannot", "be", "certain", "that", "others", "have", "not", "filed", "patent", "applications", "for", "technology", "covered", "by", "our", "owned", "and", "in-licensed", "issued", "patents", "or", "our", "pending", "applications,", "or", "that", "we", "or,", "if", "applicable,", "a", "licensor", "were", "the", "first", "to", "invent", "the", "technology.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "that", "any", "of", "our", "pending", "patent", "applications", "will", "be", "approved", "or", "that", "we", "will", "develop", "additional", "proprietary", "products", "that", "are", "patentable."], "wordsB": ["Because", "some", "patent", "applications", "in", "the", "United", "States", "may", "be", "maintained", "in", "secrecy", "until", "the", "patents", "are", "issued,", "patent", "applications", "in", "the", "United", "States", "and", "many", "foreign", "jurisdictions", "are", "typically", "not", "published", "until", "eighteen", "months", "after", "filing,", "and", "publications", "in", "the", "scientific", "literature", "often", "lag", "behind", "actual", "discoveries,", "we", "cannot", "be", "certain", "that", "others", "have", "not", "filed", "patent", "applications", "for", "technology", "covered", "by", "our", "owned", "and", "in-licensed", "issued", "patents", "or", "our", "pending", "applications,", "or", "that", "we", "or,", "if", "applicable,", "a", "licensor", "were", "the", "first", "to", "invent", "the", "technology."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p98_s4", "idA": "1095981_16_item1a_p53_s1", "sentA": "There is also no assurance that any patents issued to us will not become the subject of a re-examination, will provide us with competitive advantages, will not be challenged by any third parties, or that the patents of others will not prevent the commercialization of products incorporating our technology.", "sentB": "Status as an approved ATMP with orphan drug designation could provide us with a strong platform from which to seek higher reimbursement.", "type": 1, "words": ["<tag1>", "There", "is", "also", "no", "assurance", "that", "any", "patents", "issued", "to", "us", "will", "not", "become", "the", "subject", "of", "a", "re-examination,", "will", "provide", "us", "with", "competitive", "advantages,", "will", "not", "be", "challenged", "by", "any", "third", "parties,", "or", "that", "the", "patents", "of", "others", "will", "not", "prevent", "the", "commercialization", "of", "products", "incorporating", "our", "technology.", "<tag2>", "Status", "as", "an", "approved", "ATMP", "with", "orphan", "drug", "designation", "could", "provide", "us", "with", "a", "strong", "platform", "from", "which", "to", "seek", "higher", "reimbursement.", "<tag3>"], "wordsA": ["There", "is", "also", "no", "assurance", "that", "any", "patents", "issued", "to", "us", "will", "not", "become", "the", "subject", "of", "a", "re-examination,", "will", "provide", "us", "with", "competitive", "advantages,", "will", "not", "be", "challenged", "by", "any", "third", "parties,", "or", "that", "the", "patents", "of", "others", "will", "not", "prevent", "the", "commercialization", "of", "products", "incorporating", "our", "technology."], "wordsB": ["Status", "as", "an", "approved", "ATMP", "with", "orphan", "drug", "designation", "could", "provide", "us", "with", "a", "strong", "platform", "from", "which", "to", "seek", "higher", "reimbursement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p202_s5", "idA": "1095981_16_item1a_p53_s2", "sentA": "Furthermore, there can be no guarantee that others will not independently develop similar products, duplicate any of our products, or design around our patents.", "sentB": "Moreover, our competitors may independently develop equivalent knowledge, methods and know-how.", "type": 1, "words": ["<tag1>", "Furthermore,", "there", "can", "be", "no", "guarantee", "that", "others", "will", "not", "independently", "develop", "similar", "products,", "duplicate", "any", "of", "our", "products,", "or", "design", "around", "our", "patents.", "<tag2>", "Moreover,", "our", "competitors", "may", "independently", "develop", "equivalent", "knowledge,", "methods", "and", "know-how.", "<tag3>"], "wordsA": ["Furthermore,", "there", "can", "be", "no", "guarantee", "that", "others", "will", "not", "independently", "develop", "similar", "products,", "duplicate", "any", "of", "our", "products,", "or", "design", "around", "our", "patents."], "wordsB": ["Moreover,", "our", "competitors", "may", "independently", "develop", "equivalent", "knowledge,", "methods", "and", "know-how."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p122_s3", "idA": "1095981_16_item1a_p54_s2", "sentA": "If we are required in the future to obtain any licenses from third parties for some of our products, there can be no guarantee that we would be able to do so on commercially favorable terms, if at all.", "sentB": "If this occurs, we would likely severely curtail, suspend or even terminate our DCCT-10 program, and our business would be harmed.", "type": 1, "words": ["<tag1>", "If", "we", "are", "required", "in", "the", "future", "to", "obtain", "any", "licenses", "from", "third", "parties", "for", "some", "of", "our", "products,", "there", "can", "be", "no", "guarantee", "that", "we", "would", "be", "able", "to", "do", "so", "on", "commercially", "favorable", "terms,", "if", "at", "all.", "<tag2>", "If", "this", "occurs,", "we", "would", "likely", "severely", "curtail,", "suspend", "or", "even", "terminate", "our", "DCCT-10", "program,", "and", "our", "business", "would", "be", "harmed.", "<tag3>"], "wordsA": ["If", "we", "are", "required", "in", "the", "future", "to", "obtain", "any", "licenses", "from", "third", "parties", "for", "some", "of", "our", "products,", "there", "can", "be", "no", "guarantee", "that", "we", "would", "be", "able", "to", "do", "so", "on", "commercially", "favorable", "terms,", "if", "at", "all."], "wordsB": ["If", "this", "occurs,", "we", "would", "likely", "severely", "curtail,", "suspend", "or", "even", "terminate", "our", "DCCT-10", "program,", "and", "our", "business", "would", "be", "harmed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p209_s4", "idA": "1095981_16_item1a_p57_s1", "sentA": "If we are unsuccessful in actions we bring against the patents of other parties and it is determined that we infringe the patents of third-parties, we may be subject to litigation, or otherwise prevented from commercializing potential products in the relevant jurisdiction, or may be required to obtain licenses to those patents or develop or obtain alternative technologies, any of which could harm our business.", "sentB": "T here may be issued patents of third parties of which we are currently unaware, that are infringed or are alleged to be infringed by our product candidate or proprietary technologies.", "type": 1, "words": ["<tag1>", "If", "we", "are", "unsuccessful", "in", "actions", "we", "bring", "against", "the", "patents", "of", "other", "parties", "and", "it", "is", "determined", "that", "we", "infringe", "the", "patents", "of", "third-parties,", "we", "may", "be", "subject", "to", "litigation,", "or", "otherwise", "prevented", "from", "commercializing", "potential", "products", "in", "the", "relevant", "jurisdiction,", "or", "may", "be", "required", "to", "obtain", "licenses", "to", "those", "patents", "or", "develop", "or", "obtain", "alternative", "technologies,", "any", "of", "which", "could", "harm", "our", "business.", "<tag2>", "T", "here", "may", "be", "issued", "patents", "of", "third", "parties", "of", "which", "we", "are", "currently", "unaware,", "that", "are", "infringed", "or", "are", "alleged", "to", "be", "infringed", "by", "our", "product", "candidate", "or", "proprietary", "technologies.", "<tag3>"], "wordsA": ["If", "we", "are", "unsuccessful", "in", "actions", "we", "bring", "against", "the", "patents", "of", "other", "parties", "and", "it", "is", "determined", "that", "we", "infringe", "the", "patents", "of", "third-parties,", "we", "may", "be", "subject", "to", "litigation,", "or", "otherwise", "prevented", "from", "commercializing", "potential", "products", "in", "the", "relevant", "jurisdiction,", "or", "may", "be", "required", "to", "obtain", "licenses", "to", "those", "patents", "or", "develop", "or", "obtain", "alternative", "technologies,", "any", "of", "which", "could", "harm", "our", "business."], "wordsB": ["T", "here", "may", "be", "issued", "patents", "of", "third", "parties", "of", "which", "we", "are", "currently", "unaware,", "that", "are", "infringed", "or", "are", "alleged", "to", "be", "infringed", "by", "our", "product", "candidate", "or", "proprietary", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p60_s8", "idA": "1095981_16_item1a_p57_s2", "sentA": "Furthermore, if such challenges to our patent rights are not resolved in our favor, we could be delayed or prevented from entering into new collaborations or from commercializing certain products, which could adversely affect our business and results of operations.", "sentB": "Also, we intend to find a partner to develop our ATI-1123 drug candidate, but and if we are unsuccessful in doing so, our ATI-1123 development program could be delayed or suspended.", "type": 1, "words": ["<tag1>", "Furthermore,", "if", "such", "challenges", "to", "our", "patent", "rights", "are", "not", "resolved", "in", "our", "favor,", "we", "could", "be", "delayed", "or", "prevented", "from", "entering", "into", "new", "collaborations", "or", "from", "commercializing", "certain", "products,", "which", "could", "adversely", "affect", "our", "business", "and", "results", "of", "operations.", "<tag2>", "Also,", "we", "intend", "to", "find", "a", "partner", "to", "develop", "our", "ATI-1123", "drug", "candidate,", "but", "and", "if", "we", "are", "unsuccessful", "in", "doing", "so,", "our", "ATI-1123", "development", "program", "could", "be", "delayed", "or", "suspended.", "<tag3>"], "wordsA": ["Furthermore,", "if", "such", "challenges", "to", "our", "patent", "rights", "are", "not", "resolved", "in", "our", "favor,", "we", "could", "be", "delayed", "or", "prevented", "from", "entering", "into", "new", "collaborations", "or", "from", "commercializing", "certain", "products,", "which", "could", "adversely", "affect", "our", "business", "and", "results", "of", "operations."], "wordsB": ["Also,", "we", "intend", "to", "find", "a", "partner", "to", "develop", "our", "ATI-1123", "drug", "candidate,", "but", "and", "if", "we", "are", "unsuccessful", "in", "doing", "so,", "our", "ATI-1123", "development", "program", "could", "be", "delayed", "or", "suspended."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p201_s2", "idA": "1095981_16_item1a_p60_s1", "sentA": "We may be required to file patent infringement claims, which can be expensive and time-consuming.", "sentB": "We acquired two issued patents and one patent application related to ATI-1123 from Azaya, and intend to file additional patent application s around our ATI-1123 drug candidate.", "type": 1, "words": ["<tag1>", "We", "may", "be", "required", "to", "file", "patent", "infringement", "claims,", "which", "can", "be", "expensive", "and", "time-consuming.", "<tag2>", "We", "acquired", "two", "issued", "patents", "and", "one", "patent", "application", "related", "to", "ATI-1123", "from", "Azaya,", "and", "intend", "to", "file", "additional", "patent", "application", "s", "around", "our", "ATI-1123", "drug", "candidate.", "<tag3>"], "wordsA": ["We", "may", "be", "required", "to", "file", "patent", "infringement", "claims,", "which", "can", "be", "expensive", "and", "time-consuming."], "wordsB": ["We", "acquired", "two", "issued", "patents", "and", "one", "patent", "application", "related", "to", "ATI-1123", "from", "Azaya,", "and", "intend", "to", "file", "additional", "patent", "application", "s", "around", "our", "ATI-1123", "drug", "candidate."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p194_s0", "idA": "1095981_16_item1a_p60_s5", "sentA": "We may not be able to prevent misappropriation of our proprietary rights, particularly in countries outside the U.S. where patent rights may be more difficult to enforce.", "sentB": "The degree of future protection for our proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage.", "type": 1, "words": ["<tag1>", "We", "may", "not", "be", "able", "to", "prevent", "misappropriation", "of", "our", "proprietary", "rights,", "particularly", "in", "countries", "outside", "the", "U.S.", "where", "patent", "rights", "may", "be", "more", "difficult", "to", "enforce.", "<tag2>", "The", "degree", "of", "future", "protection", "for", "our", "proprietary", "rights", "is", "uncertain", "because", "legal", "means", "afford", "only", "limited", "protection", "and", "may", "not", "adequately", "protect", "our", "rights", "or", "permit", "us", "to", "gain", "or", "keep", "our", "competitive", "advantage.", "<tag3>"], "wordsA": ["We", "may", "not", "be", "able", "to", "prevent", "misappropriation", "of", "our", "proprietary", "rights,", "particularly", "in", "countries", "outside", "the", "U.S.", "where", "patent", "rights", "may", "be", "more", "difficult", "to", "enforce."], "wordsB": ["The", "degree", "of", "future", "protection", "for", "our", "proprietary", "rights", "is", "uncertain", "because", "legal", "means", "afford", "only", "limited", "protection", "and", "may", "not", "adequately", "protect", "our", "rights", "or", "permit", "us", "to", "gain", "or", "keep", "our", "competitive", "advantage."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p222_s1", "idA": "1095981_16_item1a_p60_s5", "sentA": "We may not be able to prevent misappropriation of our proprietary rights, particularly in countries outside the U.S. where patent rights may be more difficult to enforce.", "sentB": "If our stock is traded as a penny stock, transactions in our stock would be more difficult and cumbersome.", "type": 1, "words": ["<tag1>", "We", "may", "not", "be", "able", "to", "prevent", "misappropriation", "of", "our", "proprietary", "rights,", "particularly", "in", "countries", "outside", "the", "U.S.", "where", "patent", "rights", "may", "be", "more", "difficult", "to", "enforce.", "<tag2>", "If", "our", "stock", "is", "traded", "as", "a", "penny", "stock,", "transactions", "in", "our", "stock", "would", "be", "more", "difficult", "and", "cumbersome.", "<tag3>"], "wordsA": ["We", "may", "not", "be", "able", "to", "prevent", "misappropriation", "of", "our", "proprietary", "rights,", "particularly", "in", "countries", "outside", "the", "U.S.", "where", "patent", "rights", "may", "be", "more", "difficult", "to", "enforce."], "wordsB": ["If", "our", "stock", "is", "traded", "as", "a", "penny", "stock,", "transactions", "in", "our", "stock", "would", "be", "more", "difficult", "and", "cumbersome."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p155_s3", "idA": "1095981_16_item1a_p60_s6", "sentA": "Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential or sensitive information could be compromised by disclosure in the event of litigation.", "sentB": "In the event of any violation of such laws, rules or regulations, we could be held liable for any damages that result, and any liability could exceed the limits or fall outside the coverage of any insurance we may obtain and could exceed our financial resources.", "type": 1, "words": ["<tag1>", "Furthermore,", "because", "of", "the", "substantial", "amount", "of", "discovery", "required", "in", "connection", "with", "intellectual", "property", "litigation,", "there", "is", "a", "risk", "that", "some", "of", "our", "confidential", "or", "sensitive", "information", "could", "be", "compromised", "by", "disclosure", "in", "the", "event", "of", "litigation.", "<tag2>", "In", "the", "event", "of", "any", "violation", "of", "such", "laws,", "rules", "or", "regulations,", "we", "could", "be", "held", "liable", "for", "any", "damages", "that", "result,", "and", "any", "liability", "could", "exceed", "the", "limits", "or", "fall", "outside", "the", "coverage", "of", "any", "insurance", "we", "may", "obtain", "and", "could", "exceed", "our", "financial", "resources.", "<tag3>"], "wordsA": ["Furthermore,", "because", "of", "the", "substantial", "amount", "of", "discovery", "required", "in", "connection", "with", "intellectual", "property", "litigation,", "there", "is", "a", "risk", "that", "some", "of", "our", "confidential", "or", "sensitive", "information", "could", "be", "compromised", "by", "disclosure", "in", "the", "event", "of", "litigation."], "wordsB": ["In", "the", "event", "of", "any", "violation", "of", "such", "laws,", "rules", "or", "regulations,", "we", "could", "be", "held", "liable", "for", "any", "damages", "that", "result,", "and", "any", "liability", "could", "exceed", "the", "limits", "or", "fall", "outside", "the", "coverage", "of", "any", "insurance", "we", "may", "obtain", "and", "could", "exceed", "our", "financial", "resources."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p84_s0", "idA": "1095981_16_item1a_p60_s6", "sentA": "Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential or sensitive information could be compromised by disclosure in the event of litigation.", "sentB": "It is required for ANDA and BE drug candidates that there is a reference listed drug, or RLD, with which the drug candidate must demonstrate equivalence.", "type": 1, "words": ["<tag1>", "Furthermore,", "because", "of", "the", "substantial", "amount", "of", "discovery", "required", "in", "connection", "with", "intellectual", "property", "litigation,", "there", "is", "a", "risk", "that", "some", "of", "our", "confidential", "or", "sensitive", "information", "could", "be", "compromised", "by", "disclosure", "in", "the", "event", "of", "litigation.", "<tag2>", "It", "is", "required", "for", "ANDA", "and", "BE", "drug", "candidates", "that", "there", "is", "a", "reference", "listed", "drug,", "or", "RLD,", "with", "which", "the", "drug", "candidate", "must", "demonstrate", "equivalence.", "<tag3>"], "wordsA": ["Furthermore,", "because", "of", "the", "substantial", "amount", "of", "discovery", "required", "in", "connection", "with", "intellectual", "property", "litigation,", "there", "is", "a", "risk", "that", "some", "of", "our", "confidential", "or", "sensitive", "information", "could", "be", "compromised", "by", "disclosure", "in", "the", "event", "of", "litigation."], "wordsB": ["It", "is", "required", "for", "ANDA", "and", "BE", "drug", "candidates", "that", "there", "is", "a", "reference", "listed", "drug,", "or", "RLD,", "with", "which", "the", "drug", "candidate", "must", "demonstrate", "equivalence."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p148_s0", "idA": "1095981_16_item1a_p63_s0", "sentA": "Failure to obtain or maintain patent protection, or protect trade secrets, for any reason (or third-party claims against our patents, trade secrets, or proprietary rights, or our involvement in disputes over our patents, trade secrets, or proprietary rights, including involvement in litigation), could have a substantial negative effect on our results of operations and financial condition.", "sentB": "Anti-corruption laws generally prohibit us and our employees and intermediaries from bribing, being bribed or making other prohibited payments to government officials or other persons to obtain or retain business or gain some other business advantage.", "type": 1, "words": ["<tag1>", "Failure", "to", "obtain", "or", "maintain", "patent", "protection,", "or", "protect", "trade", "secrets,", "for", "any", "reason", "(or", "third-party", "claims", "against", "our", "patents,", "trade", "secrets,", "or", "proprietary", "rights,", "or", "our", "involvement", "in", "disputes", "over", "our", "patents,", "trade", "secrets,", "or", "proprietary", "rights,", "including", "involvement", "in", "litigation),", "could", "have", "a", "substantial", "negative", "effect", "on", "our", "results", "of", "operations", "and", "financial", "condition.", "<tag2>", "Anti-corruption", "laws", "generally", "prohibit", "us", "and", "our", "employees", "and", "intermediaries", "from", "bribing,", "being", "bribed", "or", "making", "other", "prohibited", "payments", "to", "government", "officials", "or", "other", "persons", "to", "obtain", "or", "retain", "business", "or", "gain", "some", "other", "business", "advantage.", "<tag3>"], "wordsA": ["Failure", "to", "obtain", "or", "maintain", "patent", "protection,", "or", "protect", "trade", "secrets,", "for", "any", "reason", "(or", "third-party", "claims", "against", "our", "patents,", "trade", "secrets,", "or", "proprietary", "rights,", "or", "our", "involvement", "in", "disputes", "over", "our", "patents,", "trade", "secrets,", "or", "proprietary", "rights,", "including", "involvement", "in", "litigation),", "could", "have", "a", "substantial", "negative", "effect", "on", "our", "results", "of", "operations", "and", "financial", "condition."], "wordsB": ["Anti-corruption", "laws", "generally", "prohibit", "us", "and", "our", "employees", "and", "intermediaries", "from", "bribing,", "being", "bribed", "or", "making", "other", "prohibited", "payments", "to", "government", "officials", "or", "other", "persons", "to", "obtain", "or", "retain", "business", "or", "gain", "some", "other", "business", "advantage."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p34_s0", "idA": "1095981_16_item1a_p64_s0", "sentA": "Intellectual property law outside the United States is uncertain and in many countries is currently undergoing review and revisions.", "sentB": "There are hundreds of stromal vascular fraction, or SVF, clinics within the United States alone, that purport to offer cell therapy treatments for ailments ranging from facial rejuvenation to stroke.", "type": 1, "words": ["<tag1>", "Intellectual", "property", "law", "outside", "the", "United", "States", "is", "uncertain", "and", "in", "many", "countries", "is", "currently", "undergoing", "review", "and", "revisions.", "<tag2>", "There", "are", "hundreds", "of", "stromal", "vascular", "fraction,", "or", "SVF,", "clinics", "within", "the", "United", "States", "alone,", "that", "purport", "to", "offer", "cell", "therapy", "treatments", "for", "ailments", "ranging", "from", "facial", "rejuvenation", "to", "stroke.", "<tag3>"], "wordsA": ["Intellectual", "property", "law", "outside", "the", "United", "States", "is", "uncertain", "and", "in", "many", "countries", "is", "currently", "undergoing", "review", "and", "revisions."], "wordsB": ["There", "are", "hundreds", "of", "stromal", "vascular", "fraction,", "or", "SVF,", "clinics", "within", "the", "United", "States", "alone,", "that", "purport", "to", "offer", "cell", "therapy", "treatments", "for", "ailments", "ranging", "from", "facial", "rejuvenation", "to", "stroke."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p105_s4", "idA": "1095981_16_item1a_p64_s1", "sentA": "The laws of some countries do not protect our patent and other intellectual property rights to the same extent as United States laws.", "sentB": "Further, even after an orphan drug is approved, the FDA can subsequently approve a drug with similar chemical structure for the same condition if the FDA concludes that the new drug is clinically superior to the orphan product or a market shortage occurs.", "type": 1, "words": ["<tag1>", "The", "laws", "of", "some", "countries", "do", "not", "protect", "our", "patent", "and", "other", "intellectual", "property", "rights", "to", "the", "same", "extent", "as", "United", "States", "laws.", "<tag2>", "Further,", "even", "after", "an", "orphan", "drug", "is", "approved,", "the", "FDA", "can", "subsequently", "approve", "a", "drug", "with", "similar", "chemical", "structure", "for", "the", "same", "condition", "if", "the", "FDA", "concludes", "that", "the", "new", "drug", "is", "clinically", "superior", "to", "the", "orphan", "product", "or", "a", "market", "shortage", "occurs.", "<tag3>"], "wordsA": ["The", "laws", "of", "some", "countries", "do", "not", "protect", "our", "patent", "and", "other", "intellectual", "property", "rights", "to", "the", "same", "extent", "as", "United", "States", "laws."], "wordsB": ["Further,", "even", "after", "an", "orphan", "drug", "is", "approved,", "the", "FDA", "can", "subsequently", "approve", "a", "drug", "with", "similar", "chemical", "structure", "for", "the", "same", "condition", "if", "the", "FDA", "concludes", "that", "the", "new", "drug", "is", "clinically", "superior", "to", "the", "orphan", "product", "or", "a", "market", "shortage", "occurs."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p201_s0", "idA": "1095981_16_item1a_p64_s1", "sentA": "The laws of some countries do not protect our patent and other intellectual property rights to the same extent as United States laws.", "sentB": "Our intellectual property related to Cytori Nanom edicine was acquired from Azaya.", "type": 1, "words": ["<tag1>", "The", "laws", "of", "some", "countries", "do", "not", "protect", "our", "patent", "and", "other", "intellectual", "property", "rights", "to", "the", "same", "extent", "as", "United", "States", "laws.", "<tag2>", "Our", "intellectual", "property", "related", "to", "Cytori", "Nanom", "edicine", "was", "acquired", "from", "Azaya.", "<tag3>"], "wordsA": ["The", "laws", "of", "some", "countries", "do", "not", "protect", "our", "patent", "and", "other", "intellectual", "property", "rights", "to", "the", "same", "extent", "as", "United", "States", "laws."], "wordsB": ["Our", "intellectual", "property", "related", "to", "Cytori", "Nanom", "edicine", "was", "acquired", "from", "Azaya."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p209_s7", "idA": "1095981_16_item1a_p64_s1", "sentA": "The laws of some countries do not protect our patent and other intellectual property rights to the same extent as United States laws.", "sentB": "Any such patent application may have priority over our patent applications or patents, which could further require us to obtain rights to issued patents covering such technologies.", "type": 1, "words": ["<tag1>", "The", "laws", "of", "some", "countries", "do", "not", "protect", "our", "patent", "and", "other", "intellectual", "property", "rights", "to", "the", "same", "extent", "as", "United", "States", "laws.", "<tag2>", "Any", "such", "patent", "application", "may", "have", "priority", "over", "our", "patent", "applications", "or", "patents,", "which", "could", "further", "require", "us", "to", "obtain", "rights", "to", "issued", "patents", "covering", "such", "technologies.", "<tag3>"], "wordsA": ["The", "laws", "of", "some", "countries", "do", "not", "protect", "our", "patent", "and", "other", "intellectual", "property", "rights", "to", "the", "same", "extent", "as", "United", "States", "laws."], "wordsB": ["Any", "such", "patent", "application", "may", "have", "priority", "over", "our", "patent", "applications", "or", "patents,", "which", "could", "further", "require", "us", "to", "obtain", "rights", "to", "issued", "patents", "covering", "such", "technologies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p32_s12", "idA": "1095981_16_item1a_p64_s2", "sentA": "This is particularly relevant to us as most of our current commercial product sales and clinical trials are outside of the United States.", "sentB": "Hoffman-La Roche is sponsoring Phase 3 clinical trials evaluating Actemra (tocilizumab) in patients with systemic sclerosis.", "type": 1, "words": ["<tag1>", "This", "is", "particularly", "relevant", "to", "us", "as", "most", "of", "our", "current", "commercial", "product", "sales", "and", "clinical", "trials", "are", "outside", "of", "the", "United", "States.", "<tag2>", "Hoffman-La", "Roche", "is", "sponsoring", "Phase", "3", "clinical", "trials", "evaluating", "Actemra", "(tocilizumab)", "in", "patients", "with", "systemic", "sclerosis.", "<tag3>"], "wordsA": ["This", "is", "particularly", "relevant", "to", "us", "as", "most", "of", "our", "current", "commercial", "product", "sales", "and", "clinical", "trials", "are", "outside", "of", "the", "United", "States."], "wordsB": ["Hoffman-La", "Roche", "is", "sponsoring", "Phase", "3", "clinical", "trials", "evaluating", "Actemra", "(tocilizumab)", "in", "patients", "with", "systemic", "sclerosis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p148_s1", "idA": "1095981_16_item1a_p65_s2", "sentA": "It may be necessary or useful for us to participate in proceedings to determine the validity of our patents or our competitors patents that have been issued in countries other than the U.S.", "sentB": "We participate in collaborations and relationships with third parties whose actions could potentially subject us to liability under these anti-corruption laws.", "type": 1, "words": ["<tag1>", "It", "may", "be", "necessary", "or", "useful", "for", "us", "to", "participate", "in", "proceedings", "to", "determine", "the", "validity", "of", "our", "patents", "or", "our", "competitors", "patents", "that", "have", "been", "issued", "in", "countries", "other", "than", "the", "U.S.", "<tag2>", "We", "participate", "in", "collaborations", "and", "relationships", "with", "third", "parties", "whose", "actions", "could", "potentially", "subject", "us", "to", "liability", "under", "these", "anti-corruption", "laws.", "<tag3>"], "wordsA": ["It", "may", "be", "necessary", "or", "useful", "for", "us", "to", "participate", "in", "proceedings", "to", "determine", "the", "validity", "of", "our", "patents", "or", "our", "competitors", "patents", "that", "have", "been", "issued", "in", "countries", "other", "than", "the", "U.S."], "wordsB": ["We", "participate", "in", "collaborations", "and", "relationships", "with", "third", "parties", "whose", "actions", "could", "potentially", "subject", "us", "to", "liability", "under", "these", "anti-corruption", "laws."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p60_s5", "idA": "1095981_16_item1a_p67_s0", "sentA": "The Celution System family of products is subject to stringent government regulation in the United States by the FDA under the Federal Food, Drug and Cosmetic Act.", "sentB": "Our ATI-1123 drug candidate is in early clinical stages and is subject to all of the attendant risks of an early-stage drug.", "type": 1, "words": ["<tag1>", "The", "Celution", "System", "family", "of", "products", "is", "subject", "to", "stringent", "government", "regulation", "in", "the", "United", "States", "by", "the", "FDA", "under", "the", "Federal", "Food,", "Drug", "and", "Cosmetic", "Act.", "<tag2>", "Our", "ATI-1123", "drug", "candidate", "is", "in", "early", "clinical", "stages", "and", "is", "subject", "to", "all", "of", "the", "attendant", "risks", "of", "an", "early-stage", "drug.", "<tag3>"], "wordsA": ["The", "Celution", "System", "family", "of", "products", "is", "subject", "to", "stringent", "government", "regulation", "in", "the", "United", "States", "by", "the", "FDA", "under", "the", "Federal", "Food,", "Drug", "and", "Cosmetic", "Act."], "wordsB": ["Our", "ATI-1123", "drug", "candidate", "is", "in", "early", "clinical", "stages", "and", "is", "subject", "to", "all", "of", "the", "attendant", "risks", "of", "an", "early-stage", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p89_s0", "idA": "1095981_16_item1a_p67_s1", "sentA": "The FDA regulates the design/development process, clinical testing, manufacture, safety, labeling, sale, distribution, and promotion of medical devices and drugs.", "sentB": "In Japan, the Japanese Diet recently passed the Act regarding Ensuring of Safety of Regenerative Medicine, or the Regenerative Medicine Law, and the revisions to the Pharmaceutical Affairs Law as applied to drugs, medical devices and regenerative medicine.", "type": 1, "words": ["<tag1>", "The", "FDA", "regulates", "the", "design/development", "process,", "clinical", "testing,", "manufacture,", "safety,", "labeling,", "sale,", "distribution,", "and", "promotion", "of", "medical", "devices", "and", "drugs.", "<tag2>", "In", "Japan,", "the", "Japanese", "Diet", "recently", "passed", "the", "Act", "regarding", "Ensuring", "of", "Safety", "of", "Regenerative", "Medicine,", "or", "the", "Regenerative", "Medicine", "Law,", "and", "the", "revisions", "to", "the", "Pharmaceutical", "Affairs", "Law", "as", "applied", "to", "drugs,", "medical", "devices", "and", "regenerative", "medicine.", "<tag3>"], "wordsA": ["The", "FDA", "regulates", "the", "design/development", "process,", "clinical", "testing,", "manufacture,", "safety,", "labeling,", "sale,", "distribution,", "and", "promotion", "of", "medical", "devices", "and", "drugs."], "wordsB": ["In", "Japan,", "the", "Japanese", "Diet", "recently", "passed", "the", "Act", "regarding", "Ensuring", "of", "Safety", "of", "Regenerative", "Medicine,", "or", "the", "Regenerative", "Medicine", "Law,", "and", "the", "revisions", "to", "the", "Pharmaceutical", "Affairs", "Law", "as", "applied", "to", "drugs,", "medical", "devices", "and", "regenerative", "medicine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p30_s2", "idA": "1095981_16_item1a_p67_s3", "sentA": "Other statutory and regulatory requirements govern, among other things, establishment registration and inspection, medical device listing, prohibitions against misbranding and adulteration, labeling and post-market reporting.", "sentB": "We expect that product candidates in our pipeline, if approved, to compete on the basis of, among other things, product efficacy and safety, time to market, price, coverage and reimbursement by third-party payers, extent of adverse side effects and convenience of treatment procedures.", "type": 1, "words": ["<tag1>", "Other", "statutory", "and", "regulatory", "requirements", "govern,", "among", "other", "things,", "establishment", "registration", "and", "inspection,", "medical", "device", "listing,", "prohibitions", "against", "misbranding", "and", "adulteration,", "labeling", "and", "post-market", "reporting.", "<tag2>", "We", "expect", "that", "product", "candidates", "in", "our", "pipeline,", "if", "approved,", "to", "compete", "on", "the", "basis", "of,", "among", "other", "things,", "product", "efficacy", "and", "safety,", "time", "to", "market,", "price,", "coverage", "and", "reimbursement", "by", "third-party", "payers,", "extent", "of", "adverse", "side", "effects", "and", "convenience", "of", "treatment", "procedures.", "<tag3>"], "wordsA": ["Other", "statutory", "and", "regulatory", "requirements", "govern,", "among", "other", "things,", "establishment", "registration", "and", "inspection,", "medical", "device", "listing,", "prohibitions", "against", "misbranding", "and", "adulteration,", "labeling", "and", "post-market", "reporting."], "wordsB": ["We", "expect", "that", "product", "candidates", "in", "our", "pipeline,", "if", "approved,", "to", "compete", "on", "the", "basis", "of,", "among", "other", "things,", "product", "efficacy", "and", "safety,", "time", "to", "market,", "price,", "coverage", "and", "reimbursement", "by", "third-party", "payers,", "extent", "of", "adverse", "side", "effects", "and", "convenience", "of", "treatment", "procedures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p106_s0", "idA": "1095981_16_item1a_p69_s4", "sentA": "Our Celution products under development today and in the foreseeable future will be subject to the lengthier PMA process.", "sentB": "drug application or cannot supply enough drug, or when a sec ond applicant demonstrates its drug is clinically superior to the original orphan drug.", "type": 1, "words": ["<tag1>", "Our", "Celution", "products", "under", "development", "today", "and", "in", "the", "foreseeable", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process.", "<tag2>", "drug", "application", "or", "cannot", "supply", "enough", "drug,", "or", "when", "a", "sec", "ond", "applicant", "demonstrates", "its", "drug", "is", "clinically", "superior", "to", "the", "original", "orphan", "drug.", "<tag3>"], "wordsA": ["Our", "Celution", "products", "under", "development", "today", "and", "in", "the", "foreseeable", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process."], "wordsB": ["drug", "application", "or", "cannot", "supply", "enough", "drug,", "or", "when", "a", "sec", "ond", "applicant", "demonstrates", "its", "drug", "is", "clinically", "superior", "to", "the", "original", "orphan", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p90_s7", "idA": "1095981_16_item1a_p69_s4", "sentA": "Our Celution products under development today and in the foreseeable future will be subject to the lengthier PMA process.", "sentB": "Some territories may object to the formulation ingredients in the final finished product and may require reformulation to modify or remove objectionable components; resulting in delays in regulatory approvals.", "type": 1, "words": ["<tag1>", "Our", "Celution", "products", "under", "development", "today", "and", "in", "the", "foreseeable", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process.", "<tag2>", "Some", "territories", "may", "object", "to", "the", "formulation", "ingredients", "in", "the", "final", "finished", "product", "and", "may", "require", "reformulation", "to", "modify", "or", "remove", "objectionable", "components;", "resulting", "in", "delays", "in", "regulatory", "approvals.", "<tag3>"], "wordsA": ["Our", "Celution", "products", "under", "development", "today", "and", "in", "the", "foreseeable", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process."], "wordsB": ["Some", "territories", "may", "object", "to", "the", "formulation", "ingredients", "in", "the", "final", "finished", "product", "and", "may", "require", "reformulation", "to", "modify", "or", "remove", "objectionable", "components;", "resulting", "in", "delays", "in", "regulatory", "approvals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p94_s1", "idA": "1095981_16_item1a_p69_s4", "sentA": "Our Celution products under development today and in the foreseeable future will be subject to the lengthier PMA process.", "sentB": "Some jurisdictions may object to the formulation ingredients in the final finished product and may require reformulation to modify or remove objectionable components; resulting in delays in regulatory approvals.", "type": 1, "words": ["<tag1>", "Our", "Celution", "products", "under", "development", "today", "and", "in", "the", "foreseeable", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process.", "<tag2>", "Some", "jurisdictions", "may", "object", "to", "the", "formulation", "ingredients", "in", "the", "final", "finished", "product", "and", "may", "require", "reformulation", "to", "modify", "or", "remove", "objectionable", "components;", "resulting", "in", "delays", "in", "regulatory", "approvals.", "<tag3>"], "wordsA": ["Our", "Celution", "products", "under", "development", "today", "and", "in", "the", "foreseeable", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process."], "wordsB": ["Some", "jurisdictions", "may", "object", "to", "the", "formulation", "ingredients", "in", "the", "final", "finished", "product", "and", "may", "require", "reformulation", "to", "modify", "or", "remove", "objectionable", "components;", "resulting", "in", "delays", "in", "regulatory", "approvals."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p98_s5", "idA": "1095981_16_item1a_p69_s4", "sentA": "Our Celution products under development today and in the foreseeable future will be subject to the lengthier PMA process.", "sentB": "However, the level of reimbursement Habeo Cell Therapy will receive will be directly related to the quantity and quality of clinical evidence reported by these STAR and SCLERADEC II clinical trials.", "type": 1, "words": ["<tag1>", "Our", "Celution", "products", "under", "development", "today", "and", "in", "the", "foreseeable", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process.", "<tag2>", "However,", "the", "level", "of", "reimbursement", "Habeo", "Cell", "Therapy", "will", "receive", "will", "be", "directly", "related", "to", "the", "quantity", "and", "quality", "of", "clinical", "evidence", "reported", "by", "these", "STAR", "and", "SCLERADEC", "II", "clinical", "trials.", "<tag3>"], "wordsA": ["Our", "Celution", "products", "under", "development", "today", "and", "in", "the", "foreseeable", "future", "will", "be", "subject", "to", "the", "lengthier", "PMA", "process."], "wordsB": ["However,", "the", "level", "of", "reimbursement", "Habeo", "Cell", "Therapy", "will", "receive", "will", "be", "directly", "related", "to", "the", "quantity", "and", "quality", "of", "clinical", "evidence", "reported", "by", "these", "STAR", "and", "SCLERADEC", "II", "clinical", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p180_s0", "idA": "1095981_16_item1a_p6_s0", "sentA": "The Term Loan accrues interest at a floating rate equal to the three-month LIBOR rate (with a floor of 1.00%) plus 7.95% per annum.", "sentB": "In addition to Regular Purchases, we may in our sole discretion direct Lincoln Park on each purchase date to make accelerated purchases on the following business day up to the lesser of (i) three times the number of shares purchased pursuant to such Regular Purchase or (ii) 30% of the trading volume on the accelerated purchase date at a purchase price equal to the lesser of (i) the closing sale price on the accelerated purchase date and (ii) 97% of the accelerated purchase date s volume weighted average price (such purchases, Accelerated Purchases).", "type": 1, "words": ["<tag1>", "The", "Term", "Loan", "accrues", "interest", "at", "a", "floating", "rate", "equal", "to", "the", "three-month", "LIBOR", "rate", "(with", "a", "floor", "of", "1.00%)", "plus", "7.95%", "per", "annum.", "<tag2>", "In", "addition", "to", "Regular", "Purchases,", "we", "may", "in", "our", "sole", "discretion", "direct", "Lincoln", "Park", "on", "each", "purchase", "date", "to", "make", "accelerated", "purchases", "on", "the", "following", "business", "day", "up", "to", "the", "lesser", "of", "(i)", "three", "times", "the", "number", "of", "shares", "purchased", "pursuant", "to", "such", "Regular", "Purchase", "or", "(ii)", "30%", "of", "the", "trading", "volume", "on", "the", "accelerated", "purchase", "date", "at", "a", "purchase", "price", "equal", "to", "the", "lesser", "of", "(i)", "the", "closing", "sale", "price", "on", "the", "accelerated", "purchase", "date", "and", "(ii)", "97%", "of", "the", "accelerated", "purchase", "date", "s", "volume", "weighted", "average", "price", "(such", "purchases,", "Accelerated", "Purchases).", "<tag3>"], "wordsA": ["The", "Term", "Loan", "accrues", "interest", "at", "a", "floating", "rate", "equal", "to", "the", "three-month", "LIBOR", "rate", "(with", "a", "floor", "of", "1.00%)", "plus", "7.95%", "per", "annum."], "wordsB": ["In", "addition", "to", "Regular", "Purchases,", "we", "may", "in", "our", "sole", "discretion", "direct", "Lincoln", "Park", "on", "each", "purchase", "date", "to", "make", "accelerated", "purchases", "on", "the", "following", "business", "day", "up", "to", "the", "lesser", "of", "(i)", "three", "times", "the", "number", "of", "shares", "purchased", "pursuant", "to", "such", "Regular", "Purchase", "or", "(ii)", "30%", "of", "the", "trading", "volume", "on", "the", "accelerated", "purchase", "date", "at", "a", "purchase", "price", "equal", "to", "the", "lesser", "of", "(i)", "the", "closing", "sale", "price", "on", "the", "accelerated", "purchase", "date", "and", "(ii)", "97%", "of", "the", "accelerated", "purchase", "date", "s", "volume", "weighted", "average", "price", "(such", "purchases,", "Accelerated", "Purchases)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p181_s1", "idA": "1095981_16_item1a_p6_s0", "sentA": "The Term Loan accrues interest at a floating rate equal to the three-month LIBOR rate (with a floor of 1.00%) plus 7.95% per annum.", "sentB": "The purchase price for each such Additional Purchase shall be equal to the lower of (i) 97% of the purchase price under a Regular Purchase on the date we give notice for the related Additional Purchase, or (ii) $2.00 per share.", "type": 1, "words": ["<tag1>", "The", "Term", "Loan", "accrues", "interest", "at", "a", "floating", "rate", "equal", "to", "the", "three-month", "LIBOR", "rate", "(with", "a", "floor", "of", "1.00%)", "plus", "7.95%", "per", "annum.", "<tag2>", "The", "purchase", "price", "for", "each", "such", "Additional", "Purchase", "shall", "be", "equal", "to", "the", "lower", "of", "(i)", "97%", "of", "the", "purchase", "price", "under", "a", "Regular", "Purchase", "on", "the", "date", "we", "give", "notice", "for", "the", "related", "Additional", "Purchase,", "or", "(ii)", "$2.00", "per", "share.", "<tag3>"], "wordsA": ["The", "Term", "Loan", "accrues", "interest", "at", "a", "floating", "rate", "equal", "to", "the", "three-month", "LIBOR", "rate", "(with", "a", "floor", "of", "1.00%)", "plus", "7.95%", "per", "annum."], "wordsB": ["The", "purchase", "price", "for", "each", "such", "Additional", "Purchase", "shall", "be", "equal", "to", "the", "lower", "of", "(i)", "97%", "of", "the", "purchase", "price", "under", "a", "Regular", "Purchase", "on", "the", "date", "we", "give", "notice", "for", "the", "related", "Additional", "Purchase,", "or", "(ii)", "$2.00", "per", "share."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p146_s1", "idA": "1095981_16_item1a_p70_s0", "sentA": "Securing FDA clearances and approvals may require the submission of extensive clinical data and supporting information to the FDA, and there can be no guarantee of ultimate clearance or approval.", "sentB": "Misconduct by employees could include failures to comply with FDA regulations, to provide accurate information to the FDA, to comply with manufacturing standards we have established, to comply with federal and state healthcare fraud and abuse laws and regulations, to report financial information or data accurately or to disclose unauthorized activities to us.", "type": 1, "words": ["<tag1>", "Securing", "FDA", "clearances", "and", "approvals", "may", "require", "the", "submission", "of", "extensive", "clinical", "data", "and", "supporting", "information", "to", "the", "FDA,", "and", "there", "can", "be", "no", "guarantee", "of", "ultimate", "clearance", "or", "approval.", "<tag2>", "Misconduct", "by", "employees", "could", "include", "failures", "to", "comply", "with", "FDA", "regulations,", "to", "provide", "accurate", "information", "to", "the", "FDA,", "to", "comply", "with", "manufacturing", "standards", "we", "have", "established,", "to", "comply", "with", "federal", "and", "state", "healthcare", "fraud", "and", "abuse", "laws", "and", "regulations,", "to", "report", "financial", "information", "or", "data", "accurately", "or", "to", "disclose", "unauthorized", "activities", "to", "us.", "<tag3>"], "wordsA": ["Securing", "FDA", "clearances", "and", "approvals", "may", "require", "the", "submission", "of", "extensive", "clinical", "data", "and", "supporting", "information", "to", "the", "FDA,", "and", "there", "can", "be", "no", "guarantee", "of", "ultimate", "clearance", "or", "approval."], "wordsB": ["Misconduct", "by", "employees", "could", "include", "failures", "to", "comply", "with", "FDA", "regulations,", "to", "provide", "accurate", "information", "to", "the", "FDA,", "to", "comply", "with", "manufacturing", "standards", "we", "have", "established,", "to", "comply", "with", "federal", "and", "state", "healthcare", "fraud", "and", "abuse", "laws", "and", "regulations,", "to", "report", "financial", "information", "or", "data", "accurately", "or", "to", "disclose", "unauthorized", "activities", "to", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p81_s5", "idA": "1095981_16_item1a_p70_s0", "sentA": "Securing FDA clearances and approvals may require the submission of extensive clinical data and supporting information to the FDA, and there can be no guarantee of ultimate clearance or approval.", "sentB": "Similar to the FDA process, the EMA centralized process requires bioequivalence data for generic drug candidates such as ATI-0918, and robust clinical data for non-generic drug candidates like ATI-01123 similar to clinical data required for NDA drug candidates.", "type": 1, "words": ["<tag1>", "Securing", "FDA", "clearances", "and", "approvals", "may", "require", "the", "submission", "of", "extensive", "clinical", "data", "and", "supporting", "information", "to", "the", "FDA,", "and", "there", "can", "be", "no", "guarantee", "of", "ultimate", "clearance", "or", "approval.", "<tag2>", "Similar", "to", "the", "FDA", "process,", "the", "EMA", "centralized", "process", "requires", "bioequivalence", "data", "for", "generic", "drug", "candidates", "such", "as", "ATI-0918,", "and", "robust", "clinical", "data", "for", "non-generic", "drug", "candidates", "like", "ATI-01123", "similar", "to", "clinical", "data", "required", "for", "NDA", "drug", "candidates.", "<tag3>"], "wordsA": ["Securing", "FDA", "clearances", "and", "approvals", "may", "require", "the", "submission", "of", "extensive", "clinical", "data", "and", "supporting", "information", "to", "the", "FDA,", "and", "there", "can", "be", "no", "guarantee", "of", "ultimate", "clearance", "or", "approval."], "wordsB": ["Similar", "to", "the", "FDA", "process,", "the", "EMA", "centralized", "process", "requires", "bioequivalence", "data", "for", "generic", "drug", "candidates", "such", "as", "ATI-0918,", "and", "robust", "clinical", "data", "for", "non-generic", "drug", "candidates", "like", "ATI-01123", "similar", "to", "clinical", "data", "required", "for", "NDA", "drug", "candidates."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p90_s6", "idA": "1095981_16_item1a_p70_s0", "sentA": "Securing FDA clearances and approvals may require the submission of extensive clinical data and supporting information to the FDA, and there can be no guarantee of ultimate clearance or approval.", "sentB": "Some territories may require clinical data in their indigenous population, resulting in the repeat of clinical studies in whole or in part.", "type": 1, "words": ["<tag1>", "Securing", "FDA", "clearances", "and", "approvals", "may", "require", "the", "submission", "of", "extensive", "clinical", "data", "and", "supporting", "information", "to", "the", "FDA,", "and", "there", "can", "be", "no", "guarantee", "of", "ultimate", "clearance", "or", "approval.", "<tag2>", "Some", "territories", "may", "require", "clinical", "data", "in", "their", "indigenous", "population,", "resulting", "in", "the", "repeat", "of", "clinical", "studies", "in", "whole", "or", "in", "part.", "<tag3>"], "wordsA": ["Securing", "FDA", "clearances", "and", "approvals", "may", "require", "the", "submission", "of", "extensive", "clinical", "data", "and", "supporting", "information", "to", "the", "FDA,", "and", "there", "can", "be", "no", "guarantee", "of", "ultimate", "clearance", "or", "approval."], "wordsB": ["Some", "territories", "may", "require", "clinical", "data", "in", "their", "indigenous", "population,", "resulting", "in", "the", "repeat", "of", "clinical", "studies", "in", "whole", "or", "in", "part."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p94_s0", "idA": "1095981_16_item1a_p70_s0", "sentA": "Securing FDA clearances and approvals may require the submission of extensive clinical data and supporting information to the FDA, and there can be no guarantee of ultimate clearance or approval.", "sentB": "Some jurisdictions may require clinical data in their indigenous population, resulting in the repeat of clinical studies in whole or in part.", "type": 1, "words": ["<tag1>", "Securing", "FDA", "clearances", "and", "approvals", "may", "require", "the", "submission", "of", "extensive", "clinical", "data", "and", "supporting", "information", "to", "the", "FDA,", "and", "there", "can", "be", "no", "guarantee", "of", "ultimate", "clearance", "or", "approval.", "<tag2>", "Some", "jurisdictions", "may", "require", "clinical", "data", "in", "their", "indigenous", "population,", "resulting", "in", "the", "repeat", "of", "clinical", "studies", "in", "whole", "or", "in", "part.", "<tag3>"], "wordsA": ["Securing", "FDA", "clearances", "and", "approvals", "may", "require", "the", "submission", "of", "extensive", "clinical", "data", "and", "supporting", "information", "to", "the", "FDA,", "and", "there", "can", "be", "no", "guarantee", "of", "ultimate", "clearance", "or", "approval."], "wordsB": ["Some", "jurisdictions", "may", "require", "clinical", "data", "in", "their", "indigenous", "population,", "resulting", "in", "the", "repeat", "of", "clinical", "studies", "in", "whole", "or", "in", "part."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p126_s1", "idA": "1095981_16_item1a_p71_s0", "sentA": "Medical devices are also subject to post-market reporting requirements for deaths or serious injuries when the device may have caused or contributed to the death or serious injury, and for certain device malfunctions that would be likely to cause or contribute to a death or serious injury if the malfunction were to recur.", "sentB": "We anticipate that if the FDA approves our RELIEF pilot trial IDE application, and if BARDA agrees to fund this trial, that any BARDA funding for this trial would be awarded under our existing contract.", "type": 1, "words": ["<tag1>", "Medical", "devices", "are", "also", "subject", "to", "post-market", "reporting", "requirements", "for", "deaths", "or", "serious", "injuries", "when", "the", "device", "may", "have", "caused", "or", "contributed", "to", "the", "death", "or", "serious", "injury,", "and", "for", "certain", "device", "malfunctions", "that", "would", "be", "likely", "to", "cause", "or", "contribute", "to", "a", "death", "or", "serious", "injury", "if", "the", "malfunction", "were", "to", "recur.", "<tag2>", "We", "anticipate", "that", "if", "the", "FDA", "approves", "our", "RELIEF", "pilot", "trial", "IDE", "application,", "and", "if", "BARDA", "agrees", "to", "fund", "this", "trial,", "that", "any", "BARDA", "funding", "for", "this", "trial", "would", "be", "awarded", "under", "our", "existing", "contract.", "<tag3>"], "wordsA": ["Medical", "devices", "are", "also", "subject", "to", "post-market", "reporting", "requirements", "for", "deaths", "or", "serious", "injuries", "when", "the", "device", "may", "have", "caused", "or", "contributed", "to", "the", "death", "or", "serious", "injury,", "and", "for", "certain", "device", "malfunctions", "that", "would", "be", "likely", "to", "cause", "or", "contribute", "to", "a", "death", "or", "serious", "injury", "if", "the", "malfunction", "were", "to", "recur."], "wordsB": ["We", "anticipate", "that", "if", "the", "FDA", "approves", "our", "RELIEF", "pilot", "trial", "IDE", "application,", "and", "if", "BARDA", "agrees", "to", "fund", "this", "trial,", "that", "any", "BARDA", "funding", "for", "this", "trial", "would", "be", "awarded", "under", "our", "existing", "contract."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p60_s7", "idA": "1095981_16_item1a_p71_s0", "sentA": "Medical devices are also subject to post-market reporting requirements for deaths or serious injuries when the device may have caused or contributed to the death or serious injury, and for certain device malfunctions that would be likely to cause or contribute to a death or serious injury if the malfunction were to recur.", "sentB": "Any such bioequivalency trial would be time and resource intensive, would take years to complete at considerable expense, and could ultimately fail to demonstrate ATI-0918 s bioequivalence to the reference drug.", "type": 1, "words": ["<tag1>", "Medical", "devices", "are", "also", "subject", "to", "post-market", "reporting", "requirements", "for", "deaths", "or", "serious", "injuries", "when", "the", "device", "may", "have", "caused", "or", "contributed", "to", "the", "death", "or", "serious", "injury,", "and", "for", "certain", "device", "malfunctions", "that", "would", "be", "likely", "to", "cause", "or", "contribute", "to", "a", "death", "or", "serious", "injury", "if", "the", "malfunction", "were", "to", "recur.", "<tag2>", "Any", "such", "bioequivalency", "trial", "would", "be", "time", "and", "resource", "intensive,", "would", "take", "years", "to", "complete", "at", "considerable", "expense,", "and", "could", "ultimately", "fail", "to", "demonstrate", "ATI-0918", "s", "bioequivalence", "to", "the", "reference", "drug.", "<tag3>"], "wordsA": ["Medical", "devices", "are", "also", "subject", "to", "post-market", "reporting", "requirements", "for", "deaths", "or", "serious", "injuries", "when", "the", "device", "may", "have", "caused", "or", "contributed", "to", "the", "death", "or", "serious", "injury,", "and", "for", "certain", "device", "malfunctions", "that", "would", "be", "likely", "to", "cause", "or", "contribute", "to", "a", "death", "or", "serious", "injury", "if", "the", "malfunction", "were", "to", "recur."], "wordsB": ["Any", "such", "bioequivalency", "trial", "would", "be", "time", "and", "resource", "intensive,", "would", "take", "years", "to", "complete", "at", "considerable", "expense,", "and", "could", "ultimately", "fail", "to", "demonstrate", "ATI-0918", "s", "bioequivalence", "to", "the", "reference", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p146_s3", "idA": "1095981_16_item1a_p72_s2", "sentA": "While we believe that our current activities are in compliance with FDA regulations relating to marketing and promotion, if regulators were to determine that our commercialization efforts, or those of our distributors, collaborators or customers, involve improper marketing and promotion of our products in violation of FDA regulations, our business could be substantially negatively affected.", "sentB": "These laws and regulations restrict or prohibit a wide range of activity relating to pricing, discounting, marketing and promotion, sales commissions, customer incentive programs and other business arrangements.", "type": 1, "words": ["<tag1>", "While", "we", "believe", "that", "our", "current", "activities", "are", "in", "compliance", "with", "FDA", "regulations", "relating", "to", "marketing", "and", "promotion,", "if", "regulators", "were", "to", "determine", "that", "our", "commercialization", "efforts,", "or", "those", "of", "our", "distributors,", "collaborators", "or", "customers,", "involve", "improper", "marketing", "and", "promotion", "of", "our", "products", "in", "violation", "of", "FDA", "regulations,", "our", "business", "could", "be", "substantially", "negatively", "affected.", "<tag2>", "These", "laws", "and", "regulations", "restrict", "or", "prohibit", "a", "wide", "range", "of", "activity", "relating", "to", "pricing,", "discounting,", "marketing", "and", "promotion,", "sales", "commissions,", "customer", "incentive", "programs", "and", "other", "business", "arrangements.", "<tag3>"], "wordsA": ["While", "we", "believe", "that", "our", "current", "activities", "are", "in", "compliance", "with", "FDA", "regulations", "relating", "to", "marketing", "and", "promotion,", "if", "regulators", "were", "to", "determine", "that", "our", "commercialization", "efforts,", "or", "those", "of", "our", "distributors,", "collaborators", "or", "customers,", "involve", "improper", "marketing", "and", "promotion", "of", "our", "products", "in", "violation", "of", "FDA", "regulations,", "our", "business", "could", "be", "substantially", "negatively", "affected."], "wordsB": ["These", "laws", "and", "regulations", "restrict", "or", "prohibit", "a", "wide", "range", "of", "activity", "relating", "to", "pricing,", "discounting,", "marketing", "and", "promotion,", "sales", "commissions,", "customer", "incentive", "programs", "and", "other", "business", "arrangements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p105_s3", "idA": "1095981_16_item1a_p75_s4", "sentA": "Additionally, fluctuations in currency exchange rates may adversely affect demand for our products by increasing the price of our products in the currency of the countries in which the products are sold.", "sentB": "This market exclusivity does not, however, pertain to indications other than those for which the drug was specifically designated in the approval, nor does it prevent other types of drugs from receiving orphan designations or approvals in these same indications.", "type": 1, "words": ["<tag1>", "Additionally,", "fluctuations", "in", "currency", "exchange", "rates", "may", "adversely", "affect", "demand", "for", "our", "products", "by", "increasing", "the", "price", "of", "our", "products", "in", "the", "currency", "of", "the", "countries", "in", "which", "the", "products", "are", "sold.", "<tag2>", "This", "market", "exclusivity", "does", "not,", "however,", "pertain", "to", "indications", "other", "than", "those", "for", "which", "the", "drug", "was", "specifically", "designated", "in", "the", "approval,", "nor", "does", "it", "prevent", "other", "types", "of", "drugs", "from", "receiving", "orphan", "designations", "or", "approvals", "in", "these", "same", "indications.", "<tag3>"], "wordsA": ["Additionally,", "fluctuations", "in", "currency", "exchange", "rates", "may", "adversely", "affect", "demand", "for", "our", "products", "by", "increasing", "the", "price", "of", "our", "products", "in", "the", "currency", "of", "the", "countries", "in", "which", "the", "products", "are", "sold."], "wordsB": ["This", "market", "exclusivity", "does", "not,", "however,", "pertain", "to", "indications", "other", "than", "those", "for", "which", "the", "drug", "was", "specifically", "designated", "in", "the", "approval,", "nor", "does", "it", "prevent", "other", "types", "of", "drugs", "from", "receiving", "orphan", "designations", "or", "approvals", "in", "these", "same", "indications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p86_s0", "idA": "1095981_16_item1a_p75_s4", "sentA": "Additionally, fluctuations in currency exchange rates may adversely affect demand for our products by increasing the price of our products in the currency of the countries in which the products are sold.", "sentB": "It is possible that the new legislation in our priority markets, such as the newly enacted CURES Act in the United States, will yield additional regulatory requirements for therapeutic drugs for our Cytori Nanomedicine drug candidates (the FDA s interpretation and implementation of the CURES Act has yet to be published).", "type": 1, "words": ["<tag1>", "Additionally,", "fluctuations", "in", "currency", "exchange", "rates", "may", "adversely", "affect", "demand", "for", "our", "products", "by", "increasing", "the", "price", "of", "our", "products", "in", "the", "currency", "of", "the", "countries", "in", "which", "the", "products", "are", "sold.", "<tag2>", "It", "is", "possible", "that", "the", "new", "legislation", "in", "our", "priority", "markets,", "such", "as", "the", "newly", "enacted", "CURES", "Act", "in", "the", "United", "States,", "will", "yield", "additional", "regulatory", "requirements", "for", "therapeutic", "drugs", "for", "our", "Cytori", "Nanomedicine", "drug", "candidates", "(the", "FDA", "s", "interpretation", "and", "implementation", "of", "the", "CURES", "Act", "has", "yet", "to", "be", "published).", "<tag3>"], "wordsA": ["Additionally,", "fluctuations", "in", "currency", "exchange", "rates", "may", "adversely", "affect", "demand", "for", "our", "products", "by", "increasing", "the", "price", "of", "our", "products", "in", "the", "currency", "of", "the", "countries", "in", "which", "the", "products", "are", "sold."], "wordsB": ["It", "is", "possible", "that", "the", "new", "legislation", "in", "our", "priority", "markets,", "such", "as", "the", "newly", "enacted", "CURES", "Act", "in", "the", "United", "States,", "will", "yield", "additional", "regulatory", "requirements", "for", "therapeutic", "drugs", "for", "our", "Cytori", "Nanomedicine", "drug", "candidates", "(the", "FDA", "s", "interpretation", "and", "implementation", "of", "the", "CURES", "Act", "has", "yet", "to", "be", "published)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p148_s2", "idA": "1095981_16_item1a_p79_s0", "sentA": "Anticipated or unanticipated changes in the way or manner in which the FDA or other regulators regulate products or classes/groups of products can delay, further burden, or alleviate regulatory pathways that were once available to other products.", "sentB": "In addition, we cannot predict the nature, scope or effect of future regulatory requirements to which our international operations might be subject or the manner in which existing laws might be administered or interpreted.", "type": 1, "words": ["<tag1>", "Anticipated", "or", "unanticipated", "changes", "in", "the", "way", "or", "manner", "in", "which", "the", "FDA", "or", "other", "regulators", "regulate", "products", "or", "classes/groups", "of", "products", "can", "delay,", "further", "burden,", "or", "alleviate", "regulatory", "pathways", "that", "were", "once", "available", "to", "other", "products.", "<tag2>", "In", "addition,", "we", "cannot", "predict", "the", "nature,", "scope", "or", "effect", "of", "future", "regulatory", "requirements", "to", "which", "our", "international", "operations", "might", "be", "subject", "or", "the", "manner", "in", "which", "existing", "laws", "might", "be", "administered", "or", "interpreted.", "<tag3>"], "wordsA": ["Anticipated", "or", "unanticipated", "changes", "in", "the", "way", "or", "manner", "in", "which", "the", "FDA", "or", "other", "regulators", "regulate", "products", "or", "classes/groups", "of", "products", "can", "delay,", "further", "burden,", "or", "alleviate", "regulatory", "pathways", "that", "were", "once", "available", "to", "other", "products."], "wordsB": ["In", "addition,", "we", "cannot", "predict", "the", "nature,", "scope", "or", "effect", "of", "future", "regulatory", "requirements", "to", "which", "our", "international", "operations", "might", "be", "subject", "or", "the", "manner", "in", "which", "existing", "laws", "might", "be", "administered", "or", "interpreted."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p93_s3", "idA": "1095981_16_item1a_p79_s0", "sentA": "Anticipated or unanticipated changes in the way or manner in which the FDA or other regulators regulate products or classes/groups of products can delay, further burden, or alleviate regulatory pathways that were once available to other products.", "sentB": "These changes in the RLD could invalidate clinical studies and require the initiation of new clinical studies for determining equivalence to a newly assigned RLD.", "type": 1, "words": ["<tag1>", "Anticipated", "or", "unanticipated", "changes", "in", "the", "way", "or", "manner", "in", "which", "the", "FDA", "or", "other", "regulators", "regulate", "products", "or", "classes/groups", "of", "products", "can", "delay,", "further", "burden,", "or", "alleviate", "regulatory", "pathways", "that", "were", "once", "available", "to", "other", "products.", "<tag2>", "These", "changes", "in", "the", "RLD", "could", "invalidate", "clinical", "studies", "and", "require", "the", "initiation", "of", "new", "clinical", "studies", "for", "determining", "equivalence", "to", "a", "newly", "assigned", "RLD.", "<tag3>"], "wordsA": ["Anticipated", "or", "unanticipated", "changes", "in", "the", "way", "or", "manner", "in", "which", "the", "FDA", "or", "other", "regulators", "regulate", "products", "or", "classes/groups", "of", "products", "can", "delay,", "further", "burden,", "or", "alleviate", "regulatory", "pathways", "that", "were", "once", "available", "to", "other", "products."], "wordsB": ["These", "changes", "in", "the", "RLD", "could", "invalidate", "clinical", "studies", "and", "require", "the", "initiation", "of", "new", "clinical", "studies", "for", "determining", "equivalence", "to", "a", "newly", "assigned", "RLD."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p226_s8", "idA": "1095981_16_item1a_p7_s0", "sentA": "The Company is required to make payments of principal and accrued interest in equal monthly installments sufficient to amortize the Term Loan through June 1, 2019, the maturity date.", "sentB": "These requirements prevent our Warrant holders from pursuing certain investment strategies that could provide them greater financial benefits than they might have realized had they not been required to make this representation.", "type": 1, "words": ["<tag1>", "The", "Company", "is", "required", "to", "make", "payments", "of", "principal", "and", "accrued", "interest", "in", "equal", "monthly", "installments", "sufficient", "to", "amortize", "the", "Term", "Loan", "through", "June", "1,", "2019,", "the", "maturity", "date.", "<tag2>", "These", "requirements", "prevent", "our", "Warrant", "holders", "from", "pursuing", "certain", "investment", "strategies", "that", "could", "provide", "them", "greater", "financial", "benefits", "than", "they", "might", "have", "realized", "had", "they", "not", "been", "required", "to", "make", "this", "representation.", "<tag3>"], "wordsA": ["The", "Company", "is", "required", "to", "make", "payments", "of", "principal", "and", "accrued", "interest", "in", "equal", "monthly", "installments", "sufficient", "to", "amortize", "the", "Term", "Loan", "through", "June", "1,", "2019,", "the", "maturity", "date."], "wordsB": ["These", "requirements", "prevent", "our", "Warrant", "holders", "from", "pursuing", "certain", "investment", "strategies", "that", "could", "provide", "them", "greater", "financial", "benefits", "than", "they", "might", "have", "realized", "had", "they", "not", "been", "required", "to", "make", "this", "representation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p158_s2", "idA": "1095981_16_item1a_p7_s1", "sentA": "All unpaid principal and accrued and unpaid interest with respect to the Term Loan is due and payable in full on June 1, 2019.", "sentB": "Nevertheless, the referendum has created significant uncertainty about the future relationship between the United Kingdom and the European Union, including with respect to the laws and regulations that will apply as the United Kingdom determines which European Union laws to replace or replicate in the event of a withdrawal.", "type": 1, "words": ["<tag1>", "All", "unpaid", "principal", "and", "accrued", "and", "unpaid", "interest", "with", "respect", "to", "the", "Term", "Loan", "is", "due", "and", "payable", "in", "full", "on", "June", "1,", "2019.", "<tag2>", "Nevertheless,", "the", "referendum", "has", "created", "significant", "uncertainty", "about", "the", "future", "relationship", "between", "the", "United", "Kingdom", "and", "the", "European", "Union,", "including", "with", "respect", "to", "the", "laws", "and", "regulations", "that", "will", "apply", "as", "the", "United", "Kingdom", "determines", "which", "European", "Union", "laws", "to", "replace", "or", "replicate", "in", "the", "event", "of", "a", "withdrawal.", "<tag3>"], "wordsA": ["All", "unpaid", "principal", "and", "accrued", "and", "unpaid", "interest", "with", "respect", "to", "the", "Term", "Loan", "is", "due", "and", "payable", "in", "full", "on", "June", "1,", "2019."], "wordsB": ["Nevertheless,", "the", "referendum", "has", "created", "significant", "uncertainty", "about", "the", "future", "relationship", "between", "the", "United", "Kingdom", "and", "the", "European", "Union,", "including", "with", "respect", "to", "the", "laws", "and", "regulations", "that", "will", "apply", "as", "the", "United", "Kingdom", "determines", "which", "European", "Union", "laws", "to", "replace", "or", "replicate", "in", "the", "event", "of", "a", "withdrawal."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p49_s1", "idA": "1095981_16_item1a_p81_s0", "sentA": "We have operations in a number of regions around the world, including the United States, Japan, and Europe.", "sentB": "These commercialization hurdles could increase the difficulties in finding suitable partners to hel p us commercialize this product offering in Europe.", "type": 1, "words": ["<tag1>", "We", "have", "operations", "in", "a", "number", "of", "regions", "around", "the", "world,", "including", "the", "United", "States,", "Japan,", "and", "Europe.", "<tag2>", "These", "commercialization", "hurdles", "could", "increase", "the", "difficulties", "in", "finding", "suitable", "partners", "to", "hel", "p", "us", "commercialize", "this", "product", "offering", "in", "Europe.", "<tag3>"], "wordsA": ["We", "have", "operations", "in", "a", "number", "of", "regions", "around", "the", "world,", "including", "the", "United", "States,", "Japan,", "and", "Europe."], "wordsB": ["These", "commercialization", "hurdles", "could", "increase", "the", "difficulties", "in", "finding", "suitable", "partners", "to", "hel", "p", "us", "commercialize", "this", "product", "offering", "in", "Europe."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p59_s8", "idA": "1095981_16_item1a_p81_s0", "sentA": "We have operations in a number of regions around the world, including the United States, Japan, and Europe.", "sentB": "Further, our ATI-1123 product candidate, if developed and commercialized, would compete against a number of established docetaxel drugs, including Taxotere (Sanofi S.A.) and numerous existing generic docetaxel products.", "type": 1, "words": ["<tag1>", "We", "have", "operations", "in", "a", "number", "of", "regions", "around", "the", "world,", "including", "the", "United", "States,", "Japan,", "and", "Europe.", "<tag2>", "Further,", "our", "ATI-1123", "product", "candidate,", "if", "developed", "and", "commercialized,", "would", "compete", "against", "a", "number", "of", "established", "docetaxel", "drugs,", "including", "Taxotere", "(Sanofi", "S.A.)", "and", "numerous", "existing", "generic", "docetaxel", "products.", "<tag3>"], "wordsA": ["We", "have", "operations", "in", "a", "number", "of", "regions", "around", "the", "world,", "including", "the", "United", "States,", "Japan,", "and", "Europe."], "wordsB": ["Further,", "our", "ATI-1123", "product", "candidate,", "if", "developed", "and", "commercialized,", "would", "compete", "against", "a", "number", "of", "established", "docetaxel", "drugs,", "including", "Taxotere", "(Sanofi", "S.A.)", "and", "numerous", "existing", "generic", "docetaxel", "products."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p110_s0", "idA": "1095981_16_item1a_p81_s1", "sentA": "Our global operations may be subject to risks that may limit our ability to operate our business.", "sentB": "If we experience an interruption in supply from a material sole source supplier, our business may be harmed We acquire some our components and other raw materials from sole source suppliers.", "type": 1, "words": ["<tag1>", "Our", "global", "operations", "may", "be", "subject", "to", "risks", "that", "may", "limit", "our", "ability", "to", "operate", "our", "business.", "<tag2>", "If", "we", "experience", "an", "interruption", "in", "supply", "from", "a", "material", "sole", "source", "supplier,", "our", "business", "may", "be", "harmed", "We", "acquire", "some", "our", "components", "and", "other", "raw", "materials", "from", "sole", "source", "suppliers.", "<tag3>"], "wordsA": ["Our", "global", "operations", "may", "be", "subject", "to", "risks", "that", "may", "limit", "our", "ability", "to", "operate", "our", "business."], "wordsB": ["If", "we", "experience", "an", "interruption", "in", "supply", "from", "a", "material", "sole", "source", "supplier,", "our", "business", "may", "be", "harmed", "We", "acquire", "some", "our", "components", "and", "other", "raw", "materials", "from", "sole", "source", "suppliers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p185_s1", "idA": "1095981_16_item1a_p81_s1", "sentA": "Our global operations may be subject to risks that may limit our ability to operate our business.", "sentB": "The purchase shares that may be sold pursuant to the Li ncoln Park Purchase Agreement may be sold by us to Lincoln Park at our discretion from time to time over a 30-month period.", "type": 1, "words": ["<tag1>", "Our", "global", "operations", "may", "be", "subject", "to", "risks", "that", "may", "limit", "our", "ability", "to", "operate", "our", "business.", "<tag2>", "The", "purchase", "shares", "that", "may", "be", "sold", "pursuant", "to", "the", "Li", "ncoln", "Park", "Purchase", "Agreement", "may", "be", "sold", "by", "us", "to", "Lincoln", "Park", "at", "our", "discretion", "from", "time", "to", "time", "over", "a", "30-month", "period.", "<tag3>"], "wordsA": ["Our", "global", "operations", "may", "be", "subject", "to", "risks", "that", "may", "limit", "our", "ability", "to", "operate", "our", "business."], "wordsB": ["The", "purchase", "shares", "that", "may", "be", "sold", "pursuant", "to", "the", "Li", "ncoln", "Park", "Purchase", "Agreement", "may", "be", "sold", "by", "us", "to", "Lincoln", "Park", "at", "our", "discretion", "from", "time", "to", "time", "over", "a", "30-month", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p199_s2", "idA": "1095981_16_item1a_p81_s1", "sentA": "Our global operations may be subject to risks that may limit our ability to operate our business.", "sentB": "Accordingly, we cannot predict the breadth of claims that may be allowed or enforced in the patents we own or to which we have a license or third-party patents.", "type": 1, "words": ["<tag1>", "Our", "global", "operations", "may", "be", "subject", "to", "risks", "that", "may", "limit", "our", "ability", "to", "operate", "our", "business.", "<tag2>", "Accordingly,", "we", "cannot", "predict", "the", "breadth", "of", "claims", "that", "may", "be", "allowed", "or", "enforced", "in", "the", "patents", "we", "own", "or", "to", "which", "we", "have", "a", "license", "or", "third-party", "patents.", "<tag3>"], "wordsA": ["Our", "global", "operations", "may", "be", "subject", "to", "risks", "that", "may", "limit", "our", "ability", "to", "operate", "our", "business."], "wordsB": ["Accordingly,", "we", "cannot", "predict", "the", "breadth", "of", "claims", "that", "may", "be", "allowed", "or", "enforced", "in", "the", "patents", "we", "own", "or", "to", "which", "we", "have", "a", "license", "or", "third-party", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p226_s4", "idA": "1095981_16_item1a_p81_s1", "sentA": "Our global operations may be subject to risks that may limit our ability to operate our business.", "sentB": "If you hold warrants issued pursuant to our rights offering, you may be limited in your ability to engage in certain hedging transactions that could provide you with financial benefits.", "type": 1, "words": ["<tag1>", "Our", "global", "operations", "may", "be", "subject", "to", "risks", "that", "may", "limit", "our", "ability", "to", "operate", "our", "business.", "<tag2>", "If", "you", "hold", "warrants", "issued", "pursuant", "to", "our", "rights", "offering,", "you", "may", "be", "limited", "in", "your", "ability", "to", "engage", "in", "certain", "hedging", "transactions", "that", "could", "provide", "you", "with", "financial", "benefits.", "<tag3>"], "wordsA": ["Our", "global", "operations", "may", "be", "subject", "to", "risks", "that", "may", "limit", "our", "ability", "to", "operate", "our", "business."], "wordsB": ["If", "you", "hold", "warrants", "issued", "pursuant", "to", "our", "rights", "offering,", "you", "may", "be", "limited", "in", "your", "ability", "to", "engage", "in", "certain", "hedging", "transactions", "that", "could", "provide", "you", "with", "financial", "benefits."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p111_s11", "idA": "1095981_16_item1a_p82_s2", "sentA": "Although we have significant operations in Asia, a substantial portion of transactions are denominated in U.S. dollars.", "sentB": "This acquisition materially impacted our liquidity and will materially increase our expenses (including a substantial increase in employee headcount).", "type": 1, "words": ["<tag1>", "Although", "we", "have", "significant", "operations", "in", "Asia,", "a", "substantial", "portion", "of", "transactions", "are", "denominated", "in", "U.S.", "dollars.", "<tag2>", "This", "acquisition", "materially", "impacted", "our", "liquidity", "and", "will", "materially", "increase", "our", "expenses", "(including", "a", "substantial", "increase", "in", "employee", "headcount).", "<tag3>"], "wordsA": ["Although", "we", "have", "significant", "operations", "in", "Asia,", "a", "substantial", "portion", "of", "transactions", "are", "denominated", "in", "U.S.", "dollars."], "wordsB": ["This", "acquisition", "materially", "impacted", "our", "liquidity", "and", "will", "materially", "increase", "our", "expenses", "(including", "a", "substantial", "increase", "in", "employee", "headcount)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p35_s5", "idA": "1095981_16_item1a_p82_s3", "sentA": "As appreciation against the U.S. dollar increases, it will result in an increase in the cost of our business expenses abroad.", "sentB": "Taiwan Liposome Company has reported their intent to file a Marketing Authorization Application, or MAA, with the EMA in the first half of 2017 for its generic Doxisome (TLC177) product which is ahead of our schedule for submitting our MAA for ATI-0918.", "type": 1, "words": ["<tag1>", "As", "appreciation", "against", "the", "U.S.", "dollar", "increases,", "it", "will", "result", "in", "an", "increase", "in", "the", "cost", "of", "our", "business", "expenses", "abroad.", "<tag2>", "Taiwan", "Liposome", "Company", "has", "reported", "their", "intent", "to", "file", "a", "Marketing", "Authorization", "Application,", "or", "MAA,", "with", "the", "EMA", "in", "the", "first", "half", "of", "2017", "for", "its", "generic", "Doxisome", "(TLC177)", "product", "which", "is", "ahead", "of", "our", "schedule", "for", "submitting", "our", "MAA", "for", "ATI-0918.", "<tag3>"], "wordsA": ["As", "appreciation", "against", "the", "U.S.", "dollar", "increases,", "it", "will", "result", "in", "an", "increase", "in", "the", "cost", "of", "our", "business", "expenses", "abroad."], "wordsB": ["Taiwan", "Liposome", "Company", "has", "reported", "their", "intent", "to", "file", "a", "Marketing", "Authorization", "Application,", "or", "MAA,", "with", "the", "EMA", "in", "the", "first", "half", "of", "2017", "for", "its", "generic", "Doxisome", "(TLC177)", "product", "which", "is", "ahead", "of", "our", "schedule", "for", "submitting", "our", "MAA", "for", "ATI-0918."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p145_s2", "idA": "1095981_16_item1a_p82_s5", "sentA": "From time to time, we may engage in currency hedging activities, but such activities may not be able to limit the risks of currency fluctuations.", "sentB": "Our employees, principal investigators, consultants and collaboration partners may engage in misconduct or other improper activities, including noncompliance with laws and regulatory standards and requirements and insider trading.", "type": 1, "words": ["<tag1>", "From", "time", "to", "time,", "we", "may", "engage", "in", "currency", "hedging", "activities,", "but", "such", "activities", "may", "not", "be", "able", "to", "limit", "the", "risks", "of", "currency", "fluctuations.", "<tag2>", "Our", "employees,", "principal", "investigators,", "consultants", "and", "collaboration", "partners", "may", "engage", "in", "misconduct", "or", "other", "improper", "activities,", "including", "noncompliance", "with", "laws", "and", "regulatory", "standards", "and", "requirements", "and", "insider", "trading.", "<tag3>"], "wordsA": ["From", "time", "to", "time,", "we", "may", "engage", "in", "currency", "hedging", "activities,", "but", "such", "activities", "may", "not", "be", "able", "to", "limit", "the", "risks", "of", "currency", "fluctuations."], "wordsB": ["Our", "employees,", "principal", "investigators,", "consultants", "and", "collaboration", "partners", "may", "engage", "in", "misconduct", "or", "other", "improper", "activities,", "including", "noncompliance", "with", "laws", "and", "regulatory", "standards", "and", "requirements", "and", "insider", "trading."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p185_s0", "idA": "1095981_16_item1a_p83_s1", "sentA": "Loss of this significant customer or a significant reduction in the amount of product ordered by this customer could adversely affect our revenue, results of operations, and cash flows.", "sentB": "amount of $20.0 million purchased by Lincoln Park.", "type": 1, "words": ["<tag1>", "Loss", "of", "this", "significant", "customer", "or", "a", "significant", "reduction", "in", "the", "amount", "of", "product", "ordered", "by", "this", "customer", "could", "adversely", "affect", "our", "revenue,", "results", "of", "operations,", "and", "cash", "flows.", "<tag2>", "amount", "of", "$20.0", "million", "purchased", "by", "Lincoln", "Park.", "<tag3>"], "wordsA": ["Loss", "of", "this", "significant", "customer", "or", "a", "significant", "reduction", "in", "the", "amount", "of", "product", "ordered", "by", "this", "customer", "could", "adversely", "affect", "our", "revenue,", "results", "of", "operations,", "and", "cash", "flows."], "wordsB": ["amount", "of", "$20.0", "million", "purchased", "by", "Lincoln", "Park."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p0_s2", "idA": "1095981_16_item1a_p84_s0", "sentA": "The manufacture of our products is, and the manufacture of any future cell-related therapeutic products would be, subject to periodic inspection by regulatory authorities and distribution partners.", "sentB": "The success of Habeo Cell Therapy and any future cellular therapeutic products are highly dependent on meeting our primary endpoint in our U.S. Phase III STAR clinical trial.", "type": 1, "words": ["<tag1>", "The", "manufacture", "of", "our", "products", "is,", "and", "the", "manufacture", "of", "any", "future", "cell-related", "therapeutic", "products", "would", "be,", "subject", "to", "periodic", "inspection", "by", "regulatory", "authorities", "and", "distribution", "partners.", "<tag2>", "The", "success", "of", "Habeo", "Cell", "Therapy", "and", "any", "future", "cellular", "therapeutic", "products", "are", "highly", "dependent", "on", "meeting", "our", "primary", "endpoint", "in", "our", "U.S.", "Phase", "III", "STAR", "clinical", "trial.", "<tag3>"], "wordsA": ["The", "manufacture", "of", "our", "products", "is,", "and", "the", "manufacture", "of", "any", "future", "cell-related", "therapeutic", "products", "would", "be,", "subject", "to", "periodic", "inspection", "by", "regulatory", "authorities", "and", "distribution", "partners."], "wordsB": ["The", "success", "of", "Habeo", "Cell", "Therapy", "and", "any", "future", "cellular", "therapeutic", "products", "are", "highly", "dependent", "on", "meeting", "our", "primary", "endpoint", "in", "our", "U.S.", "Phase", "III", "STAR", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p112_s0", "idA": "1095981_16_item1a_p84_s0", "sentA": "The manufacture of our products is, and the manufacture of any future cell-related therapeutic products would be, subject to periodic inspection by regulatory authorities and distribution partners.", "sentB": "inability to retain key employees of any acquired businesses.", "type": 1, "words": ["<tag1>", "The", "manufacture", "of", "our", "products", "is,", "and", "the", "manufacture", "of", "any", "future", "cell-related", "therapeutic", "products", "would", "be,", "subject", "to", "periodic", "inspection", "by", "regulatory", "authorities", "and", "distribution", "partners.", "<tag2>", "inability", "to", "retain", "key", "employees", "of", "any", "acquired", "businesses.", "<tag3>"], "wordsA": ["The", "manufacture", "of", "our", "products", "is,", "and", "the", "manufacture", "of", "any", "future", "cell-related", "therapeutic", "products", "would", "be,", "subject", "to", "periodic", "inspection", "by", "regulatory", "authorities", "and", "distribution", "partners."], "wordsB": ["inability", "to", "retain", "key", "employees", "of", "any", "acquired", "businesses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p141_s2", "idA": "1095981_16_item1a_p84_s0", "sentA": "The manufacture of our products is, and the manufacture of any future cell-related therapeutic products would be, subject to periodic inspection by regulatory authorities and distribution partners.", "sentB": "This risk exists even if a product or product candidate is approved for commercial sale by applicable regulatory authorities and manufactured in facilities regulated by such authorities.", "type": 1, "words": ["<tag1>", "The", "manufacture", "of", "our", "products", "is,", "and", "the", "manufacture", "of", "any", "future", "cell-related", "therapeutic", "products", "would", "be,", "subject", "to", "periodic", "inspection", "by", "regulatory", "authorities", "and", "distribution", "partners.", "<tag2>", "This", "risk", "exists", "even", "if", "a", "product", "or", "product", "candidate", "is", "approved", "for", "commercial", "sale", "by", "applicable", "regulatory", "authorities", "and", "manufactured", "in", "facilities", "regulated", "by", "such", "authorities.", "<tag3>"], "wordsA": ["The", "manufacture", "of", "our", "products", "is,", "and", "the", "manufacture", "of", "any", "future", "cell-related", "therapeutic", "products", "would", "be,", "subject", "to", "periodic", "inspection", "by", "regulatory", "authorities", "and", "distribution", "partners."], "wordsB": ["This", "risk", "exists", "even", "if", "a", "product", "or", "product", "candidate", "is", "approved", "for", "commercial", "sale", "by", "applicable", "regulatory", "authorities", "and", "manufactured", "in", "facilities", "regulated", "by", "such", "authorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p156_s0", "idA": "1095981_16_item1a_p84_s0", "sentA": "The manufacture of our products is, and the manufacture of any future cell-related therapeutic products would be, subject to periodic inspection by regulatory authorities and distribution partners.", "sentB": "Increased global information technology security threats and more sophisticated and targeted computer crime pose a risk to the security of our systems and networks and the confidentiality, availability and integrity of our data and communications.", "type": 1, "words": ["<tag1>", "The", "manufacture", "of", "our", "products", "is,", "and", "the", "manufacture", "of", "any", "future", "cell-related", "therapeutic", "products", "would", "be,", "subject", "to", "periodic", "inspection", "by", "regulatory", "authorities", "and", "distribution", "partners.", "<tag2>", "Increased", "global", "information", "technology", "security", "threats", "and", "more", "sophisticated", "and", "targeted", "computer", "crime", "pose", "a", "risk", "to", "the", "security", "of", "our", "systems", "and", "networks", "and", "the", "confidentiality,", "availability", "and", "integrity", "of", "our", "data", "and", "communications.", "<tag3>"], "wordsA": ["The", "manufacture", "of", "our", "products", "is,", "and", "the", "manufacture", "of", "any", "future", "cell-related", "therapeutic", "products", "would", "be,", "subject", "to", "periodic", "inspection", "by", "regulatory", "authorities", "and", "distribution", "partners."], "wordsB": ["Increased", "global", "information", "technology", "security", "threats", "and", "more", "sophisticated", "and", "targeted", "computer", "crime", "pose", "a", "risk", "to", "the", "security", "of", "our", "systems", "and", "networks", "and", "the", "confidentiality,", "availability", "and", "integrity", "of", "our", "data", "and", "communications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p146_s5", "idA": "1095981_16_item1a_p85_s1", "sentA": "There can be no guarantee that the FDA or other authorities will not, during the course of an inspection of existing or new facilities, identify what they consider to be deficiencies in our compliance with QSRs or other requirements and request, or seek remedial action.", "sentB": "It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations.", "type": 1, "words": ["<tag1>", "There", "can", "be", "no", "guarantee", "that", "the", "FDA", "or", "other", "authorities", "will", "not,", "during", "the", "course", "of", "an", "inspection", "of", "existing", "or", "new", "facilities,", "identify", "what", "they", "consider", "to", "be", "deficiencies", "in", "our", "compliance", "with", "QSRs", "or", "other", "requirements", "and", "request,", "or", "seek", "remedial", "action.", "<tag2>", "It", "is", "not", "always", "possible", "to", "identify", "and", "deter", "employee", "misconduct,", "and", "the", "precautions", "we", "take", "to", "detect", "and", "prevent", "this", "activity", "may", "not", "be", "effective", "in", "controlling", "unknown", "or", "unmanaged", "risks", "or", "losses", "or", "in", "protecting", "us", "from", "governmental", "investigations", "or", "other", "actions", "or", "lawsuits", "stemming", "from", "a", "failure", "to", "be", "in", "compliance", "with", "such", "laws", "or", "regulations.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "guarantee", "that", "the", "FDA", "or", "other", "authorities", "will", "not,", "during", "the", "course", "of", "an", "inspection", "of", "existing", "or", "new", "facilities,", "identify", "what", "they", "consider", "to", "be", "deficiencies", "in", "our", "compliance", "with", "QSRs", "or", "other", "requirements", "and", "request,", "or", "seek", "remedial", "action."], "wordsB": ["It", "is", "not", "always", "possible", "to", "identify", "and", "deter", "employee", "misconduct,", "and", "the", "precautions", "we", "take", "to", "detect", "and", "prevent", "this", "activity", "may", "not", "be", "effective", "in", "controlling", "unknown", "or", "unmanaged", "risks", "or", "losses", "or", "in", "protecting", "us", "from", "governmental", "investigations", "or", "other", "actions", "or", "lawsuits", "stemming", "from", "a", "failure", "to", "be", "in", "compliance", "with", "such", "laws", "or", "regulations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p14_s3", "idA": "1095981_16_item1a_p86_s1", "sentA": "There can be no assurance after such occurrences that we will be able to obtain additional necessary regulatory approvals or clearances on a timely basis, if at all.", "sentB": "However, regardless of whether we enter into a partnering agreement for ATI-0918, we will still incur significant near-term costs and expenses in manufacturing, testing and validating it and in performing necessary regulatory and clinical work to ready our EMA marketing dossier for submission.", "type": 1, "words": ["<tag1>", "There", "can", "be", "no", "assurance", "after", "such", "occurrences", "that", "we", "will", "be", "able", "to", "obtain", "additional", "necessary", "regulatory", "approvals", "or", "clearances", "on", "a", "timely", "basis,", "if", "at", "all.", "<tag2>", "However,", "regardless", "of", "whether", "we", "enter", "into", "a", "partnering", "agreement", "for", "ATI-0918,", "we", "will", "still", "incur", "significant", "near-term", "costs", "and", "expenses", "in", "manufacturing,", "testing", "and", "validating", "it", "and", "in", "performing", "necessary", "regulatory", "and", "clinical", "work", "to", "ready", "our", "EMA", "marketing", "dossier", "for", "submission.", "<tag3>"], "wordsA": ["There", "can", "be", "no", "assurance", "after", "such", "occurrences", "that", "we", "will", "be", "able", "to", "obtain", "additional", "necessary", "regulatory", "approvals", "or", "clearances", "on", "a", "timely", "basis,", "if", "at", "all."], "wordsB": ["However,", "regardless", "of", "whether", "we", "enter", "into", "a", "partnering", "agreement", "for", "ATI-0918,", "we", "will", "still", "incur", "significant", "near-term", "costs", "and", "expenses", "in", "manufacturing,", "testing", "and", "validating", "it", "and", "in", "performing", "necessary", "regulatory", "and", "clinical", "work", "to", "ready", "our", "EMA", "marketing", "dossier", "for", "submission."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p122_s0", "idA": "1095981_16_item1a_p87_s0", "sentA": "We were awarded the contract with BARDA in September 2012 with the aim to develop a new countermeasure for a combined injury involving thermal burn and radiation exposure which would be useful following a mass-casualty event.", "sentB": "The current contract modification to the BARDA Agreement executed by us and BARDA in September 2016 will expire in April 2017.", "type": 1, "words": ["<tag1>", "We", "were", "awarded", "the", "contract", "with", "BARDA", "in", "September", "2012", "with", "the", "aim", "to", "develop", "a", "new", "countermeasure", "for", "a", "combined", "injury", "involving", "thermal", "burn", "and", "radiation", "exposure", "which", "would", "be", "useful", "following", "a", "mass-casualty", "event.", "<tag2>", "The", "current", "contract", "modification", "to", "the", "BARDA", "Agreement", "executed", "by", "us", "and", "BARDA", "in", "September", "2016", "will", "expire", "in", "April", "2017.", "<tag3>"], "wordsA": ["We", "were", "awarded", "the", "contract", "with", "BARDA", "in", "September", "2012", "with", "the", "aim", "to", "develop", "a", "new", "countermeasure", "for", "a", "combined", "injury", "involving", "thermal", "burn", "and", "radiation", "exposure", "which", "would", "be", "useful", "following", "a", "mass-casualty", "event."], "wordsB": ["The", "current", "contract", "modification", "to", "the", "BARDA", "Agreement", "executed", "by", "us", "and", "BARDA", "in", "September", "2016", "will", "expire", "in", "April", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p153_s0", "idA": "1095981_16_item1a_p88_s0", "sentA": "On August 13, 2014, we and BARDA amended the contract exercising Option 1 to perform research, regulatory, clinical and other tasks required for initiation of a pilot clinical trial of the Celution System in thermal burn injury, amended the Statement of Work and reorganized the contract options.", "sentB": "As part of the American Recovery and Reinvestment Act 2009, or ARRA, Congress amended the privacy and security provisions of the Healthcare Information Portability and Accountability Act, or HIPAA.", "type": 1, "words": ["<tag1>", "On", "August", "13,", "2014,", "we", "and", "BARDA", "amended", "the", "contract", "exercising", "Option", "1", "to", "perform", "research,", "regulatory,", "clinical", "and", "other", "tasks", "required", "for", "initiation", "of", "a", "pilot", "clinical", "trial", "of", "the", "Celution", "System", "in", "thermal", "burn", "injury,", "amended", "the", "Statement", "of", "Work", "and", "reorganized", "the", "contract", "options.", "<tag2>", "As", "part", "of", "the", "American", "Recovery", "and", "Reinvestment", "Act", "2009,", "or", "ARRA,", "Congress", "amended", "the", "privacy", "and", "security", "provisions", "of", "the", "Healthcare", "Information", "Portability", "and", "Accountability", "Act,", "or", "HIPAA.", "<tag3>"], "wordsA": ["On", "August", "13,", "2014,", "we", "and", "BARDA", "amended", "the", "contract", "exercising", "Option", "1", "to", "perform", "research,", "regulatory,", "clinical", "and", "other", "tasks", "required", "for", "initiation", "of", "a", "pilot", "clinical", "trial", "of", "the", "Celution", "System", "in", "thermal", "burn", "injury,", "amended", "the", "Statement", "of", "Work", "and", "reorganized", "the", "contract", "options."], "wordsB": ["As", "part", "of", "the", "American", "Recovery", "and", "Reinvestment", "Act", "2009,", "or", "ARRA,", "Congress", "amended", "the", "privacy", "and", "security", "provisions", "of", "the", "Healthcare", "Information", "Portability", "and", "Accountability", "Act,", "or", "HIPAA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p158_s3", "idA": "1095981_16_item1a_p88_s1", "sentA": "The total cost plus fixed fee for the performance of Option 1 was up to approximately $12.1 million.", "sentB": "The referendum has also given rise to calls for the governments of other European Union member states to consider withdrawal.", "type": 1, "words": ["<tag1>", "The", "total", "cost", "plus", "fixed", "fee", "for", "the", "performance", "of", "Option", "1", "was", "up", "to", "approximately", "$12.1", "million.", "<tag2>", "The", "referendum", "has", "also", "given", "rise", "to", "calls", "for", "the", "governments", "of", "other", "European", "Union", "member", "states", "to", "consider", "withdrawal.", "<tag3>"], "wordsA": ["The", "total", "cost", "plus", "fixed", "fee", "for", "the", "performance", "of", "Option", "1", "was", "up", "to", "approximately", "$12.1", "million."], "wordsB": ["The", "referendum", "has", "also", "given", "rise", "to", "calls", "for", "the", "governments", "of", "other", "European", "Union", "member", "states", "to", "consider", "withdrawal."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p32_s6", "idA": "1095981_16_item1a_p88_s1", "sentA": "The total cost plus fixed fee for the performance of Option 1 was up to approximately $12.1 million.", "sentB": "Stanford University, in collaboration with United Therapeutics, is sponsoring a Phase 2 clinical trial evaluating oral Orenitram (treprostinil) for the treatment of Calcinosis in patients with systemic sclerosis.", "type": 1, "words": ["<tag1>", "The", "total", "cost", "plus", "fixed", "fee", "for", "the", "performance", "of", "Option", "1", "was", "up", "to", "approximately", "$12.1", "million.", "<tag2>", "Stanford", "University,", "in", "collaboration", "with", "United", "Therapeutics,", "is", "sponsoring", "a", "Phase", "2", "clinical", "trial", "evaluating", "oral", "Orenitram", "(treprostinil)", "for", "the", "treatment", "of", "Calcinosis", "in", "patients", "with", "systemic", "sclerosis.", "<tag3>"], "wordsA": ["The", "total", "cost", "plus", "fixed", "fee", "for", "the", "performance", "of", "Option", "1", "was", "up", "to", "approximately", "$12.1", "million."], "wordsB": ["Stanford", "University,", "in", "collaboration", "with", "United", "Therapeutics,", "is", "sponsoring", "a", "Phase", "2", "clinical", "trial", "evaluating", "oral", "Orenitram", "(treprostinil)", "for", "the", "treatment", "of", "Calcinosis", "in", "patients", "with", "systemic", "sclerosis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p107_s0", "idA": "1095981_16_item1a_p88_s2", "sentA": "In December 2014, we executed an amendment to the August 2014 contract option to fund continued investigation and development of Cytori Cell Therapy for use in thermal burn injuries , which increased the option extension to $14.1 million.", "sentB": "In April 2016, the European Commission, acting on the positive recommendation from the COMP, issued orphan drug designation to a broad range of Cytori Cell Therapy formulations when used for the treatment of systemic sclerosis.", "type": 1, "words": ["<tag1>", "In", "December", "2014,", "we", "executed", "an", "amendment", "to", "the", "August", "2014", "contract", "option", "to", "fund", "continued", "investigation", "and", "development", "of", "Cytori", "Cell", "Therapy", "for", "use", "in", "thermal", "burn", "injuries", ",", "which", "increased", "the", "option", "extension", "to", "$14.1", "million.", "<tag2>", "In", "April", "2016,", "the", "European", "Commission,", "acting", "on", "the", "positive", "recommendation", "from", "the", "COMP,", "issued", "orphan", "drug", "designation", "to", "a", "broad", "range", "of", "Cytori", "Cell", "Therapy", "formulations", "when", "used", "for", "the", "treatment", "of", "systemic", "sclerosis.", "<tag3>"], "wordsA": ["In", "December", "2014,", "we", "executed", "an", "amendment", "to", "the", "August", "2014", "contract", "option", "to", "fund", "continued", "investigation", "and", "development", "of", "Cytori", "Cell", "Therapy", "for", "use", "in", "thermal", "burn", "injuries", ",", "which", "increased", "the", "option", "extension", "to", "$14.1", "million."], "wordsB": ["In", "April", "2016,", "the", "European", "Commission,", "acting", "on", "the", "positive", "recommendation", "from", "the", "COMP,", "issued", "orphan", "drug", "designation", "to", "a", "broad", "range", "of", "Cytori", "Cell", "Therapy", "formulations", "when", "used", "for", "the", "treatment", "of", "systemic", "sclerosis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p47_s0", "idA": "1095981_16_item1a_p88_s2", "sentA": "In December 2014, we executed an amendment to the August 2014 contract option to fund continued investigation and development of Cytori Cell Therapy for use in thermal burn injuries , which increased the option extension to $14.1 million.", "sentB": "Though we believe that Habeo Cell Therapy will be regulated as an Advanced Therapeutic Medicinal Product, or ATMP, in Europe, it is possible that the EMA instead provides a medical device classification for Habeo Cell Therapy, in which case we will be unable to avail ourselves of the orphan drug designation granted to us covering use of Cytori Cell Therapy for systemic sclerosis, and will instead compete with other medical device manufacturers purporting to offer cellular therapeutics competitive with ours (and possibly at much lower price points than we currently contemplate for our therapy).", "type": 1, "words": ["<tag1>", "In", "December", "2014,", "we", "executed", "an", "amendment", "to", "the", "August", "2014", "contract", "option", "to", "fund", "continued", "investigation", "and", "development", "of", "Cytori", "Cell", "Therapy", "for", "use", "in", "thermal", "burn", "injuries", ",", "which", "increased", "the", "option", "extension", "to", "$14.1", "million.", "<tag2>", "Though", "we", "believe", "that", "Habeo", "Cell", "Therapy", "will", "be", "regulated", "as", "an", "Advanced", "Therapeutic", "Medicinal", "Product,", "or", "ATMP,", "in", "Europe,", "it", "is", "possible", "that", "the", "EMA", "instead", "provides", "a", "medical", "device", "classification", "for", "Habeo", "Cell", "Therapy,", "in", "which", "case", "we", "will", "be", "unable", "to", "avail", "ourselves", "of", "the", "orphan", "drug", "designation", "granted", "to", "us", "covering", "use", "of", "Cytori", "Cell", "Therapy", "for", "systemic", "sclerosis,", "and", "will", "instead", "compete", "with", "other", "medical", "device", "manufacturers", "purporting", "to", "offer", "cellular", "therapeutics", "competitive", "with", "ours", "(and", "possibly", "at", "much", "lower", "price", "points", "than", "we", "currently", "contemplate", "for", "our", "therapy).", "<tag3>"], "wordsA": ["In", "December", "2014,", "we", "executed", "an", "amendment", "to", "the", "August", "2014", "contract", "option", "to", "fund", "continued", "investigation", "and", "development", "of", "Cytori", "Cell", "Therapy", "for", "use", "in", "thermal", "burn", "injuries", ",", "which", "increased", "the", "option", "extension", "to", "$14.1", "million."], "wordsB": ["Though", "we", "believe", "that", "Habeo", "Cell", "Therapy", "will", "be", "regulated", "as", "an", "Advanced", "Therapeutic", "Medicinal", "Product,", "or", "ATMP,", "in", "Europe,", "it", "is", "possible", "that", "the", "EMA", "instead", "provides", "a", "medical", "device", "classification", "for", "Habeo", "Cell", "Therapy,", "in", "which", "case", "we", "will", "be", "unable", "to", "avail", "ourselves", "of", "the", "orphan", "drug", "designation", "granted", "to", "us", "covering", "use", "of", "Cytori", "Cell", "Therapy", "for", "systemic", "sclerosis,", "and", "will", "instead", "compete", "with", "other", "medical", "device", "manufacturers", "purporting", "to", "offer", "cellular", "therapeutics", "competitive", "with", "ours", "(and", "possibly", "at", "much", "lower", "price", "points", "than", "we", "currently", "contemplate", "for", "our", "therapy)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p99_s0", "idA": "1095981_16_item1a_p88_s2", "sentA": "In December 2014, we executed an amendment to the August 2014 contract option to fund continued investigation and development of Cytori Cell Therapy for use in thermal burn injuries , which increased the option extension to $14.1 million.", "sentB": "Our managed access program, or MAP (also known as early access program or named patient program), is intended to provide access in select countries across Europe, the Middle East and Africa, or EMEA, to our Habeo Cell Therapy for patients with impaired hand function due to scleroderma in advance of anticipated commercialization of Habeo Cell Therapy.", "type": 1, "words": ["<tag1>", "In", "December", "2014,", "we", "executed", "an", "amendment", "to", "the", "August", "2014", "contract", "option", "to", "fund", "continued", "investigation", "and", "development", "of", "Cytori", "Cell", "Therapy", "for", "use", "in", "thermal", "burn", "injuries", ",", "which", "increased", "the", "option", "extension", "to", "$14.1", "million.", "<tag2>", "Our", "managed", "access", "program,", "or", "MAP", "(also", "known", "as", "early", "access", "program", "or", "named", "patient", "program),", "is", "intended", "to", "provide", "access", "in", "select", "countries", "across", "Europe,", "the", "Middle", "East", "and", "Africa,", "or", "EMEA,", "to", "our", "Habeo", "Cell", "Therapy", "for", "patients", "with", "impaired", "hand", "function", "due", "to", "scleroderma", "in", "advance", "of", "anticipated", "commercialization", "of", "Habeo", "Cell", "Therapy.", "<tag3>"], "wordsA": ["In", "December", "2014,", "we", "executed", "an", "amendment", "to", "the", "August", "2014", "contract", "option", "to", "fund", "continued", "investigation", "and", "development", "of", "Cytori", "Cell", "Therapy", "for", "use", "in", "thermal", "burn", "injuries", ",", "which", "increased", "the", "option", "extension", "to", "$14.1", "million."], "wordsB": ["Our", "managed", "access", "program,", "or", "MAP", "(also", "known", "as", "early", "access", "program", "or", "named", "patient", "program),", "is", "intended", "to", "provide", "access", "in", "select", "countries", "across", "Europe,", "the", "Middle", "East", "and", "Africa,", "or", "EMEA,", "to", "our", "Habeo", "Cell", "Therapy", "for", "patients", "with", "impaired", "hand", "function", "due", "to", "scleroderma", "in", "advance", "of", "anticipated", "commercialization", "of", "Habeo", "Cell", "Therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p120_s1", "idA": "1095981_16_item1a_p89_s2", "sentA": "If the BARDA contract were terminated or suspended, our business could be adversely affected.", "sentB": "There are additional contract options under the BARDA Agreement to provide over $80 million in additional funds to:", "type": 1, "words": ["<tag1>", "If", "the", "BARDA", "contract", "were", "terminated", "or", "suspended,", "our", "business", "could", "be", "adversely", "affected.", "<tag2>", "There", "are", "additional", "contract", "options", "under", "the", "BARDA", "Agreement", "to", "provide", "over", "$80", "million", "in", "additional", "funds", "to:", "<tag3>"], "wordsA": ["If", "the", "BARDA", "contract", "were", "terminated", "or", "suspended,", "our", "business", "could", "be", "adversely", "affected."], "wordsB": ["There", "are", "additional", "contract", "options", "under", "the", "BARDA", "Agreement", "to", "provide", "over", "$80", "million", "in", "additional", "funds", "to:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p111_s0", "idA": "1095981_16_item1a_p8_s0", "sentA": "As security for its obligations under the Loan and Security Agreement, the Company granted a security interest in substantially all of its existing and after-acquired assets, subject to certain exceptions set forth in the Loan and Security Agreement and excluding its intellectual property assets, which are subject to a negative pledge by the Company.", "sentB": "We source our Celase and Intravase reagents, which are used to process patients autologous adipose (fat) tissue, under an exclusive manufacturing arrangement with Roche Diagnostics Corporation, or Roche.", "type": 1, "words": ["<tag1>", "As", "security", "for", "its", "obligations", "under", "the", "Loan", "and", "Security", "Agreement,", "the", "Company", "granted", "a", "security", "interest", "in", "substantially", "all", "of", "its", "existing", "and", "after-acquired", "assets,", "subject", "to", "certain", "exceptions", "set", "forth", "in", "the", "Loan", "and", "Security", "Agreement", "and", "excluding", "its", "intellectual", "property", "assets,", "which", "are", "subject", "to", "a", "negative", "pledge", "by", "the", "Company.", "<tag2>", "We", "source", "our", "Celase", "and", "Intravase", "reagents,", "which", "are", "used", "to", "process", "patients", "autologous", "adipose", "(fat)", "tissue,", "under", "an", "exclusive", "manufacturing", "arrangement", "with", "Roche", "Diagnostics", "Corporation,", "or", "Roche.", "<tag3>"], "wordsA": ["As", "security", "for", "its", "obligations", "under", "the", "Loan", "and", "Security", "Agreement,", "the", "Company", "granted", "a", "security", "interest", "in", "substantially", "all", "of", "its", "existing", "and", "after-acquired", "assets,", "subject", "to", "certain", "exceptions", "set", "forth", "in", "the", "Loan", "and", "Security", "Agreement", "and", "excluding", "its", "intellectual", "property", "assets,", "which", "are", "subject", "to", "a", "negative", "pledge", "by", "the", "Company."], "wordsB": ["We", "source", "our", "Celase", "and", "Intravase", "reagents,", "which", "are", "used", "to", "process", "patients", "autologous", "adipose", "(fat)", "tissue,", "under", "an", "exclusive", "manufacturing", "arrangement", "with", "Roche", "Diagnostics", "Corporation,", "or", "Roche."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p107_s6", "idA": "1095981_16_item1a_p91_s1", "sentA": "These risks include the ability of the U.S. Government to unilaterally:", "sentB": "76% of the Japan sales revenues were from four key customers, and 49% of these sales revenues were from one key customer.", "type": 1, "words": ["<tag1>", "These", "risks", "include", "the", "ability", "of", "the", "U.S.", "Government", "to", "unilaterally:", "<tag2>", "76%", "of", "the", "Japan", "sales", "revenues", "were", "from", "four", "key", "customers,", "and", "49%", "of", "these", "sales", "revenues", "were", "from", "one", "key", "customer.", "<tag3>"], "wordsA": ["These", "risks", "include", "the", "ability", "of", "the", "U.S.", "Government", "to", "unilaterally:"], "wordsB": ["76%", "of", "the", "Japan", "sales", "revenues", "were", "from", "four", "key", "customers,", "and", "49%", "of", "these", "sales", "revenues", "were", "from", "one", "key", "customer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p53_s0", "idA": "1095981_16_item1a_p91_s1", "sentA": "These risks include the ability of the U.S. Government to unilaterally:", "sentB": "Though Azaya previously completed a European ATI-0918 60-patient bioequivalence trial, the EMA has not confirmed the adequacy of the trial for purposes of determining bioequivalence of ATI-0918 to Caelyx .", "type": 1, "words": ["<tag1>", "These", "risks", "include", "the", "ability", "of", "the", "U.S.", "Government", "to", "unilaterally:", "<tag2>", "Though", "Azaya", "previously", "completed", "a", "European", "ATI-0918", "60-patient", "bioequivalence", "trial,", "the", "EMA", "has", "not", "confirmed", "the", "adequacy", "of", "the", "trial", "for", "purposes", "of", "determining", "bioequivalence", "of", "ATI-0918", "to", "Caelyx", ".", "<tag3>"], "wordsA": ["These", "risks", "include", "the", "ability", "of", "the", "U.S.", "Government", "to", "unilaterally:"], "wordsB": ["Though", "Azaya", "previously", "completed", "a", "European", "ATI-0918", "60-patient", "bioequivalence", "trial,", "the", "EMA", "has", "not", "confirmed", "the", "adequacy", "of", "the", "trial", "for", "purposes", "of", "determining", "bioequivalence", "of", "ATI-0918", "to", "Caelyx", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p62_s0", "idA": "1095981_16_item1a_p91_s1", "sentA": "These risks include the ability of the U.S. Government to unilaterally:", "sentB": "Risks relating to our current material collaborations (excluding our BARDA partnership, which is discussed below in these Risk Factors ) include the following:", "type": 1, "words": ["<tag1>", "These", "risks", "include", "the", "ability", "of", "the", "U.S.", "Government", "to", "unilaterally:", "<tag2>", "Risks", "relating", "to", "our", "current", "material", "collaborations", "(excluding", "our", "BARDA", "partnership,", "which", "is", "discussed", "below", "in", "these", "Risk", "Factors", ")", "include", "the", "following:", "<tag3>"], "wordsA": ["These", "risks", "include", "the", "ability", "of", "the", "U.S.", "Government", "to", "unilaterally:"], "wordsB": ["Risks", "relating", "to", "our", "current", "material", "collaborations", "(excluding", "our", "BARDA", "partnership,", "which", "is", "discussed", "below", "in", "these", "Risk", "Factors", ")", "include", "the", "following:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p32_s13", "idA": "1095981_16_item1a_p92_s0", "sentA": "change certain terms and conditions in our contracts.", "sentB": "Most of these studies use the primary and secondary outcome measures as used in our STAR clinical trial.", "type": 1, "words": ["<tag1>", "change", "certain", "terms", "and", "conditions", "in", "our", "contracts.", "<tag2>", "Most", "of", "these", "studies", "use", "the", "primary", "and", "secondary", "outcome", "measures", "as", "used", "in", "our", "STAR", "clinical", "trial.", "<tag3>"], "wordsA": ["change", "certain", "terms", "and", "conditions", "in", "our", "contracts."], "wordsB": ["Most", "of", "these", "studies", "use", "the", "primary", "and", "secondary", "outcome", "measures", "as", "used", "in", "our", "STAR", "clinical", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p43_s0", "idA": "1095981_16_item1a_p92_s0", "sentA": "change certain terms and conditions in our contracts.", "sentB": "Many companies in our industry have suffered significant setbacks in advanced clinical trials, despite promising results in earlier trials.", "type": 1, "words": ["<tag1>", "change", "certain", "terms", "and", "conditions", "in", "our", "contracts.", "<tag2>", "Many", "companies", "in", "our", "industry", "have", "suffered", "significant", "setbacks", "in", "advanced", "clinical", "trials,", "despite", "promising", "results", "in", "earlier", "trials.", "<tag3>"], "wordsA": ["change", "certain", "terms", "and", "conditions", "in", "our", "contracts."], "wordsB": ["Many", "companies", "in", "our", "industry", "have", "suffered", "significant", "setbacks", "in", "advanced", "clinical", "trials,", "despite", "promising", "results", "in", "earlier", "trials."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p90_s8", "idA": "1095981_16_item1a_p93_s3", "sentA": "If revenue shortfalls occur and are not offset by corresponding reductions in expenses, our business could be adversely affected.", "sentB": "Such objectionable reformulations include, but are not limited to, human or animal components, BSE/TSE risks, banned packaging components, prohibited chemicals, banned substances, etc.", "type": 1, "words": ["<tag1>", "If", "revenue", "shortfalls", "occur", "and", "are", "not", "offset", "by", "corresponding", "reductions", "in", "expenses,", "our", "business", "could", "be", "adversely", "affected.", "<tag2>", "Such", "objectionable", "reformulations", "include,", "but", "are", "not", "limited", "to,", "human", "or", "animal", "components,", "BSE/TSE", "risks,", "banned", "packaging", "components,", "prohibited", "chemicals,", "banned", "substances,", "etc.", "<tag3>"], "wordsA": ["If", "revenue", "shortfalls", "occur", "and", "are", "not", "offset", "by", "corresponding", "reductions", "in", "expenses,", "our", "business", "could", "be", "adversely", "affected."], "wordsB": ["Such", "objectionable", "reformulations", "include,", "but", "are", "not", "limited", "to,", "human", "or", "animal", "components,", "BSE/TSE", "risks,", "banned", "packaging", "components,", "prohibited", "chemicals,", "banned", "substances,", "etc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p94_s2", "idA": "1095981_16_item1a_p93_s3", "sentA": "If revenue shortfalls occur and are not offset by corresponding reductions in expenses, our business could be adversely affected.", "sentB": "Such objectionable reformulations include, but are not limited to, human or animal components, bovine spongiform encephalopathy/ transmissible spongiform encephalopathy risks, banned packaging components, prohibited chemicals, banned substances, etc.", "type": 1, "words": ["<tag1>", "If", "revenue", "shortfalls", "occur", "and", "are", "not", "offset", "by", "corresponding", "reductions", "in", "expenses,", "our", "business", "could", "be", "adversely", "affected.", "<tag2>", "Such", "objectionable", "reformulations", "include,", "but", "are", "not", "limited", "to,", "human", "or", "animal", "components,", "bovine", "spongiform", "encephalopathy/", "transmissible", "spongiform", "encephalopathy", "risks,", "banned", "packaging", "components,", "prohibited", "chemicals,", "banned", "substances,", "etc.", "<tag3>"], "wordsA": ["If", "revenue", "shortfalls", "occur", "and", "are", "not", "offset", "by", "corresponding", "reductions", "in", "expenses,", "our", "business", "could", "be", "adversely", "affected."], "wordsB": ["Such", "objectionable", "reformulations", "include,", "but", "are", "not", "limited", "to,", "human", "or", "animal", "components,", "bovine", "spongiform", "encephalopathy/", "transmissible", "spongiform", "encephalopathy", "risks,", "banned", "packaging", "components,", "prohibited", "chemicals,", "banned", "substances,", "etc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p30_s0", "idA": "1095981_16_item1a_p95_s0", "sentA": "The DHHS and the DCAA also review the adequacy of, and a contractor s compliance with, its internal control systems and policies, including the contractor s purchasing, property, estimating, compensation and management information systems.", "sentB": "The life science industry is characterized by rapidly advancing technologies, intense competition and a strong emphasis on proprietary therapeutics.", "type": 1, "words": ["<tag1>", "The", "DHHS", "and", "the", "DCAA", "also", "review", "the", "adequacy", "of,", "and", "a", "contractor", "s", "compliance", "with,", "its", "internal", "control", "systems", "and", "policies,", "including", "the", "contractor", "s", "purchasing,", "property,", "estimating,", "compensation", "and", "management", "information", "systems.", "<tag2>", "The", "life", "science", "industry", "is", "characterized", "by", "rapidly", "advancing", "technologies,", "intense", "competition", "and", "a", "strong", "emphasis", "on", "proprietary", "therapeutics.", "<tag3>"], "wordsA": ["The", "DHHS", "and", "the", "DCAA", "also", "review", "the", "adequacy", "of,", "and", "a", "contractor", "s", "compliance", "with,", "its", "internal", "control", "systems", "and", "policies,", "including", "the", "contractor", "s", "purchasing,", "property,", "estimating,", "compensation", "and", "management", "information", "systems."], "wordsB": ["The", "life", "science", "industry", "is", "characterized", "by", "rapidly", "advancing", "technologies,", "intense", "competition", "and", "a", "strong", "emphasis", "on", "proprietary", "therapeutics."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p32_s2", "idA": "1095981_16_item1a_p97_s0", "sentA": "suspension or prohibition from conducting business with the U.S. Government.", "sentB": "University of Pittsburgh, in collaboration with the NIAMS, is conducting a Phase II clinical trial evaluating Lipitor s (atorvastatin) effect on blood vessel function and Raynaud symptoms in patients with early diffuse systemic sclerosis.", "type": 1, "words": ["<tag1>", "suspension", "or", "prohibition", "from", "conducting", "business", "with", "the", "U.S.", "Government.", "<tag2>", "University", "of", "Pittsburgh,", "in", "collaboration", "with", "the", "NIAMS,", "is", "conducting", "a", "Phase", "II", "clinical", "trial", "evaluating", "Lipitor", "s", "(atorvastatin)", "effect", "on", "blood", "vessel", "function", "and", "Raynaud", "symptoms", "in", "patients", "with", "early", "diffuse", "systemic", "sclerosis.", "<tag3>"], "wordsA": ["suspension", "or", "prohibition", "from", "conducting", "business", "with", "the", "U.S.", "Government."], "wordsB": ["University", "of", "Pittsburgh,", "in", "collaboration", "with", "the", "NIAMS,", "is", "conducting", "a", "Phase", "II", "clinical", "trial", "evaluating", "Lipitor", "s", "(atorvastatin)", "effect", "on", "blood", "vessel", "function", "and", "Raynaud", "symptoms", "in", "patients", "with", "early", "diffuse", "systemic", "sclerosis."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p32_s3", "idA": "1095981_16_item1a_p97_s0", "sentA": "suspension or prohibition from conducting business with the U.S. Government.", "sentB": "Primus Pharmaceuticals is sponsoring a U.S. multi-center clinical trial to evaluate Diosmiplex in patients with Raynaud s disease.", "type": 1, "words": ["<tag1>", "suspension", "or", "prohibition", "from", "conducting", "business", "with", "the", "U.S.", "Government.", "<tag2>", "Primus", "Pharmaceuticals", "is", "sponsoring", "a", "U.S.", "multi-center", "clinical", "trial", "to", "evaluate", "Diosmiplex", "in", "patients", "with", "Raynaud", "s", "disease.", "<tag3>"], "wordsA": ["suspension", "or", "prohibition", "from", "conducting", "business", "with", "the", "U.S.", "Government."], "wordsB": ["Primus", "Pharmaceuticals", "is", "sponsoring", "a", "U.S.", "multi-center", "clinical", "trial", "to", "evaluate", "Diosmiplex", "in", "patients", "with", "Raynaud", "s", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p93_s6", "idA": "1095981_16_item1a_p97_s0", "sentA": "suspension or prohibition from conducting business with the U.S. Government.", "sentB": "Other risks with the RLD criteria are in the criteria for demonstrating bioequivalence.", "type": 1, "words": ["<tag1>", "suspension", "or", "prohibition", "from", "conducting", "business", "with", "the", "U.S.", "Government.", "<tag2>", "Other", "risks", "with", "the", "RLD", "criteria", "are", "in", "the", "criteria", "for", "demonstrating", "bioequivalence.", "<tag3>"], "wordsA": ["suspension", "or", "prohibition", "from", "conducting", "business", "with", "the", "U.S.", "Government."], "wordsB": ["Other", "risks", "with", "the", "RLD", "criteria", "are", "in", "the", "criteria", "for", "demonstrating", "bioequivalence."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p182_s1", "idA": "1095981_16_item1a_p99_s0", "sentA": "We are required, pursuant to Section 404 of the Sarbanes-Oxley Act, to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting.", "sentB": "For example, under the rules of the NASDAQ Capital Market, in no event may we issue more than 19.99% of our shares outstanding (which is approximately 4,315,814 shares based on 21,579,071 shares outstanding prior to the signing of the Lincoln Park Purchase Agreement) under the Lincoln Park Purchase Agreement unless we obtain stockholder approval or an exception pursuant to the rules of the NASDAQ Capital Market is obtained to issue more than 19.99%.", "type": 1, "words": ["<tag1>", "We", "are", "required,", "pursuant", "to", "Section", "404", "of", "the", "Sarbanes-Oxley", "Act,", "to", "furnish", "a", "report", "by", "management", "on,", "among", "other", "things,", "the", "effectiveness", "of", "our", "internal", "control", "over", "financial", "reporting.", "<tag2>", "For", "example,", "under", "the", "rules", "of", "the", "NASDAQ", "Capital", "Market,", "in", "no", "event", "may", "we", "issue", "more", "than", "19.99%", "of", "our", "shares", "outstanding", "(which", "is", "approximately", "4,315,814", "shares", "based", "on", "21,579,071", "shares", "outstanding", "prior", "to", "the", "signing", "of", "the", "Lincoln", "Park", "Purchase", "Agreement)", "under", "the", "Lincoln", "Park", "Purchase", "Agreement", "unless", "we", "obtain", "stockholder", "approval", "or", "an", "exception", "pursuant", "to", "the", "rules", "of", "the", "NASDAQ", "Capital", "Market", "is", "obtained", "to", "issue", "more", "than", "19.99%.", "<tag3>"], "wordsA": ["We", "are", "required,", "pursuant", "to", "Section", "404", "of", "the", "Sarbanes-Oxley", "Act,", "to", "furnish", "a", "report", "by", "management", "on,", "among", "other", "things,", "the", "effectiveness", "of", "our", "internal", "control", "over", "financial", "reporting."], "wordsB": ["For", "example,", "under", "the", "rules", "of", "the", "NASDAQ", "Capital", "Market,", "in", "no", "event", "may", "we", "issue", "more", "than", "19.99%", "of", "our", "shares", "outstanding", "(which", "is", "approximately", "4,315,814", "shares", "based", "on", "21,579,071", "shares", "outstanding", "prior", "to", "the", "signing", "of", "the", "Lincoln", "Park", "Purchase", "Agreement)", "under", "the", "Lincoln", "Park", "Purchase", "Agreement", "unless", "we", "obtain", "stockholder", "approval", "or", "an", "exception", "pursuant", "to", "the", "rules", "of", "the", "NASDAQ", "Capital", "Market", "is", "obtained", "to", "issue", "more", "than", "19.99%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p153_s1", "idA": "1095981_16_item1a_p99_s1", "sentA": "This assessment includes disclosure of any material weaknesses identified by our management in our internal control over financial reporting, as well as a statement that our independent registered public accounting firm has issued an attestation report on the effectiveness of our internal control over financial reporting.", "sentB": "HIPAA imposes limitations on the use and disclosure of an individual s healthcare information by healthcare providers conducting certain electronic transactions, healthcare clearinghouses, and health insurance plans, collectively referred to as covered entities.", "type": 1, "words": ["<tag1>", "This", "assessment", "includes", "disclosure", "of", "any", "material", "weaknesses", "identified", "by", "our", "management", "in", "our", "internal", "control", "over", "financial", "reporting,", "as", "well", "as", "a", "statement", "that", "our", "independent", "registered", "public", "accounting", "firm", "has", "issued", "an", "attestation", "report", "on", "the", "effectiveness", "of", "our", "internal", "control", "over", "financial", "reporting.", "<tag2>", "HIPAA", "imposes", "limitations", "on", "the", "use", "and", "disclosure", "of", "an", "individual", "s", "healthcare", "information", "by", "healthcare", "providers", "conducting", "certain", "electronic", "transactions,", "healthcare", "clearinghouses,", "and", "health", "insurance", "plans,", "collectively", "referred", "to", "as", "covered", "entities.", "<tag3>"], "wordsA": ["This", "assessment", "includes", "disclosure", "of", "any", "material", "weaknesses", "identified", "by", "our", "management", "in", "our", "internal", "control", "over", "financial", "reporting,", "as", "well", "as", "a", "statement", "that", "our", "independent", "registered", "public", "accounting", "firm", "has", "issued", "an", "attestation", "report", "on", "the", "effectiveness", "of", "our", "internal", "control", "over", "financial", "reporting."], "wordsB": ["HIPAA", "imposes", "limitations", "on", "the", "use", "and", "disclosure", "of", "an", "individual", "s", "healthcare", "information", "by", "healthcare", "providers", "conducting", "certain", "electronic", "transactions,", "healthcare", "clearinghouses,", "and", "health", "insurance", "plans,", "collectively", "referred", "to", "as", "covered", "entities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_17_item1a_p202_s1", "idA": "1095981_16_item1a_p99_s1", "sentA": "This assessment includes disclosure of any material weaknesses identified by our management in our internal control over financial reporting, as well as a statement that our independent registered public accounting firm has issued an attestation report on the effectiveness of our internal control over financial reporting.", "sentB": "Trade secrets are difficult to protect, and we have limited control over the protection of trade secrets used by our collaborators and suppliers.", "type": 1, "words": ["<tag1>", "This", "assessment", "includes", "disclosure", "of", "any", "material", "weaknesses", "identified", "by", "our", "management", "in", "our", "internal", "control", "over", "financial", "reporting,", "as", "well", "as", "a", "statement", "that", "our", "independent", "registered", "public", "accounting", "firm", "has", "issued", "an", "attestation", "report", "on", "the", "effectiveness", "of", "our", "internal", "control", "over", "financial", "reporting.", "<tag2>", "Trade", "secrets", "are", "difficult", "to", "protect,", "and", "we", "have", "limited", "control", "over", "the", "protection", "of", "trade", "secrets", "used", "by", "our", "collaborators", "and", "suppliers.", "<tag3>"], "wordsA": ["This", "assessment", "includes", "disclosure", "of", "any", "material", "weaknesses", "identified", "by", "our", "management", "in", "our", "internal", "control", "over", "financial", "reporting,", "as", "well", "as", "a", "statement", "that", "our", "independent", "registered", "public", "accounting", "firm", "has", "issued", "an", "attestation", "report", "on", "the", "effectiveness", "of", "our", "internal", "control", "over", "financial", "reporting."], "wordsB": ["Trade", "secrets", "are", "difficult", "to", "protect,", "and", "we", "have", "limited", "control", "over", "the", "protection", "of", "trade", "secrets", "used", "by", "our", "collaborators", "and", "suppliers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p57_s3", "idA": "1095981_17_item1a_p106_s0", "sentA": "drug application or cannot supply enough drug, or when a sec ond applicant demonstrates its drug is clinically superior to the original orphan drug.", "sentB": "The planned duration of treatment with study drug is 52 weeks.", "type": 1, "words": ["<tag1>", "drug", "application", "or", "cannot", "supply", "enough", "drug,", "or", "when", "a", "sec", "ond", "applicant", "demonstrates", "its", "drug", "is", "clinically", "superior", "to", "the", "original", "orphan", "drug.", "<tag2>", "The", "planned", "duration", "of", "treatment", "with", "study", "drug", "is", "52", "weeks.", "<tag3>"], "wordsA": ["drug", "application", "or", "cannot", "supply", "enough", "drug,", "or", "when", "a", "sec", "ond", "applicant", "demonstrates", "its", "drug", "is", "clinically", "superior", "to", "the", "original", "orphan", "drug."], "wordsB": ["The", "planned", "duration", "of", "treatment", "with", "study", "drug", "is", "52", "weeks."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p29_s1", "idA": "1095981_17_item1a_p129_s1", "sentA": "These risks include the ability of the U.S. Government to unilaterally:", "sentB": "Recently enacted U.S. tax legislation has significantly changed the U.S. federal income taxation of U.S. corporations, including by reducing the U.S. corporate income tax rate, and revising the rules governing net operating losses and foreign tax credits.", "type": 1, "words": ["<tag1>", "These", "risks", "include", "the", "ability", "of", "the", "U.S.", "Government", "to", "unilaterally:", "<tag2>", "Recently", "enacted", "U.S.", "tax", "legislation", "has", "significantly", "changed", "the", "U.S.", "federal", "income", "taxation", "of", "U.S.", "corporations,", "including", "by", "reducing", "the", "U.S.", "corporate", "income", "tax", "rate,", "and", "revising", "the", "rules", "governing", "net", "operating", "losses", "and", "foreign", "tax", "credits.", "<tag3>"], "wordsA": ["These", "risks", "include", "the", "ability", "of", "the", "U.S.", "Government", "to", "unilaterally:"], "wordsB": ["Recently", "enacted", "U.S.", "tax", "legislation", "has", "significantly", "changed", "the", "U.S.", "federal", "income", "taxation", "of", "U.S.", "corporations,", "including", "by", "reducing", "the", "U.S.", "corporate", "income", "tax", "rate,", "and", "revising", "the", "rules", "governing", "net", "operating", "losses", "and", "foreign", "tax", "credits."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p68_s7", "idA": "1095981_17_item1a_p129_s1", "sentA": "These risks include the ability of the U.S. Government to unilaterally:", "sentB": "In addition, we recently released a more detailed assessment of STAR Trial data at the World Scleroderma Congress this past February, and in late 2017, submitted a request for a a pre-submission meeting with FDA, which shall happen later this quarter, and shall provide us with a clearer picture of the optimal path forward with Habeo Cell therapy in the U.S.", "type": 1, "words": ["<tag1>", "These", "risks", "include", "the", "ability", "of", "the", "U.S.", "Government", "to", "unilaterally:", "<tag2>", "In", "addition,", "we", "recently", "released", "a", "more", "detailed", "assessment", "of", "STAR", "Trial", "data", "at", "the", "World", "Scleroderma", "Congress", "this", "past", "February,", "and", "in", "late", "2017,", "submitted", "a", "request", "for", "a", "a", "pre-submission", "meeting", "with", "FDA,", "which", "shall", "happen", "later", "this", "quarter,", "and", "shall", "provide", "us", "with", "a", "clearer", "picture", "of", "the", "optimal", "path", "forward", "with", "Habeo", "Cell", "therapy", "in", "the", "U.S.", "<tag3>"], "wordsA": ["These", "risks", "include", "the", "ability", "of", "the", "U.S.", "Government", "to", "unilaterally:"], "wordsB": ["In", "addition,", "we", "recently", "released", "a", "more", "detailed", "assessment", "of", "STAR", "Trial", "data", "at", "the", "World", "Scleroderma", "Congress", "this", "past", "February,", "and", "in", "late", "2017,", "submitted", "a", "request", "for", "a", "a", "pre-submission", "meeting", "with", "FDA,", "which", "shall", "happen", "later", "this", "quarter,", "and", "shall", "provide", "us", "with", "a", "clearer", "picture", "of", "the", "optimal", "path", "forward", "with", "Habeo", "Cell", "therapy", "in", "the", "U.S."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p29_s2", "idA": "1095981_17_item1a_p139_s0", "sentA": "The manufacturing of these oncology drug assets is a highly complex process that requires significant experience and know-how.", "sentB": "Many of these changes are effective immediately, without any transition periods or grandfathering for existing transactions.", "type": 1, "words": ["<tag1>", "The", "manufacturing", "of", "these", "oncology", "drug", "assets", "is", "a", "highly", "complex", "process", "that", "requires", "significant", "experience", "and", "know-how.", "<tag2>", "Many", "of", "these", "changes", "are", "effective", "immediately,", "without", "any", "transition", "periods", "or", "grandfathering", "for", "existing", "transactions.", "<tag3>"], "wordsA": ["The", "manufacturing", "of", "these", "oncology", "drug", "assets", "is", "a", "highly", "complex", "process", "that", "requires", "significant", "experience", "and", "know-how."], "wordsB": ["Many", "of", "these", "changes", "are", "effective", "immediately,", "without", "any", "transition", "periods", "or", "grandfathering", "for", "existing", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p5_s11", "idA": "1095981_17_item1a_p153_s0", "sentA": "As part of the American Recovery and Reinvestment Act 2009, or ARRA, Congress amended the privacy and security provisions of the Healthcare Information Portability and Accountability Act, or HIPAA.", "sentB": "We sold a total of 10,000 units as part of the 2017 Rights Offering, under our registration statement on Form S-1, filed on August 14, 2017, as amended.", "type": 1, "words": ["<tag1>", "As", "part", "of", "the", "American", "Recovery", "and", "Reinvestment", "Act", "2009,", "or", "ARRA,", "Congress", "amended", "the", "privacy", "and", "security", "provisions", "of", "the", "Healthcare", "Information", "Portability", "and", "Accountability", "Act,", "or", "HIPAA.", "<tag2>", "We", "sold", "a", "total", "of", "10,000", "units", "as", "part", "of", "the", "2017", "Rights", "Offering,", "under", "our", "registration", "statement", "on", "Form", "S-1,", "filed", "on", "August", "14,", "2017,", "as", "amended.", "<tag3>"], "wordsA": ["As", "part", "of", "the", "American", "Recovery", "and", "Reinvestment", "Act", "2009,", "or", "ARRA,", "Congress", "amended", "the", "privacy", "and", "security", "provisions", "of", "the", "Healthcare", "Information", "Portability", "and", "Accountability", "Act,", "or", "HIPAA."], "wordsB": ["We", "sold", "a", "total", "of", "10,000", "units", "as", "part", "of", "the", "2017", "Rights", "Offering,", "under", "our", "registration", "statement", "on", "Form", "S-1,", "filed", "on", "August", "14,", "2017,", "as", "amended."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p35_s2", "idA": "1095981_17_item1a_p15_s1", "sentA": "Further, while consistent trends were observed in most secondary endpoints relative to the placebo group in our ACT-OA knee osteoarthritis trial, the 12-week endpoint of single pain on walking question did not achieve statistical significance, so there can be no assurance that our partnering efforts for our ECCS-50 therapeutics will be successful.", "sentB": "In this trial, Habeo did not achieve its primary endpoint of improvement in hand dysfunction, compared to placebo, as measured by the Cochin Hand Function Score, or CHFS, at twenty-four (24) and forty-eight (48) weeks, nor did it achieve its secondary endpoints of improvement in the Raynaud s Condition Score and the Scleroderma Health Assessment Questionnaire at forty-eight (48) weeks, compared to placebo.", "type": 1, "words": ["<tag1>", "Further,", "while", "consistent", "trends", "were", "observed", "in", "most", "secondary", "endpoints", "relative", "to", "the", "placebo", "group", "in", "our", "ACT-OA", "knee", "osteoarthritis", "trial,", "the", "12-week", "endpoint", "of", "single", "pain", "on", "walking", "question", "did", "not", "achieve", "statistical", "significance,", "so", "there", "can", "be", "no", "assurance", "that", "our", "partnering", "efforts", "for", "our", "ECCS-50", "therapeutics", "will", "be", "successful.", "<tag2>", "In", "this", "trial,", "Habeo", "did", "not", "achieve", "its", "primary", "endpoint", "of", "improvement", "in", "hand", "dysfunction,", "compared", "to", "placebo,", "as", "measured", "by", "the", "Cochin", "Hand", "Function", "Score,", "or", "CHFS,", "at", "twenty-four", "(24)", "and", "forty-eight", "(48)", "weeks,", "nor", "did", "it", "achieve", "its", "secondary", "endpoints", "of", "improvement", "in", "the", "Raynaud", "s", "Condition", "Score", "and", "the", "Scleroderma", "Health", "Assessment", "Questionnaire", "at", "forty-eight", "(48)", "weeks,", "compared", "to", "placebo.", "<tag3>"], "wordsA": ["Further,", "while", "consistent", "trends", "were", "observed", "in", "most", "secondary", "endpoints", "relative", "to", "the", "placebo", "group", "in", "our", "ACT-OA", "knee", "osteoarthritis", "trial,", "the", "12-week", "endpoint", "of", "single", "pain", "on", "walking", "question", "did", "not", "achieve", "statistical", "significance,", "so", "there", "can", "be", "no", "assurance", "that", "our", "partnering", "efforts", "for", "our", "ECCS-50", "therapeutics", "will", "be", "successful."], "wordsB": ["In", "this", "trial,", "Habeo", "did", "not", "achieve", "its", "primary", "endpoint", "of", "improvement", "in", "hand", "dysfunction,", "compared", "to", "placebo,", "as", "measured", "by", "the", "Cochin", "Hand", "Function", "Score,", "or", "CHFS,", "at", "twenty-four", "(24)", "and", "forty-eight", "(48)", "weeks,", "nor", "did", "it", "achieve", "its", "secondary", "endpoints", "of", "improvement", "in", "the", "Raynaud", "s", "Condition", "Score", "and", "the", "Scleroderma", "Health", "Assessment", "Questionnaire", "at", "forty-eight", "(48)", "weeks,", "compared", "to", "placebo."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p142_s2", "idA": "1095981_17_item1a_p160_s3", "sentA": "We expect to continue to incur net losses and negative cash flow from operating activities for at least the next year.", "sentB": "We initiated RELIEF in 2017 and expect to enroll first patients into this trial in 2018.", "type": 1, "words": ["<tag1>", "We", "expect", "to", "continue", "to", "incur", "net", "losses", "and", "negative", "cash", "flow", "from", "operating", "activities", "for", "at", "least", "the", "next", "year.", "<tag2>", "We", "initiated", "RELIEF", "in", "2017", "and", "expect", "to", "enroll", "first", "patients", "into", "this", "trial", "in", "2018.", "<tag3>"], "wordsA": ["We", "expect", "to", "continue", "to", "incur", "net", "losses", "and", "negative", "cash", "flow", "from", "operating", "activities", "for", "at", "least", "the", "next", "year."], "wordsB": ["We", "initiated", "RELIEF", "in", "2017", "and", "expect", "to", "enroll", "first", "patients", "into", "this", "trial", "in", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p57_s4", "idA": "1095981_17_item1a_p165_s2", "sentA": "We cannot be certain that additional capital will be available on terms acceptable to us, or at all.", "sentB": "Subjects will be randomized 1:1:1 t o receive lenabasum 5 mg twice per day, lenabasum 20 mg twice per day, or placebo twice per day.", "type": 1, "words": ["<tag1>", "We", "cannot", "be", "certain", "that", "additional", "capital", "will", "be", "available", "on", "terms", "acceptable", "to", "us,", "or", "at", "all.", "<tag2>", "Subjects", "will", "be", "randomized", "1:1:1", "t", "o", "receive", "lenabasum", "5", "mg", "twice", "per", "day,", "lenabasum", "20", "mg", "twice", "per", "day,", "or", "placebo", "twice", "per", "day.", "<tag3>"], "wordsA": ["We", "cannot", "be", "certain", "that", "additional", "capital", "will", "be", "available", "on", "terms", "acceptable", "to", "us,", "or", "at", "all."], "wordsB": ["Subjects", "will", "be", "randomized", "1:1:1", "t", "o", "receive", "lenabasum", "5", "mg", "twice", "per", "day,", "lenabasum", "20", "mg", "twice", "per", "day,", "or", "placebo", "twice", "per", "day."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p155_s0", "idA": "1095981_17_item1a_p169_s1", "sentA": "Prior to January 2017, we made interest-only payments on the Term Loan.", "sentB": "On September 1, 2017, we announced a corporate restructuring intended to significantly reduce expenses.", "type": 1, "words": ["<tag1>", "Prior", "to", "January", "2017,", "we", "made", "interest-only", "payments", "on", "the", "Term", "Loan.", "<tag2>", "On", "September", "1,", "2017,", "we", "announced", "a", "corporate", "restructuring", "intended", "to", "significantly", "reduce", "expenses.", "<tag3>"], "wordsA": ["Prior", "to", "January", "2017,", "we", "made", "interest-only", "payments", "on", "the", "Term", "Loan."], "wordsB": ["On", "September", "1,", "2017,", "we", "announced", "a", "corporate", "restructuring", "intended", "to", "significantly", "reduce", "expenses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p158_s2", "idA": "1095981_17_item1a_p186_s4", "sentA": "Additionally, the sale of a substantial number of shares of our common stock to Lincoln Park, or the anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales.", "sentB": "In addition, these changes and measures could distract our employees, decrease employee morale and make it more difficult to retain and hire new talent, and harm our reputation.", "type": 1, "words": ["<tag1>", "Additionally,", "the", "sale", "of", "a", "substantial", "number", "of", "shares", "of", "our", "common", "stock", "to", "Lincoln", "Park,", "or", "the", "anticipation", "of", "such", "sales,", "could", "make", "it", "more", "difficult", "for", "us", "to", "sell", "equity", "or", "equity-related", "securities", "in", "the", "future", "at", "a", "time", "and", "at", "a", "price", "that", "we", "might", "otherwise", "wish", "to", "effect", "sales.", "<tag2>", "In", "addition,", "these", "changes", "and", "measures", "could", "distract", "our", "employees,", "decrease", "employee", "morale", "and", "make", "it", "more", "difficult", "to", "retain", "and", "hire", "new", "talent,", "and", "harm", "our", "reputation.", "<tag3>"], "wordsA": ["Additionally,", "the", "sale", "of", "a", "substantial", "number", "of", "shares", "of", "our", "common", "stock", "to", "Lincoln", "Park,", "or", "the", "anticipation", "of", "such", "sales,", "could", "make", "it", "more", "difficult", "for", "us", "to", "sell", "equity", "or", "equity-related", "securities", "in", "the", "future", "at", "a", "time", "and", "at", "a", "price", "that", "we", "might", "otherwise", "wish", "to", "effect", "sales."], "wordsB": ["In", "addition,", "these", "changes", "and", "measures", "could", "distract", "our", "employees,", "decrease", "employee", "morale", "and", "make", "it", "more", "difficult", "to", "retain", "and", "hire", "new", "talent,", "and", "harm", "our", "reputation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p57_s2", "idA": "1095981_17_item1a_p200_s6", "sentA": "We currently have pending patent applications in Europe, Australia, Japan, Canada, China, South Korea, Brazil, South Africa, among other jurisdictions.", "sentB": "The study will enroll approximately 354 subjects at 70 sites in North America, Europe, Israel, Japan, South Korea, and Australia.", "type": 1, "words": ["<tag1>", "We", "currently", "have", "pending", "patent", "applications", "in", "Europe,", "Australia,", "Japan,", "Canada,", "China,", "South", "Korea,", "Brazil,", "South", "Africa,", "among", "other", "jurisdictions.", "<tag2>", "The", "study", "will", "enroll", "approximately", "354", "subjects", "at", "70", "sites", "in", "North", "America,", "Europe,", "Israel,", "Japan,", "South", "Korea,", "and", "Australia.", "<tag3>"], "wordsA": ["We", "currently", "have", "pending", "patent", "applications", "in", "Europe,", "Australia,", "Japan,", "Canada,", "China,", "South", "Korea,", "Brazil,", "South", "Africa,", "among", "other", "jurisdictions."], "wordsB": ["The", "study", "will", "enroll", "approximately", "354", "subjects", "at", "70", "sites", "in", "North", "America,", "Europe,", "Israel,", "Japan,", "South", "Korea,", "and", "Australia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p28_s0", "idA": "1095981_17_item1a_p31_s1", "sentA": "If approved for the treatment of hand dysfunction and/or Raynaud s Phenomenon in scleroderma patients, Habeo Cell Therapy will likely compete against other products and product candidates.", "sentB": "Furthermore, under recently enacted U.S. tax legislation, although the treatment of tax losses generated before December 31, 2017 has generally n ot changed, tax losses generated in calendar year 2018 and beyond may be used to offset only 80% of taxable income.", "type": 1, "words": ["<tag1>", "If", "approved", "for", "the", "treatment", "of", "hand", "dysfunction", "and/or", "Raynaud", "s", "Phenomenon", "in", "scleroderma", "patients,", "Habeo", "Cell", "Therapy", "will", "likely", "compete", "against", "other", "products", "and", "product", "candidates.", "<tag2>", "Furthermore,", "under", "recently", "enacted", "U.S.", "tax", "legislation,", "although", "the", "treatment", "of", "tax", "losses", "generated", "before", "December", "31,", "2017", "has", "generally", "n", "ot", "changed,", "tax", "losses", "generated", "in", "calendar", "year", "2018", "and", "beyond", "may", "be", "used", "to", "offset", "only", "80%", "of", "taxable", "income.", "<tag3>"], "wordsA": ["If", "approved", "for", "the", "treatment", "of", "hand", "dysfunction", "and/or", "Raynaud", "s", "Phenomenon", "in", "scleroderma", "patients,", "Habeo", "Cell", "Therapy", "will", "likely", "compete", "against", "other", "products", "and", "product", "candidates."], "wordsB": ["Furthermore,", "under", "recently", "enacted", "U.S.", "tax", "legislation,", "although", "the", "treatment", "of", "tax", "losses", "generated", "before", "December", "31,", "2017", "has", "generally", "n", "ot", "changed,", "tax", "losses", "generated", "in", "calendar", "year", "2018", "and", "beyond", "may", "be", "used", "to", "offset", "only", "80%", "of", "taxable", "income."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p35_s3", "idA": "1095981_17_item1a_p32_s9", "sentA": "Invtiva Pharma is sponsoring a Phase 2 clinical trial evaluating IVA337 in patients with diffuse cutaneous systemic sclerosis.", "sentB": "Analysis of the STAR data indicated that within a pre-specified subgroup analysis, Habeo-treated patients within the diffuse cutaneous scleroderma subset indicated improvements in the CHFS and the Health Assessment Questionnaire-Disability Index (a measure of functional disability), that met or exceeded the published criteria for minimally important clinical differences in these measures as compared to STAR patients with diffuse cutaneous scleroderma within the placebo group.", "type": 1, "words": ["<tag1>", "Invtiva", "Pharma", "is", "sponsoring", "a", "Phase", "2", "clinical", "trial", "evaluating", "IVA337", "in", "patients", "with", "diffuse", "cutaneous", "systemic", "sclerosis.", "<tag2>", "Analysis", "of", "the", "STAR", "data", "indicated", "that", "within", "a", "pre-specified", "subgroup", "analysis,", "Habeo-treated", "patients", "within", "the", "diffuse", "cutaneous", "scleroderma", "subset", "indicated", "improvements", "in", "the", "CHFS", "and", "the", "Health", "Assessment", "Questionnaire-Disability", "Index", "(a", "measure", "of", "functional", "disability),", "that", "met", "or", "exceeded", "the", "published", "criteria", "for", "minimally", "important", "clinical", "differences", "in", "these", "measures", "as", "compared", "to", "STAR", "patients", "with", "diffuse", "cutaneous", "scleroderma", "within", "the", "placebo", "group.", "<tag3>"], "wordsA": ["Invtiva", "Pharma", "is", "sponsoring", "a", "Phase", "2", "clinical", "trial", "evaluating", "IVA337", "in", "patients", "with", "diffuse", "cutaneous", "systemic", "sclerosis."], "wordsB": ["Analysis", "of", "the", "STAR", "data", "indicated", "that", "within", "a", "pre-specified", "subgroup", "analysis,", "Habeo-treated", "patients", "within", "the", "diffuse", "cutaneous", "scleroderma", "subset", "indicated", "improvements", "in", "the", "CHFS", "and", "the", "Health", "Assessment", "Questionnaire-Disability", "Index", "(a", "measure", "of", "functional", "disability),", "that", "met", "or", "exceeded", "the", "published", "criteria", "for", "minimally", "important", "clinical", "differences", "in", "these", "measures", "as", "compared", "to", "STAR", "patients", "with", "diffuse", "cutaneous", "scleroderma", "within", "the", "placebo", "group."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p155_s1", "idA": "1095981_17_item1a_p86_s0", "sentA": "It is possible that the new legislation in our priority markets, such as the newly enacted CURES Act in the United States, will yield additional regulatory requirements for therapeutic drugs for our Cytori Nanomedicine drug candidates (the FDA s interpretation and implementation of the CURES Act has yet to be published).", "sentB": "The restructuring reduced our workforce by approximately 50%.", "type": 1, "words": ["<tag1>", "It", "is", "possible", "that", "the", "new", "legislation", "in", "our", "priority", "markets,", "such", "as", "the", "newly", "enacted", "CURES", "Act", "in", "the", "United", "States,", "will", "yield", "additional", "regulatory", "requirements", "for", "therapeutic", "drugs", "for", "our", "Cytori", "Nanomedicine", "drug", "candidates", "(the", "FDA", "s", "interpretation", "and", "implementation", "of", "the", "CURES", "Act", "has", "yet", "to", "be", "published).", "<tag2>", "The", "restructuring", "reduced", "our", "workforce", "by", "approximately", "50%.", "<tag3>"], "wordsA": ["It", "is", "possible", "that", "the", "new", "legislation", "in", "our", "priority", "markets,", "such", "as", "the", "newly", "enacted", "CURES", "Act", "in", "the", "United", "States,", "will", "yield", "additional", "regulatory", "requirements", "for", "therapeutic", "drugs", "for", "our", "Cytori", "Nanomedicine", "drug", "candidates", "(the", "FDA", "s", "interpretation", "and", "implementation", "of", "the", "CURES", "Act", "has", "yet", "to", "be", "published)."], "wordsB": ["The", "restructuring", "reduced", "our", "workforce", "by", "approximately", "50%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p187_s3", "idA": "1095981_17_item1a_p86_s0", "sentA": "It is possible that the new legislation in our priority markets, such as the newly enacted CURES Act in the United States, will yield additional regulatory requirements for therapeutic drugs for our Cytori Nanomedicine drug candidates (the FDA s interpretation and implementation of the CURES Act has yet to be published).", "sentB": "We requested an additional 180 calendar day compliance period, or until September 4, 2018, to regain compliance and was granted such extension on March 6, 2018.", "type": 1, "words": ["<tag1>", "It", "is", "possible", "that", "the", "new", "legislation", "in", "our", "priority", "markets,", "such", "as", "the", "newly", "enacted", "CURES", "Act", "in", "the", "United", "States,", "will", "yield", "additional", "regulatory", "requirements", "for", "therapeutic", "drugs", "for", "our", "Cytori", "Nanomedicine", "drug", "candidates", "(the", "FDA", "s", "interpretation", "and", "implementation", "of", "the", "CURES", "Act", "has", "yet", "to", "be", "published).", "<tag2>", "We", "requested", "an", "additional", "180", "calendar", "day", "compliance", "period,", "or", "until", "September", "4,", "2018,", "to", "regain", "compliance", "and", "was", "granted", "such", "extension", "on", "March", "6,", "2018.", "<tag3>"], "wordsA": ["It", "is", "possible", "that", "the", "new", "legislation", "in", "our", "priority", "markets,", "such", "as", "the", "newly", "enacted", "CURES", "Act", "in", "the", "United", "States,", "will", "yield", "additional", "regulatory", "requirements", "for", "therapeutic", "drugs", "for", "our", "Cytori", "Nanomedicine", "drug", "candidates", "(the", "FDA", "s", "interpretation", "and", "implementation", "of", "the", "CURES", "Act", "has", "yet", "to", "be", "published)."], "wordsB": ["We", "requested", "an", "additional", "180", "calendar", "day", "compliance", "period,", "or", "until", "September", "4,", "2018,", "to", "regain", "compliance", "and", "was", "granted", "such", "extension", "on", "March", "6,", "2018."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "1095981_18_item1a_p62_s0", "idA": "1095981_17_item1a_p93_s5", "sentA": "These additional requirements could result in additional clinical studies or delays in the regulatory process.", "sentB": "Intas / Accord and INSYS / NeoPharm which previously completed clinical studies of liposomal docetaxel for breast cancer, metastatic pancreatic cancer, metastatic prostate cancer, and solid tumors.", "type": 1, "words": ["<tag1>", "These", "additional", "requirements", "could", "result", "in", "additional", "clinical", "studies", "or", "delays", "in", "the", "regulatory", "process.", "<tag2>", "Intas", "/", "Accord", "and", "INSYS", "/", "NeoPharm", "which", "previously", "completed", "clinical", "studies", "of", "liposomal", "docetaxel", "for", "breast", "cancer,", "metastatic", "pancreatic", "cancer,", "metastatic", "prostate", "cancer,", "and", "solid", "tumors.", "<tag3>"], "wordsA": ["These", "additional", "requirements", "could", "result", "in", "additional", "clinical", "studies", "or", "delays", "in", "the", "regulatory", "process."], "wordsB": ["Intas", "/", "Accord", "and", "INSYS", "/", "NeoPharm", "which", "previously", "completed", "clinical", "studies", "of", "liposomal", "docetaxel", "for", "breast", "cancer,", "metastatic", "pancreatic", "cancer,", "metastatic", "prostate", "cancer,", "and", "solid", "tumors."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
